Patient Protection and Affordable Care Act; Establishment of the Multi-State Plan Program for the Affordable Insurance Exchanges, 15559-15596 [2013-04954]
Download as PDF
Vol. 78
Monday,
No. 47
March 11, 2013
Part III
Office of Personnel Management
mstockstill on DSK4VPTVN1PROD with RULES3
45 CFR Part 800
Patient Protection and Affordable Care Act; Establishment of the MultiState Plan Program for the Affordable Insurance Exchanges; Final Rule
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
PO 00000
Frm 00001
Fmt 4717
Sfmt 4717
E:\FR\FM\11MRR3.SGM
11MRR3
15560
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
OFFICE OF PERSONNEL
MANAGEMENT
45 CFR Part 800
RIN 3206–AM47
Patient Protection and Affordable Care
Act; Establishment of the Multi-State
Plan Program for the Affordable
Insurance Exchanges
U.S. Office of Personnel
Management.
ACTION: Final rule.
AGENCY:
The U.S. Office of Personnel
Management (OPM) is issuing a final
regulation establishing the Multi-State
Plan Program (MSPP) pursuant to the
Patient Protection and Affordable Care
Act, as amended by the Health Care and
Education Reconciliation Act of 2010,
referred to collectively as the Affordable
Care Act. Through contracts with OPM,
health insurance issuers will offer at
least two multi-State plans (MSPs) on
each of the Affordable Insurance
Exchanges (Exchanges). One of the
issuers must be non-profit. Under the
law, an MSPP issuer may phase in the
States in which it offers coverage over
4 years, but it must offer MSPs on
Exchanges in all States and the District
of Columbia by the fourth year in which
the MSPP issuer participates in the
MSPP. This rule aims to balance
adhering to the statutory goals of MSPP
while aligning its standards to those
applying to qualified health plans to
promote a level playing field across
health plans.
DATES: Effective May 10, 2013, except
for § 800.503. OPM will publish a
document announcing the effective date
of § 800.503 in the Federal Register.
SUMMARY:
Note: Section 2719 of the Public Health
Service Act and its implementing regulations
apply to all non-grandfathered group health
plans and health insurance issuers, including
MSPP issuers, with respect to internal claims
and appeals and external review. Because
rulemaking implementing section 2719 has
not yet been completed, the provisions of this
regulation relating to external review
(§ 800.503) will take effect on the effective
date of those regulations.
Julia
Elam by telephone at (202) 606–2128, by
FAX at (202) 606–0033, or by email at
mspp@opm.gov.
SUPPLEMENTARY INFORMATION: The
Patient Protection and Affordable Care
Act (Pub. L. 111–148), as amended by
the Health Care and Education
Reconciliation Act of 2010 (Pub. L. 111–
152), together known as the Affordable
Care Act, provides for the establishment
of Health Insurance Marketplaces, or
Exchanges, in each State, where
mstockstill on DSK4VPTVN1PROD with RULES3
FOR FURTHER INFORMATION CONTACT:
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
individuals and small businesses can
purchase qualified coverage. The
Exchanges will provide competitive
marketplaces for individuals and small
employers to directly compare available
private health insurance options on the
basis of price, quality, and other factors.
The Exchanges will enhance
competition in the health insurance
market, improve choice of affordable
health insurance, and give individuals
and small businesses purchasing power
comparable to that of large businesses.
The U.S. Office of Personnel
Management is issuing this final
regulation to implement section 1334 of
the Affordable Care Act by establishing
the Multi-State Plan Program, as
described below.
Abbreviations
FEHBA Federal Employees Health Benefits
Act (5 U.S.C. 8901 et seq.)
FEHBP Federal Employees Health Benefits
Program
HHS U.S. Department of Health and Human
Services
HMO Health Maintenance Organization
I/T/Us Indian Health Service, tribes and
tribal organizations, and urban Indian
organizations
MSP Multi-State Plan
MSPP Multi-State Plan Program
NAIC National Association of Insurance
Commissioners
OPM U.S. Office of Personnel Management
PHS Act Public Health Service Act
QHP Qualified Health Plan
SHOP Small Business Health Options
Program
Pursuant to its responsibilities under
the Affordable Care Act, the U.S.
Department of Health and Human
Services (HHS) issued regulations
outlining standards to certify Exchanges
and qualified health plans (QHPs) that
will be offered on Exchanges. If a State
does not elect to operate an Exchange or
is not certified (or conditionally
approved) to operate one, HHS will
operate the Exchange in that State.
Section 1334 of the Affordable Care
Act directs the U.S. Office of Personnel
Management (OPM) to establish the
Multi-State Plan Program (MSPP) to
foster competition among plans
competing in the individual and small
group health insurance markets on the
Exchanges. Specifically, section 1334
directs OPM to contract with private
health insurance issuers (one of which
must be non-profit) to offer at least two
multi-State plans (MSPs) on each of the
Exchanges in each State. The law allows
MSPP issuers to phase in coverage, but
coverage must be offered on Exchanges
in all States and the District of Columbia
by the fourth year in which the MSPP
issuer participates in the MSPP. The
first open enrollment period for plans
PO 00000
Frm 00002
Fmt 4701
Sfmt 4700
offered through Exchanges will begin on
October 1, 2013, for coverage starting
January 1, 2014.
The purpose of this regulation is to
outline the process by which OPM will
establish and administer the MSPP, as
well as to establish standards and
requirements for MSPs and MSPP
issuers.
Summary of Comments
On December 5, 2012, OPM published
proposed regulations (77 FR 72582)
establishing the MSPP at part 800 of
title 45, Code of Federal Regulations.
The comment period for the proposed
rule closed on January 4, 2013. OPM
received about 350 comments from a
wide variety of entities and individuals.
A summary of the comments we
received follows, along with our
responses to the comments and changes
we are making to the proposed
regulations in light of the comments. In
addition, we are making some minor
technical and editorial changes to the
proposed regulations to correct errors
and improve clarity and readability.
Responses to Overarching Comments
Of the approximately 350 comments
we received on the proposed rule, about
105 were unique comment letters. Many
of the others were form letters,
including letters requesting an
extension of the comment period.
A broad range of stakeholders
commented on the proposed regulation,
including 14 States and the National
Association of Insurance Commissioners
(NAIC). We also received comments
from about a dozen health insurance
issuers, group health plans, and their
associations. Most of the remaining
comments came from health care
providers, pharmaceutical companies,
business groups, labor unions, and
consumer groups.
Length of the Comment Period
We received many comments about
the 30-day comment period and
whether we would extend it. Some
commenters contended that the 30-day
comment period did not provide
sufficient time to provide feedback.
Our comment period is consistent
with the Administrative Procedure Act
and Executive Orders 12866 and 13563.
OPM values the participation of a broad
array of diverse stakeholders, and we
have succeeded in obtaining that
participation, as evidenced by the
volume of comments as well as the
diversity of viewpoints offered in
response to our proposed regulation.
Moreover, OPM has provided several
other opportunities for public input on
policies relating to the MSPP. On June
E:\FR\FM\11MRR3.SGM
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
16, 2011, OPM issued a Request for
Information (RFI) to solicit feedback
from stakeholders about the program.
On September 21, 2012, OPM issued a
draft MSPP application and received
public comments over a 30-day period.
OPM has also held meetings and phone
calls with numerous stakeholders to
seek input and guidance, including from
the NAIC, States, tribal governments,
consumer advocates, health insurance
issuers, labor organizations, provider
associations, and trade groups.
mstockstill on DSK4VPTVN1PROD with RULES3
Church Plans
One commenter urged OPM to
consider entering into an MSPP contract
with a church plan. The commenter
explained that church plans are defined
in various sections of the law, including
section 414(e) of the Internal Revenue
Code and section 3(33) of the Employee
Retirement Income Security Act
(ERISA). A church plan does not, by
itself, meet the definition of health
insurance issuer in section 2791(b)(2) of
the PHS Act; in addition, enrollment is
limited to church employees and
members of the clergy. The commenter
interpreted section 1334 of the
Affordable Care Act as allowing OPM to
contract with church plans to offer
coverage through the MSPP. First, the
commenter stated that, while section
1334(a)(1) provides that the Director
shall enter into contracts for MSPs with
health insurance issuers, it does not
expressly preclude OPM from entering
into contracts with entities other than
issuers. The commenter asserted that
church plans should be considered
eligible to contract for an MSP because
OPM can treat a church plan as
equivalent to an issuer under the
Church Parity and Entanglement
Protections Act, Public Law 106–244
(‘‘Parity Act’’). The commenter
recommended that OPM could exercise
its discretion to exempt church plans
from a number of requirements for
MSPs, including permitting a church
plan MSP to limit enrollment to
members of the clergy and church
employees.
We disagree with the commenter’s
interpretation of section 1334 and do
not believe that a church plan meets the
requirements necessary for OPM to offer
such a plan under an MSPP contract.
Section 1334(a)(1) explicitly requires
OPM to enter into contracts for MSPs
with ‘‘health insurance issuers,’’ and we
do not agree that the statute authorizes
OPM to enter into contracts with
entities other than health insurance
issuers. Because church plans, by
themselves, do not meet the definition
of health insurance issuers as described
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
above, OPM does not have the authority
to contract for them under § 1334.
Responses to Comments on the
Regulations
Subpart A—General Provisions and
Definitions
Basis and Scope (§ 800.10)
OPM proposed this section to define
the basis and scope of part 800, which
establishes the primary authority for the
establishment of the MSPP under the
Affordable Care Act. Other relevant
statutory provisions MSPP issuers and
MSPs must comply with include all
provisions of part A of title XXVII of the
Public Health Service (PHS) Act.
Section 800.10 also sets forth the scope
of this regulation, which establishes
standards for health insurance issuers
wishing to contract with OPM to
participate in the MSPP and for the
appeals processes for both MSPP issuers
and enrollees.
We received no comments on § 800.10
as proposed. Accordingly, we are
adopting it as final, with no changes.
Definitions (§ 800.20)
In § 800.20, OPM proposed
definitions for terms that are used
throughout part 800. In general, the
definitions contained in § 800.20 come
from the following sources: title I of the
Affordable Care Act and the final
Exchange regulation at 45 CFR parts
155, 156, and 157; title XXVII of the
PHS Act and the regulations at 45 CFR
part 144; and the Federal Employees
Health Benefits Act (FEHBA) at chapter
89 of title 5, United States Code, and the
regulations governing the Federal
Employees Health Benefits Program
(FEHBP) at 5 CFR part 890 and 48 CFR
1609.70. Some new definitions were
created for the purpose of implementing
the MSPP. The application of the terms
defined in this section is limited to this
final rule.
OPM proposes definitions for several
terms based on three HHS regulations.
First, HHS published an Essential
Health Benefits (EHB) final rule in the
Federal Register on February 25, 2013,
to provide standards related to EHB,
actuarial value (AV), and accreditation.
Second, HHS published a final rule in
the Federal Register on February 27,
2013, to provide standards related to fair
health insurance premiums, guaranteed
availability, guaranteed renewability,
risk pools, and rate review (the health
insurance market rules). Third, HHS
published a final rule elsewhere in
today’s edition of the Federal Register,
to provide notice of standards relating to
benefit and payment parameters for
2014, including standards related to
PO 00000
Frm 00003
Fmt 4701
Sfmt 4700
15561
advance payments of the premium tax
credit and cost-sharing reductions (the
payment rule). OPM is using the
definitions promulgated by HHS.
Comments: OPM received several
comments recommending changes in
the definitions in proposed § 800.20. A
few commenters expressed concern
with how OPM plans to operationalize
the definition of ‘‘Indian.’’ Specifically,
the commenters suggested that OPM
adopt the definition at 42 CFR 447.50
and not use the definition at 45 CFR
155.300(a) as we proposed. OPM was
also asked to correct the definition of
‘‘Indian Plan Variation,’’ which
currently cross references 45 CFR
156.400, so that there is no confusion
regarding eligibility of Indians for zerocost-sharing and variable cost-sharing
plan variations.
Response: While the terms ‘‘Indian’’
and ‘‘Indian Plan Variation’’ were
introduced in the proposed rule,
referencing 45 CFR 155.300(a) and 45
CFR 155.400, respectively, we are
removing them from the final rule, as
they are not used elsewhere in the rule.
Comments: A few commenters noted
that OPM should not exclude policies
and contracts from the ‘‘benefit plan
material or information’’ definition.
Two commenters said that we should
not exclude policies and contracts from
the definition, because including them
in the scope of the regulation could be
helpful to limited-English-proficient
(LEP) individuals in making effective
decisions.
One commenter wanted us to clarify
that a provider directory falls within the
definition of ‘‘benefit plan material or
information.’’
Response: We are adopting the
proposed definition of ‘‘benefit plan
material or information.’’ The term, as
defined, includes explanations or
descriptions, whether printed or
electronic, that describe a health
insurance issuer’s products. The term
does not include a policy or contract for
health insurance coverage. As it does in
the FEHBP, OPM will review and
approve the policy or contract for health
insurance coverage. Such approval is
necessary for effective contract
administration and oversight. We agree
that a provider directory does fall
within the scope of the definition.
Comment: One commenter suggested
that introducing a second prong to the
definition of ‘‘group of issuers’’—to
include ‘‘an affiliation of health
insurance issuers and an entity who is
not an issuer but who owns a nationally
licensed service mark’’—would expand
the authority granted under section
1334 of the Affordable Care Act. The
commenter recommended that we not
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15562
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
expand the definition of ‘‘group of
issuers’’ to include entities not
identified in the Affordable Care Act as
potential participants in the MSPP.
Response: Section 1334 does not
define ‘‘group of issuers,’’ but only
provides examples of affiliations of
health insurance issuers that may be
considered health insurance issuers.
Thus, OPM, in the exercise of its
discretion, and within the parameters
set by section 1334, has established a
definition that we believe affords
flexibility in terms of the types of
entities with which OPM may contract.
In addition, this definition, which
attempts to encompass a diversity of
contractual arrangements similarly
available to OPM under the FEHBP,
promotes the goals of section 1334(a) of
the Affordable Care Act, which directs
OPM to implement the MSPP in a
manner similar to the manner in which
we implement the contracting
provisions with respect to carriers under
the FEHBP. As we noted in the
proposed rule, this definition of ‘‘group
of issuers’’ is applicable only for the
purposes of section 1334.
Comment: One commenter
recommended that OPM revise the
definition of ‘‘non-profit entity’’ to
exclude the portion of the definition
that states a non-profit entity may also
be, for purposes of the MSPP, ‘‘a group
of health insurance issuers licensed
under State law a substantial portion of
which are incorporated under State law
as non-profit entities,’’ as this would
further reduce competition in a State
where a ‘‘for-profit’’ issuer may already
have a significant market share.
Response: We are adopting the
proposed definition of ‘‘non-profit
entity.’’ This definition is consistent
with the manner in which OPM
implements the contracting provisions
with respect to carriers under the
FEHBP and builds on our significant
experience in contracting with and
overseeing carriers under that program.
Comment: Another commenter
recommended amending the definitions
of ‘‘multi-State plan (MSP)’’ and ‘‘MultiState Plan Program issuer (MSPP
issuer)’’ to clarify whether each MSP
will be under separate contract with
OPM or will contract through the MSPP
issuer.
Response: OPM is revising the
definition of ‘‘MSP’’ to clarify that an
MSP is offered under contract with
OPM via an MSPP issuer.
Comment: A commenter suggested
that OPM broaden the definition of
‘‘State Insurance Commissioner’’ to
acknowledge the potential for multiple
regulatory roles in a State.
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
Response: We understand the
commenter’s concern and acknowledge
the possibility of multiple regulatory
roles in some States, but we are
retaining the proposed definition. This
term is a standard term that is
understood in the industry; therefore,
we decline to amend the definition. Our
definition of ‘‘State Insurance
Commissioner’’ aligns with the
definition used in many of the model
acts issued by the National Association
of Insurance Commissioners (NAIC) to
ensure consistency with definitions
widely used by State insurance
regulatory entities.
Subpart B—Multi-State Plan Program
Issuer Requirements
General Requirements (§ 800.101)
Section 800.101 of the proposed rule
sets forth standards to implement
§ 1334(b) of the Affordable Care Act.
The general requirements include
licensure, a contract with OPM,
required levels of coverage, eligibility
and enrollment, compliance with OPM
direction and other legal requirements.
In § 800.101(i), we also proposed that an
MSPP issuer must comply with
applicable non-discrimination statutes
and ensure that their MSPs do not
discriminate based on race, color,
national origin, disability, age, sex,
gender identity, or sexual orientation.
We sought comment on any unique
enrollment and eligibility issues that
might affect MSPs. A broad spectrum of
consumer and professional
organizations commented on this
provision.
Comments: Many commenters
support OPM’s intent to include nondiscrimination provisions, but
recommended adding specific
additional language to strengthen these
protections, including clarifying nondiscrimination based on sex or gender
identity.
Some commenters requested that
OPM add specific non-discrimination
language in § 800.101(d) that describes
the MSP and MSPP issuer
responsibilities for eligibility and
enrollment. The specific suggestion was
to notify MSPP issuers that benefit
packages must be ‘‘substantially equal’’
to EHB benchmarks and not include any
discriminatory benefit design elements
as defined under 45 CFR 156.125.
Response: In response to comments,
we are revising § 800.101(i) of this final
rule to ensure consistency with the
prohibition on discrimination with
respect to EHB in 45 CFR 156.125 and
the non-discrimination standards
applicable to QHPs under 45 CFR
156.200(e). With regard to defining EHB
PO 00000
Frm 00004
Fmt 4701
Sfmt 4700
benchmarks, we have determined that
these comments are outside the scope of
this rule. These standards are governed
by HHS regulations.
Comments: Some commenters
suggested that certain health care
providers be included as protected
categories for non-discrimination, and
one commenter wanted MSPP issuers
and MSPs to align their payment
systems to comply with State and
Federal non-discrimination provisions.
Response: The broad prohibition on
discrimination in § 800.101(i) clearly
bars discrimination against certain
health care providers of the MSPP
issuer. Similar comments were
addressed in § 800.109, concerning
health providers and network adequacy.
We are concerned that specifying types
of providers who are protected from
discrimination would detract from the
larger issue of broadly ensuring access
to the full range of covered services.
Accordingly, no further change in
proposed § 800.101(i) is needed to
address this concern.
Comments: A few commenters
recommended that OPM expressly
clarify in § 800.101(i) that the Indian
Health Service, tribes and tribal
organizations, and urban Indian
organizations (collectively, I/T/Us) are
not violating the non-discrimination
requirements if they limit their services,
in whole or part, to American Indians/
Alaska Natives.
Response: An MSPP issuer would not
violate the non-discrimination
requirements by contracting with health
care providers who are authorized or
directed by law to serve specific
populations, such as Indian health
providers. We note that an MSPP issuer
must meet all standards related to
network adequacy and essential
community providers specified in
§ 800.109 and 45 CFR 156.235,
respectively.
Comments: A few commenters stated
that OPM should clarify that MSPs and
MSPP issuers must comply with any
consumer protections and regulatory
procedures a State or Exchange has put
in place.
Response: As explained in our
proposed regulation, MSPs and MSPP
issuers are generally required to comply
with applicable State law. This would
include the application of stronger
protections in the Exchange provided by
State law, as long as application of those
provisions to the MSPP is consistent
with the Affordable Care Act. We
received no comments to indicate that
the consumer protections applicable to
the MSPP are any weaker than those
required by any State or Exchange. On
the contrary, OPM intends to protect
E:\FR\FM\11MRR3.SGM
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
consumers through its administration of
the MSPP in a manner similar to the
manner in which it has protected
enrollees in the FEHBP for more than 50
years. In any event, if there are specific
consumer protections and regulatory
procedures that go above and beyond
Federal standards, OPM encourages
States to identify them so OPM can
consider and address them through a
memorandum of understanding (MOU)
with the State and, if appropriate, in its
contracts with issuers.
Comments: A few commenters asked
how OPM will work with active
purchasing Exchanges and
recommended that OPM incorporate a
‘‘do no harm’’ objective in the preamble.
Response: We will retain our current
language and decline to incorporate a
‘‘do no harm’’ provision, as such a
provision would be vague and
ambiguous. Instead, we will maintain
our approach of applying standards that
neither competitively advantage nor
disadvantage MSPs and MSPP issuers.
Comment: One commenter stated that
OPM should require MSPP issuers to
meet standards for certification and
licensing prior to signing a contract with
OPM for MSPs in the State.
Response: Section 800.101 clearly
provides that an MSPP issuer must be
licensed as a health insurance issuer in
each State where it offers health
insurance coverage, and it is deemed
certified by OPM when it signs a
contract with OPM.
mstockstill on DSK4VPTVN1PROD with RULES3
Compliance With Federal law
(§ 800.102)
Proposed § 800.102 specifies the
Federal laws with which MSPP issuers
must comply as a condition of
participation in the MSPP. Paragraph (a)
refers to applicable provisions of title
XXVII of the PHS Act, while paragraph
(b) refers to applicable provisions of title
I of the Affordable Care Act.
In this final rule, paragraphs (a) and
(b) no longer refer to Appendix A and
B, respectively, which in the proposed
rule listed specific provisions of title
XXVII of the PHS Act and title I of the
Affordable Care Act. We are omitting
these appendices because, although the
statutes listed in those appendices do
apply to MSPP issuers, they may not
necessarily be a comprehensive list of
all applicable statutes. Also, it is
possible that the list of statutes in the
appendices may change over time.
We are also omitting Appendix C in
this final rule, because § 36B of the
Internal Revenue Code does not set forth
responsibilities of issuers.
Comments: Commenters suggested
that OPM had erroneously neglected to
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
include section 2716 of the PHS Act and
section 1312 of the Affordable Care Act.
Response: MSPP issuers that choose
to participate in the Small Business
Health Options Program (SHOP) will
operate under the same rules as issuers
of health insurance coverage in the
small group market generally. OPM
agrees that section 1312 of the
Affordable Care Act applies to MSPP
issuers.
Comments: A few commenters noted
that we listed section 2707 of the PHS
Act in Appendix A to the proposed rule,
which listed PHS Act provisions
applicable to MSPs, and asked OPM to
clarify that the PHS Act requirements
were applicable solely to the offExchange markets and would not apply
to MSPP issuers for products sold
through an Exchange.
Response: While all the requirements
applicable to QHP issuers contained in
section 2707 are also contained in
requirements applicable to QHPs, they
also apply directly.
Authority To Contract With Issuers
(§ 800.103)
As provided in section 1334(a)(1) of
the Affordable Care Act, OPM proposed
in § 800.103 that it may enter into an
MSPP contract with a group of issuers
affiliated either by common ownership
and control or by the use of a nationally
licensed service mark, or an affiliation
of health insurance issuers and an entity
that is not an issuer but that owns a
nationally licensed service mark.
We received no substantive comments
on this section. Accordingly, we are
adopting proposed § 800.103 as final,
with no changes.
Phased Expansion (§ 800.104)
In § 800.104, we proposed phased
expansion of the MSPP into States and
that MSPP issuers may provide partial
coverage within a State. We also
proposed that MSPP issuers must be
licensed in the State where they offer
coverage and OPM may enter into a
contract with an issuer that is not
licensed in all States. We stated in the
preamble of the proposed regulation
that § 800.104 implements provisions of
section 1334(e) of the Affordable Care
Act regarding the phase-in of multiState plans. OPM proposed in
§ 800.104(b) that MSPP issuers offering
MSPs can offer coverage in part of a
State, and do not have to offer coverage
throughout the entire State. We also
solicited comment on whether an MSPP
issuer should be required to offer
coverage statewide by the fourth year of
participation in the MSPP, when
coverage must be offered in each
PO 00000
Frm 00005
Fmt 4701
Sfmt 4700
15563
Exchange in all States and the District
of Columbia.
Comments: Several commenters
expressed support for phased expansion
into States. Another commenter stated
that a multi-year phase-in process will
allow MSPs to build appropriate
networks and partnerships to satisfy the
requirements of the Affordable Care Act
and satisfy the needs of the citizens of
each State. One commenter stated that
MSPP issuers should be required to
offer coverage on each Exchange in all
States and the District of Columbia as
soon as possible or in as many States as
possible. Another commenter
recommended an extension of the
phase-in period to 6 years instead of a
4-year phase-in.
Response: We are retaining the
standards that are outlined in section
1334(e) of the Affordable Care Act.
However, we have removed from the
regulatory text the number of States that
an issuer must phase into because
section 1334(e) refers to percentages and
not specific numbers. We believe the
phased expansion approach into States
will encourage MSPP issuers to expand
MSPs to provide more consumer choice
throughout the country. It is our
intention to ensure that MSPP issuers
have appropriate networks to
adequately serve MSP enrollees, and we
will take these comments into
consideration when we are evaluating
potential MSPP issuers.
Comment: One commenter was
concerned that MSPP issuers will
subcontract to meet the phase-in
requirements and that these will
encourage ‘‘marriages of convenience.’’
Response: Section 1334 permits OPM
to contract with health insurance issuers
and entities that come together in order
to apply as an MSP issuer. We
encourage any such new entities to give
careful thought and planning to their
strategies for phasing in coverage to the
States and the District of Columbia, and
we will ensure through our application
review and contracting process that
these entities are prepared to offer
quality health insurance options in the
States for which they are applying.
Comment: One commenter
recommended that OPM should require
licensure in all jurisdictions by the end
of the phase-in.
Response: We have adequately
addressed the licensure requirement in
§ 800.104(c). As stated in that section,
OPM may enter into a contract with an
MSPP issuer that is not licensed in
every State, provided that the issuer is
licensed in every State where it offers
MSP coverage through any Exchanges in
that State and demonstrates to OPM that
it is making a good-faith effort to
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15564
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
become licensed in every State,
consistent with the timeframe for the
phase-in.
Comments: We received many
comments on whether OPM should
have a role in selecting the States in
which MSPP issuers should or should
not offer coverage during phased
expansion. Several commenters
recommended that OPM not specify
which States an MSPP issuer must cover
in the first year. Other commenters
recommended that OPM should
consider slow-tracking implementation
of the MSPP in certain States and
granting these States waivers from
participation. Another commenter
suggested that OPM limit MSPP issuers
to offering MSPs in States that will have
Federally-facilitated Exchanges or State
Partnership Exchanges in 2014. One
commenter suggested that OPM focus
the phase-in on States where consumers
lack viable coverage options.
Response: OPM declines to identify
specific States that MSPP issuers should
cover during phased expansion. We
recognize the importance of providing
consumers with more health insurance
coverage options and, while we will not
choose specific States where MSPP
issuers must provide coverage during
the phase-in, we will use our oversight
and contract negotiation roles to provide
consumers with the additional choice of
two high-quality health insurance plans
and promote competition on the
Exchanges.
Comments: One commenter
supported OPM’s proposal that OPM
may enter into contracts with issuers
that cannot provide statewide coverage
and stated that it will give MSPP issuers
time to develop the capacity to offer
coverage throughout a service area,
which will enhance competition in the
MSPP. Several commenters appreciated
that issuers failing to offer statewide
coverage must propose a plan for
becoming statewide, but expressed that
without more specificity American
Indians/Alaska Natives will not be able
to access MSPs.
Response: We acknowledge the
importance of access to health coverage
and MSPs, especially in rural and
underserved areas. However, we are
providing in the final regulation that
OPM may enter into a contract with an
MSPP issuer that will provide partial
coverage within a State. We recognize
the challenges that issuers would face if
there were a requirement to offer
coverage statewide, and we were made
aware of these challenges from issuers
in the MSPP Request for Information as
well as comments on the proposed rule.
However, we are maintaining in the
final rule our proposed requirement for
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
MSPP issuers who are offering partial
coverage in a State to supply a plan for
offering coverage throughout the State.
As we review MSPP issuer applications,
we will pay special attention to service
areas that are medically underserved,
such as rural areas and American
Indian/Alaska Native populations. We
intend to encourage issuers to offer
coverage statewide where they have
capacity to do so, and will take these
comments into consideration when
negotiating MSPP contracts.
Comments: Several commenters
wanted clarification of phased
expansion in terms of MSPs being able
to meet network adequacy standards.
One commenter recommended that
MSPP issuers not be permitted to offer
MSPs in a State unless the plan is
capable of offering coverage to all
residents of a State, including meeting
network adequacy standards throughout
the State, to avoid selective coverage by
issuers.
Response: While we appreciate the
concern for network adequacy, we
decline to set a standard of phased
expansion and statewide coverage in
terms of network adequacy. We believe
that network adequacy is sufficiently
addressed in § 800.109 to ensure that an
MSP’s services are available to all
enrollees.
Comments: Many commenters were
concerned by our proposal to allow
partial coverage within a State. Some
stated that MSPP issuers should be
required to comply with all State
requirements regarding geographic
scope of coverage that apply to QHPs.
One commenter recommended that
MSPs follow specific State standards for
statewideness. Some commenters stated
that, without a requirement of
statewideness, there is a possibility of
red-lining by MSPP issuers or adverse
selection resulting in MSPP issuers
avoiding certain populations.
Commenters were also concerned about
market dislocation. One commenter
stated that MSPP issuers would be able
to avoid offering coverage in rural and
other high-cost areas, which would give
them a competitive advantage over both
QHP issuers and issuers not offering on
an Exchange. Lastly, one commenter
stated that a core purpose of the MSPP
is to benefit individuals who lack
options, and allowing issuers to avoid
certain difficult areas in a State
contradicts this basic purpose. One
commenter suggested that we include
language indicating that we will consult
with State regulators and the State
Exchange in determining that MSP
coverage does not exclude specific highutilizing, high-cost, or medicallyunderserved populations.
PO 00000
Frm 00006
Fmt 4701
Sfmt 4700
Response: We are not prohibiting
MSPP issuers from being statewide; on
the contrary, we encourage them to do
so from the start if they have the
capacity. MSPP issuers should follow
State laws regarding statewideness to
the extent it is within their capability to
do so. In addition, we are finalizing this
regulation with the requirement for an
MSPP issuer to provide a plan for
expanding coverage statewide.
Furthermore, we intend to address an
MSPP issuer’s ability to expand
coverage statewide as part of the MSPP
application and contract negotiation
processes. We acknowledge the
commenters’ concern for red-lining and
other ‘‘cherry-picking’’ practices where
an issuer might offer plans only in
geographic areas that are expected to
have lower risk. Therefore, we will
evaluate MSPP issuers to ensure that the
locations in which they propose to offer
MSP coverage have been established
without regard to racial, ethnic,
language, health-status-related factors
listed in section 2705(a) of the PHS Act,
or other factors that exclude specific
high-utilizing, high-cost, or medicallyunderserved populations. We agree that
a core purpose of the MSPP is to
provide additional choice of health
insurance plans and promote
competition on the Exchanges, and
MSPP issuers should not be permitted
to avoid areas in a State that are difficult
to serve. We are aware of these concerns
and are committed to MSPP issuers
being neither competitively advantaged
nor disadvantaged, compared to QHP
issuers.
OPM proposed that, by the end of the
phase-in period, MSPP issuers should
be required to offer coverage on the
SHOP in addition to the individual
Exchange. We solicited comments on
this approach to SHOP participation,
including on whether participation in
SHOP should be required from the
outset or whether we should allow
MSPP issuers to provide a plan that
requires a period longer than the phasein period to fully participate in the
SHOP. We received comments on the
phase-in to SHOPs from States, an
issuer association, and professional
organizations.
Comments: Several commenters
supported our approach of allowing
MSPP issuers the flexibility to phase-in
to SHOPs. One commenter asked that
OPM clarify whether the statement in
the preamble that the ‘‘MSPP issuer may
choose to participate in the SHOP’’ is a
proposal to phase-in MSPP issuer
coverage in the SHOP. Some
commenters were concerned that MSPs
will have a competitive advantage if
they are not required to follow the same
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
rules as the Federally-facilitated
Exchange and State requirements for
QHPs to offer coverage in both the
individual and SHOP markets. One
commenter noted that OPM’s approach
presents a significant challenge, since it
has merged markets. Some commenters
would like OPM to require participation
in the SHOP from the outset or require
full participation in the SHOP at the
fourth year of phase-in.
Response: We appreciate the support
for our approach of allowing MSPP
issuers the flexibility to phase-in
coverage to the SHOPs, which was
discussed in the preamble of the
proposed rule, though not addressed in
the regulatory text. Based on the policy
for Federally-facilitated SHOP
participation published in the HHS
Payment Notice, we are finalizing our
regulation to require MSPP issuers to
comply with 45 CFR 156.200(g). In the
HHS Payment Notice, HHS adopted a
provision stating that a QHP issuer
applicant will participate in a Federallyfacilitated SHOP based on an issuer
applicant’s current small group market
share. The provision uses a threshold of
20 percent market share to determine
whether a small group market issuer is
subject to the tying provision for QHPs
in the Federally-facilitated SHOPs. For
the MSPP, we believe this standard for
the Federally-facilitated SHOP can be
met if a State-level MSPP issuer or any
other issuer in the same issuer group
affiliated with an MSPP issuer provides
coverage on the Federally-facilitated
SHOP.
In this final rule, we adopt a policy
for the MSPP that mirrors the standard
set by HHS for the Federally-facilitated
SHOP. We also adopt a policy for SHOP
participation on State-based Exchanges
that is consistent with our approach to
State law under § 800.114 while
retaining OPM discretion on timing of
MSPP issuers to participate in the
SHOP. For State-based SHOPs, we will
permit an MSPP issuer flexibility to
phase-in participation in the SHOP if
the State has set a standard that requires
QHPs to participate. We understand the
burden of building capacity and
network in order to offer in the SHOPs
and want to balance the needs of small
employers, MSPP issuers, and States.
We believe section 1334(e) provides
OPM discretion to allow an MSPP issuer
to phase-in SHOP participation in States
that require participation and this
flexibility meets the needs of many
stakeholders. Therefore, we are
finalizing regulatory text in § 800.104(c)
that requires MSPP issuers to comply
with standards in 45 CFR 156.200(g)
and with State standards for SHOP
participation, subject to § 800.114, and
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
gives OPM discretion to provide MSPP
issuers flexibility during the initial
years of the program to phase into the
SHOP in a State-based Exchange. We
also clarify that an MSPP issuer must
offer coverage for both individuals and
small groups in a State with a merged
individual and small group market. We
encourage MSPP issuers to expand
coverage in States and SHOPs when
they have adequate capacity to accept
enrollees.
Benefits (§ 800.105)
In § 800.105, OPM proposed to
implement section 1334(c)(1)(A) of the
Affordable Care Act, which directs an
MSP to offer a benefits package that is
uniform in each State and consists of
the EHB described in section 1302 of the
Affordable Care Act. OPM developed its
benefits policy in coordination with
HHS, which promulgated the EHB rule.
Generally, under that rule, EHB would
be defined by a benchmark plan
selected by each State or, in the absence
of a State benchmark designation, a
default benchmark. However, the EHB
rule also states at 45 CFR 156.105 that
MSPs must meet benchmark standards
set by OPM.
In § 800.105(a)(1), OPM proposed that
an MSPP issuer must offer a uniform
benefits package for each MSP and that
the benefits for each MSP must be
uniform within a State, but not
necessarily uniform among States. In
§ 800.105(a)(2), OPM proposed that the
benefits package referred to in
§ 800.105(a)(1) must comply with
section 1302 of the Affordable Care Act,
as well as any applicable standards set
by OPM or HHS in regulations.
Together, these provisions clarify that
MSPP issuers must comply with
applicable HHS requirements and that
OPM may issue additional guidance
regarding any issues unique to MSPs.
In § 800.105(b)(1), OPM proposed
allowing MSPP issuers to offer a
benefits package, in all States, that is
substantially equal to either (1) each
State’s EHB-benchmark plan in each
State in which it operates; or (2) any
EHB-benchmark plan selected by OPM.
The second option offers administrative
efficiencies for MSPP issuers, who face
a number of challenges in being able to
offer MSPs on each Exchange in all
States and the District of Columbia. We
also noted in our proposed rule that
MSPP issuers could potentially achieve
a similar consistency in their benefits
offerings by adhering to State EHBbenchmark plans and applying the EHB
substitution rules at 45 CFR 156.115.
Comments: We received many
comments on the proposed EHBbenchmark policy from a broad range of
PO 00000
Frm 00007
Fmt 4701
Sfmt 4700
15565
stakeholders. Many commenters argued
that the proposed policy would lead to
adverse selection or consumer
confusion. Some commenters argued
that the proposed policy would also
constitute Federal preemption of State
authority to regulate insurance. At least
one commenter said that the proposed
policy would lead to administrative
complexities and inefficiencies. Finally,
some commenters preferred to have
only a national benchmark.
Some commenters noted that
differences between an OPM-selected
benchmark and State-selected
benchmark are unlikely to be actuarially
significant. Some commenters also
noted that the proposed policy would
encourage issuers to participate in the
MSPP. Other commenters also noted
that OPM-selected benchmarks would
provide robust prescription drug
coverage, obesity treatment services,
medical nutrition therapy, pediatric
services, and chiropractic care.
Response: We agree with commenters
who noted that the differences between
an OPM-selected benchmark and Stateselected benchmark are unlikely to be
actuarially significant. We are not aware
of any compelling evidence that
multiple benchmarks would lead to
adverse selection or consumer
confusion, nor did the commenters
produce any evidence of adverse
selection or consumer confusion.
Accordingly, we are adopting as final
the proposed provision to allow an
MSPP issuer to offer a benefits package
in all States that is substantially equal
to either the EHB-benchmark plan in
each State in which it proposes to offer
an MSP or any EHB-benchmark plan
selected by OPM.
Comments: Several commenters
discussed the need for national MSPs
for American Indians/Alaska Natives.
Response: We acknowledge that
consistency among States would be
helpful for I/T/Us that may consider
purchasing plans for tribes that are in
multiple States. Members of tribes
would still need to access the Exchanges
in their States to determine their
eligibility and enrollment for products
available through the Exchange,
including an MSP. While the MSPP is
not a national plan, reciprocity of
coverage among MSPs in States is an
issue we intend to take up in contract
negotiations with MSPP issuers. We
look forward to conferring with tribes
on this approach and engaging them in
how the MSPP may best meet their
needs.
Comments: Several commenters asked
us to eliminate or provide additional
guidance regarding the ‘‘substantially
equal’’ standard.
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15566
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
Response: Because HHS is defining
the standard for the term ‘‘substantially
equal,’’ we expect MSPP issuers to
follow HHS guidance relating to this
term.
OPM also proposed that even if an
MSPP issuer chooses to use an EHBbenchmark plan selected by OPM in all
States, the MSPP issuer must still use a
State-selected benchmark in States that
do not allow any substitution for
services within the benchmark benefits.
The reason for this is if an MSPP issuer
were to use an OPM-selected benchmark
in States that require all plans to offer
the same set of benefits, then the MSP
in that State would be different from all
of the other plans offered on the market,
which could potentially lead to market
disruption, adverse selection, or
consumer confusion could occur.
Comments: Many commenters
supported the policy that OPM-selected
benchmarks and substitutions not be
allowed in States having standard
benefit designs.
Response: We are adding a paragraph
(b)(3) to § 800.105 to clarify that an
MSPP issuer must comply with any
State standards relating to substitution
of benchmark benefits or standard
benefit designs. Accordingly, in a State
that does not allow substitution of
benchmark benefits, or that has standard
benefit designs, an MSPP issuer that has
chosen to use an OPM-selected EHBbenchmark plan under paragraph
(b)(2)(ii) must use the State’s EHBbenchmark plan.
No matter which option an MSPP
issuer chooses, it must apply that option
uniformly in each State in which the
MSPP issuer proposes to offer MSPs.
This means that, except as discussed
above, our approach will not permit an
issuer to use a State benchmark plan in
some States in which it operates and an
OPM-chosen benchmark plan in others.
In § 800.105(c)(1), OPM proposed
selecting, as EHB-benchmark plans, the
three largest FEHBP plan options by
enrollment that are open to Federal
employees and annuitants, which were
identified by HHS pursuant to section
1302(b) of the Affordable Care Act. On
July 3, 2012, HHS identified the three
largest FEHBP plan options (as of March
31, 2012) as Blue Cross Blue Shield
(BCBS) Standard Option; BCBS Basic
Option; and Government Employees
Health Association (GEHA) Standard
Option.1 An MSPP issuer that selects
one of these benchmarks must offer this
1 Centers for Medicare and Medicaid Services,
Essential Health Benefits: List of the Largest Three
Small Group Products by State, available at
https://cciio.cms.gov/resources/files/largestsmgroup-products-7-2-2012.pdf.PDF (July 3, 2012).
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
benefits package in all States in which
it operates an MSP.
Several commenters urged OPM to be
judicious in evaluating all proposed
benchmarks. Based on initial
comparative research, it appears that the
proposed OPM-selected EHBbenchmark plans are largely similar in
scope of benefits covered to those
benchmark-eligible plans in the small
group markets.2 This research also
indicates that the OPM-selected EHBbenchmark plans, like other benchmarkeligible plans, may lack coverage for
pediatric oral services, pediatric vision
services, and habilitative services and
devices. Moreover, the EHB-benchmark
may also lack State-required benefits.
Accordingly, OPM proposed standards
to supplement the OPM-selected EHBbenchmark plans in § 800.105(c)(2)–
(c)(4).
In § 800.105(c)(2), we proposed that
any OPM-selected EHB-benchmark plan
lacking coverage of pediatric oral
services or pediatric vision services
must be supplemented by the addition
of the entire category of benefits from
the largest Federal Employee Dental and
Vision Insurance Program (FEDVIP)
dental or vision plan option,
respectively, pursuant to 45 CFR
156.110(b) and section 1302(b) of the
Affordable Care Act. On July 3, 2012,
HHS identified the largest FEDVIP
dental and vision plan options, as of
March 31, 2012, to be, respectively,
MetLife Federal Dental Plan High
Option and FEP BlueVision High
Option.
We also solicited comments on the
provision of pediatric oral services by
MSPs in order to meet the requirements
of section 1302(b)(1)(J) of the Affordable
Care Act. Under one proposed
approach, an MSP would include
pediatric oral services in its benefit
package. Finally, we solicited comments
on how stand-alone dental plans offered
on the Exchanges should affect this
requirement, if at all.
Comments: While some commenters
favored offering stand-alone dental
plans, others expressed concern that the
expense of separate out-of-pocket
maximums might discourage families
from purchasing separate coverage for
pediatric oral services. Some
commenters proposed to require all
MSPs to offer both a complete medical
package and an identical plan without
pediatric oral services in areas where
2 U.S. Department of Health and Human Services,
Office of the Assistant Secretary for Planning and
Evaluation, ASPE Research Brief, Essential Health
Benefits: Comparing Benefits in Small Group
Products and State and Federal Employee Plans,
available at https://aspe.hhs.gov/health/reports/
2011/MarketComparison/rb.pdf (December 2011).
PO 00000
Frm 00008
Fmt 4701
Sfmt 4700
stand-alone pediatric dental coverage is
available.
Response: Given the range of possible
benefit designs, we are not promulgating
any further regulatory provisions
regarding coverage of pediatric oral
services. Instead, we will keep these
comments in mind during MSPP
contract negotiations, which would
allow greater flexibility on benefit
designs.
In § 800.105(c)(3), we proposed that
an MSPP issuer must follow State
definitions for habilitative services and
devices where the State chooses to
specifically define this category
pursuant to 45 CFR 156.110(f). When a
State chooses not to define this category
and any OPM-selected EHB-benchmark
plan lacks coverage of habilitative
services and devices, OPM may
determine what to include in this
category.
Comments: All commenters
supported OPM’s intention to include
habilitative services and devices in the
MSPs. However, they disagreed on
whether we should defer to State
definitions or have OPM define a
specific set of habilitative services and
devices that each MSP must cover.
Some asked that we require parity in
scope, amount, and duration for
habilitative and rehabilitative services.
Other commenters supported our
proposed approach for when a State
chooses not to define the category of
habilitation. When this happens, we
will determine what habilitative
services and devices must be included
in an OPM-selected EHB-benchmark
plan. One commenter suggested that we
refer to both habilitative ‘‘services and
devices’’ in § 800.105(c)(3) as we do in
§ 800.105(c)(4).
Response: Based on the comments, we
will direct MSPP issuers to follow State
definitions of habilitative services and
devices where they exist and, where
they do not exist, OPM will consider
these comments during MSPP contract
negotiation. We are adopting proposed
§ 800.105(c)(3) as final, with the one
technical correction mentioned above.
In § 800.105(c)(4), OPM proposed
that, at least for years 2014 and 2015,
OPM’s EHB-benchmark plans would
also include, for each State, any Staterequired benefits enacted by December
31, 2011, that are included in a State’s
EHB-benchmark plan or specific to the
market in which the MSPP issuer offers
coverage. Accordingly, these Staterequired benefits would be treated as
part of the EHB. However, consistent
with 45 CFR 155.170, OPM proposed
that State-required benefits enacted after
December 31, 2011, would be in
addition to the EHB. Under section
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
1334(c)(4) of the Affordable Care Act, a
State must assume the cost of such
additional benefits over the EHB by
making payments either to the enrollee
or on behalf of the enrollee to the MSPP
issuer, if applicable. An MSPP issuer
must calculate and report the costs of
additional State-required benefits
pursuant to § 800.105(e). This standard
is also consistent with 45 CFR 155.170.
Comments: Most commenters
supported the inclusion of Staterequired benefits before December 31,
2011. However, one commenter
opposed the inclusion of State-required
benefits. Another commenter stated that
the cutoff date for inclusion of Staterequired benefits should be November
26, 2012, the date when the proposed
EHB rule was published.
Response: We are making no changes
to § 800.105(c)(4), because it is
consistent with standards applicable to
QHPs at 45 CFR 155.170.
Comments: Several commenters
recommended that State payments for
State-required benefits above the EHB
benchmark be made only to issuers
instead of allowing States the option of
making payments to either issuers or
enrollees.
Response: We are making no changes
to proposed § 800.105(e), because it is
consistent with section 1334(c)(4) of the
Affordable Care Act, as well as
standards applicable to QHPs at 45 CFR
155.170.
In § 800.105(d), OPM proposed that
an MSPP issuer’s benefits package,
including its prescription drug list, must
be submitted to and approved by OPM,
which will determine whether a benefits
package proposed by an MSPP issuer is
substantially equal to an EHBbenchmark plan, in accordance with the
requirements set forth by HHS in the
proposed EHB rule. In determining
whether an MSPP issuer’s benefits
package should be approved, OPM
proposed to follow the HHS approach
set forth at 45 CFR 156.115, 156.122,
and 156.125. Section 156.115(b) of title
45, Code of Federal Regulations, allows
issuers to make benefit substitutions
within each EHB category and directs
issuers to submit evidence of actuarial
equivalence of substituted benefits to a
State. We requested comments on
whether MSPP issuers should submit
evidence of actuarial equivalence of
substituted benefits to OPM in addition
to, or in lieu of, their submission to a
State.
Comments: Many commenters
recommended that, if MSPP issuers are
allowed to make actuarially equivalent
substitutions, evidence should be
submitted to both States and OPM.
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
Response: We are adopting the
proposed § 800.105(d), and we will
work collaboratively with State
regulatory officials during the MSPP
application process to ensure they
receive evidence of actuarial
equivalence of substituted benefits.
In reviewing an MSPP issuer’s
proposed benefit design, OPM plans to
review an MSPP issuer’s benefits
package for discriminatory benefit
design, consistent with section
1302(b)(4) of the Affordable Care Act
and 45 CFR 156.110(d), 156.110(e), and
156.125, and will work closely with
States and HHS to identify and
investigate any potentially
discriminatory benefit design in MSPs.
In summary, we are adopting
proposed § 800.105 as final, with the
change described above relating to
standardized benefit designs. We also
are making minor technical corrections,
including by inserting a reference to
both habilitative ‘‘services and devices’’
in § 800.105(c)(3) to be consistent with
§ 800.105(c)(4).
Cost-Sharing Limits, Premium Tax
Credits, and Cost-Sharing Reductions
(§ 800.106)
In § 800.106(a), OPM proposed that,
for each MSP it offers, an MSPP issuer
must ensure that the cost-sharing
provisions of the MSP comply with
section 1302(c) of the Affordable Care
Act as well as any applicable standards
set by OPM or HHS in regulations. The
HHS standards are set forth in 45 CFR
156.130. In § 800.106(b), OPM proposed
that an MSPP issuer, for each MSP it
offers, must ensure that an eligible
individual receives advance payments
of premium tax credits under section
36B of the Internal Revenue Code (the
Code) and cost-sharing reductions under
section 1402 of the Affordable Care Act.
This provision would establish MSPP
issuer responsibilities under section
1334(c)(3)(A) of the Affordable Care Act,
which specifies that an individual
enrolled in an MSP is eligible for the
premium tax credits and cost-sharing
reductions in the same manner as an
individual who is enrolled in a QHP.
We clarify that under § 800.106(b),
MSPP issuers must comply with the
same standards as QHP issuers,
including applicable provisions of
sections 1402(a)(2) and 1412(c)(2)(B) of
the Affordable Care Act and 45 CFR part
156, subpart E. OPM may issue
additional guidance regarding any
unique issues faced by MSPs.
We received comments on this section
from a broad spectrum of consumer and
professional organizations and a few
individual States. In general, our
intention is to require MSPP issuers to
PO 00000
Frm 00009
Fmt 4701
Sfmt 4700
15567
comply with Exchange rules to ensure
that MSPs operate on a level playing
field with other issuers operating in the
Exchanges. To the extent any rules
governing MSPs differ from those
governing QHPs, OPM will design them
to afford the MSPs and MSPP issuers
neither a competitive advantage nor a
disadvantage with respect to other plans
offered on the Exchange.
Comments: Some commenters
requested that OPM clarify its
requirement that MSPPs must comply
with State cost-sharing restrictions.
Response: It is our intention to require
MSPP issuers to follow HHS rules
regarding cost-sharing except when
State laws impose stricter requirements
for their Exchanges. In the event a State
standardizes cost-sharing arrangements
and these standards comply with HHS
regulations, an MSPP issuer will also be
required to comply with State standards
for cost-sharing.
Comments: One group of commenters
suggested that OPM require an MSP to
cover out-of-network subspecialty care
with the same cost-sharing
arrangements as in-network.
Response: As acknowledged in our
final application for the MSPP, we may,
in some circumstances, also require
MSPP issuers to provide in-network
benefits for services from certain out-ofnetwork providers; however, this would
not be done through rulemaking. We
will take these comments under
consideration during our contract
negotiation with MSPP issuers.
Concerns about the cost-sharing
variation for American Indian/Alaska
Native families who want to purchase
child-only coverage are not within the
scope of OPM’s rulemaking authority.
The Exchanges and HHS will facilitate
all plan variations between MSPP
issuers and potential enrollees just as
they will do for families participating in
the QHPs. However, where appropriate,
OPM will coordinate closely with HHS
on areas of special concern for
American Indian/Alaska Native adults
and children.
We are adopting proposed
§ 800.106(a) as final, with no changes,
and we are making technical changes to
§ 800.106(b).
Levels of Coverage (§ 800.107)
In § 800.107, we proposed that an
MSPP issuer, like a QHP issuer
participating in Exchanges, must offer at
least one plan at the silver level of
coverage and one plan at the gold level
of coverage in each Exchange in which
the issuer is certified to offer an MSP
pursuant to a contract with OPM. OPM
will use its discretion about whether an
MSPP issuer may offer products in
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15568
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
addition to the required gold and silver
products.
We also proposed that an MSPP issuer
must offer a child-only plan at the same
level of coverage as any health
insurance coverage offered to
individuals who, as of the beginning of
the plan year, have not attained the age
of 21. OPM proposed that MSPP issuers
must comply with applicable HHS
requirements to offer plan variations
that will reduce or eliminate costsharing for eligible enrollees pursuant to
section 1402 of the Affordable Care Act.
Any MSP plan variations will be
submitted to OPM for review and
approval, and OPM will coordinate its
approach to them with the final HHS
notice of benefit and payment
parameters for 2014. OPM will exercise
this discretion to promote the best
interests of enrollees and potential
enrollees in the MSPP and to ensure
adequate administrative oversight of
each MSP and MSPP issuer.
A number of comments, although
informative, relate to issues that do not
fall within the scope of OPM’s
rulemaking. In general, our intention is
to direct MSPP issuers to comply with
State requirements related to the
offering of levels of coverage, including
but not limited to standardized benefit
designs and tiers.
Comments: Some commenters
recommended that OPM require or
encourage MSPP issuers to offer
coverage beyond gold and silver plans.
The suggestions included requiring
MSPP issuers to offer one or more of the
following: At least one bronze plan; a
plan in both the MSP and State
Medicaid program; and catastrophic
coverage.
Response: The Affordable Care Act
requires each MSPP issuer to offer both
a gold and silver plan. OPM will not
require bronze coverage through this
regulation, but has the discretion to
approve other levels of coverage through
contract negotiation with issuers.
Therefore, where a State allows it, we
will consider plans that offer
catastrophic or bronze levels of
coverage. We will also consider
applicants to the MSPP that propose to
offer an MSP in the Exchange and
simultaneously provide coverage
through a State Medicaid program. We
agree with commenters that this would
reduce the potential for gaps as
consumers transition between Medicaid
and Exchange eligibility. However, we
do not have authority to require MSPP
issuers to participate in Medicaid.
No changes are needed in § 800.107 in
light of the comments we received.
Therefore, we are adopting proposed
§ 800.107 as final, with no changes.
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
Assessments and User Fees (§ 800.108)
The proposed rule provides OPM
discretion to collect an assessment or
user fee from MSPP issuers as a
condition of participating in the MSPP.
The proposed rule also describes,
generally, that any OPM-collected
assessments and user fees would be to
cover the administrative costs of
performing the contracting and
certification of MSPs and of operating
the program, functions typically
conducted through an Exchange for
QHPs.
Comments: Some commenters asked
OPM to confirm that MSPP issuers
would pay any State-based Exchange
user fees in addition to the MSPPspecific assessments or user fees. These
commenters were concerned that any
administrative fee above and beyond the
Exchange fee charged to QHP issuers is
duplicative and could lead to a
competitive disadvantage for MSPP
issuers. One commenter asked how the
process for paying assessments and user
fees to OPM would work.
Response: In this final rule, OPM is
preserving its discretion to collect an
MSPP assessment or user fee, and
clarifies that it may begin collecting the
fee in 2015; OPM does not intend to
collect an assessment or user fee in
2014. The user fee could be used to fund
OPM activities directly related to MSPP
certification and administration. We
currently estimate that any future
assessment or fee would be no more
than 0.2 percent of premiums.
The MSPP user fee would not be a
substitute for any user fee or assessment
imposed by a State-based Exchange or
Federally-facilitated Exchange. Rather,
OPM intends for any MSPP user fee it
collects to be offset against any Statebased Exchange or Federally-facilitated
Exchange user fee that the MSPP issuer
must pay. This offset would preserve a
level playing field for MSPP issuers.
Under this approach, the MSPP issuers
would pay the same total assessment or
user fee to participate in an Exchange as
all other QHPs participating in that
Exchange. In addition, this process
would allow the Exchanges to receive
the bulk of the user fee from MSPP
issuers to cover the Exchange costs,
while also providing a marginal amount
to fund the certification activities that
OPM will perform in the place of an
Exchange with respect to the MSPs.
OPM would issue further guidance in
advance of collecting any user fees in
2015. For example, OPM would provide
instructions on whether MSPP issuers
should pay the MSPP portion of the user
fee to OPM and pay separately the
balance of the State-based or Federally-
PO 00000
Frm 00010
Fmt 4701
Sfmt 4700
facilitated Exchange user fee to the State
or HHS, as appropriate.
Comments: Several commenters
wanted more detail about OPM’s costs
for certifying and administering the
MSPP and to what use the assessment
or user fee would be put. One
commenter suggested eliminating the
assessment or user fee since MSPP
administration is a function of OPM.
Response: As stated in the proposed
rule, the MSPP assessment or user fee
would be used for OPM’s MSPP
functions for administration, including
entering into contracts with, certifying,
recertifying, decertifying, and
overseeing MSPs and MSPP issuers for
that plan year. OPM will communicate
such costs to MSPP issuers and
Exchanges when available. The MSPP
user fee is similar to a fee that OPM
collects and uses to administer contracts
for the FEHBP and will only be used to
administer the MSPP as it performs plan
management functions similar to Statebased and Federally-facilitated
Exchanges.
Network Adequacy (§ 800.109)
OPM proposed, in § 800.109, a
standard for network adequacy for the
MSPP that mirrors the HHS standard set
forth in 45 CFR 156.230 and is intended
to ensure that an MSP’s services are
available to all enrollees. Consistent
with the Exchange final rule’s alignment
with the NAIC Model Act, OPM
proposed directing an MSPP issuer to
(1) maintain a network that is sufficient
in the number and types of providers to
ensure that all services will be
accessible without reasonable delay for
enrollees; (2) offer a provider network
that is consistent with network
adequacy provisions set forth in section
2702(c) of the PHS Act; and (3) offer a
provider network that includes essential
community providers in compliance
with 45 CFR 156.235. OPM intends for
an MSPP issuer to make its provider
directory available to the Exchange for
online publication and to potential
enrollees in hard copy, upon request.
The proposed regulation stated that
OPM would issue guidance containing
the criteria and standards that OPM will
use to determine the adequacy of a
provider network. In addition, we
solicited comment on State licensure
and any issues for MSPs with respect to
State-specific network adequacy
requirements.
Comments: Some commenters
recommended that network adequacy
provisions include specific provider
types, such as certified registered nurse
anesthetists, tribal health care providers,
chiropractic physicians, optometrists,
and Christian Science providers. Some
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
commenters also stated that OPM
should prohibit discrimination against
specific provider types. A few
commenters recommended that OPM
require MSPP issuers to adopt a
standard Indian Addendum for
contracting with tribal health care
providers.
Response: While the MSP network
adequacy standard should provide
access to a range of health care
providers, specifying the inclusion of
specified provider types, beyond what is
required under the Affordable Care Act
for QHPs (e.g., essential community
providers), would detract from the
larger issue of broadly ensuring
affordable access to the full range of
covered services. Accordingly, the final
rule retains the language in proposed
§ 800.109(a) that requires MSPP issuers
to maintain networks that include
sufficient numbers and types of
providers to ensure all services will be
accessible without unreasonable delay.
This includes providers representing
medical, surgical, pediatric, mental
health, and allied health disciplines to
meet the anticipated health care needs
of a diverse patient population. We
acknowledge the importance of having
standards in place to prevent
discrimination against specific provider
types, because a variety of providers is
important for accessing services.
However, we believe that the nondiscrimination standards set forth in
§§ 800.101 and 800.102 adequately
prohibit discrimination against specific
provider types. OPM will reinforce
these protections through its contract
negotiations with MSPP issuers.
With regard to the comments on the
standard Indian Addendum, OPM
recognizes that furnishing MSPP issuers
with a standard Indian Addendum to a
provider contract may make it easier for
MSPP issuers to contract with Indian
providers. We are aware that the Centers
for Medicare and Medicaid Services
(CMS) has partnered with the Indian
Health Service to develop a Draft Model
Qualified Health Program Addendum
for contracting between QHP issuers
and tribal health care providers.
However, CMS has not required that
QHP issuers use the Addendum in the
Exchange rule. We think it more
appropriate to address this issue in our
contract negotiations. We will continue
to coordinate closely with CMS on the
use of the standard Indian Addendum
by MSPP issuers when contracting with
Indian providers.
Comments: A few commenters
recommended that OPM require MSPP
issuers to contract with ‘‘any willing
essential community provider.’’
Similarly, a few commenters suggested
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
that OPM require MSPP issuers to
comply with any State laws concerning
‘‘any willing provider’’ or ‘‘any willing
pharmacy.’’
Response: In proposed § 800.109(a)(3),
OPM adopted an approach that mirrors
that of HHS regarding inclusion of
essential community providers for
QHPs. OPM intends for MSPP issuers to
contract with essential community
providers. We do not intend to change
this provision of the proposed
regulation, but we wish to assure
commenters that we consider
§§ 800.109(a) and 800.114 to require
MSPP issuers to comply with State ‘‘any
willing provider’’ laws.
Comments: We received some
comments related to standards for
provider directories under proposed
§ 800.109(b). Overall, commenters
supported the proposed standards,
which mirrored the HHS standards in
the Exchange final rule. However, one
commenter suggested that OPM require
MSPP issuers to maintain a dedicated
email address that providers and
consumers could use to submit
inaccurate provider directory
information for correction. In addition,
another commenter requested that OPM
streamline requirements for provider
directories by allowing downloadable
electronic versions in place of hard copy
and avoiding requiring regular updates
of providers accepting new patients.
Response: The proposed § 800.109(c)
mirrors the HHS approach to provider
directories for QHPs. We will consider,
during the MSPP contract negotiations,
the comment on an MSPP issuer
maintaining a dedicated email address
for changes in provider directory
information. With regard to the
commenter who suggested that MSPP
issuers not be required to provide a hard
copy of the provider directory to
potential enrollees upon request, this
suggestion conflicts with HHS
standards.
Comments: We received numerous
comments related to establishing a
uniform MSPP network adequacy
standard. Many commenters did not
support OPM developing a uniform
standard for the MSPP. These
commenters suggested that not applying
the same standards to all QHPs and
MSPs within a State would lead to
adverse selection and market
dislocation, and would not be in the
best interests of consumers, though they
did not submit any evidence to support
these contentions. Specifically, two
commenters identified States that had
existing network adequacy standards for
managed care products and
recommended that an MSPP issuer
comply with those standards.
PO 00000
Frm 00011
Fmt 4701
Sfmt 4700
15569
Conversely, many other commenters
recommended that OPM establish a
national, uniform standard for network
adequacy for the MSPP. These
commenters indicated that a uniform
standard would be considered a critical
component of the MSPP and is
especially important in ensuring that
MSPs provide reasonable and timely
access to health care.
Response: OPM recognizes that many,
though not all, States direct health
insurance issuers to evaluate the
adequacy of their provider networks on
an ongoing basis and monitor network
adequacy in their traditional role of
regulating health insurance. Based on
comments received on the proposed
rule, and informed by previous
comments concerning the RFI and the
draft application, we have adopted an
approach under which the MSPP will
establish a uniform standard for
network adequacy using time and
distance standards that are based on
those published by CMS for Medicare
Advantage plans (for providers and
facilities) and Medicare Part D (for retail
pharmacies), which we note meet the
QHP network standards in 45 CFR
156.230. For 2014, we will assess MSPP
issuers’ compliance with these time and
distance standards for a broad, diverse
list of provider types and facility types,
which we believe adequately reflects the
ability of an MSPP issuer to assure that
all services will be accessible without
unreasonable delay for enrollees. More
information is available in our final
MSPP application that was published
on January 18, 2013, on the Federal
Business Opportunities Web site at
www.FBO.gov under solicitation
number OPM35–12–R–0006, Multi-State
Plan Program.
In the first year of the MSPP, we will
apply only the MSPP standard for MSPP
issuer networks, and in future years may
require an MSPP issuer to meet State
network standards, if appropriate and in
the best interest of MSP enrollees.
Accordingly, we are adopting proposed
§ 800.109 as final, with no changes;
however, we will continue to consider
these comments during the MSPP
contract negotiations.
Service Area (§ 800.110)
In § 800.110, OPM proposed that
MSPP issuers comply with the service
areas defined by Exchanges, but this
does not necessarily require that an
MSP be offered in all defined service
areas. We also proposed that for each
State in which the MSPP issuer does not
offer coverage in all service areas, the
MSPP issuer’s application for
participation in the MSPP and the
information it submits to support
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15570
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
renewal of a contract must include a
plan for offering coverage throughout
the State. We sought comment on
whether MSPP issuers should be
required to offer MSPs in all service
areas by the fourth year of participation
in the MSPP.
Comments: We received some support
for our proposal on service areas from
a commenter stating that our policy
allows MSPP issuers time to develop the
capacity to offer coverage throughout a
service area and this will enhance
competition. Several commenters were
concerned about MSPP issuers’ ability
to cherry-pick the areas where they offer
plans. Some commenters recommended
that MSP service and rating areas be
aligned to prevent issuers from cherrypicking. Another commenter
recommended that MSPs be required to
comply with the service area
requirements applicable to all other
issuers in a State. One commenter
recommended that MSPs be required to
cover geographic service areas in a
particular State where they are licensed
if their license is other than statewide,
and the commenter also recommended
that MSPs should follow the same rules
as QHPs, concerning partial rating
regions. Finally, several commenters
were concerned that our proposed
policy may not ensure access in a
meaningful way or promote
competition.
Response: Similar to our response to
comments on § 800.104, we are not
prohibiting MSPP issuers from offering
coverage in all service areas; on the
contrary, we encourage them to do so if
they have the capacity. We are clarifying
in the final rule that MSPs will be
required to comply with the service area
requirements applicable to all QHPs in
a State. We are not making any
additional requirements regarding
partial rating regions or geographic
service areas in States with certain
licensure laws that determine service
area. We acknowledge the commenters’
concern that issuers may cherry-pick
certain service areas. However, we
believe that requiring that MSPs be
subject to the same service area
requirements as QHPs will create a level
playing field and prevent issuers from
cherry-picking. In addition, we intend
to pay special attention to whether
service areas include rural areas and
American Indian/Alaska Natives during
MSPP contract negotiations. We will
evaluate the service area of an MSP to
ensure that it has been established
without regard to racial, ethnic,
language, health status-related factors
specified under section 2705(a) of the
PHS Act, or other factors that exclude
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
specific high-utilizing, high-cost or
medically-underserved populations.
Similar to our changes under
§ 800.104, we are removing the
requirement in the proposed rule that,
for each State in which the MSPP issuer
does not offer coverage in all service
areas, the MSPP issuer would submit a
plan on expanding coverage throughout
the State. For reasons described in our
responses to comments on § 800.104
related to statewide coverage, we intend
to encourage MSPP issuers to expand
coverage and will assess their capacity
to do so through the MSPP contract
negotiations.
Accreditation Requirement (§ 800.111)
In § 800.111, OPM proposed a
requirement that MSPP issuers be or
become accredited consistent with the
HHS standards for QHP issuers. We also
proposed that the MSPP issuer must
authorize the accrediting entity to
release to OPM and to Exchanges a copy
of the MSPP issuer’s most recent
accreditation survey, along with any
survey-related information that OPM or
an Exchange may require. OPM also
proposed that an issuer that is not
accredited as of the date that it enters
into a contract with OPM must become
accredited within the timeframe
established by OPM in accordance with
45 CFR 155.1045.
Comments: Several commenters
recommended that OPM set a timeframe
for accreditation that meets the
accreditation timeframe set for QHP
issuers either participating in Federallyfacilitated Exchanges or in State-based
Exchanges. Some commenters
supported a unique timeline for MSPP
issuer accreditation.
Response: OPM intends to follow the
timeframe for accreditation in 45 CFR
155.1045 and similar provisions
adopted by State-based Exchanges,
though we are reserving the authority to
set our own timeframe under narrow
circumstances that take into account the
unique nature of the MSPP. Due to the
broad geographic coverage required for
the MSPP, MSPP issuers may need
additional time to collect data on local
performance for accreditation.
Similarly, a group of issuers coming
together to contract as an MSPP issuer
under a common service mark may need
additional time to coordinate between
accrediting entities or among
component plans. Additional time may
also be required if a component plan has
previously been accredited by an entity
other than the accrediting entities
recognized by the Secretary. Therefore,
in accordance with our authority under
45 CFR 155.1045, we are adopting our
PO 00000
Frm 00012
Fmt 4701
Sfmt 4700
proposed approach in the final
regulation, with no changes.
Comment: One commenter
recommended that the MSPP issuer
must have a schedule for a review of
policies and procedures with a
recognized accrediting agency during
that initial year and have
documentation that a readiness review
for accreditation has been completed.
Response: OPM will consider this
comment in creating contract language
for MSPP issuers who are obtaining
accreditation in accordance with
§ 800.111(c).
Comment: One commenter asked
OPM to clarify how consumers will be
educated about the differences between
an accredited and unaccredited plan;
another commenter requested that
accreditation surveys be made public.
Response: Accreditation status of
MSPP issuers (as well as all QHP
issuers) will be made available to
consumers through Exchange systems.
No change in the regulation is needed.
Comment: One commenter suggested
that to allow a group of independent
insurance issuers to jointly offer an
MSP, accreditation must be required at
the State level rather than at a national
level.
Response: MSPP issuers will be
accredited on the basis of local
performance in accordance with the
requirements for QHP issuers specified
in section 1311 of the Affordable Care
Act and 45 CFR 156.275(a). No change
is required in the proposed rule.
Reporting Requirements (§ 800.112)
The proposed § 800.112(a) specified
that OPM may collect such data and
information as are permitted or required
by the Affordable Care Act to be
collected from an MSPP issuer. OPM
has also proposed to collect such other
data and information as it determines
necessary for the oversight and
administration of the MSPP.
OPM will use its FEHBP contract
administration as a model for reporting
requirements. Examples of reporting
that is currently required for FEHBP
carriers and that may be required for the
MSPP include financial reports,
premium payment information,
enrollment reporting, and quality
assurance information.3 OPM will
determine the data and information that
MSPP issuers report and the frequency
and process for submitting such reports
to be published in future guidance.
Reporting of certain types of
information is critical for OPM to
3 OPM’s Routine Reports and Submissions
required for FEHB carriers is available at https://
www.opm.gov/carrier/reports/index.asp.
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
implement and administer the MSPP.
To oversee MSPP contracts, OPM will
need to collect certain information to
ensure the integrity of the MSPP, to
protect enrollees, to prevent fraud and
abuse, to monitor quality and quality
improvement, and for other purposes.
Comments: Commenters raised
several issues with regard to MSPP
reporting requirements. Many
commenters noted that MSPP issuers
should comply with applicable State
and Exchange standards.
Response: We note that § 800.115(e)
requires MSPP issuers to comply with
all Federal and State quality
improvement and reporting
requirements.
Comments: Many commenters also
urged that we coordinate with States on
data collection to avoid duplicative
efforts. Some also asked us to share data
with the public. A couple of
commenters stated that OPM should not
use a centralized health claims data
warehouse for the MSPP, but adopt a
decentralized approach.
Response: We agree with commenters
that our approach to data collection
should be coordinated with States. OPM
intends to enter into MOUs with States
to streamline data collection and reduce
duplicate reporting requirements. This
rule does not address specifics of how
OPM will collect data, and our method
for data collection will be developed in
future policy guidance, in consultation
with HHS.
Comment: One commenter stated that
the MSPP should adopt the pharmacy
benefit manager (PBM) transparency
standards that OPM has established for
the FEHBP, while another commenter
opposed such an approach.
Response: PBM transparency
standards will be established through
the MSPP contract, and we will
consider these comments in developing
contract language.
Comments: Several commenters urged
us to adopt specific data collection
requirements, such as annual reports on
each health plan, including data on the
number of enrollees receiving treatment
for drug and alcohol abuse and MSPP
issuer definitions of medical necessity
and rider policies.
Response: Specific reporting
requirements may change from year to
year based on the needs of the program.
Accordingly, such issues are more
appropriately addressed through
contract negotiations, rather than this
regulation.
Comments: The preamble of the
proposed rule also suggested that OPM
may collect demographic data. Several
commenters supported data collection
on demographics. A couple of
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
commenters noted that issuers may not
currently collect demographic data and,
in some States, demographic data
collection could be prohibited by law.
One commenter opposed all
demographic data collection.
Response: Although we are not
finalizing any specific demographic data
collection in this rule, our authority to
administer MSPP contracts includes
collection of demographic data, if we
decide to do so in the future. In that
event, we will consult with any States
that have laws prohibiting collection of
demographic data.
Section 800.112(b) specifies quality
and quality improvement standards.
With respect to quality reporting, under
the FEHBP, OPM requires all health
plans to report their performance
through Healthcare Effectiveness Data
and Information Set (HEDIS) metrics
and Consumer Assessment of
Healthcare Providers and Systems
(CAHPS) surveys, independent of the
source of plan accreditation. This allows
for comparison among plans in a
consistent manner. OPM expects to
begin with a similar approach to
performance measurement in MSPs to
facilitate oversight. We expect our
approach to evolve as HHS sets forth
further guidance on quality reporting
standards for QHPs.
Comments: Several commenters
supported our proposed approach
regarding quality and quality
improvement standards. One
commenter was concerned that
requiring HEDIS reporting, which is
proprietary to one accrediting entity,
would be an undue burden to other
accrediting entities. One commenter
recommended that we immediately use
the eValue8 quality reporting tool.
Another commenter noted that we
include measures applicable to
children, including specific modules for
children with special health care needs
across the entire breadth of conditions
and domains (preventive care, mental
health, and chronic care).
Response: We are adopting in this
final regulation our proposed approach
to quality and quality improvement
standards, because it reflects current
FEHBP policies and Federal standards
for QHPs. We anticipate that quality
reporting standards will evolve over
time, and we will consider these
comments as the standards develop.
Benefit Plan Material or Information
(§ 800.113)
In proposed § 800.20, OPM defined
the term ‘‘benefit plan material or
information’’ to include explanations or
descriptions, whether printed or
electronic, that describe a health
PO 00000
Frm 00013
Fmt 4701
Sfmt 4700
15571
insurance issuer’s products. The term
does not include a policy or contract for
health insurance coverage. As it does in
the FEHBP, OPM will review and
approve the policy or contract for health
insurance coverage. We view oversight
of such contractual documents as
uniquely within OPM’s responsibilities
under section 1334(a)(4) to implement
the MSPP in a manner similar to the
manner in which we implement the
contracting provisions with respect to
carriers under the FEHBP. OPM cannot
manage MSPP contracts similarly to
FEHBP contracts without the authority
to review and revise these documents.
See the discussion of § 800.20 for our
responses to comments on the definition
of ‘‘benefit plan material or
information.’’
Section 800.113(a) states that MSPP
issuers must comply with Federal and
State laws related to benefit plan
material or information. An MSPP
issuer must also comply with OPM
guidance specifying OPM standards,
process, and timeline for approval of
benefit plan material or information.
Comments: We received many
comments about the proposed policy on
compliance with Federal and State law.
Several commenters supported the
requirement that MSPP issuers comply
with both Federal and State laws
relating to benefit plan material or
information. Several commenters
wanted OPM to clarify that State
approval of a policy form is a
precondition of OPM approval. One
commenter wanted OPM to defer to
States for approval of policy forms,
except where a State’s action or inaction
prevents an MSP from being offered on
an exchange.
Response: While OPM intends to
review and approve policy forms for
health insurance coverage, OPM expects
MSPP issuers to comply with related
State law requirements for form review.
Accordingly, an MSPP issuer’s
requirement to comply with State law
includes the requirement to comply
with form review laws. However, State
approval of a policy form is not a
precondition of OPM approval. OPM
expects that few disagreements will
arise between OPM and a State
regarding form review and, if they do,
we will work with the State to
successfully resolve the discrepancy in
a manner that is acceptable to both OPM
and the particular State.
Proposed § 800.113(b) states that all
MSP enrollee notices must meet
minimum access standards for
individuals with limited English
proficiency (LEP) and for individuals
with disabilities as described in 45 CFR
155.205(c). As stated in the final
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15572
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
Exchange rule, HHS intends to issue
further guidance on minimum standards
to address language access and
coordinate HHS accessibility standards
with insurance affordability programs,
and across HHS programs, as
appropriate. OPM expects MSPP issuers
to comply with these minimum access
standards once HHS publishes this
guidance. OPM may also establish
additional standards for MSPP
applications and notices.
Comments: Several commenters
wanted OPM to clarify that obligations
to provide materials in different
languages be calculated by State or
service area, not nationwide. Two
commenters wanted us to provide
clearer guidance on our language access
policies. They suggested that, to start
with, OPM clarify that LEP guidance set
forth by HHS’ Office of Civil Rights,
which is referenced in footnote 48 of the
HHS proposed rule with respect to
appeals, will also apply to other benefit
material or information.
Response: Such guidance will be
addressed through the contract
negotiation process.
Section 800.113(c) states that an
MSPP issuer is responsible for the
accuracy of its benefit plan material or
information. Section 800.113(d) states
that benefit plan material or information
must also be in plain language, be
truthful, not be misleading, and have no
material omissions.
QHPs must comply with the
provisions of section 2715 of the PHS
Act and its implementing regulations at
45 CFR 147.200 on Summary of Benefit
and Coverage and Uniform Glossary
requirements. Under § 800.113(e), OPM
also will require MSPs to comply with
the statute and regulations.
Additionally, OPM expects that MSPP
issuers will meet any requirements that
allow standardized benefit information
to be displayed on HHS or Exchange
web portals.
Section 800.113(f) states that OPM
will review and approve certain benefit
plan material or information as defined
in § 800.20 of the proposed regulation.
OPM may not necessarily review all
benefit plan material or information. It
may request from MSPP issuers those
materials that it wishes to review and
approve. OPM’s review will focus on
the MSPP issuer’s compliance with the
standards promulgated by OPM with
respect to benefit plan material or
information.
Comments: One commenter did not
want OPM to review and approve
benefit plan material or information.
One commenter was concerned about
the practical difficulties for both issuers
and regulators with respect to the dual
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
requirement that OPM review and
approve policy forms and that issuers
also comply with State requirements.
One commenter wanted more clarity on
the interplay between Federal and State
review. One commenter stated that OPM
review of communication materials, and
its discussion with States, should be
concluded no later than 90 days prior to
the beginning of the annual enrollment
period.
Response: OPM cannot entirely cede
responsibility for the review of benefit
plan material or information since such
review is important to oversight.
Nonetheless, in order to avoid
unnecessary duplication and burden,
OPM will work with States concerning
the review of benefit plan material or
information and may work with States
to define respective roles through
MOUs. OPM will also aim for prompt
review of benefit plan material or
information.
Section 800.113(g) states that OPM
will allow an MSPP issuer to state that
OPM has certified a plan as an MSP and
will oversee its administration. OPM is
aware that many States have adopted
laws or regulations prohibiting issuers
from using advertisements that ‘‘may
lead the public to believe that the
advertised coverages are somehow
provided by or endorsed by [a]
governmental agenc[y].’’ 4 However,
because OPM will have certified an
MSPP issuer and an MSP as meeting
certain standards, potential issuers may
wish to include this fact in materials
they distribute to the public subject to
review by OPM. OPM does not view this
as a violation of State law antiendorsement provisions because it is
not misleading, but rather a recitation of
the fact that the issuer is providing
coverage pursuant to a contract with
OPM.
Comment: One commenter did not
want MSPP issuers to include a
statement on certification by OPM.
Response: For the reasons set forth
above, we are adopting the proposed
policy regarding statement of
certification.
Comments: Several commenters
stated that it is critical that the
information about the special
protections for American Indians/
Alaska Natives be clearly stated in all
plan materials so that they are informed
about the cost-sharing plan variations
that may apply to them so they can
enroll in the correct plan. The
commenters also stated that American
Indians/Alaska Natives should know
4 These State law prohibitions derive from the
NAIC’s Advertisements of Accident and Sickness
Insurance Model Regulation § 13.C. (Apr. 1999).
PO 00000
Frm 00014
Fmt 4701
Sfmt 4700
whether a plan network includes their
I/T/U provider.
Response: We acknowledge that
certain American Indians/Alaska
Natives should be made aware of special
protections and whether a plan includes
I/T/U providers. We encourage MSPP
issuers to make this information
available to MSPP plan participants. We
will continue to work with CMS and the
Indian Health Service to make sure
American Indians/Alaska Natives are
informed about the cost-sharing plan
variations.
Because no changes are required
based on the comments received, OPM
is adopting proposed § 800.113 as final,
with no changes.
Compliance With Applicable State Law
(§ 800.114)
As proposed, § 800.114 would require
MSPP issuers generally to comply with
State law. Paragraph (a) of the proposed
regulation restated the requirement set
forth in section 1334(b)(2) of the
Affordable Care Act, including the three
categories of State laws with which
MSPP issuers need not comply: (1) State
laws that are inconsistent with section
1334; (2) State laws that prevent the
application of a requirement of part A
of title XXVII of the PHS Act; and (3)
State laws that prevent the application
of a requirement of title I of the
Affordable Care Act. We have made a
technical edit in paragraph (a) to make
it more consistent with § 800.116.
In paragraph (b) of proposed
§ 800.114, we provided greater detail on
the methods OPM would use to
determine whether a State law fits into
one of the above categories. Specifically,
we proposed that OPM would use a list
of four factors: (1) Whether the law in
question imposes a requirement that
differs from those applicable to QHPs
and QHP issuers on one or more
Exchanges in the State; (2) whether the
law creates responsibilities,
administrative burdens, or costs that
would significantly deter or impede the
MSPP issuer from offering a viable
product on one or more Exchanges; (3)
whether the law creates responsibilities,
administrative burdens, or costs that
significantly deter or impede OPM’s
effective implementation of the MSPP;
or (4) whether the law prevents an
MSPP issuer from offering an MSP on
one or more Exchanges in the State.
Comments: Many commenters found
the factors listed in paragraph (b) to be
too broad and vague. A few commenters
noted that paragraph (b)(1) compares
MSP requirements to QHP
requirements, whereas (b)(2) appears to
lack an analog against which to measure
responsibilities, administrative burdens,
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
or costs that apply to MSPs and MSPP
issuers. A few commenters expressed
specific concern about the use of the
words ‘‘significantly deter or impede’’
in paragraphs (b)(2) and (b)(3). A few
commenters requested that the word
‘‘unreasonable’’ be added to paragraph
(b)(2) to modify ‘‘responsibilities,
administrative burdens, or costs.’’ A few
commenters generally opposed OPM’s
authority to find that a State law is
inconsistent with Federal law, and one
commenter questioned OPM’s legal
authority to preempt State law through
a determination of inconsistency.
Response: At proposed § 800.114(a),
we listed the justifications for
nonapplicability of a State law to the
MSPP, as set forth at section 1334(b)(2)
of the Affordable Care Act, which
provides that an MSPP issuer must be
‘‘subject to all requirements of State law
not inconsistent with this section,
including the standards and
requirements that a State imposes that
do not prevent the application of a
requirement of part A of title XXVII of
the [PHS] Act, or a requirement of this
title [I of the Affordable Care Act.]’’ In
proposed paragraph (b), we listed
factors that may inform OPM’s analysis
under paragraph (a). Although these
listed elements would be considered
relevant to the analysis, OPM would
only be authorized to excuse an MSPP
issuer from compliance with a State law
that is inconsistent with section 1334 of
the Affordable Care Act, prevents the
application of a provision of part A of
title XXVII of the PHS Act, or prevents
the application of a requirement of title
I of the Affordable Care Act.
In light of the concerns expressed
concerning the regulatory factors
identified in the proposed regulation,
we have amended the regulatory text to
remove the list of factors. By removing
these factors from the regulation, we do
not disavow them as relevant
considerations in evaluating whether
the statutory standard for preemption
has been satisfied. Rather, we do not
wish to give the impression that they are
any more or less important than any
other factors that may be relevant in a
specific circumstance to a determination
of whether a State law should be
preempted.
Comment: One commenter
recommended that OPM consider the
seamlessness of a consumer’s
experience purchasing health insurance
on an Exchange and the avoidance of
consumer confusion in evaluating State
laws under this section.
Response: We will consider all
relevant information, including
consumers’ experiences in shopping on
Exchanges, when determining whether a
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
State law must be preempted under the
statutory standards listed in paragraph
(a). Each determination under this
section will depend on specific facts
and circumstances.
Comments: A few commenters
recommended that OPM consult with
States and Exchanges prior to making a
determination of inconsistency under
this section.
Response: We agree that OPM should
work collaboratively with States,
particularly in making determinations
regarding State laws. OPM intends to
continue to establish and cultivate
working relationships with officials in
State regulatory agencies and
Exchanges. Such relationships may exist
informally, or may eventually be
reflected in MOUs, as OPM intends to
pursue MOUs with each State in which
the MSPs are being offered. In either
case, OPM would consult with States
during the process of making a
determination of inconsistency
regarding a State law. We have changed
paragraph (b) to state expressly our
intention to engage in such
consultation.
Comments: Some commenters expect
that OPM’s ability to render a
determination of inconsistency under
this section will create competitive
advantages for MSPs over QHPs. A few
commenters stated that ‘‘double
regulation,’’ by both OPM and each
State, will competitively disadvantage
MSPs.
Response: We are sensitive to
concerns that the MSPP will create
disruptions in different markets, and
this regulation has been designed to
comply with the statutory directives of
the Affordable Care Act while
minimizing any such disruptions. The
proposed rule reflects a balanced
approach under which an MSPP issuer
will comply with all State laws except
any with respect to which OPM has
determined that such State law is
contrary to Federal law. This approach
will keep each MSP in relative balance
with QHPs offered on the same
Exchange. No evidence has been offered
to support the commenters’ assertion
that OPM’s reservation and potential
exercise of this authority creates a
competitive advantage for the MSPs or
MSPP issuers.
Moreover, OPM’s proposed
framework for MSPP compliance
incorporates State law and sets
standards and requirements similar to
those used successfully under the
FEHBP. We designed this regulatory
framework to ensure that the program is
capable of sufficient flexibility to
facilitate its implementation. We intend
to employ that flexibility to take any
PO 00000
Frm 00015
Fmt 4701
Sfmt 4700
15573
appropriate action to ensure that MSPs
are neither unreasonably competitively
advantaged nor disadvantaged.
Comments: Some commenters
recommended that we require
compliance not only with State law but
also with QHP standards set by States
and Exchange authorities. A few
commenters recommended that OPM
require MSPP issuers to enter into
contracts with Exchanges that will
actively or selectively contract with
QHP issuers. One commenter requested
clarification that MSPP issuers would be
required to comply with technical
requirements for QHPs, such as data
submission formatting.
Response: As noted in the preamble to
the proposed rule, we intend that MSPs
and MSPP issuers be subject to all of the
same standards and requirements as
QHPs and QHP issuers, except where
deviations are authorized by law. We
look forward to working collaboratively
with States to ensure that we are aware
of all relevant standards, including
those of a technical nature, to ensure
that MSPs and MSPP issuers comply
with such standards.
Requiring MSPP issuers to enter into
a contract with Exchanges would
circumvent section 1334(d) of the
Affordable Care Act, which vests
certification authority for MSPs in OPM
rather than Exchanges by providing that
MSPs offered under a contract with
OPM are deemed to be certified by an
Exchange. We consider active or
selective contracting models employed
by Exchanges to be operational
processes rather than QHP standards,
and we will not direct MSPP issuers to
participate in such processes, consistent
with statute.
Comment: One commenter requested
clarification that OPM’s determination
of inconsistency under this section
would only apply to MSPs and MSPP
issuers in Exchanges in one State, as
opposed to throughout all States.
Response: A determination of
inconsistency under this section would
be limited to the State in which the
State law in question exists. OPM
recognizes that some State laws are
based on model acts, and that several
States may employ the same or similar
language in State laws. However, we
also realize that the facts and
circumstances that give rise to a
determination of inconsistency may
vary from one State to another. OPM
will evaluate State laws carefully, and
will refer to previous determinations as
precedent when determining the
applicability of a State law, but will not
automatically apply a determination of
inconsistency to more than one State
law without consulting with the State
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15574
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
regulatory agencies and Exchange(s),
and thoroughly evaluating the unique
facts and circumstances in each State.
Comment: One commenter requested
clarification as to whether OPM would
conduct independent research or rely on
a complaint-driven process to select
which State laws may be subject to a
determination of inconsistency under
this section.
Response: We intend to use all
available information to assess the
compatibility of State laws with the
MSPP, including complaints from
enrollees, communication with issuers,
collaboration with States, and
additional research.
Comment: One commenter
recommended that OPM adopt a
standard for noncompliance with State
law where only a ‘‘compelling national
goal’’ would justify a finding that a State
law does not apply to MSPP issuers.
Response: The standards we have
adopted are those set forth in the
statute.
Comment: One commenter supported
the proposed approach, but requested
acknowledgement that OPM would
assume responsibility for enforcement
of State law with respect to MSPP
issuers.
Response: Although we intend to
communicate closely with States to
ensure compliance with State and
Federal laws, OPM is not authorized to
assume responsibility for enforcement
of State law. The same vehicles
available to States to enforce their laws
against QHPs would also be available to
enforce them against MSPs. As noted
above, we look forward to working
collaboratively with States to ensure
that consumers receive high-quality
coverage.
Comment: One commenter supported
our proposal, but requested clarification
that OPM would decide whether a State
law applies, as opposed to an issuer or
another party.
Response: As reflected in the
proposed regulatory text, we agree that
OPM should decide whether a State law
meets one of the three standards in
paragraph (a). This responsibility flows
from the statutory authority granted to
OPM by section 1334 of the Affordable
Care Act to implement and administer
the MSPP.
Comments: A few commenters
recommended that Federal Indian law
be recognized separately from State law.
Response: The requirement for MSPP
issuer compliance with State law set
forth in § 800.114 is included in the
final regulation to implement section
1334(b)(2) of the Affordable Care Act,
which specifies that an MSPP issuer ‘‘is
subject to all requirements of State law
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
not inconsistent with this section
[1334], including the standards and
requirements that a State imposes that
do not prevent the application of a
requirement of’’ part A of title 27 of the
PHS Act or title I of the Affordable Care
Act. We acknowledge the unique
concerns of I/T/Us, including concerns
that involve the interaction of State law
and Federal Indian law, and we intend
to address them, to the extent
practicable, through contractual terms.
Level Playing Field (§ 800.115)
In § 800.115, we proposed that an
MSPP issuer would comply with
Federal and State laws involving
guaranteed renewal, rating, preexisting
conditions, non-discrimination, quality
improvement and reporting, fraud and
abuse, licensure, solvency and financial
requirements, market conduct, prompt
payment, appeals and grievances,
privacy and confidentiality, and benefit
plan material or information. This
section addresses compliance directly
involving these areas of law, which are
expressly listed at section 1324 of the
Affordable Care Act. Section 1324 states
that, if an MSP is not subject to a
Federal or State law that falls into one
of the 13 categories listed, no private
health insurance coverage would be
subject to such law. We received
comments from States, Exchanges,
consumer groups, providers and
provider groups, pharmaceutical
companies, and professional
associations.
Comments: A few commenters, while
generally supporting OPM’s proposed
approach, expressed concern that our
approaches to rate review, benefit plan
material and information, and external
review may trigger section 1324 (i.e.,
that they would cause private insurance
plans to be exempt from laws listed in
that section).
Response: As explained in the
preamble to the proposed rule and in
the responses to comments regarding
§§ 800.201, 800.501–504, and 800.113,
our approach to rate review, benefit
plan material or information, and
external review would not excuse
private health insurance coverage from
compliance under section 1324. First,
laws involving rate review do not fall
within a category listed in section 1324
of the Affordable Care Act.
Second, our proposed rule explicitly
requires MSPP issuers to comply with
Federal and State laws related to benefit
plan material or information. As set
forth in § 800.20, and as discussed in
responses to comments regarding that
section and § 800.113, the definition of
‘‘benefit plan material and information’’
PO 00000
Frm 00016
Fmt 4701
Sfmt 4700
does not include a policy or contract for
health insurance coverage.
Finally, as we indicated in the
proposed rule, we believe that our
approach to external review is required
by section 1334 of the Affordable Care
Act and does not trigger the level
playing field provisions of section 1324
because our approach will comply with
external review requirements.
Specifically, we believe our approach
to external review is required by section
1334(a)(4), which directs OPM to
implement the MSPP in a manner
similar to the manner in which we
implement the contracting provisions
with respect to carriers under the
FEHBP. External review is part of the
contracting process. Through the
external review process, matters of
contract coverage are resolved.
As noted in the proposed rule, section
2719 of the PHS Act and its
implementing regulations apply to all
non-grandfathered group health plans
and health insurance issuers, including
MSPP issuers, with respect to internal
claims and appeals and external review.
We understand that the Departments of
HHS, Labor, and the Treasury (the triDepartments) intend to amend those
regulations at 45 CFR 147.136 to clarify
that the MSPP external review process
is governed by section 2719(b)(2)(B).
Under section 2719(b)(2), the external
review requirements that must be met
are established by the tri-Departments,
which have made the judgment that the
external review process adopted in this
rule satisfies the requirements under
that section. Thus, the level playing
field provisions of section 1324 of the
Affordable Care Act would not be
triggered because MSPs and MSPP
issuers would comply with the external
review requirements in section 2719(b)
of the PHS Act, just as other health
insurance issuers in the group and
individual markets are required to do.
As noted in the DATES section of this
notice of final rulemaking, rulemaking
by the tri-Departments interpreting
section 2719 in this manner has not yet
been completed. We are making the
provisions of this regulation on external
review effective on the date that such
tri-Department regulations become
effective.
In addition, our approach to external
review does not afford the MSPs any
competitive advantage. Although
OPM—instead of the States—will
administer the external review process
for MSPs, that process provides for
application of the standards and
requirements with which other issuers
must comply under section 2719(b)(2) of
the PHS Act. Thus, MSPs will in fact be
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
subject to, and comply with, the same
law on external review as other issuers.
No commenter identified any State
external review law that imposes higher
standards than does the Federal external
review law proposed for the MSPP.
Based on our experience with the
disputed claims process under the
FEHBP, we believe that our external
review process is comparable to any
State external review process. We look
forward to working collaboratively with
States to ensure that our external review
process is no less protective than the
most protective State standards.
Comment: One commenter
recommended the expansion of the
scope of ‘‘licensure’’ under this section.
Response: We recognize that licensure
laws in some States may impose varying
requirements on health insurance
issuers. Compliance with a broader
range of State laws that may be
conditions of licensure would be
required under § 800.114 of this
regulation, subject to the exceptions
listed there. However, for purposes of
analysis under this section, an MSPP
issuer complies with laws ‘‘relating to’’
licensure by being licensed in each State
in which the issuer offers an MSP.
Comment: One commenter requested
clarification as to whether the inverse of
section 1324 would also be required,
i.e., whether the other private health
insurance coverage in a State would be
subject to a State law to which an MSP
is subject.
Response: States typically regulate
health insurance markets, and the MSPs
will operate within those markets. As
set forth in § 800.114, MSPs and MSPP
issuers generally are subject to the same
laws to which the rest of the health
insurance market is subject.
Comments: A few commenters
expressed concern that OPM would
prompt a ‘‘race to the bottom’’ by
circumventing, through the MSPP,
consumer protections provided by State
laws.
Response: The MSPP will promote
uniformly high standards for MSPs to be
made available to consumers. As noted
in the proposed rule, we will deviate
from State standards only when the
standards are inconsistent with the
implementation of OPM’s statutory
directive to implement this program.
Like plans offered through the FEHBP,
MSPs will be high-quality products that
are subject to the experienced oversight
of OPM.
We are adopting proposed § 800.115
as final, with no changes.
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
Process for Dispute Resolution
(§ 800.116)
In § 800.116, we proposed a process
by which a State may request that OPM
reconsider a determination under
§ 800.114 that a State law does not
apply to MSPs or MSPP issuers. The
proposed process calls for a State to
demonstrate that the State law at issue
is not inconsistent with section 1334 of
the Affordable Care Act, does not
prevent the application of a requirement
of part A of title XXVII of the PHS Act,
and does not prevent the application of
a requirement of title I of the Affordable
Care Act. This section goes on to set
forth the procedural framework for the
process, including the form of the
request, permissible supporting
information and documentation, the
timeframe for resolution, and the nature
of OPM’s written decision as final
agency action. Most of the comments we
received regarding this section were
from States and Exchanges, and a few
additional comments were submitted by
consumer groups, issuers, and
professional organizations.
Comments: A few commenters
recommended that this process be
conducted by a third party outside of
OPM. One commenter suggested that
disputes over the applicability of State
law be conducted through State
administrative and judicial processes.
Response: OPM cannot cede authority
to make these determinations to an
outside entity, because Congress
directed OPM to implement and
administer the MSPP.
The process outlined in this section
offers a formal route to seek resolution
of a complaint without having to initiate
costly, contentious litigation over the
applicability of State laws under the
MSPP. Thus, review under this section
would be conducted by a different
official within OPM than the official
who made an initial determination
under § 800.114. Similar review is
conducted under certain circumstances
in the FEHBP when a dispute arises
between OPM and a carrier. OPM’s
experience with such review has shown
that it is an effective means of resolving
disputes.
Comments: One commenter requested
a shorter timeframe than the 60 days
proposed in paragraph (c)(3). Another
commenter recommended that OPM
ensure the resolution of all potential
disputes involving a State’s law prior to
an MSP being offered on an Exchange
within that State.
Response: Sixty days is an
appropriate period within which
written decisions must be issued, but
we intend to resolve each dispute under
PO 00000
Frm 00017
Fmt 4701
Sfmt 4700
15575
this section as quickly as possible after
it arises.
We have attempted, through the
provisions of this regulation, to
anticipate potential Exchange
approaches to substantive standards and
requirements. However, we are aware
that new State laws may be enacted or
QHP standards established subsequent
to the promulgation of this regulation.
This process is necessitated in part by
the evolving nature of health insurance
regulation and QHP standards. In
addition, we anticipate that any
inconsistencies between State laws and
section 1334 of the Affordable Care Act
may not become apparent until after
MSPP operations have begun. We
intend to work collaboratively with
States to mitigate or avoid any potential
disruptions that may result from the
ongoing nature of this process.
Comments: A few commenters
recommended that a de novo review be
conducted under this section, that State
law applicability be presumed, or that
OPM bear the ‘‘burden’’ of
demonstrating that a determination of
inconsistency is supported.
Response: This process is designed to
create an avenue for a State to show that
OPM’s considered determination under
§ 800.114 was made in error, which
would present an opportunity to avoid
potential litigation that could arise from
such a determination. As such, the State
is responsible for demonstrating
consistency between Federal and State
law.
Comments: A few commenters
recommended that determinations
regarding laws under both §§ 800.114
and 800.115 be subject to the process for
dispute resolution under this section.
Other commenters requested
clarification as to whether the dispute
resolution applied to all State laws or
only to State laws that do not fit into the
list of categories under section 1324(b)
of the Affordable Care Act.
Response: We agree that a State
should have an opportunity to request
reconsideration of a determination of
inconsistency regarding any State law
and we are revising paragraph (a)
accordingly.
Comment: One commenter
recommended that the record for
judicial review under paragraph (c)(4)
include all relevant information, not
only the record that was before OPM
when a decision was rendered.
Response: The Administrative
Procedure Act permits judicial review of
final agency action, and limits such
review to the record that was before the
agency when it took the action being
reviewed. This regulation neither
restricts nor expands that limitation.
E:\FR\FM\11MRR3.SGM
11MRR3
15576
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
Comments: A few commenters
recommended that parties other than
States be permitted to seek dispute
resolution under this section. One
commenter recommended that MSPP
issuers bear the burden of
demonstrating that State laws should
not apply to them.
Response: This process is designed to
assist States in working with OPM to
prevent and mitigate market
disruptions. State health insurance laws
are regulatory by nature; the most expert
entities to address them are therefore
the regulatory agency and/or Exchange
charged with their implementation.
Regulatory agencies and Exchanges are
well-equipped to represent the interests
of the issuers with which they work and
the consumers they serve.
We are amending paragraph (a) of
§ 800.116 as indicated above, to reflect
that a determination of inconsistency
involving any State law may be the
subject of the process outlined in this
section. We are also making a technical
correction in paragraph (b) and inserting
a technical amendment in paragraph
(c)(3) for greater clarity.
Subpart C—Premiums, Rating Factors,
Medical Loss Ratios, and Risk
Adjustment
mstockstill on DSK4VPTVN1PROD with RULES3
General Requirements (§ 800.201)
Under § 800.201, OPM proposed a
number of standards for setting rates in
the MSPP. First, we proposed that OPM
would negotiate premiums, as provided
in section 1334(a)(4) of the Affordable
Care Act, in a similar manner to the way
we negotiate with FEHBP carriers each
year.
Second, the proposed rule included a
provision that required MSPP rates to
remain in effect for the 12-month plan
year.
Third, OPM proposed to issue rating
guidance for the MSPP, similar to the
way OPM communicates with FEHBP
carriers.
Fourth, we proposed that MSPP
issuers comply with standards in HHS
guidance for calculating actuarial value
(AV), specifically those standards
proposed in 45 CFR 156.135.
Fifth, OPM proposed a process for
rate setting and review that requires an
MSPP issuer to follow State rating
standards with respect to rating factors
generally applicable in a State. With
respect to rate review, OPM’s proposal
reflected that some States have a prior
approval process for rates and the
authority to reject rates. Therefore, we
proposed to work closely with each
State in approving a rate for the MSPs
in that State and to consult with that
State about patterns in its markets and
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
about other rates that an MSPP issuer
might be proposing in that State for nonMSPs. In doing so, MSPP issuers would
be required to file rates with a State, but
the final decision regarding rates for
MSPs would rest with OPM, as required
by the statute. As described in proposed
§ 800.201(e) and (f), with respect to rate
review, OPM’s rate process and analysis
will be transparent to States in which
the MSP is operating. MSPP issuers will
be subject to a State’s rate review
process, including a State’s Effective
Rate Review Program established by
HHS pursuant to section 2794 of the
PHS Act and 45 CFR part 154. OPM
proposed that, for States with Effective
Rate Review Programs under section
2794 of the PHS Act, the MSPP issuer
would comply with the State standards.
In addition, OPM proposed that in
States where HHS is reviewing rates,
HHS would accept the judgment of
OPM for MSP rates. Furthermore, MSPP
issuers must comply with the reporting
and disclosure requirements for all rate
justifications to HHS, States, and
Exchanges, such as the requirements set
forth in 42 CFR 156.210(c). In the event
that a State withholds approval of an
MSP rate for reasons that OPM
determines, in its discretion, to be
arbitrary, capricious, or an abuse of
discretion, the Act authorizes the
Director to make the final decision to
approve rates for participation in the
MSPP, notwithstanding the absence of
State approval.
Finally, OPM proposed that MSPP
issuers must comply with section
1312(c)(1) and (2) of the Affordable Care
Act and implementing regulations,
which provide that a health insurance
issuer consider all enrollees in all nongrandfathered health plans in the
individual market to be members of a
single risk pool and all enrollees in nongrandfathered health plans in the small
group market to be members of a single
risk pool within a State. With proposed
§ 800.201(g), OPM clarified that an
MSPP issuer must consider MSP
enrollees to be members of the same risk
pool as all other enrollees of the issuer
in non-grandfathered health plans in the
individual and small group markets,
respectively. OPM received several
comments on our general standards
related to MSPP rate setting and review
policies applicable to an MSPP issuer
and related to compliance with sections
2701 and 2794 of the PHS Act.
Comments: Many commenters
supported the general rate review
approach set out for the MSPP, such as
compliance with State rate review
processes, single risk pool, calculation
of AV, and State-based rating. Most of
these commenters were concerned about
PO 00000
Frm 00018
Fmt 4701
Sfmt 4700
OPM retaining discretion to negotiate
premiums and having final approval of
rates. A few commenters noted that
there are administrative and judicial
remedies available under State law for
issuers who believe that rate approval
has been withheld for reasons that are
‘‘arbitrary, capricious, or an abuse of
discretion’’ and generally a State would
be violating its own laws if it were to
withhold for reasons that are ‘‘arbitrary,
capricious, or an abuse of discretion.’’
The commenters also noted that this
standard is broad and asked OPM to
narrow its scope. One commenter
suggested that if OPM were to bypass
these remedies, MSPs would be given
an unfair advantage over QHPs and
would be violating State law. A few
commenters recommended that OPM
not reserve discretion in States with
Effective Rate Review Programs. One
commenter believed OPM’s authority to
negotiate rates in section 1334 of the
Affordable Care Act is constrained by
sections 1324 and 1252.
Response: Based on support from
some commenters on our proposed
approach, we are adopting this section
as final, with modifications. Section
1334(a)(4) of the Affordable Care Act
explicitly authorizes the Director to
make the final decision to approve rates
for participation in the MSPP,
notwithstanding the existence or
absence of State approval. We are fully
aware of the complexities of rate review
in 2014 and subsequent years, and we
intend to collaborate closely with HHS
and States on MSP rates. We agree with
comments that MSPP issuers should use
the remedies available under State laws
related to rate review decisions. OPM
will require MSPP issuers to allow the
rate review process in States, including
administrative and judicial remedies, to
proceed unless the timeline for
administration of the MSPP is
threatened. In order to give MSPP
issuers adequate time to prepare for
open enrollment periods, we maintain
our discretion to issue final decisions on
MSP rates. For this reason, we are
revising § 800.201(f) to clarify that OPM
would exercise its discretion only in the
event that the State’s action would
impede the Federal objective by
preventing OPM from operating the
MSPP. In addition, we are removing
from the final regulation the ‘‘arbitrary,
capricious, or an abuse of discretion’’
language, based on the comments we
received. We expect that the Director
will rarely, if ever, have to exercise this
authority to disapprove or approve MSP
rates over the approval or non-approval
of a State.
We disagree with the interpretation
that sections 1324 and 1252 constrain
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
OPM’s authority to negotiate premiums.
Were we to interpret these sections in
the manner suggested by the
commenter, section 1334(a)(4) of the
Affordable Care Act, which requires the
Director to ‘‘negotiate[] * * * with each
multi-state plan * * * the premiums to
be charged,’’ would be rendered
inoperative. Section 1324(b)(2) refers to
‘‘rating.’’ OPM has defined ‘‘rating’’ for
purposes of section 1324(b)(2) to require
compliance with the rating factors
permitted by the PHS Act as detailed in
§ 800.202. Rating factors refer to the
factors issuers must use to develop their
premiums. With regard to the MSPP, we
do not consider ‘‘rating’’ to be the same
as ‘‘rate review.’’ Rate review is a
broader concept and is a necessary
component of premium negotiation. As
mentioned above, we intend to conduct
our own process to review rates, and
each State will have the opportunity to
review the MSP rates under its own
procedures. We intend to work
cooperatively with the States, and have
coordinated our policy with HHS.
In addition, the MSPP will comply
with section 1252 of the Affordable Care
Act. That section, entitled ‘‘Rating
Reforms Must Apply Uniformly * * *’’
requires rating reforms adopted by a
State pursuant to title I of the Affordable
Care Act to apply uniformly within a
market. Rating reforms, again, do not
equate to ‘‘rate review’’ processes.
Rather, consistent with OPM’s
interpretation of ‘‘rating’’ for purposes
of section 1324(b)(2), rating reforms
refer to reforms that constrain the
factors upon which issuers rely to
develop their premiums. Section 1252
does not constrain the Director’s power
to negotiate rates with MSP issuers
under section 1334(a)(4).
Comment: In addition, the same
commenter indicated its view that
section 1252 constrains network
adequacy rules.
Response: OPM does not agree with
this comment, as section 1252 is limited
in its scope to rating reforms.
Comment: This commenter further
indicated that section 1301(a)(2) applies
with ‘‘equal force’’ to MSPP issuers.
Response: While OPM acknowledges
that QHP standards generally apply to
the MSPP, section 1334(c) specifically
reserves to the Director the discretion to
determine whether QHP rules are
satisfied in the context of the MSPP.
Therefore, OPM does not agree that
section 1301(a)(2) causes QHP rules to
apply to MSPP ‘‘with equal force,’’ as
they do not apply in the same manner
with respect to enforcement.
Comment: One commenter asked
OPM to clarify that the single risk pool
standard proposed in the rule applies to
VerDate Mar<15>2010
19:06 Mar 08, 2013
Jkt 229001
MSPP issuers’ pools within a State and
not across States.
Response: Our intent was for an
MSPP issuer to consider all enrollees in
an MSP to be in the same risk pool as
all enrollees in all other nongrandfathered health plans in the
individual market or small group
market, respectively, in compliance
with section 1312(c) of the Affordable
Care Act as well as HHS regulations
implementing that section. Consistent
with HHS guidance, we affirm that
MSPP issuers will pool risk within a
State and not across States, but we do
not believe a change in the regulatory
text is needed.
Comments: Some commenters
suggested that OPM establish rules and
conditions that will facilitate tribal
sponsorship, to allow tribes to perform
premium aggregation for individuals to
enroll in MSPs.
Response: We are exploring whether
potential issuers have the capacity to
perform premium aggregation and/or
accept aggregated premiums. In the
MSPP issuer application, OPM will ask
applicants to indicate whether they
have this capacity and will take the
applicants’ responses into consideration
when negotiating contracts.
Rating Factors (§ 800.202)
The proposed § 800.202 required
MSPP issuers to comply with section
2701 of the PHS Act, as amended by the
Affordable Care Act. We proposed in
§ 800.202(a) that MSPP issuers must
comply with requirements setting
standards for fair health insurance
premiums appearing in HHS
regulations. In addition, we proposed
that MSPP issuers must follow
standards set for rating areas in a State
established under any HHS or State
regulations implementing section 2701
of the PHS Act. OPM received
numerous comments related to rating
standards and factors from States,
consumer organizations, and issuers.
Comments: Many commenters
supported the general approach we
proposed that MSPP issuers must
comply with Federal standards and
more narrow State standards for rating
factors. A few commenters asked OPM
to clarify the requirement that MSPP
issuers use the age curves established
under Federal regulations implementing
section 2701(a), including that an MSPP
issuer must also use any age curve
established by a State pursuant to 45
CFR 147.103(e).
Response: We clarify that our intent is
for an MSPP issuer to use any age curve
established by a State pursuant to 45
CFR 147.103(e). In the event that a State
does not establish an age curve, the
PO 00000
Frm 00019
Fmt 4701
Sfmt 4700
15577
MSPP issuer would use the standard age
curve established by HHS. We are
amending proposed § 800.202(c)(2) to
reference State-established age curves.
Comments: A few commenters
requested that OPM have MSPP issuers
comply with PHS Act section 2705 and
its implementing regulations on
incentives for nondiscriminatory
wellness programs in group health plans
pursuant to 45 CFR parts 146 and 147,
29 CFR part 2590, and 26 CFR part 54.
Response: We agree with the
commenters and their suggestion.
Accordingly, we have added a
paragraph (f) to § 800.202 to require
MSPP issuers offering group health
plans to comply with section 2705 of
the PHS Act and any implementing
Federal or State regulations. We believe
this appropriately resolves the concerns
of commenters.
Comments: Some commenters urged
OPM to clarify how MSPP issuers will
define ‘‘family’’ as it applies to coverage
and rating. Specifically, commenters
recommended OPM coordinate with
HHS to ensure that the coverage and
rating requirements established by HHS
under section 2701 clearly apply to
MSPs, adopt broad definitions for
minimum categories for family policies,
and adopt four types of family coverage
categories: Individual; two adults; adult
plus child(ren); and two-adult with
child(ren) or other family composition.
Response: The proposed rule did not
require specific standards around
categories of family members, and
intended to coordinate MSPP standards
with HHS standards published at 45
CFR part 147. Therefore, the final rule
does not specify the minimum
categories of family members that must
be rated in a family policy.
However, we encourage MSPs to
provide the same benefits for all family
compositions, including but not limited
to same-sex domestic partners and their
children. We note that individuals not
eligible for family coverage will be able
to purchase individual coverage on a
guaranteed issue basis.
While we intend to administer the
MSPP in a manner that supports a broad
definition of family coverage categories,
we are finalizing the proposed provision
without a change. We must coordinate
our approach in applying rating factors
consistent with HHS guidance and State
law, and as a result will implement the
policy for extending coverage rules so
that they apply to a broad definition of
family coverage categories through the
MSPP contract negotiation process.
Medical Loss Ratio (§ 800.203)
The proposed rule requires MSPP
issuers to attain the medical loss ratio
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15578
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
(MLR) in section 2718 of the PHS Act.
The proposed rule also codifies section
1334(a)(4) of the Affordable Care Act,
which gives OPM the explicit authority
to negotiate premiums, profit margins,
and an MLR by allowing OPM to set an
MSP-specific MLR that is either in the
interest of MSP enrollees or conforms to
State MLR standards. Failure to attain
the MLR could result in intermediate
sanctions, which include, but are not
limited to, suspension of marketing,
decertification in one or more States, or
termination of an MSPP issuer’s
contract.
Comments: Several commenters
expressed support for OPM’s approach.
Commenters supported an MLR
calculation that was State-based, rather
than nationwide. Commenters also
supported pooling MSP and non-MSP
experience in MLR calculation.
Response: OPM is retaining in the
final rule its approach to have MSPP
issuers calculate MLR on a State-byState basis as well as pool MSP and
non-MSP experience within a State.
Comments: Several commenters
expressed concern that OPM having
authority to set an MSP-specific MLR
different from the State or Federal
standard could give MSPs an advantage
over QHPs.
Response: OPM recognizes the
concerns of States and other
stakeholders regarding authority to set
an MLR standard for the MSPP.
However, section 1334(a)(4)(B) of the
Affordable Care Act explicitly grants
OPM legal authority to negotiate an
MLR with each MSP. As a matter of
policy, however, OPM does not foresee
exercising the authority to set an MSPspecific MLR. If OPM were to consider
implementing an MSP-specific MLR, it
would only be under extraordinary and
rare circumstances, and after consulting
with the State.
Comment: A commenter was
concerned that OPM may decertify an
MSP mid-year for failing to meet the
applicable MLR standard.
Response: While OPM has the
authority to decertify an MSP at any
time, we do not want to disrupt State
insurance markets or harm consumers.
Decertifying an MSP is one of many
compliance actions OPM proposed in
the rule. We want to clarify that OPM
would only decertify an MSP mid-year
under unusual circumstances, such as
widespread and repeated failure to
comply with the legal or MSPP
contractual requirements. Before
decertifying an MSP, we would consult
with a State and/or HHS, as appropriate,
to avoid market disruption and protect
consumers. Our approach to compliance
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
actions is discussed in more detail in
relation to § 800.404.
Comment: One commenter requested
that MSPP issuers pay a rebate in
addition to other MLR sanctions.
Response: MSPP issuers, like all
health insurance issuers regulated by
HHS, are subject to the MLR rebate
requirements under the Affordable Care
Act, and OPM will not require
additional rebates.
Comment: One commenter wants
MSPP user fees to qualify for MLR
inclusion.
Response: This final rule clarifies in
§ 800.108 that MSPP user fees will be
part of the State-based Exchange or
Federally-facilitated Exchange user fee.
According to technical guidance
document CCIIO 2012–002, released
April 20, 2012, by HHS, Exchange user
fees are subtracted from premiums in
the MLR calculation, as are all other
Federal and State regulatory and
licensing fees. MSPP user fees,
therefore, will not be included in the
MLR calculation.
We are adopting § 800.203 of the
proposed rule as final, with one
technical correction in paragraph (b),
relating to the sanctions for not attaining
the required medical loss ratio.
Reinsurance, Risk Corridors, and Risk
Adjustment (§ 800.204)
The proposed § 800.204 would
require MSPP issuer participation in the
transitional reinsurance program in the
individual market, risk adjustment
program, and temporary risk corridors
program to ensure that all issuers have
the same fiscal responsibilities and
protections. OPM proposed that MSPP
issuers be required to participate in the
transitional reinsurance program for the
individual market established pursuant
to section 1341 of the Affordable Care
Act, and comply with HHS standards
set forth in 45 CFR part 153 and, if
applicable, any State regulations
implementing the program. OPM also
proposed that an MSPP issuer must
participate in the temporary risk
corridors program established pursuant
to section 1342 of the Affordable Care
Act and comply with 45 CFR part 153,
as well as any additional HHS standards
implementing the program. Finally,
OPM proposed that an MSPP issuer
must participate in the risk adjustment
program established pursuant to section
1343 of the Affordable Care Act and
comply with HHS standards set forth in
45 CFR part 153 and, if applicable, any
State standards implementing the
program.
Comments: The majority of the
comments we received supported
OPM’s approach to requiring MSPP
PO 00000
Frm 00020
Fmt 4701
Sfmt 4700
issuers to participate, like QHP issuers,
in the transitional reinsurance program,
risk adjustment program, and temporary
risk corridors program. States, consumer
organizations, and issuers supported the
general approach OPM proposed that
MSPP issuers must comply with Federal
standards and State standards, if
applicable, in the administration of the
reinsurance program and risk
adjustment program. One commenter
suggested OPM has legal discretion to
allow a church health plan offered
through the MSPP to vary premiums to
adjust for risk across its enrollees, using
risk adjustment criteria related to
Medicare Part D and Medicare
Advantage plans.
Response: OPM appreciates the
comments and is adopting the proposed
regulation as final, with two technical
corrections. First, in § 800.204(b), we are
changing ‘‘any applicable Federal or
State regulations under that section’’ to
‘‘any applicable Federal regulations
under that section’’ because HHS will be
operating the temporary risk corridors
program. Second, we are correcting an
editorial error in paragraph (c) of
§ 800.204 by changing ‘‘An MSPP issuer
must comply with participate in the risk
adjustment program established
pursuant to section 1343 of the
Affordable Care Act’’ to ‘‘An MSPP
issuer must comply with section 1343 of
the Affordable Care Act’’.
Finally, we do not agree with the
commenter’s analysis that OPM would
have legal discretion to allow a church
health plan offered through the MSPP to
vary premiums to adjust for risk across
its enrollees, using risk adjustment
criteria related to Medicare Part D and
Medicare Advantage plans. Therefore,
we are not adopting this suggestion.
Subpart D—Application and
Contracting Procedures
In subpart D of proposed 45 CFR part
800, OPM set forth proposed processes
for accepting and evaluating
applications to participate in the MSPP
and for executing contracts to offer
coverage under the MSPP. In general,
these processes were designed based on
OPM’s experience in the operation of
the FEHBP while reflecting the unique
aspects of the MSPP, as directed in
section 1334 of the Affordable Care Act.
Subpart D includes sections relating to
an application process, review of
applications, MSPP contracting, term of
the contract, contract renewal process,
and nonrenewal. OPM received both
general comments on this subpart and
specific comments on several sections.
We address first the general comments
on the subpart, followed by comments
on specific sections within the subpart.
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
Any regulatory changes are noted
within the discussion of each section.
Comment: One commenter requested
additional information on the
application and contracting procedures,
including form, manner, and timeline
for submission and review of
applications, contracting, and renewal
of contracts.
Response: OPM has released a final
paper application setting forth the
information that we will collect from
health insurance issuers that apply to
become MSPP issuers, available on the
Federal Business Opportunities Web
site at www.FBO.gov under solicitation
number OPM35–12–R–0006, Multi-State
Plan Program. The final paper
application was posted on January 18,
2013. The solicitation notes that OPM
expects to begin receiving application
material from issuers in February 2013,
and instructs issuers to submit a notice
of intent to apply to receive access to
the MSPP Portal, through which issuers
will submit the requested information to
OPM electronically.
Due to the generally compressed
deadlines for the first year of this
program and the first years of operation
of many Exchanges, timelines may vary
from one year to the next. We therefore
will not establish rigid timelines in this
regulation, but will evaluate MSPP
timelines and address them through
guidance. Similarly, we intend to share
additional information on initial
execution and renewal of contracts
through guidance.
Comments: A few commenters
recommended that OPM incorporate
States and Exchanges into the process of
evaluating applicants and negotiating
contracts with issuers. Specifically,
commenters noted that some Exchanges
will employ an ‘‘active purchaser’’
model, whereby QHP certification will
depend on a contract between a QHP
issuer and the Exchange, and
recommended that OPM address this
model in its application and contracting
procedures. Other commenters voiced
concern that the absence of State
representation in application and
contracting procedures, including
evaluation of rate and benefit proposals,
would result in inconsistent application
of State insurance laws and regulations.
Response: OPM is directed by section
1334 of the Affordable Care Act to enter
into contracts with health insurance
issuers, and to do so in a manner similar
to the manner in which contracting
provisions under the FEHBP are
implemented. The Affordable Care Act
also provides for deemed certification of
MSPs by virtue of an MSPP contract. We
acknowledge that States will retain
responsibility for the enforcement of
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
their insurance laws and regulations,
and we will continue to develop
relationships with States’ Departments
of Insurance and Exchange authorities
to collaborate to ensure that MSPs may
be offered on Exchanges without
creating market disruptions.
Based on the phased expansion
provisions of section 1334 of the
Affordable Care Act and of § 800.104 of
this regulation, we do not expect each
MSPP issuer to offer an MSP on each
Exchange in 2014. We will
communicate with appropriate State
officials on an ongoing basis regarding
the MSPs that we expect to certify.
Application and Contracting Procedures
(§ 800.301)
In § 800.301, we proposed that a
health insurance issuer may submit an
application to OPM to participate in the
MSPP. We specified that such
applications would meet guidelines to
be released regarding the form and
manner of applications, and the
timeline for submission. OPM received
a few comments specifically addressing
this section.
Comment: One commenter noted the
absence of specific timeframes in the
proposed regulation and requested that
such timeframes allow each State to
perform its ‘‘traditional role’’ in
regulating health insurance products.
Response: As discussed in greater
depth regarding subpart C of this
regulation, OPM intends to collaborate
with appropriate State officials
regarding the review and approval of
rates and benefits. We intend to be as
flexible as possible to ensure that each
State has adequate opportunity to
review MSP documentation as
appropriate.
Comment: One commenter
recommended that OPM ensure that
issuers’ proprietary information be
protected from information requests,
including under the Freedom of
Information Act (FOIA).
Response: We acknowledge that
certain information given to OPM by
applicant issuers may be proprietary,
and should therefore not be subject to
public inspection. Applicants will be
given an opportunity to mark submitted
information as confidential, pursuant to
instructions that will accompany the
application in the MSPP Portal, subject
to the limits of FOIA and its
implementing regulations.
OPM does not believe that any of
these comments require any changes in
the regulatory text. Therefore, we are
adopting proposed § 800.301 as final,
with no changes.
PO 00000
Frm 00021
Fmt 4701
Sfmt 4700
15579
Review of Applications (§ 800.302)
Proposed § 800.302 provided that an
issuer that has applied under § 800.301
may be accepted to enter into contract
negotiations if OPM determines that the
applicant meets the requirements of part
800; that OPM may request additional
information from issuers in making such
a determination; that OPM will inform
the applicant in writing if OPM declines
to enter into contract negotiations with
the applicant; that OPM alone may
determine whether an application is to
be accepted or declined; and that a
declined applicant may apply for a
subsequent year. OPM received no
specific comments on this section.
Therefore, we are adopting proposed
§ 800.302 as final, with no changes.
MSPP Contracting (§ 800.303)
In proposed § 800.303, OPM provided
that, to become an MSPP issuer, an
applicant must execute a contract with
OPM; that OPM would establish a
standard contract for the MSPP; that
OPM and an applicant would negotiate
premiums for each plan year; that OPM
would review for approval an
applicant’s benefit packages; that OPM
may negotiate additional contractual
terms and conditions; and that MSPP
issuers would be certified to offer MSP
coverage on Exchanges.
Comments: Several commenters
recommended that I/T/Us be
contractually allowed to participate in
MSP networks as providers, and that
MSPP issuers comply with Federal laws
governing I/T/Us.
Response: OPM will address the
specific terms of the MSPP standard
contract through a development process
following the publication of this final
rule. We acknowledge the unique
concerns of I/T/Us, and we intend to
address them, to the extent practicable,
through contractual terms.
Comment: One commenter
recommended that OPM adopt for the
MSPP the same transparency and passthrough pricing standards and
requirements that exist under the
FEHBP for PBMs.
Response: As noted above, OPM will
address specific contract terms through
a process following the publication of
this rule. Such terms will include
standards and requirements for PBMs.
Comments: A few commenters
suggested that OPM’s proposed
contracting process would be
duplicative of State regulatory or
Exchange processes or would
circumvent such processes. One
commenter recommended that MSPP
issuers be required to attest to
compliance with all State laws as a
E:\FR\FM\11MRR3.SGM
11MRR3
15580
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES3
condition of certification. Another
commenter recommended that issuers
be required to attest to understanding
and compliance with a specific State
law as a condition of contracting. One
commenter recommended that MSPP
contracts incorporate consultation with
State-based Exchanges to measure
performance and compliance.
Response: In general, MSPP issuers
will be expected to comply with State
laws and regulations. Although we
intend to monitor such compliance and
to evaluate contract performance in part
on such compliance, we decline to
specifically list State laws with which
issuers must comply. Specifically listing
laws with which an issuer must comply
may have the unintended result of
implying that an issuer need not comply
with unlisted laws and regulations, and
OPM cannot list every relevant State
law with which an MSPP issuer must
comply.
We intend to promote information
sharing between OPM and States, and
OPM will measure MSP performance
using standards similar to those
measured under the FEHBP. Sharing
information with States will help ensure
that MSPs meet comparable standards to
QHPs in the same markets and that
issuers comply with State laws. By
measuring contract quality assurance
standards across MSPs, OPM will be
able to ensure that MSPs are of
comparably high quality across States.
We will set forth the specific standards
that MSPs will be expected to meet in
the model MSPP contract.
We are adopting proposed § 800.303
as final, with the inclusion of a minor
editorial correction.
Term of the Contract (§ 800.304)
In § 800.304, we proposed that the
term of an MSPP contract be for a period
of at least 12 consecutive months, as set
forth in the MSPP contract; that a plan
year be a consecutive 12-month period
during which an MSP provides coverage
for health benefits; and that a plan year
may be a calendar year or other 12month period.
Comment: One commenter
recommended that the term of the MSPP
contract coincide with the calendar year
so that MSP plan years and open
enrollment periods would coincide with
those of QHPs, which would preserve a
level playing field.
Response: In § 800.20, we are
adopting the definition of ‘‘plan year’’
established by HHS at 45 CFR 155.20.
Section 800.101 states that MSPs will
comply with the same standards for
eligibility, enrollment, and termination
of coverage as QHPs on the same
Exchange. Open enrollment periods for
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
MSPs, therefore, will coincide with
those of QHPs.
Comment: One commenter
recommended that OPM adopt an initial
contract term of 3 to 5 years, rather than
1 year.
Response: We acknowledge that
participation in the MSPP may require
significant initial investment on the part
of MSPP issuers, and that a longer
contract term may assure issuers that
such investment may require several
years of participation in the program to
become cost-effective. OPM has
modeled the application and contracting
procedures in subpart D after those used
in the FEHBP, including the
automatically renewable nature of
contracts. We anticipate that all MSPP
issuers will participate in the program
for many contract terms. However, rates
and benefits will be revised each year,
and some terms of the MSPP contract
may need to be updated from one term
to the next. Therefore, the contract term
will be 1 year.
We are adopting proposed § 800.304
as final, with no changes.
Contract Renewal Process (§ 800.305)
In proposed § 800.305, we set forth a
process by which OPM and an MSPP
issuer would renew an MSPP contract,
including the issuer’s submission of
information to OPM and criteria for a
determination by OPM of whether to
renew the contract. This section also
provides that if OPM and the issuer fail
to agree to premiums and/or benefits
with respect to an MSP on an Exchange,
the contract may nevertheless be
renewed with the same premiums and
benefits in effect for the previous term.
OPM received no comments directly
addressing this section. Therefore, we
are adopting proposed § 800.305 as
final, with no changes.
Nonrenewal (§ 800.306)
In § 800.306, we proposed that either
OPM or an issuer could decline to
renew an MSPP contract at the end of
a plan year by timely notifying the other
party and MSP enrollees.
Comments: Some commenters
recommended lengthening the period of
notice to enrollees of nonrenewal from
90 days to 180 days.
Response: OPM proposed that issuers
would be required to notify enrollees of
nonrenewal of an MSPP contract no
fewer than 90 days prior to the date on
which coverage would end. The
proposed 90-day period was taken from
the same requirement in the FEHBP.
Conversely, Exchanges may have notice
periods as short as 30 days. As noted at
§ 800.306(c), the 90-day requirement
would only take effect in the absence of
PO 00000
Frm 00022
Fmt 4701
Sfmt 4700
an Exchange rule requiring a different
notice period.
Comments: Some commenters
recommended that OPM require issuers
to assist MSP enrollees who will lose
their coverage to find new coverage.
One commenter recommended that
OPM defer to a determination by the
Centers for Medicare and Medicaid
Services that a QHP issuer must
continue to offer coverage outside of an
Exchange.
Response: Enrollment of individuals
in QHPs following nonrenewal of an
MSPP contract falls outside of the
responsibilities set forth at section 1334
of the Affordable Care Act. However, as
noted throughout this regulation, we
look forward to working collaboratively
with States and Exchanges to best serve
consumers, including by ensuring
cooperation with efforts to assist
enrollees who lose MSP coverage.
Comments: A few commenters
recommended that OPM clarify the
language of paragraph (c) to require
issuers to comply with any State law
requirements relating to nonrenewal of
coverage and withdrawal from an
Exchange market.
Response: Proposed § 800.306(c)
states that an MSPP issuer must comply
with ‘‘any requirements imposed by an
Exchange with respect to the
termination of a QHP * * *’’ Such
requirements would include a State law
requirement relating to nonrenewal of
coverage or withdrawal from an
Exchange market. Therefore, no change
to § 800.306 is necessary.
Comment: One commenter noted that
§ 800.404(d), like § 800.306(c), addresses
notice to enrollees who will lose
coverage due to an MSP ceasing to be
offered on an Exchange, and
recommended using the same language
in both sections.
Response: We agree that the language
should be the same in both sections.
OPM is adopting proposed § 800.306
as final, with one change. Paragraph (c)
will be revised as follows, to include a
technical, clarifying edit: ‘‘The MSPP
issuer’s written notice of nonrenewal
must be made in accordance with its
MSPP contract with OPM. The MSPP
issuer also must comply with any
requirements regarding the termination
of a plan that are applicable to a QHP
offered on an Exchange on which the
MSP was offered, including a
requirement to provide advance written
notice of termination to enrollees. If an
Exchange does not have requirements
about advance written notice of
termination to enrollees, the MSPP
issuer must inform current MSP
enrollees in writing of the nonrenewal
of the MSP no later than 90 days prior
E:\FR\FM\11MRR3.SGM
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES3
to termination of coverage, unless OPM
determines that good cause justifies less
than 90 days’ notice.’’ We will also
revise § 800.404(d) to mirror this
language.
Subpart E—Compliance
In subpart E of the proposed rule,
OPM set forth standards and
requirements with which MSPP issuers
must comply and a non-exhaustive list
of actions OPM may take to enforce
provisions of an MSPP contract. Like
subpart D, these standards,
requirements, and compliance actions
have been designed based on OPM’s
experience in the operation of the
FEHBP, while reflecting the unique
aspects of the MSPP, as required by
section 1334 of the Affordable Care Act.
Subpart E addresses contract
performance, contract quality assurance,
fraud and abuse, compliance actions,
and a process for reconsideration of
compliance actions. OPM received both
general comments on this subpart and
specific comments on several sections.
We address first the general comments
on this subpart, followed by comments
on specific sections within this subpart.
Any regulatory changes are noted
within the discussion of each individual
section.
Commenters on this subpart included
States and State Exchange authorities,
plan/issuer associations, consumer
advocacy organizations, and a public
policy advocacy organization.
Comments on this subpart generally
supported the overall structure of
contract compliance under the MSPP,
and several offered specific suggestions
for improvement. We received one
comment regarding cost accounting
systems that is outside the scope of this
rulemaking.
Comments: Some commenters
recommended adding specific
requirements, such as network
adequacy, to one of the sections of this
subpart as a contract performance
standard, a contract quality assurance
standard, or a basis for a compliance
action.
Response: OPM acknowledges the
importance of requirements and
consumer protections like network
adequacy, and addressed network
adequacy in § 800.109 of the proposed
rule. We have set forth other provisions
in this regulation that we intend to
enforce through contractual measures
and compliance actions; this subpart is
structured to provide OPM the authority
to do so in a manner similar to the
administration of the FEHBP. In
particular, § 800.404(a)(1) lists as a
cause for OPM to impose a compliance
action a failure by the MSPP issuer to
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
meet the requirements of § 800.401(a),
which includes any violation of section
1334 of the Affordable Care Act or these
regulations. Therefore, a violation of
network adequacy standards, or any
other MSPP standard or requirement,
would constitute cause for a compliance
action.
Comments: A few commenters
recommended that review of financial
resources, records, novation and change
of name agreements, and claims
processing practices be left solely to
States, and that OPM rely on States to
communicate findings regarding these
matters. One commenter noted States’
experience in measurements of these
kinds. Another commenter
recommended establishing a notice and
communication process between OPM
and the States and Exchanges to ensure
MSPP issuers comply with State laws as
well as OPM’s standards and
requirements.
Response: We acknowledge States’
expertise in measuring performance and
compliance, and, as noted above in our
responses to comments on subpart D,
we look forward to working with States
to ensure compliance and comparability
within States as well as across States.
We also note that OPM has more than
50 years of experience administering the
FEHBP, which includes measurement of
numerous performance standards,
contract quality assurance measures,
and compliance actions. Section 1334 of
the Affordable Care Act directs OPM to
implement this program in a manner
similar to the manner in which the
contracting provisions of the FEHBP are
implemented, which includes the
compliance measures set forth in
subpart E.
Contract Performance (§ 800.401)
In proposed § 800.401, we set forth
requirements for MSPP issuers,
including that the issuer must comply
with section 1334 of the Affordable Care
Act and with the provisions of this
regulation; that it must meet minimum
threshold issuer standards; that it must
demonstrate specified prudent business
practices; that it must not engage in
specified poor business practices; and
that OPM may collect an assessment to
a performance escrow account. OPM
received several comments specifically
addressing this section.
Comment: One commenter
recommended that these regulations
reflect OPM’s commitment to the
protection of enrollees’ private and
confidential information. Specifically,
the commenter recommended that we
require issuers to comply with Fair
Information Practice Principles by
PO 00000
Frm 00023
Fmt 4701
Sfmt 4700
15581
listing failure to comply with such
Principles as a poor business practice.
Response: We appreciate the need to
protect private and confidential
information in the MSPP. Personally
identifiable information (PII) and
protected health information (PHI) are
protected by the Health Insurance
Portability and Accountability Act
(HIPAA) and the Privacy Act of 1974, as
well as contractual provisions that will
mirror those used under the FEHBP. By
ensuring compliance with these laws
and provisions, OPM will adequately
protect PII and PHI.
Comments: Several commenters
recommended adding to the list of
‘‘poor business practices’’ failure to
properly pay I/T/Us in compliance with
25 U.S.C. 1621e and the cost-sharing
protections under section 1402 of the
Affordable Care Act.
Response: The list of ‘‘poor business
practices’’ does not include failures to
comply with specific laws. This
regulation, at § 800.102, addresses
compliance with Federal and State laws.
Section 800.404(a)(4) permits OPM to
impose a compliance action for any
violation of law or regulation. We will
address compliance more specifically in
the terms of MSPP contracts.
Comment: One commenter
interpreted the list of ‘‘poor business
practices’’ to include innovative
payment arrangements or delivery
models such as Accountable Care
Organizations (ACOs) or PatientCentered Medical Homes (PCMHs), and
recommended that such models not be
prohibited.
Response: The list of ‘‘poor business
practices’’ does not address health care
delivery models. The list includes
‘‘[e]ntering into contracts or
employment agreements * * * that
include provisions or financial
incentives that directly or indirectly
create an inducement to limit or restrict
communication about medically
necessary services to any individual
covered under the MSPP.’’ Limitation of
communication about medically
necessary services to enrollees is not an
innovative payment arrangement or
delivery model, and is not a feature of
an ACO or PCMH.
Comments: A few commenters
recommended against requiring issuers
to contribute to a performance escrow
account. One commenter requested
clarification that OPM’s proposal to
reserve authority to require MSPP
issuers to contribute to a performance
escrow account is limited to MSPP
issuers, presumably as opposed to QHP
issuers; that contributions would be
based on premiums rather than a flat
fee; that contributions be assessed at the
E:\FR\FM\11MRR3.SGM
11MRR3
15582
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
beginning of the year; and that any
refunds be remitted to consumers
similarly to MLR rebates.
Response: We continue to explore
establishing a performance escrow
account to use in enforcement of MSPP
contracts. OPM may develop more
specific policies to begin using such an
account no sooner than 2015. We will
issue specific guidance on the
operations of a performance escrow
account well in advance of the date on
which it takes effect.
We are adopting proposed § 800.401
as final, with no changes except for
minor technical edits.
mstockstill on DSK4VPTVN1PROD with RULES3
Contract Quality Assurance (§ 800.402)
In proposed § 800.402, we set forth
general policies and procedures to
ensure that MSPP contracts conform to
quality standards and requirements,
specifically with respect to the issuer’s
internal controls and performance
standards to be set by OPM.
Comment: One commenter
recommended that OPM require MSPP
issuers to meet and comply with States’
quality assurance standards and
requirements. The commenter suggested
that OPM ensure such compliance by
requiring MSPP issuers to contract with
each State, in addition to contracting
with OPM, or by inserting regulatory
text.
Response: As noted throughout our
responses to comments, we appreciate
the need for coordination with States to
ensure that MSPs are comparable to a
QHP offered on the same Exchange.
Requiring MSPP issuers to enter into a
contract with Exchanges would
circumvent section 1334(d) of the
Affordable Care Act, which vests
certification authority for MSPs in OPM
rather than State Exchanges by
providing that MSPs offered under a
contract with OPM are deemed to be
certified by an Exchange. We intend to
hold MSPs to performance standards
that are comparable to those set for
QHPs by States and Exchanges. OPM
will establish and enforce these
standards through contractual
negotiation and compliance.
We are adopting proposed § 800.402
as final, with no changes.
Fraud and Abuse (§ 800.403)
In proposed § 800.403, we required
MSPP issuers to maintain a program to
assess and address vulnerabilities to
fraud and abuse, to maintain a system
to detect and eliminate fraud and abuse,
and to provide certain information to
OPM. One commenter specifically
addressed this section, requesting
further information on the required
fraud detection system. We intend to set
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
forth specific standards and
requirements for systems to detect and
eliminate fraud and abuse in the model
MSPP contract. This does not require a
change in the proposed rule; therefore,
we are adopting § 800.403 of the
proposed regulation as final, with no
changes.
Compliance Actions (§ 800.404)
In § 800.404 of the proposed rule, we
set forth the bases for OPM to impose a
compliance action; the compliance
actions that OPM may impose; the
notices that OPM will send to issuers
upon imposition of a compliance action;
and the notices that issuers must send
to enrollees upon imposition of certain
compliance actions.
Comment: One commenter noted that
mid-year decertification of MSPs may
disrupt markets and harm consumers
and recommended that OPM clarify that
such a compliance action would be used
only when it is strictly necessary.
Response: We agree that mid-year
decertification creates potential for
disruption, and OPM would only
terminate or decertify an MSP if, in the
discretion of the Director, such action
was necessary. However, compliance
actions are discretionary, so the
regulatory text need not be modified to
reflect that those particular compliance
actions would not be routinely imposed.
Comment: One commenter
recommended using State performance
evaluations in reviewing MSP
performance and developing processes
to communicate with States and
Exchanges regarding compliance
actions.
Response: As noted above, we look
forward to working with States and
Exchanges to ensure that MSPs meet
appropriate standards within States and
across States. Because some compliance
actions directly affect Exchange
markets, we agree that Exchanges
should receive notice of such
compliance actions. Specifically,
regulatory text will be amended to
provide that OPM will notify State and/
or Exchange officials when we reduce
the service area or areas of an MSP in
the State, withdraw certification for an
MSP in the State, decline to renew the
MSPP contract under which an MSP is
offered in the State, or terminate the
MSPP contract under which an MSP is
offered in the State.
Section 800.404 of the proposed rule
is adopted as final, with two changes:
First, the following new paragraph
will be added after paragraph (c)(2): ‘‘(3)
Upon imposition of a compliance action
listed in paragraphs (b)(2)(iv) through
(b)(2)(vii) of this section, OPM must
notify the State Insurance
PO 00000
Frm 00024
Fmt 4701
Sfmt 4700
Commissioner(s) and Exchange officials
in the State or States in which the
compliance action is effective.’’
Second, pursuant to a comment on
subpart D of this regulation, we are
inserting language in paragraph (d) of
this section to add clarity and to
conform to the wording of § 800.306(c),
which sets forth a similar notice
requirement. The revised paragraph (d)
will read as follows: ‘‘If OPM terminates
an MSPP issuer’s MSPP contract with
OPM, or OPM withdraws the MSPP
issuer’s certification to offer the MSP on
an Exchange, the MSPP issuer must
comply with any requirements
regarding the termination of a plan that
are applicable to a QHP offered on an
Exchange on which the MSP was
offered, including a requirement to
provide advance written notice of
termination to enrollees. If an Exchange
does not have requirements about
advance written notice of termination to
enrollees, the MSPP issuer must inform
current MSP enrollees in writing of the
nonrenewal of the MSP no later than 90
days prior to termination of coverage,
unless OPM determines that good cause
justifies less than 90 days’ notice.’’
Reconsideration of Compliance Actions
(§ 800.405)
In proposed § 800.405, we set forth
the right of an MSPP issuer to request
reconsideration of the imposition of
certain compliance actions, the form
and manner of such a request, and
OPM’s notice to the issuer of a decision
upon reconsideration. One commenter
specifically addressed this section,
recommending that OPM notify States
of requests for reconsideration under
this section. As noted above, we intend
to communicate extensively with States
and Exchanges to ensure that MSPs
meet appropriate standards. No change
is needed in the wording of proposed
§ 800.405; therefore, we are adopting it
as final, with no changes.
Subpart F—Appeals by Enrollees for
Denials of Claims for Payment or
Service
In subpart F, we proposed a process
by which MSP enrollees (and
individuals acting on behalf of
enrollees) could seek an internal appeal
and external review of an adverse
benefit determination. The proposed
subpart included sections on general
requirements, MSPP issuer internal
claims and appeals processes, MSPP
issuer internal claims and appeals
timeframes and notice of determination,
external review, and judicial review.
The proposed regulation adopted the
standards and timeframes established
under section 2719 of the PHS Act, and
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
will be administratively similar to the
disputed claims process employed
within the FEHBP. By adopting the
standards and timeframes applicable to
health insurance issuers under the PHS
Act, we proposed to provide MSP
enrollees with comparable processes to
those that will apply to QHPs and other
coverage. In particular, the MSPP
external review process will include
binding final decisions by independent
review organizations (IRO) on enrollee
disputes that involve medical judgment
(including, but not limited to, those
based on medical necessity,
appropriateness, health care setting,
level of care, or effectiveness of a
covered benefit). The preamble to our
proposed rule noted that we intend to
issue further guidance explaining the
details of these processes.
As indicated in the proposed rule,
OPM has considerable experience in
resolving disputed claims pursuant to
OPM’s statutory authority under 5
U.S.C. 8902(j). Claims disputed by
FEHBP enrollees, generally governed by
5 CFR 890.105, are first submitted to
FEHBP carriers for an internal level of
reconsideration, and FEHBP carriers are
required to comply with the same
timeframes that are contained in section
2719 of the PHS Act. OPM then
externally reviews any FEHBP carrier
reconsideration decisions that enrollees
submit for OPM’s review—including
decisions related to medical judgment,
as well as decision related to
interpretation of contract coverage. This
process is central to OPM’s contractual
oversight of FEHBP carriers, allowing
OPM to determine whether the health
plan’s daily operations are functioning
appropriately and whether the plan’s
benefits are meeting enrollees’ needs,
which informs the following benefit
negotiation cycle. OPM reviews claims
efficiently; in 2012, 97 percent of all
FEHB disputed claims reviewed by
OPM were resolved by OPM within 60
days of being received.
Accordingly, in addition to engaging
an independent review organization for
final, binding decisions on MSPP claims
disputes involving medical judgments,
we have designed the external review
process for the MSPP to accommodate
final, binding decisions by OPM on
claims disputes involving interpretation
of contract coverage that does not
involve medical judgments.
Commenters on this subpart included
States, Exchanges, State associations,
consumer groups, provider groups,
pharmaceutical companies, and plan
and issuer groups. Several comments
were generally supportive of the
proposed approach, whereas some
commenters generally preferred specific
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
compliance with each separate State
process in each State. Some commenters
expressed support for the adoption of
the standards and timeframes applicable
under section 2719 of the PHS Act. A
few commenters recommended specific
changes. Below, we address first the
general comments on the approach
proposed in this subpart, followed by
the specific content of each section of
the final regulation.
Comments: Some commenters
suggested that consumers would be
confused by OPM’s approach, noting
that MSPs in some States would seek an
internal appeal or external review by
following a different process than a QHP
on the same Exchange. A few
commenters recommended that notices
to enrollees include contact information
for Consumer Assistance Programs
(CAPs) or Ombudsman offices available
to assist consumers in filing appeals.
Response: We believe the proposed
process adequately addresses the
potential for confusion in several ways.
First, MSP issuers must comply with the
internal claims and appeals process
under 45 CFR 147.136(b). Regarding
external review, MSP enrollees would
send any request for external review,
whether of a determination based on
medical judgment or otherwise, to OPM.
Some processes may call for resolution
of medical judgment determinations
separately from, for example,
determinations of whether a benefit is
covered under a plan. OPM plans to
ensure that this process will be
explained clearly in plan documents
and enrollee notices. Second, the
process will be administratively
operated based on the existing disputed
claims process under the FEHBP. We
have operated this process for more than
35 years across the country, alongside
health coverage that has been subject to
different appeals processes, (for
example, separate processes applicable
to ERISA plans, commercial insurance
products, non-Federal governmental
plans, or church plans). OPM has
nevertheless guided consumers through
the disputed claims process. Finally, we
will ensure that notices to enrollees are
accessible and meet the standards
established under section 2719 of the
PHS Act and its implementing
regulations.
We agree that notices should include
contact information for CAPs and
Ombudsman offices. Proposed
§§ 800.502 and 800.503 state that MSPP
issuers must comply with 45 CFR
147.136(b), which includes the
following provision at
§ 147.136(b)(2)(ii)(E)(4): issuers ‘‘must
disclose the availability of, and contact
information for, any applicable office of
PO 00000
Frm 00025
Fmt 4701
Sfmt 4700
15583
health insurance consumer assistance or
ombudsman established under PHS Act
section 2793 to assist individuals with
the internal claims and appeals and
external review processes.’’
Comments: Some commenters
objected to the proposed process in
general, preferring instead that MSP
enrollees be limited to the processes
available in their State. A few of those
commenters suggested that the proposed
approach may trigger the ‘‘level playing
field’’ provision at section 1324 of the
Affordable Care Act, as discussed under
§ 800.115 of this regulation.
Response: As noted in the preamble to
the proposed rule, our primary
objectives in establishing the internal
appeals and external review processes
are to ensure that (1) enrollees have
adequate access to review of adverse
benefit determinations and (2) OPM
collects the information necessary for
the enforcement of MSPP contracts and
implementation of the program. We
consider both objectives integral to the
implementation of the MSPP, and
therefore required under section 1334 of
the Affordable Care Act.
We have addressed the applicability
of the ‘‘level playing field’’ provision in
our responses to comments relating to
§ 800.115 of this regulation. As
explained in that discussion, our
approach to external appeals will not
trigger the level playing field provision
because MSPP issuers will be subject to
the same rules as other issuers: Section
2719 of the PHS Act and its
implementing regulations.
Comments: A few commenters
recommended that OPM require MSPP
issuers to comply with our proposed
process unless a State’s process is more
protective, in which case the more
protective State provisions would take
effect for MSP enrollees.
Response: Our proposed process
protects consumers by allowing us to
ensure that all MSP enrollees are able to
seek review of a broad range of
determinations, and that requests for
external review are resolved
consistently across the States. Although
States’ appeals processes, in many
cases, offer a different approach to
consumer protection, we believe that
our processes provide a comparable or
greater degree of protection, which
would apply uniformly across the States
for MSP enrollees.
Comments: A few commenters noted
that State regulatory agencies often use
external review as a means of
ascertaining information regarding
compliance with laws and regulations,
and recommended that we therefore
decline to establish a process that would
preclude States’ collection of such
E:\FR\FM\11MRR3.SGM
11MRR3
15584
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
information. Of those commenters, two
suggested that States provide OPM with
data and information to use for the
MSPP, and one requested that OPM
develop a process to share information
with States and Exchanges to facilitate
enforcement of State laws and
standards.
Response: As noted above, OPM
intends to use these processes to
monitor and enforce MSPP contracts.
We consider our ability to resolve
disputes arising under MSPP contracts
integral to our implementation of this
program. However, we recognize that
external review data and information
may also be important to State
regulatory agencies and Exchanges, and
we intend to share information collected
through this process, to the extent that
it is legally and operationally feasible,
with States and Exchanges. We look
forward to working in collaboration
with States and Exchanges to ensure
that the appropriate information is
shared seamlessly.
General Requirements (§ 800.501)
In this section, we set forth
definitions, and provide that an MSP
enrollee or a person acting on behalf of
an MSP enrollee may seek review of an
adverse determination under this
program. We are adopting proposed
§ 800.501 as final, with no changes.
mstockstill on DSK4VPTVN1PROD with RULES3
MSPP Issuer Internal Claims and
Appeals Processes (§ 800.502) and
MSPP Issuer Internal Claims and
Appeals Timeframes and Notice of
Determination (§ 800.503)
In § 800.502, we provided that an
MSPP issuer must comply with internal
claims and appeals processes applicable
under 45 CFR 147.136(b). In § 800.503,
we provide that an MSPP issuer must
comply with notice requirements under
45 CFR 147.136(b) and (e) upon
rendering a determination on a claim
under § 800.502. We are not making any
substantive changes in these sections;
however, because they are so closely
related, we have decided to combine
§§ 800.502 and 800.503 into a single
section numbered 800.502, with
paragraph (a) of § 800.502 containing
the content of proposed § 800.502, and
paragraph (b) of § 800.502 containing
the content of proposed § 800.503.
External Review (§ 800.504)
In § 800.504, we proposed an external
review process under which OPM
would conduct external review of
adverse benefit determinations under
the MSPP, enrollees would receive
notices pursuant to 45 CFR 147.136(e),
and MSPP issuers would be required to
pay a claim or provide a service
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
pursuant to a final decision by OPM or
an IRO. In the proposed rule, we
referred to the State external review
process under standards in paragraph
(c)(2) of the appeals regulation, 45 CFR
147.136(c)(2). The standards outlined in
paragraph (c)(2), however, expressly
apply only to a State external review
process, and would be inconsistent with
the national approach OPM was
proposing. OPM’s national approach
more appropriately falls under 45 CFR
147.136(d). We therefore wish to clarify
that we intended the State external
review standards in paragraph (c)(2) to
serve as a model for the consumer
protections that OPM would incorporate
into its proposed external review
process. Accordingly, the change in
citation from 45 CFR 147.136(c)(2) to 45
CFR 147.136(d) has been made.
Judicial Review (§ 800.505)
In proposed § 800.505, we provided
that OPM’s written decision pursuant to
completed external review of an adverse
benefit determination would constitute
final agency action under the
Administrative Procedure Act, and that
review of such a decision in the
appropriate U.S. district court would be
limited to the record that was before
OPM when it made its decision. We are
adopting proposed § 800.505 as final,
with one change, and renumbering it as
§ 800.504. Although OPM will conduct
external review under the MSPP, final
decisions on adverse benefit
determinations related to medical
judgment will be made by IROs, in
accordance with section 2719 of the
PHS Act. Decisions made by IROs will
be final, and OPM will not be
responsible for their approval. Such
decisions therefore cannot be
considered final agency action. The
regulation will provide that a decision
by an IRO on external review of an
adverse benefit determination related to
medical judgment will not be
considered final agency action.
Subpart G—Miscellaneous
Reservation of Authority (§ 800.601)
We received no comment on this
section of the proposed rule, which
simply provides that OPM reserves the
right to implement and supplement its
regulations with written operational
guidelines. Therefore, we are adopting
this section as final, with no changes.
Consumer Choice With Respect to
Certain Services (§ 800.602)
Section 800.602 of the proposed rule
requires that at least one MSP on each
Exchange not offer services described at
section 1303(b)(1)(B)(i) of the Affordable
PO 00000
Frm 00026
Fmt 4701
Sfmt 4700
Care Act. Further, MSPs in States that
prohibit these services must comply
with State law.
Comments: Several commenters
expressed concern that OPM is
proposing to preempt State law
regarding coverage of services described
in section 1303(b)(1)(B)(i) of the
Affordable Care Act. Some commenters
expressed a preference that at least one
MSP in each Exchange be required to
provide coverage for these services. In
particular, there was concern that, since
FEHBP plans do not generally cover
services described at section
1303(b)(1)(B)(i), the FEHBP benchmark
plan would exclude these services for
an MSP. One commenter was concerned
that requiring enrollees to make separate
payments for these services would be
burdensome.
Response: OPM is complying with
section 1334(a)(6) of the Affordable Care
Act, which directs that at least one of
the MSPs in a State not offer services
described in section 1303(b)(1)(B)(i). If
an MSP is offered in a State that
requires coverage of the services
described in section 1303(b)(1)(B)(i),
OPM will discuss options for
compliance with State and Federal laws
in contract negotiations with MSPP
applicants. Although an FEHBP
benchmark would not include services
described in section 1303(b)(1)(B)(i),
MSPP issuers can include services
permitted by law as long as the EHB
benefits are substantially equal. OPM
will require MSPs to comply with HHS
rules about segregation of funds as
described in 45 CFR part 156.
We are adopting as final proposed
subpart G, with a technical correction to
§ 800.602, which included an incorrect
reference to the Affordable Care Act
provision describing the services in
section 1303(b)(1)(B)(i).
Executive Orders 13563 and 12866;
Regulatory Review
OPM has examined the impact of this
rule as required by Executive Order
12866 on Regulatory Planning and
Review (September 30, 1993) and
Executive Order 13563 on Improving
Regulation and Regulatory Review
(January 18, 2011). Executive Orders
12866 and 13563 direct agencies to
assess all costs and benefits of available
regulatory alternatives and, if regulation
is necessary, to select regulatory
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). A regulatory impact analysis
must be prepared for major rules with
economically significant effects ($100
million or more in any one year,
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
adjusted for inflation). Section 3(f) of
Executive Order 12866 defines a
‘‘significant regulatory action’’ as an
action that is likely to result in a rule
that may:
(1) Have an annual effect on the
economy of $100 million or more in any
one year or adversely affect in a material
way a sector of the economy,
productivity, competition, jobs, the
environment, public health or safety, or
State, local, or tribal government or
communities;
(2) Create a serious inconsistency or
otherwise interfere with an action taken
or planned by another agency;
(3) Materially alter the budgetary
impacts of entitlement grants, user fees,
or loan programs, or the rights and
obligations of recipients thereof; or
(4) Raise novel legal or policy issues
arising out of legal mandates, the
President’s priorities, or the principles
set forth in Executive Order 12866.
The economic impact of this rule may
exceed the $100 million threshold for at
least one year; we therefore assess costs
and benefits as required by the
Executive order.
This rule gives health insurance
issuers the opportunity to contract with
OPM to offer a product on the
Affordable Insurance Exchanges, but
does not require those issuers to outlay
funds. In 2013, the Congressional
Budget Office (CBO) and the Joint
Committee on Taxation (JCT) estimated
the effects of the Affordable Care Act on
nationwide insurance enrollment and
on the Federal budget.5 CBO and JCT
estimated that from 2016 on, between 24
million and 27 million people will
receive individually purchased coverage
through the Exchanges, and another 3–
4 million people will receive
employment-based coverage through the
Exchanges. In the preamble to the
proposed rule, we noted that OPM lacks
the information necessary to make
assumptions about the potential
enrollment penetration for MSPs on the
Exchanges. We sought comments on the
number of States where MSPs will
participate and the influence of current
market dynamics on enrollment in
MSPs, but received none. As we have
not yet begun contract negotiations or
closed the application process, we do
not have any more information on
projected enrollment than we had at the
time of the proposed rule. As such, this
analysis will continue to largely reflect
5 Congressional Budget Office, Effects of the
Affordable Care Act on Health Insurance
Coverage—February 2013 Baseline, available at
https://www.cbo.gov/publication/43900 (February 5,
2013).
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
qualitative analysis, with quantitative
analysis where possible.
One primary benefit of health
insurance coverage would be an
increase in longevity or health for
newly-enrolled individuals. Improved
access to health care services has been
shown to lead to higher use of
preventive services and health
improvements, such as reduced
hypertension, improved vision and
better self-reported health status, as well
as better clinical outcomes and lower
mortality.6 7
Additional benefits would be
generated for newly-enrolled
individuals in the form of improved
financial security. There is evidence
that bankruptcy filings, for instance,
decrease in response to increases in
Medicaid eligibility.8 Furthermore, a
2011 analysis by the Office of the
Assistant Secretary for Planning and
Evaluation (ASPE) found that most of
the uninsured were unable to afford a
single hospitalization, because 90
percent of the uninsured reported
having total financial assets below
$13,000.9 A related benefit would be
generated by increased access to nonemployment-based health insurance,
which can give individuals greater
flexibility to take positions that better
match their skills or interests.
Expansion of health insurance
coverage leads to many benefits, such as
improved access to health care and
improved financial security for the
newly insured. However, insurance
coverage can lead to increased
utilization of health services for
individuals who become newly insured.
6 Brook, Robert H., John E. Ware, William H.
Rogers, Emmett B. Keeler, Allyson Ross Davies,
Cathy D. Sherbourne, George A. Goldberg, Kathleen
N. Lohr, Patricia Camp and Joseph P. Newhouse.
The Effect of Coinsurance on the Health of Adults:
Results from the RAND Health Insurance
Experiment. Santa Monica, CA: RAND Corporation,
1984. Finkelstein, A. et al. ‘‘The Oregon Health
Insurance Experiment: Evidence from the First
Year.’’ NBER Working Paper No. 17190, July 2011.
Doyle, J.J. ‘‘Health Insurance, Treatment and
Outcomes: Using Auto Accidents and Health
Shocks.’’ National Bureau of Economic Research.
NBER Working Paper No. 11099, February 2005.
7 See the regulatory impact analysis developed by
HHS for the Exchange Establishment final rule,
available at https://cciio.cms.gov under ‘‘Regulations
and Guidance’’, for a comprehensive overview of
the empirical evidence on the benefits of enhanced
availability of quality, affordable health insurance,
which to great extent applies to the MSPP program
and this proposed rule as well.
8 Gross, T., Notowidigdo, M. ‘‘Health Insurance
and the Consumer Bankruptcy Decision: Evidence
from Medicaid Expansions.’’ Journal of Public
Economics 95 (7–8): 2011.
9 Assistant Secretary for Planning and Evaluation
The Value of Health Insurance: Few of the
Uninsured Have Adequate Resources to Pay
Potential Hospital Bills: 2011. Washington, DC: U.S.
Department of Health and Human Services.
PO 00000
Frm 00027
Fmt 4701
Sfmt 4700
15585
While a portion of this increased
utilization may be economically
inefficient, studies that estimated the
effects of Medicare found that the cost
of this inefficiency is likely more than
offset by the benefit of risk
reduction.10 11
Administrative costs of the rule
would be generated both within OPM
and by issuers deciding to offer MSPs.
The costs that MSPP issuers may incur
are the same as those of QHPs and, as
stated in 45 CFR part 157, will include
accreditation, network adequacy
standards, and quality improvement
strategy reporting. The costs associated
with MSP certification offset the costs
that issuers would face were they to be
certified by the State, or HHS on behalf
of the State, to offer QHPs through the
Exchange.
Finally, some of the most notable
effects of Exchanges in general, and
MSPs in particular, may not be net
social costs or benefits, but would
instead be transfers between members of
society—in particular, decreases in
uncompensated care.
OPM lacks data to quantify most of
these benefits, costs and transfers.
Perhaps most notably, OPM cannot
isolate the effects of MSPs from
forecasts of the overall effects of the
Affordable Care Act coverage
provisions. We requested comments on
our cost-benefit analysis, but received
no comments.
Paperwork Reduction Act
The Paperwork Reduction Act of 1995
(44 U.S.C. chapter 35; see 5 CFR part
1320) requires that OMB approve all
collections of information by a Federal
agency from the public before they can
be implemented. Respondents are not
required to respond to any collection of
information unless it displays a current
valid OMB control number. OPM will
have several collections from MSPP
issuers or applicants seeking to become
MSPP issuers, but we have determined
that they are exempt from the
requirements of the Paperwork
Reduction Act. For example, we seek to
collect information in connection with
the MSPP application process and
reporting requirements under § 800.112.
We are also requiring issuers to
authorize accrediting entities to send
documentation to OPM under § 800.111.
We are setting up a process under
10 Finkelstein, A, McKnight R: ‘‘What Did
Medicare Do? The Initial Impact of Medicare on
Mortality and Out Of Pocket Medical Spending ’’
Journal of Public Economics 2008, 92:1644–1668.
11 Finkelstein, A., ‘‘The Aggregate Effects of
Health Insurance: Evidence from the Introduction of
Medicare,’’ National Bureau of Economic Research.
Working Paper No. 11619, Sept, 2005.
E:\FR\FM\11MRR3.SGM
11MRR3
15586
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
§ 800.116 for States to request that OPM
reconsider a standard applicable to
MSPs or MSPP issuers that does not
comply with that State’s laws for QHPs.
Under § 800.503, MSPP issuers are
directed to provide certain written
notices, which are third-party
disclosures under the Paperwork
Reduction Act. These collections would
generally be considered reporting
requirements under the Paperwork
Reduction Act. Moreover, based on
responses to the RFI, subsequent
conversations with both responding
health insurance issuers and other
health insurance issuers subsequent to
the RFI, and other practical
considerations, OPM expects fewer than
ten responsible entities to respond to all
of the collections noted above. For that
reason alone, the collections are exempt
from the Paperwork Reduction Act
under 44 U.S.C. 3502(3)(A)(i). There
may also be other reasons why these
collections are exempt from these
requirements. We sought comments on
these assumptions but received none.
mstockstill on DSK4VPTVN1PROD with RULES3
Regulatory Flexibility Act
The Regulatory Flexibility Act
(RFA) 12 requires agencies to prepare an
initial regulatory flexibility analysis to
describe the impact of the final rule on
small entities, unless the head of the
agency can certify that the rule would
not have a significant economic impact
on a substantial number of small
entities. The RFA generally defines a
‘‘small entity’’ as (1) a proprietary firm
meeting the size standards of the Small
Business Administration (SBA); (2) a
not-for-profit organization that is not
dominant in its field; or (3) a small
government jurisdiction with a
population of less than 50,000. States
and individuals are not included in the
definition of ‘‘small entity.’’
The RFA requires agencies to analyze
options for regulatory relief of small
businesses, if a rule has a significant
impact on a substantial number of small
entities. For purposes of the RFA, small
entities include small businesses, small
non-profit organizations, and small
government jurisdictions. Small
businesses are those with sizes below
thresholds established by the SBA. With
respect to health insurers, the SBA size
standard is $7.0 million in annual
receipts.13
12 5
U.S.C. 601 et seq.
to the SBA size standards, entities
with average annual receipts of $7 million or less
would be considered small entities for North
American Industry Classification System (NAICS)
Code 524114 (Direct Health and Medical Insurance
Carriers) (for more information, see ‘‘Table of Size
Standards Matched To North American Industry
Classification System Codes,’’ effective March 26,
13 According
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
OPM does not think that small
businesses with annual receipts less
than $7.0 million would likely have
sufficient economies of scale to become
MSPP issuers or be part of a group of
MSPP issuers. Similarly, while the
Director must enter into an MSPP
contract with at least one non-profit
entity, OPM does not think that small
non-profit organizations would likely
have sufficient economies of scale to
become MSPP issuers or be part of a
group of MSPP issuers.
OPM does not think that these
regulations will have a significant
economic impact on a substantial
number of small businesses with annual
receipts less than $7.0 million, because
there are only a few health insurance
issuers that could be considered small
businesses. Moreover, while the
Director must enter into an MSPP
contract with at least one non-profit
entity, OPM does not think that these
regulations will have a significant
economic impact on a substantial
number of small non-profit
organizations, because few health
insurance issuers are small non-profit
organizations.
OPM incorporates by reference
previous analysis by HHS, which
provides some insight into the number
of health insurance issuers that could be
small entities. Particularly, as discussed
by HHS in the Medical Loss Ratio
interim final rule (75 FR 74918), few, if
any, issuers are small enough to fall
below the size thresholds for small
business established by the SBA. In that
rule, HHS used a data set created from
2009 NAIC Health and Life Blank
annual financial statement data to
develop an updated estimate of the
number of small entities that offer
comprehensive major medical coverage
in the individual and group markets.
For purposes of that analysis, HHS used
total Accident and Health earned
premiums as a proxy for annual
receipts. HHS estimated that there are
28 small entities with less than $7
million in accident and health earned
premiums offering individual or group
comprehensive major medical coverage.
OPM concurs with this HHS analysis,
and, thus, does not think that these
regulations will have a significant
economic impact on a substantial
number of small entities.
Based on the foregoing, OPM is not
preparing an analysis for the RFA
because OPM has determined, and the
Director certifies, that these regulations
will not have a significant economic
2012, U.S. Small Business Administration, available
at https://www.sba.gov).
PO 00000
Frm 00028
Fmt 4701
Sfmt 4700
impact on a substantial number of small
entities.
Unfunded Mandates
Section 202 of the Unfunded
Mandates Reform Act of 1995
(UMRA) 14 requires that agencies assess
anticipated costs and benefits and take
certain other actions before issuing a
final rule that includes any Federal
mandate that may result in expenditures
in any one year by a State, local, or
tribal government, in the aggregate, or
by the private sector, of $100 million in
1995 dollars, updated annually for
inflation. In 2013, that threshold is
approximately $150 million. UMRA
does not address the total cost of a rule.
Rather, it focuses on certain categories
of costs, mainly those ‘‘Federal
mandate’’ costs resulting from (1)
imposing enforceable duties on State,
local, or tribal governments, or on the
private sector; or (2) increasing the
stringency of conditions in, or
decreasing the funding of, State, local,
or tribal governments under entitlement
programs.
These regulations do not place any
Federal mandates on State, local, or
tribal governments, or on the private
sector. This final rule would establish
the MSPP, a voluntary Federal program
that provides health insurance issuers
the opportunity to contract with OPM to
offer MSPs on the Exchanges. Section 3
of UMRA excludes from the definition
of ‘‘Federal mandate’’ duties that arise
from participation in a voluntary
Federal program. Accordingly, no
analysis under UMRA is required.
Federalism
Executive Order 13132 outlines
fundamental principles of federalism,
and requires the adherence to specific
criteria by Federal agencies in the
process of their formulation and
implementation of policies that have
‘‘substantial direct effects’’ on the
States, the relationship between the
national government and States, or on
the distribution of power and
responsibilities among the various
levels of government. Federal agencies
promulgating regulations that have
these federalism implications must
consult with State and local officials,
and describe the extent of their
consultation and the nature of the
concerns of State and local officials in
the preamble to the regulation.
These regulations have federalism
implications, because they have direct
effects on the States, the relationship
between the national government and
States, or on the distribution of power
14 Public
E:\FR\FM\11MRR3.SGM
Law 104–4.
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with RULES3
and responsibilities among various
levels of government. In particular,
under § 800.114, OPM may deem a State
law to be inconsistent with section 1334
of the Affordable Care Act, and, thus,
inapplicable to an MSP or MSPP issuer.
However, in OPM’s view, the federalism
implications of these regulations are
substantially mitigated because OPM
expects that the vast majority of States
have laws that are consistent with
section 1334 of the Affordable Care Act.
Furthermore, § 800.116 sets forth a
process for dispute resolution if a State
seeks to challenge OPM’s determination
that a State law is inapplicable to an
MSP or MSPP issuer.
We received one comment that OPM
is not in compliance with Executive
Order 13132, because we do not defer to
more consumer-protective State
standards. However, we respectfully
disagree because, as noted throughout
this rule, OPM defers to more consumerprotective State standards. Moreover, in
compliance with the requirement of
Executive Order 13132 that agencies
examine closely any policies that may
have federalism implications or limit
the policy-making discretion of the
States, OPM has engaged in efforts to
consult with and work cooperatively
with affected State and local officials,
including attending meetings of the
NAIC and consulting with State
insurance officials on an individual
basis. OPM expects to act in a similar
fashion in enforcing the Affordable Care
Act requirements. Throughout the
process of developing these final
regulations, OPM has attempted to
balance the States’ interests in
regulating health insurance issuers, and
the statutory requirement to provide two
MSPs in all Exchanges in the 50 States
and the District of Columbia. By doing
so, it is OPM’s view that it has complied
with the requirements of Executive
Order 13132.
Pursuant to the requirements set forth
in section 8(a) of Executive Order
13132, and by the signature affixed to
these regulations, OPM certifies that it
has complied with the requirements of
Executive Order 13132 for the attached
regulations in a meaningful and timely
manner.
Congressional Review Act
This final rule is subject to the
Congressional Review Act provisions of
the Small Business Regulatory
Enforcement Fairness Act of 1996 (5
U.S.C. 801, et seq.), which specifies that
before a rule can take effect, the Federal
agency promulgating the rule must
submit to each House of Congress and
to the Comptroller General a report
containing a copy of the rule along with
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
other specified information. In
accordance with this requirement, OPM
has transmitted this rule to Congress
and the Comptroller General for review.
List of Subjects in 5 CFR Part 800
Administrative practice and
procedure, Health facilities, Health
insurance, Health professions, Reporting
and recordkeeping requirements.
U.S. Office of Personnel Management.
John Berry,
Director.
Accordingly, the U.S. Office of
Personnel Management is adding part
800 to title 45, chapter VIII, Code of
Federal Regulations, as follows:
PART 800—MULTI-STATE PLAN
PROGRAM
Subpart A—General Provisions and
Definitions
Sec.
800.10 Basis and scope.
800.20 Definitions.
Subpart B—Multi-State Plan Program Issuer
Requirements
800.101 General requirements.
800.102 Compliance with Federal law.
800.103 Authority to contract with issuers.
800.104 Phased expansion.
800.105 Benefits.
800.106 Cost-sharing limits, advance
payments of premium tax credits, and
cost-sharing reductions.
800.107 Levels of coverage.
800.108 Assessments and user fees.
800.109 Network adequacy.
800.110 Service area.
800.111 Accreditation requirement.
800.112 Reporting requirements.
800.113 Benefit plan material or
information.
800.114 Compliance with applicable State
law.
800.115 Level playing field.
800.116 Process for dispute resolution.
Subpart C—Premiums Rating Factors,
Medical Loss Ratios, and Risk Adjustment
800.201 General requirements.
800.202 Rating factors.
800.203 Medical loss ratio.
800.204 Reinsurance, risk corridors, and
risk adjustment.
Subpart D—Application and Contracting
Procedures
800.301 Application process.
800.302 Review of applications.
800.303 MSPP contracting.
800.304 Term of the contract.
800.305 Contract renewal process.
800.306 Nonrenewal.
Subpart E—Compliance
800.401 Contract performance.
800.402 Contract quality assurance.
800.403 Fraud and abuse.
800.404 Compliance actions.
800.405 Reconsideration of compliance
actions.
PO 00000
Frm 00029
Fmt 4701
Sfmt 4700
15587
Subpart F—Appeals by Enrollees of Denials
of Claims for Payment or Service
800.501 General requirements.
800.502 MSPP issuer internal claims and
appeals.
800.503 External review.
800.504 Judicial review.
Subpart G—Miscellaneous
800.601 Reservation of authority.
800.602 Consumer choice with respect to
certain services.
Authority: Sec. 1334 of Pub. L. 111–148,
124 Stat. 119; Pub. L. 111–152, 124 Stat.
1029.
Subpart A—General Provisions and
Definitions
§ 800.10
Basis and scope.
(a) Basis. This part is based on the
following sections of title I of the
Affordable Care Act:
1001. Amendments to the Public
Health Service Act.
1302. Essential Health Benefits
Requirements.
1311. Affordable Choices of Health
Benefit Plans.
1324. Level Playing Field.
1334. Multi-State Plans.
1341. Transitional Reinsurance
Program for Individual Market in Each
State.
1342. Establishment of Risk Corridors
for Plans in Individual and Small Group
Markets.
1343. Risk Adjustment.
(b) Scope. This part establishes
standards for health insurance issuers to
contract with the United States Office of
Personnel Management (OPM) to offer
multi-State plans to provide health
insurance coverage on Exchanges for
each State. It also establishes standards
for appeal of a decision by OPM
affecting the issuer’s participation in the
Multi-State Plan Program (MSPP) and
standards for an enrollee in a multiState plan (MSP) to appeal denials of
payment or services by an MSPP issuer.
§ 800.20
Definitions.
For purposes of this part:
Actuarial value (AV) has the meaning
given that term in 45 CFR 156.20.
Affordable Care Act means the Patient
Protection and Affordable Care Act
(Pub. L. 111–148), as amended by the
Health Care and Education
Reconciliation Act of 2010 (Pub. L. 111–
152).
Applicant means an issuer or group of
issuers that has submitted an
application to OPM to be considered for
participation in the Multi-State Plan
Program.
Benefit plan material or information
means explanations or descriptions,
whether printed or electronic, that
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15588
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
describe a health insurance issuer’s
products. The term does not include a
policy or contract for health insurance
coverage.
Cost sharing has the meaning given
that term in 45 CFR 155.20.
Director means the Director of the
United States Office of Personnel
Management.
EHB-benchmark plan has the meaning
given that term in 45 CFR 156.20.
Exchange means a governmental
agency or non-profit entity that meets
the applicable requirements of 45 CFR
part 155 and makes qualified health
plans (QHPs) and MSPs available to
qualified individuals and qualified
employers. Unless otherwise identified,
this term refers to State Exchanges,
regional Exchanges, subsidiary
Exchanges, and a Federally-facilitated
Exchange.
Federal Employees Health Benefits
Program or FEHBP means the health
benefits program administered by the
United States Office of Personnel
Management pursuant to chapter 89 of
title 5, United States Code.
Group of issuers means:
(1) A group of health insurance
issuers who are affiliated either by
common ownership and control or by
common use of a nationally licensed
service mark (as defined in this
paragraph); or
(2) An affiliation of health insurance
issuers and an entity that is not an
issuer but that owns a nationally
licensed service mark (as defined in this
paragraph).
Health insurance coverage means
benefits consisting of medical care
(provided directly, through insurance or
reimbursement, or otherwise) under any
hospital or medical service policy or
certificate, hospital or medical service
plan contract, or HMO contract offered
by a health insurance issuer. Health
insurance coverage includes group
health insurance coverage, individual
health insurance coverage, and shortterm, limited duration insurance.
Health insurance issuer or issuer
means an insurance company, insurance
service, or insurance organization
(including an HMO) that is required to
be licensed to engage in the business of
insurance in a State and that is subject
to State law that regulates insurance
(within the meaning of section 514(b)(2)
of the Employee Retirement Income
Security Act (ERISA)). This term does
not include a group health plan as
defined in 45 CFR 146.145(a).
HHS means the United States
Department of Health and Human
Services.
Level of coverage means one of four
standardized actuarial values of plan
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
coverage as defined by section
1302(d)(1) of the Affordable Care Act.
Licensure means the authorization
obtained from the appropriate State
official or regulatory authority to offer
health insurance coverage in the State.
Multi-State Plan or MSP means a
health plan that is offered under a
contract between OPM and the MSPP
issuer pursuant to section 1334 of the
Affordable Care Act and that meets the
requirements of this part.
Multi-State Plan Program or MSPP
means the program administered by
OPM pursuant to section 1334 of the
Affordable Care Act.
Multi-State Plan Program issuer or
MSPP issuer means a health insurance
issuer or group of issuers (as defined in
this section) that has a contract with
OPM to offer health plans pursuant to
section 1334 of the Affordable Care Act
and meets the requirements of this part.
Nationally licensed service mark
means a word, name, symbol, or device,
or any combination thereof, that an
issuer or group of issuers uses
consistently nationwide to identify
itself.
Non-profit entity means:
(1) An organization that is
incorporated under State law as a nonprofit entity and licensed under State
law as a health insurance issuer; or
(2) A group of health insurance
issuers licensed under State law, a
substantial portion of which are
incorporated under State law as nonprofit entities.
OPM means the United States Office
of Personnel Management.
Percentage of total allowed cost of
benefits has the meaning given that term
in 45 CFR 156.20.
Plan year means a consecutive 12month period during which a health
plan provides coverage for health
benefits. A plan year may be a calendar
year or otherwise.
Prompt payment means a requirement
imposed on a health insurance issuer to
pay a provider or enrollee for a claimed
benefit or service within a defined time
period, including the penalty or
consequence imposed on the issuer for
failure to meet the requirement.
Qualified Health Plan or QHP means
a health plan that has in effect a
certification that it meets the standards
described in subpart C of 45 CFR part
156 issued or recognized by each
Exchange through which such plan is
offered pursuant to the process
described in subpart K of 45 CFR part
155.
Rating means the process, including
rating factors, numbers, formulas,
methodologies, and actuarial
PO 00000
Frm 00030
Fmt 4701
Sfmt 4700
assumptions, used to set premiums for
a health plan.
Secretary means the Secretary of the
Department of Health and Human
Services.
SHOP means a Small Business Health
Options Program operated by an
Exchange through which a qualified
employer can provide its employees and
their dependents with access to one or
more qualified health plans (QHPs).
Silver plan variation has the meaning
given that term in 45 CFR 156.400.
Small employer means, in connection
with a group health plan with respect to
a calendar year and a plan year, an
employer who employed an average of
at least one but not more than 100
employees on business days during the
preceding calendar year and who
employs at least one employee on the
first day of the plan year. In the case of
plan years beginning before January 1,
2016, a State may elect to define small
employer by substituting ‘‘50
employees’’ for ‘‘100 employees.’’
Standard plan has the meaning given
that term in 45 CFR 156.400.
State means each of the 50 States or
the District of Columbia.
State Insurance Commissioner means
the commissioner or other chief
insurance regulatory official of a State.
Subpart B—Multi-State Plan Program
Issuer Requirements
§ 800.101
General requirements.
An MSPP issuer must:
(a) Licensed. Be licensed as a health
insurance issuer in each State where it
offers health insurance coverage;
(b) Contract with OPM. Have a
contract with OPM pursuant to this part;
(c) Required levels of coverage. Offer
levels of coverage as required by
§ 800.107;
(d) Eligibility and enrollment. MSPs
and MSPP issuers must meet the same
requirements for eligibility, enrollment,
and termination of coverage as those
that apply to QHPs and QHP issuers
pursuant to 45 CFR part 155, subparts
D, E, and H, and 45 CFR 156.250,
156.260, 156.265, 156.270, and 156.285;
(e) Applicable to each MSP. Ensure
that each of its MSPs meets the
requirements of this part;
(f) Compliance. Comply with all
standards set forth in this part;
(g) OPM direction and other legal
requirements. Timely comply with OPM
instructions and directions and with
other applicable law; and
(h) Other requirements. Meet such
other requirements as determined
appropriate by OPM, in consultation
with HHS, pursuant to section
1334(b)(4) of the Affordable Care Act.
E:\FR\FM\11MRR3.SGM
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
(i) Non-discrimination. MSPs and
MSPP issuers must comply with
applicable Federal and State nondiscrimination laws, including the
standards set forth in 45 CFR 156.125
and 156.200(e).
§ 800.102
Compliance with Federal law.
(a) Public Health Service Act. As a
condition of participation in the MSPP,
an MSPP issuer must comply with
applicable provisions of part A of title
XXVII of the PHS Act. Compliance shall
be determined by the Director.
(b) Affordable Care Act. As a
condition of participation in the MSPP,
an MSPP issuer must comply with
applicable provisions of title I of the
Affordable Care Act. Compliance shall
be determined by the Director.
§ 800.103
issuers.
Authority to contract with
(a) General. OPM may enter into
contracts with health insurance issuers
to offer at least two MSPs on Exchanges
and SHOPs in each State, without
regard to any statutes that would
otherwise require competitive bidding.
(b) Non-profit entity. In entering into
contracts with health insurance issuers
to offer MSPs, OPM will enter into a
contract with at least one non-profit
entity as defined in § 800.20 of this part.
(c) Group of issuers. Any contract to
offer an MSP may be with a group of
issuers as defined in § 800.20.
(d) Individual and group coverage.
The contracts will provide for
individual health insurance coverage
and for group health insurance coverage
for small employers.
mstockstill on DSK4VPTVN1PROD with RULES3
§ 800.104
Phased expansion.
(a) Phase-in. OPM may enter into a
contract with a health insurance issuer
to offer an MSP if the health insurance
issuer agrees that:
(1) With respect to the first year for
which the health insurance issuer offers
an MSP, the health insurance issuer will
offer the MSP in at least 60 percent of
the States;
(2) With respect to the second such
year, the health insurance issuer will
offer the MSP in at least 70 percent of
the States;
(3) With respect to the third such
year, the health insurance issuer will
offer the MSP in at least 85 percent of
the States; and
(4) With respect to each subsequent
year, the health insurance issuer will
offer the MSP in all States.
(b) Partial coverage within a State.
OPM may enter into a contract with an
MSPP issuer even if the MSPP issuer’s
MSPs for a State cover fewer than all the
service areas specified for that State
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
pursuant to § 800.110. For each State in
which the MSPP issuer offers partial
coverage, the MSPP issuer must submit
a plan for offering coverage throughout
the State. OPM will monitor the MSPP
issuer’s progress in implementing the
plan as part of its contract compliance
activities under subpart E of this part.
(c) Participation in SHOPs. (1) An
MSPP issuer’s participation in the
Federally-facilitated SHOP must be
consistent with the requirements for
QHP issuers specified in 45 CFR
156.200(g).
(2) An MSPP issuer must comply with
State standards governing participation
in State-based SHOPs, consistent with
§ 800.114. For these State-based SHOP
standards, OPM retains discretion to
allow an MSPP issuer to phase-in SHOP
participation in States pursuant to
section 1334(e) of the Affordable Care
Act.
(d) Licensed where offered. OPM may
enter into a contract with an MSPP
issuer who is not licensed in every
State, provided that the issuer is
licensed in every State where it offers
MSP coverage through any Exchanges in
that State and demonstrates to OPM that
it is making a good faith effort to
become licensed in every State
consistent with the timeframe in
paragraph (a) of this section.
§ 800.105
Benefits.
(a) Benefits package. (1) An MSPP
issuer must offer a uniform benefits
package, including the essential health
benefits (EHB) described in section 1302
of the Affordable Care Act, for each MSP
within a State.
(2) The benefits package referred to in
paragraph (a)(1) of this section must
comply with section 1302 of the
Affordable Care Act, as well as any
applicable standards set by OPM or
HHS.
(b) Benefits package options. (1) An
MSPP issuer must offer a benefits
package, in all States, that is
substantially equal to:
(i) The EHB-benchmark plan in each
State in which it operates; or
(ii) Any EHB-benchmark plan selected
by OPM under paragraph (c) of this
section.
(2) An issuer applying to participate
in the MSPP must select one of the two
benefits package options described in
paragraph (b)(1) of this section in its
application.
(3) An issuer must comply with any
State standards relating to substitution
of benchmark benefits or standard
benefit designs.
(c) OPM selection of benchmark
plans. (1) The OPM-selected EHBbenchmark plans are the three largest
PO 00000
Frm 00031
Fmt 4701
Sfmt 4700
15589
Federal Employees Health Benefits
Program (FEHBP) plan options, as
identified by HHS pursuant to section
1302(b) of the Affordable Care Act, and
as supplemented pursuant to paragraphs
(c)(2) through (c)(4) of this section.
(2) Any EHB-benchmark plan selected
by OPM under paragraph (c)(1) of this
section lacking coverage of pediatric
oral services or pediatric vision services
must be supplemented by the addition
of the entire category of benefits from
the largest Federal Employee Dental and
Vision Insurance Program (FEDVIP)
dental or vision plan options,
respectively, pursuant to 45 CFR
156.110(b) and section 1302(b) of the
Affordable Care Act.
(3) An MSPP issuer must follow State
definitions where the State chooses to
specifically define the habilitative
services and devices category pursuant
to 45 CFR 156.110(f). In the case of any
State that chooses not to define this
category, if any OPM-selected EHBbenchmark plan lacks coverage of
habilitative services and devices, OPM
may determine what habilitative service
and devices are to be included in that
EHB-benchmark plan.
(4) Any EHB-benchmark plan selected
by OPM under paragraph (c)(1) of this
section must include, for each State, any
State-required benefits enacted before
December 31, 2011, that are included in
the State’s EHB-benchmark plan as
described in paragraph (b)(1)(i) of this
section, or specific to the market in
which the plan is offered.
(d) OPM approval. An MSPP issuer’s
benefits package, including its
prescription drug list, must be
submitted for approval by OPM, which
will review a benefits package proposed
by an MSPP issuer and determine if it
is substantially equal to an EHBbenchmark plan described in paragraph
(b)(1) of this section, pursuant to
standards set forth by OPM or HHS,
including 45 CFR 156.115, 156.122, and
156.125.
(e) State payments for additional
State-required benefits. If a State
requires that benefits in addition to the
benchmark package be offered to MSP
enrollees in that State, then pursuant to
section 1334(c)(2) of the Affordable Care
Act, the State must assume the cost of
such additional benefits by making
payments either to the enrollee or on
behalf of the enrollee to the MSPP
issuer.
§ 800.106 Cost-sharing limits, advance
payments of premium tax credits, and costsharing reductions.
(a) Cost-sharing limits. For each MSP
it offers, an MSPP issuer must ensure
that the cost-sharing provisions of the
E:\FR\FM\11MRR3.SGM
11MRR3
15590
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
MSP comply with section 1302(c) of the
Affordable Care Act, as well as any
applicable standards set by OPM or
HHS.
(b) Advance payments of premium tax
credits and cost-sharing reductions. For
each MSP it offers, an MSPP issuer must
ensure that an eligible individual
receives the benefit of advance
payments of premium tax credits under
section 36B of the Internal Revenue
Code and the cost-sharing reductions
under section 1402 of the Affordable
Care Act. An MSPP issuer must also
comply with any applicable standards
set by OPM or HHS.
§ 800.107
Levels of coverage.
(a) Silver and gold levels of coverage
required. An MSPP issuer must offer at
least one MSP at the silver level of
coverage and at least one MSP at the
gold level of coverage on each Exchange
in which the issuer is certified to offer
an MSP pursuant to a contract with
OPM.
(b) Bronze or platinum metal levels of
coverage permitted. Pursuant to a
contract with OPM, an MSPP issuer may
offer one or more MSPs at the bronze
level of coverage or the platinum level
of coverage, or both, on any Exchange or
SHOP in any State.
(c) Child-only plans. For each level of
coverage, the MSPP issuer must offer a
child-only plan at the same level of
coverage as any health insurance
coverage offered to individuals who, as
of the beginning of the plan year, have
not attained the age of 21.
(d) Plan variations for the reduction
or elimination of cost-sharing. An MSPP
issuer must comply with section 1402 of
the Affordable Care Act, as well as any
applicable standards set by OPM or
HHS.
(e) OPM approval. An MSPP issuer
must submit the levels of coverage plans
and plan variations to OPM for review
and approval by OPM.
mstockstill on DSK4VPTVN1PROD with RULES3
§ 800.108
Assessments and user fees.
(a) Discretion to charge assessment
and user fees. Beginning in 2015, OPM
may require an MSPP issuer to pay an
assessment or user fee as a condition of
participating in the MSPP.
(b) Determination of amount. The
amount of the assessment or user fee
charged by OPM for a plan year is the
amount determined necessary by OPM
to meet the costs of OPM’s functions
under the Affordable Care Act for a plan
year, including but not limited to such
functions as entering into contracts
with, certifying, recertifying,
decertifying, and overseeing MSPs and
MSPP issuers for that plan year. The
amount of the assessment or user fee
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
charged by OPM will be offset against
the assessment or user fee amount
required by any State-based Exchange or
Federally-facilitated Exchange such that
the total of all assessments and user fees
paid by the MSPP issuer for the year for
the MSP shall be no greater than nor
less than the amount of the assessment
or user fee paid by QHP issuers in that
State-based Exchange or Federallyfacilitated Exchange for that year.
(c) Process for collecting MSPP
assessment or user fees. OPM may
require an MSPP issuer to make
payment of the MSPP assessment or
user fee amount directly to OPM, and
the MSPP issuer will deduct the MSPP
assessment or user fee required under
paragraph (a) of this section from the
amount for any State-based Exchange or
Federally-facilitated Exchange and the
MSPP issuer would forward the
remainder of the payment to the State or
to HHS, as appropriate.
§ 800.109
Network adequacy.
(a) General requirement. An MSPP
issuer must ensure that the provider
network of each of its MSPs, as available
to all enrollees, meets the following
standards:
(1) Maintains a network that is
sufficient in number and types of
providers to assure that all services will
be accessible without unreasonable
delay;
(2) Is consistent with the network
adequacy provisions of section 2702(c)
of the Public Health Service Act; and
(3) Includes essential community
providers in compliance with 45 CFR
156.235.
(b) Provider directory. An MSPP
issuer must make its provider directory
for an MSP available to the Exchange for
publication online pursuant to guidance
from the Exchange and to potential
enrollees in hard copy, upon request. In
the provider directory, an MSPP issuer
must identify providers that are not
accepting new patients.
(c) OPM guidance. OPM will issue
guidance containing the criteria and
standards that it will use to determine
the adequacy of a provider network.
§ 800.110
Service area.
An MSPP issuer must offer an MSP
within one or more service areas in a
State defined by each Exchange
pursuant to 45 CFR 155.1055. If an
Exchange permits issuers to define their
service areas, an MSPP issuer must
obtain OPM’s approval for its proposed
service areas. Pursuant to § 800.104,
OPM may enter into a contract with an
MSPP issuer even if the MSPP issuer’s
MSPs for a State cover fewer than all the
service areas specified for that State.
PO 00000
Frm 00032
Fmt 4701
Sfmt 4700
MSPs will follow the same standards for
service areas for QHPs pursuant to 45
CFR 155.1055. As part of its contract
compliance activities under subpart E of
this part, OPM will consult with State
regulators and the State Exchange to
monitor the MSPP issuer’s progress
expanding coverage statewide and will
ensure that MSPs meet QHP
requirements in 45 CFR 155.1055(b).
§ 800.111
Accreditation requirement.
(a) General requirement. An MSPP
issuer must be or become accredited
consistent with the requirements for
QHP issuers specified in section 1311 of
the Affordable Care Act and 45 CFR
156.275(a).
(b) Release of survey. An MSPP issuer
must authorize the accrediting entity
that accredits the MSPP issuer to release
to OPM and to the Exchange a copy of
its most recent accreditation survey,
together with any survey-related
information that OPM or an Exchange
may require, such as corrective action
plans and summaries of findings.
(c) Timeframe for accreditation. An
MSPP issuer that is not accredited as of
the date that it enters into a contract
with OPM must become accredited
within the timeframe established by
OPM as authorized by 45 CFR 155.1045.
§ 800.112
Reporting requirements.
(a) OPM specification of reporting
requirements. OPM will specify the data
and information that must be reported
by an MSPP issuer, including data
permitted or required by the Affordable
Care Act and such other data as OPM
may determine necessary for the
oversight and administration of the
MSPP. OPM will also specify the form,
manner, processes, and frequency for
the reporting of data and information.
The Director may require that MSPP
issuers submit claims payment and
enrollment data to facilitate OPM’s
oversight and administration of the
MSPP in a manner similar to the
FEHBP.
(b) Quality and quality improvement
standards. An MSPP issuer must
comply with any standards required by
OPM for reporting quality and quality
improvement activities, including but
not limited to implementation of a
quality improvement strategy,
disclosure of quality measures to
enrollees and prospective enrollees,
reporting of pediatric quality measures,
and implementation of rating and
enrollee satisfaction surveys, which will
be similar to standards under section
1311(c)(1)(E), (H), and (I), (c)(3), and
(c)(4) of the Affordable Care Act.
E:\FR\FM\11MRR3.SGM
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
§ 800.113 Benefit plan material or
information.
(a) Compliance with Federal and State
law. An MSPP issuer must comply with
Federal and State laws relating to
benefit plan material or information,
including the provisions of this section
and guidance issued by OPM specifying
its standards, process, and timeline for
approval of benefit plan material or
information.
(b) General standards for MSP
applications and notices. An MSPP
issuer must provide all applications and
notices to enrollees in accordance with
the standards described in 45 CFR
155.205(c). OPM may establish
additional standards to meet the needs
of MSP enrollees.
(c) Accuracy. An MSPP issuer is
responsible for the accuracy of its
benefit plan material or information.
(d) Truthful, not misleading, no
material omissions, and plain language.
All benefit plan material or information
must be:
(1) Truthful, not misleading, and
without material omissions; and
(2) Written in plain language, as
defined in section 1311(e)(3)(B) of the
Affordable Care Act.
(e) Uniform explanation of coverage
documents and standardized
definitions. An MSPP issuer must
comply with the provisions of section
2715 of the PHS Act and regulations
issued to implement that section.
(f) OPM review and approval of
benefit plan material or information.
OPM may request an MSPP issuer to
submit to OPM benefit plan material or
information, as defined in § 800.20.
OPM reserves the right to review and
approve benefit plan material or
information to ensure that an MSPP
issuer complies with Federal and State
laws, and the standards prescribed by
OPM with respect to benefit plan
material or information.
(g) Statement on certification by OPM.
An MSPP issuer may include a
statement in its benefit plan material or
information that:
(1) OPM has certified the MSP as
eligible to be offered on the Exchange;
and
(2) OPM monitors the MSP for
compliance with all applicable law.
mstockstill on DSK4VPTVN1PROD with RULES3
§ 800.114 Compliance with applicable
State law.
(a) Compliance with State law. An
MSPP issuer must, with respect to each
of its MSPs, generally comply with State
law pursuant to section 1334(b)(2) of the
Affordable Care Act. However, the MSPs
and MSPP issuers are not subject to
State laws that:
(1) Are inconsistent with section 1334
of the Affordable Care Act or this part;
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
(2) Prevent the application of a
requirement of part A of title XXVII of
the PHS Act; or
(3) Prevent the application of a
requirement of title I of the Affordable
Care Act.
(b) Determination of inconsistency.
After consultation with the State and
HHS, OPM reserves the right to
determine, in its judgment, as
effectuated through an MSPP contract,
these regulations, or OPM guidance,
whether the standards set forth in
paragraph (a) of this section are satisfied
with respect to particular State laws.
§ 800.115
Level playing field.
An MSPP issuer must, with respect to
each of its MSPs, meet the following
requirements in order to ensure a level
playing field:
(a) Guaranteed renewal. Guarantee
that an enrollee can renew enrollment
in an MSP in compliance with sections
2703 and 2742 of the PHS Act;
(b) Rating. In proposing premiums for
OPM approval, use only the rating
factors permitted under section 2701 of
the PHS Act and State law;
(c) Preexisting conditions. Not impose
any preexisting condition exclusion and
comply with section 2704 of the PHS
Act;
(d) Non-discrimination. Comply with
section 2705 of the PHS Act;
(e) Quality improvement and
reporting. Comply with all Federal and
State quality improvement and
reporting requirements. Quality
improvement and reporting means
quality improvement as defined in
section 1311(h) of the Affordable Care
Act and quality improvement plans or
strategies required under State law, and
quality reporting as defined in section
2717 of the PHS Act and section 1311(g)
of the Affordable Care Act. Quality
improvement also includes activities
such as, but not limited to,
implementation of a quality
improvement strategy, disclosure of
quality measures to enrollees and
prospective enrollees, and reporting of
pediatric quality measures, which will
be similar to standards under section
1311(c)(1)(E), (H), and (I) of the
Affordable Care Act;
(f) Fraud and abuse. Comply with all
Federal and State fraud and abuse laws;
(g) Licensure. Be licensed in every
State in which it offers an MSP;
(h) Solvency and financial
requirements. Comply with the solvency
standards set by each State in which it
offers an MSP;
(i) Market conduct. Comply with the
market conduct standards of each State
in which it offers an MSP;
(j) Prompt payment. Comply with
applicable State law in negotiating the
PO 00000
Frm 00033
Fmt 4701
Sfmt 4700
15591
terms of payment in contracts with its
providers and in making payments to
claimants and providers;
(k) Appeals and grievances. Comply
with Federal standards under section
2719 of the PHS Act for appeals and
grievances relating to adverse benefit
determinations, as described in subpart
F of this part;
(l) Privacy and confidentiality.
Comply with all Federal and State
privacy and security laws and
requirements, including any standards
required by OPM in guidance or
contract, which will be similar to the
standards contained in 45 CFR part 162
and applicable State law; and
(m) Benefit plan material or
information. Comply with Federal and
State law, including § 800.113.
§ 800.116
Process for dispute resolution.
(a) Determinations about applicability
of State law under section 1334(b)(2) of
the Affordable Care Act. In the event of
a dispute about the applicability to an
MSP or MSPP issuer of a State law, the
State may request that OPM reconsider
a determination that an MSP or MSPP
issuer is not subject to such State law.
(b) Required demonstration. A State
making a request under paragraph (a) of
this section must demonstrate that the
State law at issue:
(1) Is not inconsistent with section
1334 of the Affordable Care Act or this
part;
(2) Does not prevent the application of
a requirement of part A of title XXVII of
the PHS Act; and
(3) Does not prevent the application of
a requirement of title I of the Affordable
Care Act.
(c) Request for review. The request
must be in writing and include contact
information, including the name,
telephone number, email address, and
mailing address of the person or persons
whom OPM may contact regarding the
request for review. The request must be
in such form, contain such information,
and be submitted in such manner and
within such timeframe as OPM may
prescribe.
(1) The requester may submit to OPM
any relevant information to support its
request.
(2) OPM may obtain additional
information relevant to the request from
any source as it may, in its judgment,
deem necessary. OPM will provide the
requester with a copy of any additional
information it obtains and provide an
opportunity for the requester to respond
(including by submission of additional
information or explanation).
(3) OPM will issue a written decision
within 60 calendar days after receiving
the written request, or after the due date
E:\FR\FM\11MRR3.SGM
11MRR3
15592
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
for a response under paragraph (c)(2) of
this section, whichever is later, unless a
different timeframe is agreed upon.
(4) OPM’s written decision will
constitute final agency action that is
subject to review under the
Administrative Procedure Act in the
appropriate U.S. district court. Such
review is limited to the record that was
before OPM when OPM made its
decision.
Subpart C—Premiums, Rating Factors,
Medical Loss Ratios, and Risk
Adjustment
mstockstill on DSK4VPTVN1PROD with RULES3
§ 800.201
General requirements.
(a) Premium negotiation. OPM will
negotiate annually with an MSPP issuer,
on a State by State basis, the premiums
for each MSP offered by that issuer in
that State. Such negotiations may
include negotiations about the costsharing provisions of an MSP.
(b) Duration. Premiums will remain in
effect for the plan year.
(c) Guidance on rate development.
OPM will issue guidance addressing
methods for the development of
premiums for the MSPP. That guidance
will follow State rating standards
generally applicable in a State, to the
greatest extent practicable.
(d) Calculation of actuarial value. An
MSPP issuer must calculate actuarial
value in the same manner as QHP
issuers under section 1302(d) of the
Affordable Care Act, as well as any
applicable standards set by OPM or
HHS.
(e) OPM rate review process. An
MSPP issuer must participate in the rate
review process established by OPM to
negotiate rates for MSPs. The rate
review process established by OPM will
be similar to the process established by
HHS pursuant to section 2794 of the
PHS Act and disclosure and review
standards established under 45 CFR part
154.
(f) State Effective Rate Review. With
respect to its MSPs, an MSPP issuer is
subject to a State’s rate review process,
including a State’s Effective Rate
Review Program established by HHS
pursuant to section 2794 of the PHS Act
and 45 CFR part 154. In the event HHS
is reviewing rates for a State pursuant to
section 2794 of the PHS Act, HHS will
defer to OPM’s judgment regarding the
MSPs’ proposed rate increase. If a State
withholds approval of an MSP and OPM
determines, in its discretion, that the
State’s action would prevent OPM from
operating the MSPP, OPM retains
authority to make the final decision to
approve rates for participation in the
MSPP, notwithstanding the absence of
State approval.
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
(g) Single risk pool. An MSPP issuer
must consider all enrollees in an MSP
to be in the same risk pool as all
enrollees in all other health plans in the
individual market or the small group
market, respectively, in compliance
with section 1312(c) of the Affordable
Care Act, 45 CFR 156.80, and any
applicable Federal or State laws and
regulations implementing that section.
§ 800.202
Rating factors.
(a) Permissible rating factors. In
proposing premiums for each MSP, an
MSPP issuer must use only the rating
factors permitted under section 2701 of
the PHS Act.
(b) Application of variations based on
age or tobacco use. Rating variations
permitted under section 2701 of the
PHS Act must be applied by an MSPP
issuer based on the portion of the
premium attributable to each family
member covered under the coverage in
accordance with any applicable Federal
or State laws and regulations
implementing section 2701(a) of the
PHS Act.
(c) Age rating. For age rating, an
MSPP issuer must use the ratio
established by the State in which the
MSP is offered, if it is less than 3:1.
(1) Age bands. An MSPP issuer must
use the uniform age bands established
under HHS regulations implementing
section 2701(a) of the PHS Act.
(2) Age curves. An MSPP issuer must
use the age curves established under
HHS regulations implementing section
2701(a) of the PHS Act, or age curves
established by a State pursuant to HHS
regulations.
(d) Rating areas. An MSP must use
the rating areas appropriate to the State
in which the MSP is offered and
established under HHS regulations
implementing section 2701(a) if the PHS
Act.
(e) Tobacco rating. An MSPP issuer
must apply tobacco use as a rating factor
in accordance with any applicable
Federal or State laws and regulations
implementing section 2701(a) of the
PHS Act.
(f) Wellness programs. An MSPP
issuer must comply with any applicable
Federal or State laws and regulations
implementing section 2702 of the PHS
Act.
§ 800.203
Medical loss ratio.
(a) Required medical loss ratio. An
MSPP issuer must attain:
(1) The medical loss ratio (MLR)
required under section 2718 of the PHS
Act and regulations promulgated by
HHS; and
(2) Any MSP-specific MLR that OPM
may set in the best interests of MSP
PO 00000
Frm 00034
Fmt 4701
Sfmt 4700
enrollees or that is necessary to be
consistent with a State’s requirements
with respect to MLR.
(b) Consequences of not attaining
required medical loss ratio. If an MSPP
issuer fails to attain an MLR set forth in
paragraph (a) of this section, OPM may
take any appropriate action, including
but not limited to intermediate
sanctions, such as suspension of
marketing, decertifying an MSP in one
or more States, or terminating an MSPP
issuer’s contract pursuant to § 800.404.
§ 800.204 Reinsurance, risk corridors, and
risk adjustment.
(a) Transitional reinsurance program.
An MSPP issuer must comply with
section 1341 of the Affordable Care Act,
45 CFR part 153, and any applicable
Federal or State regulations under
section 1341 that set forth requirements
to implement the transitional
reinsurance program for the individual
market.
(b) Temporary risk corridors program.
An MSPP issuer must comply with
section 1342 of the Affordable Care Act,
45 CFR part 153, and any applicable
Federal regulations under section 1342
that set forth requirements to implement
the risk corridor program.
(c) Risk adjustment program. An
MSPP issuer must comply with section
1343 of the Affordable Care Act, 45 CFR
part 153, and any applicable Federal or
State regulations under section 1343
that set forth requirements to implement
the risk adjustment program.
Subpart D—Application and
Contracting Procedures
§ 800.301
Application process.
(a) Acceptance of applications.
Without regard to section 6101(b)–(d) of
title 41, United States Code, or any other
statute requiring competitive bidding,
OPM may consider annually
applications from health insurance
issuers, including groups of health
insurance issuers as defined in § 800.20,
to participate in the MSPP. If OPM
determines that it is not beneficial for
the MSPP to consider new applications
for an upcoming year, OPM will issue
a notice to that effect.
(b) Form and manner of applications.
An applicant must submit to OPM, in
the form and manner and in accordance
with the timeline specified by OPM, the
information requested by OPM for
determining whether an applicant meets
the requirements of this part.
§ 800.302
Review of applications.
(a) Determinations. OPM will
determine if an applicant meets the
requirements of this part. If OPM
determines that an applicant meets the
E:\FR\FM\11MRR3.SGM
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
requirements of this part, OPM may
accept the applicant to enter into
contract negotiations with OPM to
participate in the MSPP.
(b) Requests for additional
information. OPM may request
additional information from an
applicant before making a decision
about whether to enter into contract
negotiations with that applicant to
participate in the MSPP.
(c) Declination of application. If, after
reviewing an application to participate
in the MSPP, OPM declines to enter into
contract negotiations with the applicant,
OPM will inform the applicant in
writing of the reasons for that decision.
(d) Discretion. The decision whether
to enter into contract negotiations with
a health insurance issuer who has
applied to participate in the MSPP is
committed to OPM’s discretion.
(e) Impact on future applications.
OPM’s declination of an application to
participate in the MSPP will not
preclude the applicant from submitting
an application for a subsequent year to
participate in the MSPP.
mstockstill on DSK4VPTVN1PROD with RULES3
§ 800.303
MSPP contracting.
(a) Participation in MSPP. To become
an MSPP issuer, the applicant and the
Director or the Director’s designee must
sign a contract that meets the
requirements of this part.
(b) Standard contract. OPM will
establish a standard contract for the
MSPP.
(c) Premiums. OPM and the applicant
will negotiate the premiums for an
MSPP for each plan year in accordance
with the provisions of subpart C of this
part.
(d) Benefit packages. OPM must
approve the applicant’s benefit packages
for an MSP.
(e) Additional terms and conditions.
OPM may elect to negotiate with an
applicant such additional terms,
conditions, and requirements that:
(1) Are in the interests of MSP
enrollees; or
(2) OPM determines to be appropriate.
(f) Certification to offer health
insurance coverage.
(1) For each plan year, an MSPP
contract will contain a certification that
specifies the Exchanges in which the
MSPP issuer is authorized to offer an
MSP, as well as the specific benefit
packages authorized to be offered on
each Exchange and the premiums to be
charged for each benefit package on
each Exchange.
(2) An MSPP issuer may not offer an
MSP on an Exchange unless its MSPP
contract with OPM includes a
certification authorizing the MSPP
issuer to offer the MSP on that Exchange
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
in accordance with paragraph (f)(1) of
this section.
§ 800.304
Term of the contract.
(a) Term of a contract. The term of the
contract will be specified in the MSPP
contract and must be for a period of at
least the 12 consecutive months defined
as the plan year.
(b) Plan year. The plan year is a
consecutive 12-month period during
which an MSP provides coverage for
health benefits. A plan year may be a
calendar year or otherwise.
§ 800.305
Contract renewal process.
(a) Renewal. To continue participating
in the MSPP, an MSPP issuer must
provide to OPM, in the form and
manner and in accordance with the
timeline prescribed by OPM, the
information requested by OPM for
determining whether the MSPP issuer
continues to meet the requirements of
this part.
(b) OPM decision. Subject to
paragraph (c) of this section, OPM will
renew the MSPP contract of an MSPP
issuer who timely submits the
information described in paragraph (a).
(c) OPM discretion not to renew. OPM
may decline to renew the contract of an
MSPP issuer if:
(1) OPM and the MSPP issuer fail to
agree on premiums and benefits for an
MSP for the subsequent plan year;
(2) The MSPP issuer has engaged in
conduct described in § 800.404(a) of this
part; or
(3) OPM determines that the MSPP
issuer will be unable to comply with a
material provision of section 1334 of the
Affordable Care Act or this part.
(d) Failure to agree on premiums and
benefits. Except as otherwise provided
in this part, if an MSPP issuer has
complied with paragraph (a) of this
section and OPM and the MSPP issuer
fail to agree on premiums and benefits
for an MSP on one or more Exchanges
for the subsequent plan year by the date
required by OPM, either party may
provide notice of nonrenewal pursuant
to § 800.306, or OPM may in its
discretion withdraw the certification of
that MSP on the Exchange or Exchanges
for that plan year. In addition, if OPM
and the MSPP issuer fail to agree on
benefits and premiums for an MSP on
one or more Exchanges by the date set
by OPM and in the event of no action
(no notice of nonrenewal or renewal) by
either party, the MSPP contract will be
renewed and the existing premiums and
benefits for that MSP on that Exchange
or Exchanges will remain in effect for
the subsequent plan year.
PO 00000
Frm 00035
Fmt 4701
Sfmt 4700
§ 800.306
15593
Nonrenewal.
(a) Definition of nonrenewal. As used
in this subpart and subpart E of this
part, ‘‘nonrenewal’’ means a decision by
either OPM or an MSPP issuer not to
renew an MSPP contract.
(b) Notice required. Either OPM or an
MSPP issuer may decline to renew an
MSPP contract by providing a written
notice of nonrenewal to the other party.
(c) MSPP issuer responsibilities. The
MSPP issuer’s written notice of
nonrenewal must be made in
accordance with its MSPP contract with
OPM. The MSPP issuer also must
comply with any requirements
regarding the termination of a plan that
are applicable to a QHP offered on an
Exchange on which the MSP was
offered, including a requirement to
provide advance written notice of
termination to enrollees. If an Exchange
does not have requirements about
advance written notice of termination to
enrollees, the MSPP issuer must inform
current MSP enrollees in writing of the
nonrenewal of the MSP no later than 90
days prior to termination of coverage,
unless OPM determines that good cause
justifies less than 90 days’ notice.
Subpart E—Compliance
§ 800.401
Contract performance.
(a) General. An MSPP issuer must
perform an MSPP contract with OPM in
accordance with the requirements of
section 1334 of the Affordable Care Act
and this part. The MSPP issuer must
continue to meet such requirements
while under an MSPP contract with
OPM.
(b) Specific requirements for issuers.
In addition to the requirements
described in paragraph (a) of this
section, the following requirements
apply to each MSPP issuer:
(1) It must have, in the judgment of
OPM, the financial resources to carry
out its obligations under the MSPP;
(2) It must keep such reasonable
financial and statistical records, and
furnish to OPM such reasonable
financial and statistical reports with
respect to the MSP or the MSPP, as may
be requested by OPM;
(3) It must permit representatives of
OPM (including the OPM Office of
Inspector General), the U.S. Government
Accountability Office, and any other
applicable Federal Government auditing
entities to audit and examine its records
and accounts that pertain, directly or
indirectly, to the MSP at such
reasonable times and places as may be
designated by OPM or the U.S.
Government Accountability Office;
(4) It must timely submit to OPM a
properly completed and signed novation
E:\FR\FM\11MRR3.SGM
11MRR3
mstockstill on DSK4VPTVN1PROD with RULES3
15594
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
or change-of-name agreement in
accordance with subpart 42.12 of 48
CFR part 42;
(5) It must perform the MSPP contract
in accordance with prudent business
practices, as described in paragraph (c)
of this section; and
(6) It must not perform the MSPP
contract in accordance with poor
business practices, as described in
paragraph (d) of this section.
(c) Prudent business practices. For
purposes of paragraph (b)(5) of this
section, prudent business practices
include, but are not limited to, the
following:
(1) Timely compliance with OPM
instructions and directives;
(2) Legal and ethical business and
health care practices;
(3) Compliance with the terms of the
MSPP contract, regulations, and
statutes;
(4) Timely and accurate adjudication
of claims or rendering of medical
services;
(5) Operating a system for accounting
for costs incurred under the MSPP
contract, which includes segregating
and pricing MSP medical utilization
and allocating indirect and
administrative costs in a reasonable and
equitable manner;
(6) Maintaining accurate accounting
reports of costs incurred in the
administration of the MSPP contract;
(7) Applying performance standards
for assuring contract quality as outlined
at § 800.402; and
(8) Establishing and maintaining a
system of internal controls that provides
reasonable assurance that:
(i) The provision and payments of
benefits and other expenses comply
with legal, regulatory, and contractual
guidelines;
(ii) MSP funds, property, and other
assets are safeguarded against waste,
loss, unauthorized use, or
misappropriation; and
(iii) Data are accurately and fairly
disclosed in all reports required by
OPM.
(d) Poor business practices. For
purposes of paragraph (b)(6) of this
section, poor business practices include,
but are not limited to, the following:
(1) Using fraudulent or unethical
business or health care practices or
otherwise displaying a lack of business
integrity or honesty;
(2) Repeatedly or knowingly
providing false or misleading
information in the rate setting process;
(3) Failing to comply with OPM
instructions and directives;
(4) Having an accounting system that
is incapable of separately accounting for
costs incurred under the contract and/
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
or that lacks the internal controls
necessary to fulfill the terms of the
contract;
(5) Failing to assure that the MSP
properly pays or denies claims, or, if
applicable, provides medical services
that are inconsistent with standards of
good medical practice; and
(6) Entering into contracts or
employment agreements with providers,
provider groups, or health care workers
that include provisions or financial
incentives that directly or indirectly
create an inducement to limit or restrict
communication about medically
necessary services to any individual
covered under the MSPP. Financial
incentives are defined as bonuses,
withholds, commissions, profit sharing
or other similar adjustments to basic
compensation (e.g., service fee,
capitation, salary) which have the effect
of limiting or reducing communication
about appropriate medically necessary
services.
(e) Performance escrow account. OPM
may require MSPP issuers to pay an
assessment into an escrow account to
ensure contract compliance and benefit
MSP enrollees.
§ 800.402
Contract quality assurance.
(a) General. This section prescribes
general policies and procedures to
ensure that services acquired under
MSPP contracts conform to the
contract’s quality requirements.
(b) Internal controls. OPM will
periodically evaluate the contractor’s
system of internal controls under the
quality assurance program required by
the contract and will acknowledge in
writing whether or not the system is
consistent with the requirements set
forth in the contract. OPM’s reviews do
not diminish the contractor’s obligation
to implement and maintain an effective
and efficient system to apply the
internal controls.
(c) Performance standards. (1) OPM
will issue specific performance
standards for MSPP contracts and will
inform MSPP issuers of the applicable
performance standards prior to
negotiations for the contract year. OPM
may benchmark its standards against
standards generally accepted in the
insurance industry. OPM may authorize
nationally recognized standards to be
used to fulfill this requirement.
(2) MSPP issuers must comply with
the performance standards issued under
this section.
§ 800.403
Fraud and abuse.
(a) Program required. An MSPP issuer
must conduct a program to assess its
vulnerability to fraud and abuse as well
as to address such vulnerabilities.
PO 00000
Frm 00036
Fmt 4701
Sfmt 4700
(b) Fraud detection system. An MSPP
issuer must operate a system designed
to detect and eliminate fraud and abuse
by employees and subcontractors of the
MSPP issuer, by providers furnishing
goods or services to MSP enrollees, and
by MSP enrollees.
(c) Submission of information. An
MSPP issuer must provide to OPM such
information or assistance as may be
necessary for the agency to carry out the
duties and responsibilities, including
those of the Office of Inspector General
as specified in sections 4 and 6 of the
Inspector General Act of 1978 (5 U.S.C.
App.). An MSPP issuer must provide
any requested information in the form,
manner, and timeline prescribed by
OPM.
§ 800.404
Compliance actions.
(a) Causes for OPM compliance
actions. The following constitute cause
for OPM to impose a compliance action
described in paragraph (b) of this
section against an MSPP issuer:
(1) Failure by the MSPP issuer to meet
the requirements set forth in
§ 800.401(a) and (b);
(2) An MSPP issuer’s sustained failure
to perform the MSPP contract in
accordance with prudent business
practices, as described in § 800.401(c);
(3) A pattern of poor conduct or
evidence of poor business practices
such as those described in § 800.401(d);
or
(4) Such other violations of law or
regulation as OPM may determine.
(b) Compliance actions. (1) OPM may
impose a compliance action against an
MSPP issuer at any time during the
contract term if it determines that the
MSPP issuer is not in compliance with
applicable law, this part, or the terms of
its contract with OPM.
(2) Compliance actions may include,
but are not limited to:
(i) Establishment and implementation
of a corrective action plan;
(ii) Imposition of intermediate
sanctions, such as suspensions of
marketing;
(iii) Performance incentives;
(iv) Reduction of service area or areas;
(v) Withdrawal of the certification of
the MSPP issuer to offer the MSP on one
or more Exchanges;
(vi) Nonrenewal of the MSPP contract;
and
(vii) Withdrawal of approval or
termination of the MSPP contract.
(c) Notice of compliance action. (1)
OPM must notify an MSPP issuer in
writing of a compliance action under
this section. Such notice must indicate
the specific compliance action
undertaken and the reason for the
compliance action.
E:\FR\FM\11MRR3.SGM
11MRR3
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
(2) For compliance actions listed in
paragraphs (b)(2)(v) through (b)(2)(vii) of
this section, such notice must include a
statement that the MSPP issuer is
entitled to request a reconsideration of
OPM’s determination to impose a
compliance action pursuant to
§ 800.405.
(3) Upon imposition of a compliance
action listed in paragraphs (b)(2)(iv)
through (b)(2)(vii) of this section, OPM
must notify the State Insurance
Commissioner(s) and Exchange officials
in the State or States in which the
compliance action is effective.
(d) Notice to enrollees. If OPM
terminates an MSPP issuer’s MSPP
contract with OPM, or OPM withdraws
the MSPP issuer’s certification to offer
the MSP on an Exchange, the MSPP
issuer must comply with any
requirements regarding the termination
of a plan that are applicable to a QHP
offered on an Exchange on which the
MSP was offered, including a
requirement to provide advance written
notice of termination to enrollees. If an
Exchange does not have requirements
about advance written notice of
termination to enrollees, the MSPP
issuer must inform current MSP
enrollees in writing of the nonrenewal
of the MSP no later than 90 days prior
to termination of coverage, unless OPM
determines that good cause justifies less
than 90 days’ notice.
(e) Definition. As used in this subpart,
‘‘termination’’ means a decision by OPM
to cancel an MSPP contract prior to the
end of its contract term. The term
includes OPM’s withdrawal of approval
of an MSPP contract.
mstockstill on DSK4VPTVN1PROD with RULES3
§ 800.405
actions.
Reconsideration of compliance
(a) Right to request reconsideration.
An MSPP issuer may request that OPM
reconsider a determination to impose
one of the following compliance actions:
(1) Withdrawal of the certification of
the MSPP issuer to offer the MSP on one
or more Exchanges;
(2) Nonrenewal of the MSPP contract;
or
(3) Termination of the MSPP contract.
(b) Request for reconsideration and/or
hearing. (1) An MSPP issuer with a right
to request reconsideration specified in
paragraph (a) of this section may request
a hearing in which OPM will reconsider
its determination to impose a
compliance action.
(2) A request under this section must
be in writing and contain contact
information, including the name,
telephone number, email address, and
mailing address of the person or persons
whom OPM may contact regarding a
request for a hearing with respect to the
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
reconsideration. The request must be in
such form, contain such information,
and be submitted in such manner as
OPM may prescribe.
(3) The request must be received by
OPM within 15 calendar days after the
date of the MSPP issuer’s receipt of the
notice of compliance action. The MSPP
issuer may request that OPM’s
reconsideration allow a representative
of the MSPP issuer to appear personally
before OPM.
(4) A request under this section must
include a detailed statement of the
reasons that the MSPP issuer disagrees
with OPM’s imposition of the
compliance action, and may include any
additional information that will assist
OPM in rendering a final decision under
this section.
(5) OPM may obtain additional
information relevant to the request from
any source as it may, in its judgment,
deem necessary. OPM will provide the
MSPP issuer with a copy of any
additional information it obtains and
provide an opportunity for the MSPP
issuer to respond (including by
submitting additional information or
explanation).
(6) OPM’s reconsideration and
hearing, if requested, may be conducted
by the Director or a representative
designated by the Director who did not
participate in the initial decision that is
the subject of the request for review.
(c) Notice of final decision. OPM will
notify the MSPP issuer, in writing, of
OPM’s final decision on the MSPP
issuer’s request for reconsideration and
the specific reasons for that final
decision. OPM’s written decision will
constitute final agency action that is
subject to review under the
Administrative Procedure Act in the
appropriate U.S. district court. Such
review is limited to the record that was
before OPM when it made its decision.
Subpart F—Appeals by Enrollees of
Denials of Claims for Payment or
Service
§ 800.501
General requirements.
(a) Definitions. For purposes of this
subpart:
(1) Adverse benefit determination has
the meaning given that term in 45 CFR
147.136(a)(2)(i).
(2) Claim means a request for:
(i) Payment of a health-related bill; or
(ii) Provision of a health-related
service or supply.
(b) Applicability. This subpart applies
to enrollees and to other individuals or
entities who are acting on behalf of an
enrollee and who have the enrollee’s
specific written consent to pursue a
remedy of an adverse benefit
determination.
PO 00000
Frm 00037
Fmt 4701
Sfmt 4700
§ 800.502
appeals.
15595
MSPP issuer internal claims and
(a) Processes. MSPP issuers must
comply with the internal claims and
appeals processes applicable to group
health plans and health insurance
issuers under 45 CFR 147.136(b).
(b) Timeframes and notice of
determination. An MSPP issuer must
provide written notice to an enrollee of
its determination on a claim brought
under paragraph (a) of this section
according to the timeframes and
notification rules under 45 CFR
147.136(b) and (e), including the
timeframes for urgent claims. If the
MSPP issuer denies a claim (or a portion
of the claim), the enrollee may appeal
the adverse benefit determination to the
MSPP issuer in accordance with 45 CFR
147.136(b).
§ 800.503
External review.
(a) External review by OPM. OPM will
conduct external review of adverse
benefit determinations using a process
similar to OPM review of disputed
claims under 5 CFR 890.105(e), subject
to the standards and timeframes set
forth in 45 CFR 147.136(d).
(b) Notice. Notices to MSP enrollees
regarding external review under
paragraph (a) of this section must
comply with 45 CFR 147.136(e), and are
subject to review and approval by OPM.
(c) Issuer obligation. An MSPP issuer
must pay a claim or provide a healthrelated service or supply pursuant to
OPM’s final decision or the final
decision of an independent review
organization without delay, regardless
of whether the plan or issuer intends to
seek judicial review of the external
review decision and unless or until
there is a judicial decision otherwise.
§ 800.504
Judicial review.
(a) OPM’s written decision under the
external review process established
under § 800.503(a) will constitute final
agency action that is subject to review
under the Administrative Procedure Act
in the appropriate U.S. district court. A
decision made by an independent
review organization under the process
established under § 800.503(a) is not
within OPM’s discretion and therefore
is not final agency action.
(b) Judicial review under paragraph
(a) of this section is limited to the record
that was before OPM when OPM made
its decision.
Subpart G—Miscellaneous
§ 800.601
Reservation of authority.
OPM reserves the right to implement
and supplement these regulations with
written operational guidelines.
E:\FR\FM\11MRR3.SGM
11MRR3
15596
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules and Regulations
§ 800.602 Consumer choice with respect
to certain services.
mstockstill on DSK4VPTVN1PROD with RULES3
(a) Assured availability of varied
coverage. Consistent with § 800.104,
OPM will ensure that at least one of the
MSPP issuers on each Exchange in each
VerDate Mar<15>2010
17:17 Mar 08, 2013
Jkt 229001
State offers at least one MSP that does
not provide coverage of services
described in section 1303(b)(1)(B)(i) of
the Affordable Care Act.
(b) State opt-out. An MSP may not
offer abortion coverage in any State
PO 00000
Frm 00038
Fmt 4701
Sfmt 9990
where such coverage of abortion
services is prohibited by State law.
[FR Doc. 2013–04954 Filed 3–1–13; 11:15 am]
BILLING CODE 6325–64–P
E:\FR\FM\11MRR3.SGM
11MRR3
Agencies
[Federal Register Volume 78, Number 47 (Monday, March 11, 2013)]
[Rules and Regulations]
[Pages 15559-15596]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-04954]
[[Page 15559]]
Vol. 78
Monday,
No. 47
March 11, 2013
Part III
Office of Personnel Management
-----------------------------------------------------------------------
45 CFR Part 800
Patient Protection and Affordable Care Act; Establishment of the
Multi-State Plan Program for the Affordable Insurance Exchanges; Final
Rule
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Rules
and Regulations
[[Page 15560]]
-----------------------------------------------------------------------
OFFICE OF PERSONNEL MANAGEMENT
45 CFR Part 800
RIN 3206-AM47
Patient Protection and Affordable Care Act; Establishment of the
Multi-State Plan Program for the Affordable Insurance Exchanges
AGENCY: U.S. Office of Personnel Management.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The U.S. Office of Personnel Management (OPM) is issuing a
final regulation establishing the Multi-State Plan Program (MSPP)
pursuant to the Patient Protection and Affordable Care Act, as amended
by the Health Care and Education Reconciliation Act of 2010, referred
to collectively as the Affordable Care Act. Through contracts with OPM,
health insurance issuers will offer at least two multi-State plans
(MSPs) on each of the Affordable Insurance Exchanges (Exchanges). One
of the issuers must be non-profit. Under the law, an MSPP issuer may
phase in the States in which it offers coverage over 4 years, but it
must offer MSPs on Exchanges in all States and the District of Columbia
by the fourth year in which the MSPP issuer participates in the MSPP.
This rule aims to balance adhering to the statutory goals of MSPP while
aligning its standards to those applying to qualified health plans to
promote a level playing field across health plans.
DATES: Effective May 10, 2013, except for Sec. 800.503. OPM will
publish a document announcing the effective date of Sec. 800.503 in
the Federal Register.
Note: Section 2719 of the Public Health Service Act and its
implementing regulations apply to all non-grandfathered group health
plans and health insurance issuers, including MSPP issuers, with
respect to internal claims and appeals and external review. Because
rulemaking implementing section 2719 has not yet been completed, the
provisions of this regulation relating to external review (Sec.
800.503) will take effect on the effective date of those
regulations.
FOR FURTHER INFORMATION CONTACT: Julia Elam by telephone at (202) 606-
2128, by FAX at (202) 606-0033, or by email at mspp@opm.gov.
SUPPLEMENTARY INFORMATION: The Patient Protection and Affordable Care
Act (Pub. L. 111-148), as amended by the Health Care and Education
Reconciliation Act of 2010 (Pub. L. 111-152), together known as the
Affordable Care Act, provides for the establishment of Health Insurance
Marketplaces, or Exchanges, in each State, where individuals and small
businesses can purchase qualified coverage. The Exchanges will provide
competitive marketplaces for individuals and small employers to
directly compare available private health insurance options on the
basis of price, quality, and other factors. The Exchanges will enhance
competition in the health insurance market, improve choice of
affordable health insurance, and give individuals and small businesses
purchasing power comparable to that of large businesses. The U.S.
Office of Personnel Management is issuing this final regulation to
implement section 1334 of the Affordable Care Act by establishing the
Multi-State Plan Program, as described below.
Abbreviations
FEHBA Federal Employees Health Benefits Act (5 U.S.C. 8901 et seq.)
FEHBP Federal Employees Health Benefits Program
HHS U.S. Department of Health and Human Services
HMO Health Maintenance Organization
I/T/Us Indian Health Service, tribes and tribal organizations, and
urban Indian organizations
MSP Multi-State Plan
MSPP Multi-State Plan Program
NAIC National Association of Insurance Commissioners
OPM U.S. Office of Personnel Management
PHS Act Public Health Service Act
QHP Qualified Health Plan
SHOP Small Business Health Options Program
Pursuant to its responsibilities under the Affordable Care Act, the
U.S. Department of Health and Human Services (HHS) issued regulations
outlining standards to certify Exchanges and qualified health plans
(QHPs) that will be offered on Exchanges. If a State does not elect to
operate an Exchange or is not certified (or conditionally approved) to
operate one, HHS will operate the Exchange in that State.
Section 1334 of the Affordable Care Act directs the U.S. Office of
Personnel Management (OPM) to establish the Multi-State Plan Program
(MSPP) to foster competition among plans competing in the individual
and small group health insurance markets on the Exchanges.
Specifically, section 1334 directs OPM to contract with private health
insurance issuers (one of which must be non-profit) to offer at least
two multi-State plans (MSPs) on each of the Exchanges in each State.
The law allows MSPP issuers to phase in coverage, but coverage must be
offered on Exchanges in all States and the District of Columbia by the
fourth year in which the MSPP issuer participates in the MSPP. The
first open enrollment period for plans offered through Exchanges will
begin on October 1, 2013, for coverage starting January 1, 2014.
The purpose of this regulation is to outline the process by which
OPM will establish and administer the MSPP, as well as to establish
standards and requirements for MSPs and MSPP issuers.
Summary of Comments
On December 5, 2012, OPM published proposed regulations (77 FR
72582) establishing the MSPP at part 800 of title 45, Code of Federal
Regulations. The comment period for the proposed rule closed on January
4, 2013. OPM received about 350 comments from a wide variety of
entities and individuals. A summary of the comments we received
follows, along with our responses to the comments and changes we are
making to the proposed regulations in light of the comments. In
addition, we are making some minor technical and editorial changes to
the proposed regulations to correct errors and improve clarity and
readability.
Responses to Overarching Comments
Of the approximately 350 comments we received on the proposed rule,
about 105 were unique comment letters. Many of the others were form
letters, including letters requesting an extension of the comment
period.
A broad range of stakeholders commented on the proposed regulation,
including 14 States and the National Association of Insurance
Commissioners (NAIC). We also received comments from about a dozen
health insurance issuers, group health plans, and their associations.
Most of the remaining comments came from health care providers,
pharmaceutical companies, business groups, labor unions, and consumer
groups.
Length of the Comment Period
We received many comments about the 30-day comment period and
whether we would extend it. Some commenters contended that the 30-day
comment period did not provide sufficient time to provide feedback.
Our comment period is consistent with the Administrative Procedure
Act and Executive Orders 12866 and 13563. OPM values the participation
of a broad array of diverse stakeholders, and we have succeeded in
obtaining that participation, as evidenced by the volume of comments as
well as the diversity of viewpoints offered in response to our proposed
regulation. Moreover, OPM has provided several other opportunities for
public input on policies relating to the MSPP. On June
[[Page 15561]]
16, 2011, OPM issued a Request for Information (RFI) to solicit
feedback from stakeholders about the program. On September 21, 2012,
OPM issued a draft MSPP application and received public comments over a
30-day period. OPM has also held meetings and phone calls with numerous
stakeholders to seek input and guidance, including from the NAIC,
States, tribal governments, consumer advocates, health insurance
issuers, labor organizations, provider associations, and trade groups.
Church Plans
One commenter urged OPM to consider entering into an MSPP contract
with a church plan. The commenter explained that church plans are
defined in various sections of the law, including section 414(e) of the
Internal Revenue Code and section 3(33) of the Employee Retirement
Income Security Act (ERISA). A church plan does not, by itself, meet
the definition of health insurance issuer in section 2791(b)(2) of the
PHS Act; in addition, enrollment is limited to church employees and
members of the clergy. The commenter interpreted section 1334 of the
Affordable Care Act as allowing OPM to contract with church plans to
offer coverage through the MSPP. First, the commenter stated that,
while section 1334(a)(1) provides that the Director shall enter into
contracts for MSPs with health insurance issuers, it does not expressly
preclude OPM from entering into contracts with entities other than
issuers. The commenter asserted that church plans should be considered
eligible to contract for an MSP because OPM can treat a church plan as
equivalent to an issuer under the Church Parity and Entanglement
Protections Act, Public Law 106-244 (``Parity Act''). The commenter
recommended that OPM could exercise its discretion to exempt church
plans from a number of requirements for MSPs, including permitting a
church plan MSP to limit enrollment to members of the clergy and church
employees.
We disagree with the commenter's interpretation of section 1334 and
do not believe that a church plan meets the requirements necessary for
OPM to offer such a plan under an MSPP contract. Section 1334(a)(1)
explicitly requires OPM to enter into contracts for MSPs with ``health
insurance issuers,'' and we do not agree that the statute authorizes
OPM to enter into contracts with entities other than health insurance
issuers. Because church plans, by themselves, do not meet the
definition of health insurance issuers as described above, OPM does not
have the authority to contract for them under Sec. 1334.
Responses to Comments on the Regulations
Subpart A--General Provisions and Definitions
Basis and Scope (Sec. 800.10)
OPM proposed this section to define the basis and scope of part
800, which establishes the primary authority for the establishment of
the MSPP under the Affordable Care Act. Other relevant statutory
provisions MSPP issuers and MSPs must comply with include all
provisions of part A of title XXVII of the Public Health Service (PHS)
Act. Section 800.10 also sets forth the scope of this regulation, which
establishes standards for health insurance issuers wishing to contract
with OPM to participate in the MSPP and for the appeals processes for
both MSPP issuers and enrollees.
We received no comments on Sec. 800.10 as proposed. Accordingly,
we are adopting it as final, with no changes.
Definitions (Sec. 800.20)
In Sec. 800.20, OPM proposed definitions for terms that are used
throughout part 800. In general, the definitions contained in Sec.
800.20 come from the following sources: title I of the Affordable Care
Act and the final Exchange regulation at 45 CFR parts 155, 156, and
157; title XXVII of the PHS Act and the regulations at 45 CFR part 144;
and the Federal Employees Health Benefits Act (FEHBA) at chapter 89 of
title 5, United States Code, and the regulations governing the Federal
Employees Health Benefits Program (FEHBP) at 5 CFR part 890 and 48 CFR
1609.70. Some new definitions were created for the purpose of
implementing the MSPP. The application of the terms defined in this
section is limited to this final rule.
OPM proposes definitions for several terms based on three HHS
regulations. First, HHS published an Essential Health Benefits (EHB)
final rule in the Federal Register on February 25, 2013, to provide
standards related to EHB, actuarial value (AV), and accreditation.
Second, HHS published a final rule in the Federal Register on February
27, 2013, to provide standards related to fair health insurance
premiums, guaranteed availability, guaranteed renewability, risk pools,
and rate review (the health insurance market rules). Third, HHS
published a final rule elsewhere in today's edition of the Federal
Register, to provide notice of standards relating to benefit and
payment parameters for 2014, including standards related to advance
payments of the premium tax credit and cost-sharing reductions (the
payment rule). OPM is using the definitions promulgated by HHS.
Comments: OPM received several comments recommending changes in the
definitions in proposed Sec. 800.20. A few commenters expressed
concern with how OPM plans to operationalize the definition of
``Indian.'' Specifically, the commenters suggested that OPM adopt the
definition at 42 CFR 447.50 and not use the definition at 45 CFR
155.300(a) as we proposed. OPM was also asked to correct the definition
of ``Indian Plan Variation,'' which currently cross references 45 CFR
156.400, so that there is no confusion regarding eligibility of Indians
for zero-cost-sharing and variable cost-sharing plan variations.
Response: While the terms ``Indian'' and ``Indian Plan Variation''
were introduced in the proposed rule, referencing 45 CFR 155.300(a) and
45 CFR 155.400, respectively, we are removing them from the final rule,
as they are not used elsewhere in the rule.
Comments: A few commenters noted that OPM should not exclude
policies and contracts from the ``benefit plan material or
information'' definition. Two commenters said that we should not
exclude policies and contracts from the definition, because including
them in the scope of the regulation could be helpful to limited-
English-proficient (LEP) individuals in making effective decisions.
One commenter wanted us to clarify that a provider directory falls
within the definition of ``benefit plan material or information.''
Response: We are adopting the proposed definition of ``benefit plan
material or information.'' The term, as defined, includes explanations
or descriptions, whether printed or electronic, that describe a health
insurance issuer's products. The term does not include a policy or
contract for health insurance coverage. As it does in the FEHBP, OPM
will review and approve the policy or contract for health insurance
coverage. Such approval is necessary for effective contract
administration and oversight. We agree that a provider directory does
fall within the scope of the definition.
Comment: One commenter suggested that introducing a second prong to
the definition of ``group of issuers''--to include ``an affiliation of
health insurance issuers and an entity who is not an issuer but who
owns a nationally licensed service mark''--would expand the authority
granted under section 1334 of the Affordable Care Act. The commenter
recommended that we not
[[Page 15562]]
expand the definition of ``group of issuers'' to include entities not
identified in the Affordable Care Act as potential participants in the
MSPP.
Response: Section 1334 does not define ``group of issuers,'' but
only provides examples of affiliations of health insurance issuers that
may be considered health insurance issuers. Thus, OPM, in the exercise
of its discretion, and within the parameters set by section 1334, has
established a definition that we believe affords flexibility in terms
of the types of entities with which OPM may contract. In addition, this
definition, which attempts to encompass a diversity of contractual
arrangements similarly available to OPM under the FEHBP, promotes the
goals of section 1334(a) of the Affordable Care Act, which directs OPM
to implement the MSPP in a manner similar to the manner in which we
implement the contracting provisions with respect to carriers under the
FEHBP. As we noted in the proposed rule, this definition of ``group of
issuers'' is applicable only for the purposes of section 1334.
Comment: One commenter recommended that OPM revise the definition
of ``non-profit entity'' to exclude the portion of the definition that
states a non-profit entity may also be, for purposes of the MSPP, ``a
group of health insurance issuers licensed under State law a
substantial portion of which are incorporated under State law as non-
profit entities,'' as this would further reduce competition in a State
where a ``for-profit'' issuer may already have a significant market
share.
Response: We are adopting the proposed definition of ``non-profit
entity.'' This definition is consistent with the manner in which OPM
implements the contracting provisions with respect to carriers under
the FEHBP and builds on our significant experience in contracting with
and overseeing carriers under that program.
Comment: Another commenter recommended amending the definitions of
``multi-State plan (MSP)'' and ``Multi-State Plan Program issuer (MSPP
issuer)'' to clarify whether each MSP will be under separate contract
with OPM or will contract through the MSPP issuer.
Response: OPM is revising the definition of ``MSP'' to clarify that
an MSP is offered under contract with OPM via an MSPP issuer.
Comment: A commenter suggested that OPM broaden the definition of
``State Insurance Commissioner'' to acknowledge the potential for
multiple regulatory roles in a State.
Response: We understand the commenter's concern and acknowledge the
possibility of multiple regulatory roles in some States, but we are
retaining the proposed definition. This term is a standard term that is
understood in the industry; therefore, we decline to amend the
definition. Our definition of ``State Insurance Commissioner'' aligns
with the definition used in many of the model acts issued by the
National Association of Insurance Commissioners (NAIC) to ensure
consistency with definitions widely used by State insurance regulatory
entities.
Subpart B--Multi-State Plan Program Issuer Requirements
General Requirements (Sec. 800.101)
Section 800.101 of the proposed rule sets forth standards to
implement Sec. 1334(b) of the Affordable Care Act. The general
requirements include licensure, a contract with OPM, required levels of
coverage, eligibility and enrollment, compliance with OPM direction and
other legal requirements. In Sec. 800.101(i), we also proposed that an
MSPP issuer must comply with applicable non-discrimination statutes and
ensure that their MSPs do not discriminate based on race, color,
national origin, disability, age, sex, gender identity, or sexual
orientation. We sought comment on any unique enrollment and eligibility
issues that might affect MSPs. A broad spectrum of consumer and
professional organizations commented on this provision.
Comments: Many commenters support OPM's intent to include non-
discrimination provisions, but recommended adding specific additional
language to strengthen these protections, including clarifying non-
discrimination based on sex or gender identity.
Some commenters requested that OPM add specific non-discrimination
language in Sec. 800.101(d) that describes the MSP and MSPP issuer
responsibilities for eligibility and enrollment. The specific
suggestion was to notify MSPP issuers that benefit packages must be
``substantially equal'' to EHB benchmarks and not include any
discriminatory benefit design elements as defined under 45 CFR 156.125.
Response: In response to comments, we are revising Sec. 800.101(i)
of this final rule to ensure consistency with the prohibition on
discrimination with respect to EHB in 45 CFR 156.125 and the non-
discrimination standards applicable to QHPs under 45 CFR 156.200(e).
With regard to defining EHB benchmarks, we have determined that these
comments are outside the scope of this rule. These standards are
governed by HHS regulations.
Comments: Some commenters suggested that certain health care
providers be included as protected categories for non-discrimination,
and one commenter wanted MSPP issuers and MSPs to align their payment
systems to comply with State and Federal non-discrimination provisions.
Response: The broad prohibition on discrimination in Sec.
800.101(i) clearly bars discrimination against certain health care
providers of the MSPP issuer. Similar comments were addressed in Sec.
800.109, concerning health providers and network adequacy. We are
concerned that specifying types of providers who are protected from
discrimination would detract from the larger issue of broadly ensuring
access to the full range of covered services. Accordingly, no further
change in proposed Sec. 800.101(i) is needed to address this concern.
Comments: A few commenters recommended that OPM expressly clarify
in Sec. 800.101(i) that the Indian Health Service, tribes and tribal
organizations, and urban Indian organizations (collectively, I/T/Us)
are not violating the non-discrimination requirements if they limit
their services, in whole or part, to American Indians/Alaska Natives.
Response: An MSPP issuer would not violate the non-discrimination
requirements by contracting with health care providers who are
authorized or directed by law to serve specific populations, such as
Indian health providers. We note that an MSPP issuer must meet all
standards related to network adequacy and essential community providers
specified in Sec. 800.109 and 45 CFR 156.235, respectively.
Comments: A few commenters stated that OPM should clarify that MSPs
and MSPP issuers must comply with any consumer protections and
regulatory procedures a State or Exchange has put in place.
Response: As explained in our proposed regulation, MSPs and MSPP
issuers are generally required to comply with applicable State law.
This would include the application of stronger protections in the
Exchange provided by State law, as long as application of those
provisions to the MSPP is consistent with the Affordable Care Act. We
received no comments to indicate that the consumer protections
applicable to the MSPP are any weaker than those required by any State
or Exchange. On the contrary, OPM intends to protect
[[Page 15563]]
consumers through its administration of the MSPP in a manner similar to
the manner in which it has protected enrollees in the FEHBP for more
than 50 years. In any event, if there are specific consumer protections
and regulatory procedures that go above and beyond Federal standards,
OPM encourages States to identify them so OPM can consider and address
them through a memorandum of understanding (MOU) with the State and, if
appropriate, in its contracts with issuers.
Comments: A few commenters asked how OPM will work with active
purchasing Exchanges and recommended that OPM incorporate a ``do no
harm'' objective in the preamble.
Response: We will retain our current language and decline to
incorporate a ``do no harm'' provision, as such a provision would be
vague and ambiguous. Instead, we will maintain our approach of applying
standards that neither competitively advantage nor disadvantage MSPs
and MSPP issuers.
Comment: One commenter stated that OPM should require MSPP issuers
to meet standards for certification and licensing prior to signing a
contract with OPM for MSPs in the State.
Response: Section 800.101 clearly provides that an MSPP issuer must
be licensed as a health insurance issuer in each State where it offers
health insurance coverage, and it is deemed certified by OPM when it
signs a contract with OPM.
Compliance With Federal law (Sec. 800.102)
Proposed Sec. 800.102 specifies the Federal laws with which MSPP
issuers must comply as a condition of participation in the MSPP.
Paragraph (a) refers to applicable provisions of title XXVII of the PHS
Act, while paragraph (b) refers to applicable provisions of title I of
the Affordable Care Act.
In this final rule, paragraphs (a) and (b) no longer refer to
Appendix A and B, respectively, which in the proposed rule listed
specific provisions of title XXVII of the PHS Act and title I of the
Affordable Care Act. We are omitting these appendices because, although
the statutes listed in those appendices do apply to MSPP issuers, they
may not necessarily be a comprehensive list of all applicable statutes.
Also, it is possible that the list of statutes in the appendices may
change over time.
We are also omitting Appendix C in this final rule, because Sec.
36B of the Internal Revenue Code does not set forth responsibilities of
issuers.
Comments: Commenters suggested that OPM had erroneously neglected
to include section 2716 of the PHS Act and section 1312 of the
Affordable Care Act.
Response: MSPP issuers that choose to participate in the Small
Business Health Options Program (SHOP) will operate under the same
rules as issuers of health insurance coverage in the small group market
generally. OPM agrees that section 1312 of the Affordable Care Act
applies to MSPP issuers.
Comments: A few commenters noted that we listed section 2707 of the
PHS Act in Appendix A to the proposed rule, which listed PHS Act
provisions applicable to MSPs, and asked OPM to clarify that the PHS
Act requirements were applicable solely to the off-Exchange markets and
would not apply to MSPP issuers for products sold through an Exchange.
Response: While all the requirements applicable to QHP issuers
contained in section 2707 are also contained in requirements applicable
to QHPs, they also apply directly.
Authority To Contract With Issuers (Sec. 800.103)
As provided in section 1334(a)(1) of the Affordable Care Act, OPM
proposed in Sec. 800.103 that it may enter into an MSPP contract with
a group of issuers affiliated either by common ownership and control or
by the use of a nationally licensed service mark, or an affiliation of
health insurance issuers and an entity that is not an issuer but that
owns a nationally licensed service mark.
We received no substantive comments on this section. Accordingly,
we are adopting proposed Sec. 800.103 as final, with no changes.
Phased Expansion (Sec. 800.104)
In Sec. 800.104, we proposed phased expansion of the MSPP into
States and that MSPP issuers may provide partial coverage within a
State. We also proposed that MSPP issuers must be licensed in the State
where they offer coverage and OPM may enter into a contract with an
issuer that is not licensed in all States. We stated in the preamble of
the proposed regulation that Sec. 800.104 implements provisions of
section 1334(e) of the Affordable Care Act regarding the phase-in of
multi-State plans. OPM proposed in Sec. 800.104(b) that MSPP issuers
offering MSPs can offer coverage in part of a State, and do not have to
offer coverage throughout the entire State. We also solicited comment
on whether an MSPP issuer should be required to offer coverage
statewide by the fourth year of participation in the MSPP, when
coverage must be offered in each Exchange in all States and the
District of Columbia.
Comments: Several commenters expressed support for phased expansion
into States. Another commenter stated that a multi-year phase-in
process will allow MSPs to build appropriate networks and partnerships
to satisfy the requirements of the Affordable Care Act and satisfy the
needs of the citizens of each State. One commenter stated that MSPP
issuers should be required to offer coverage on each Exchange in all
States and the District of Columbia as soon as possible or in as many
States as possible. Another commenter recommended an extension of the
phase-in period to 6 years instead of a 4-year phase-in.
Response: We are retaining the standards that are outlined in
section 1334(e) of the Affordable Care Act. However, we have removed
from the regulatory text the number of States that an issuer must phase
into because section 1334(e) refers to percentages and not specific
numbers. We believe the phased expansion approach into States will
encourage MSPP issuers to expand MSPs to provide more consumer choice
throughout the country. It is our intention to ensure that MSPP issuers
have appropriate networks to adequately serve MSP enrollees, and we
will take these comments into consideration when we are evaluating
potential MSPP issuers.
Comment: One commenter was concerned that MSPP issuers will
subcontract to meet the phase-in requirements and that these will
encourage ``marriages of convenience.''
Response: Section 1334 permits OPM to contract with health
insurance issuers and entities that come together in order to apply as
an MSP issuer. We encourage any such new entities to give careful
thought and planning to their strategies for phasing in coverage to the
States and the District of Columbia, and we will ensure through our
application review and contracting process that these entities are
prepared to offer quality health insurance options in the States for
which they are applying.
Comment: One commenter recommended that OPM should require
licensure in all jurisdictions by the end of the phase-in.
Response: We have adequately addressed the licensure requirement in
Sec. 800.104(c). As stated in that section, OPM may enter into a
contract with an MSPP issuer that is not licensed in every State,
provided that the issuer is licensed in every State where it offers MSP
coverage through any Exchanges in that State and demonstrates to OPM
that it is making a good-faith effort to
[[Page 15564]]
become licensed in every State, consistent with the timeframe for the
phase-in.
Comments: We received many comments on whether OPM should have a
role in selecting the States in which MSPP issuers should or should not
offer coverage during phased expansion. Several commenters recommended
that OPM not specify which States an MSPP issuer must cover in the
first year. Other commenters recommended that OPM should consider slow-
tracking implementation of the MSPP in certain States and granting
these States waivers from participation. Another commenter suggested
that OPM limit MSPP issuers to offering MSPs in States that will have
Federally-facilitated Exchanges or State Partnership Exchanges in 2014.
One commenter suggested that OPM focus the phase-in on States where
consumers lack viable coverage options.
Response: OPM declines to identify specific States that MSPP
issuers should cover during phased expansion. We recognize the
importance of providing consumers with more health insurance coverage
options and, while we will not choose specific States where MSPP
issuers must provide coverage during the phase-in, we will use our
oversight and contract negotiation roles to provide consumers with the
additional choice of two high-quality health insurance plans and
promote competition on the Exchanges.
Comments: One commenter supported OPM's proposal that OPM may enter
into contracts with issuers that cannot provide statewide coverage and
stated that it will give MSPP issuers time to develop the capacity to
offer coverage throughout a service area, which will enhance
competition in the MSPP. Several commenters appreciated that issuers
failing to offer statewide coverage must propose a plan for becoming
statewide, but expressed that without more specificity American
Indians/Alaska Natives will not be able to access MSPs.
Response: We acknowledge the importance of access to health
coverage and MSPs, especially in rural and underserved areas. However,
we are providing in the final regulation that OPM may enter into a
contract with an MSPP issuer that will provide partial coverage within
a State. We recognize the challenges that issuers would face if there
were a requirement to offer coverage statewide, and we were made aware
of these challenges from issuers in the MSPP Request for Information as
well as comments on the proposed rule. However, we are maintaining in
the final rule our proposed requirement for MSPP issuers who are
offering partial coverage in a State to supply a plan for offering
coverage throughout the State. As we review MSPP issuer applications,
we will pay special attention to service areas that are medically
underserved, such as rural areas and American Indian/Alaska Native
populations. We intend to encourage issuers to offer coverage statewide
where they have capacity to do so, and will take these comments into
consideration when negotiating MSPP contracts.
Comments: Several commenters wanted clarification of phased
expansion in terms of MSPs being able to meet network adequacy
standards. One commenter recommended that MSPP issuers not be permitted
to offer MSPs in a State unless the plan is capable of offering
coverage to all residents of a State, including meeting network
adequacy standards throughout the State, to avoid selective coverage by
issuers.
Response: While we appreciate the concern for network adequacy, we
decline to set a standard of phased expansion and statewide coverage in
terms of network adequacy. We believe that network adequacy is
sufficiently addressed in Sec. 800.109 to ensure that an MSP's
services are available to all enrollees.
Comments: Many commenters were concerned by our proposal to allow
partial coverage within a State. Some stated that MSPP issuers should
be required to comply with all State requirements regarding geographic
scope of coverage that apply to QHPs. One commenter recommended that
MSPs follow specific State standards for statewideness. Some commenters
stated that, without a requirement of statewideness, there is a
possibility of red-lining by MSPP issuers or adverse selection
resulting in MSPP issuers avoiding certain populations. Commenters were
also concerned about market dislocation. One commenter stated that MSPP
issuers would be able to avoid offering coverage in rural and other
high-cost areas, which would give them a competitive advantage over
both QHP issuers and issuers not offering on an Exchange. Lastly, one
commenter stated that a core purpose of the MSPP is to benefit
individuals who lack options, and allowing issuers to avoid certain
difficult areas in a State contradicts this basic purpose. One
commenter suggested that we include language indicating that we will
consult with State regulators and the State Exchange in determining
that MSP coverage does not exclude specific high-utilizing, high-cost,
or medically-underserved populations.
Response: We are not prohibiting MSPP issuers from being statewide;
on the contrary, we encourage them to do so from the start if they have
the capacity. MSPP issuers should follow State laws regarding
statewideness to the extent it is within their capability to do so. In
addition, we are finalizing this regulation with the requirement for an
MSPP issuer to provide a plan for expanding coverage statewide.
Furthermore, we intend to address an MSPP issuer's ability to expand
coverage statewide as part of the MSPP application and contract
negotiation processes. We acknowledge the commenters' concern for red-
lining and other ``cherry-picking'' practices where an issuer might
offer plans only in geographic areas that are expected to have lower
risk. Therefore, we will evaluate MSPP issuers to ensure that the
locations in which they propose to offer MSP coverage have been
established without regard to racial, ethnic, language, health-status-
related factors listed in section 2705(a) of the PHS Act, or other
factors that exclude specific high-utilizing, high-cost, or medically-
underserved populations. We agree that a core purpose of the MSPP is to
provide additional choice of health insurance plans and promote
competition on the Exchanges, and MSPP issuers should not be permitted
to avoid areas in a State that are difficult to serve. We are aware of
these concerns and are committed to MSPP issuers being neither
competitively advantaged nor disadvantaged, compared to QHP issuers.
OPM proposed that, by the end of the phase-in period, MSPP issuers
should be required to offer coverage on the SHOP in addition to the
individual Exchange. We solicited comments on this approach to SHOP
participation, including on whether participation in SHOP should be
required from the outset or whether we should allow MSPP issuers to
provide a plan that requires a period longer than the phase-in period
to fully participate in the SHOP. We received comments on the phase-in
to SHOPs from States, an issuer association, and professional
organizations.
Comments: Several commenters supported our approach of allowing
MSPP issuers the flexibility to phase-in to SHOPs. One commenter asked
that OPM clarify whether the statement in the preamble that the ``MSPP
issuer may choose to participate in the SHOP'' is a proposal to phase-
in MSPP issuer coverage in the SHOP. Some commenters were concerned
that MSPs will have a competitive advantage if they are not required to
follow the same
[[Page 15565]]
rules as the Federally-facilitated Exchange and State requirements for
QHPs to offer coverage in both the individual and SHOP markets. One
commenter noted that OPM's approach presents a significant challenge,
since it has merged markets. Some commenters would like OPM to require
participation in the SHOP from the outset or require full participation
in the SHOP at the fourth year of phase-in.
Response: We appreciate the support for our approach of allowing
MSPP issuers the flexibility to phase-in coverage to the SHOPs, which
was discussed in the preamble of the proposed rule, though not
addressed in the regulatory text. Based on the policy for Federally-
facilitated SHOP participation published in the HHS Payment Notice, we
are finalizing our regulation to require MSPP issuers to comply with 45
CFR 156.200(g). In the HHS Payment Notice, HHS adopted a provision
stating that a QHP issuer applicant will participate in a Federally-
facilitated SHOP based on an issuer applicant's current small group
market share. The provision uses a threshold of 20 percent market share
to determine whether a small group market issuer is subject to the
tying provision for QHPs in the Federally-facilitated SHOPs. For the
MSPP, we believe this standard for the Federally-facilitated SHOP can
be met if a State-level MSPP issuer or any other issuer in the same
issuer group affiliated with an MSPP issuer provides coverage on the
Federally-facilitated SHOP.
In this final rule, we adopt a policy for the MSPP that mirrors the
standard set by HHS for the Federally-facilitated SHOP. We also adopt a
policy for SHOP participation on State-based Exchanges that is
consistent with our approach to State law under Sec. 800.114 while
retaining OPM discretion on timing of MSPP issuers to participate in
the SHOP. For State-based SHOPs, we will permit an MSPP issuer
flexibility to phase-in participation in the SHOP if the State has set
a standard that requires QHPs to participate. We understand the burden
of building capacity and network in order to offer in the SHOPs and
want to balance the needs of small employers, MSPP issuers, and States.
We believe section 1334(e) provides OPM discretion to allow an MSPP
issuer to phase-in SHOP participation in States that require
participation and this flexibility meets the needs of many
stakeholders. Therefore, we are finalizing regulatory text in Sec.
800.104(c) that requires MSPP issuers to comply with standards in 45
CFR 156.200(g) and with State standards for SHOP participation, subject
to Sec. 800.114, and gives OPM discretion to provide MSPP issuers
flexibility during the initial years of the program to phase into the
SHOP in a State-based Exchange. We also clarify that an MSPP issuer
must offer coverage for both individuals and small groups in a State
with a merged individual and small group market. We encourage MSPP
issuers to expand coverage in States and SHOPs when they have adequate
capacity to accept enrollees.
Benefits (Sec. 800.105)
In Sec. 800.105, OPM proposed to implement section 1334(c)(1)(A)
of the Affordable Care Act, which directs an MSP to offer a benefits
package that is uniform in each State and consists of the EHB described
in section 1302 of the Affordable Care Act. OPM developed its benefits
policy in coordination with HHS, which promulgated the EHB rule.
Generally, under that rule, EHB would be defined by a benchmark plan
selected by each State or, in the absence of a State benchmark
designation, a default benchmark. However, the EHB rule also states at
45 CFR 156.105 that MSPs must meet benchmark standards set by OPM.
In Sec. 800.105(a)(1), OPM proposed that an MSPP issuer must offer
a uniform benefits package for each MSP and that the benefits for each
MSP must be uniform within a State, but not necessarily uniform among
States. In Sec. 800.105(a)(2), OPM proposed that the benefits package
referred to in Sec. 800.105(a)(1) must comply with section 1302 of the
Affordable Care Act, as well as any applicable standards set by OPM or
HHS in regulations. Together, these provisions clarify that MSPP
issuers must comply with applicable HHS requirements and that OPM may
issue additional guidance regarding any issues unique to MSPs.
In Sec. 800.105(b)(1), OPM proposed allowing MSPP issuers to offer
a benefits package, in all States, that is substantially equal to
either (1) each State's EHB-benchmark plan in each State in which it
operates; or (2) any EHB-benchmark plan selected by OPM. The second
option offers administrative efficiencies for MSPP issuers, who face a
number of challenges in being able to offer MSPs on each Exchange in
all States and the District of Columbia. We also noted in our proposed
rule that MSPP issuers could potentially achieve a similar consistency
in their benefits offerings by adhering to State EHB-benchmark plans
and applying the EHB substitution rules at 45 CFR 156.115.
Comments: We received many comments on the proposed EHB-benchmark
policy from a broad range of stakeholders. Many commenters argued that
the proposed policy would lead to adverse selection or consumer
confusion. Some commenters argued that the proposed policy would also
constitute Federal preemption of State authority to regulate insurance.
At least one commenter said that the proposed policy would lead to
administrative complexities and inefficiencies. Finally, some
commenters preferred to have only a national benchmark.
Some commenters noted that differences between an OPM-selected
benchmark and State-selected benchmark are unlikely to be actuarially
significant. Some commenters also noted that the proposed policy would
encourage issuers to participate in the MSPP. Other commenters also
noted that OPM-selected benchmarks would provide robust prescription
drug coverage, obesity treatment services, medical nutrition therapy,
pediatric services, and chiropractic care.
Response: We agree with commenters who noted that the differences
between an OPM-selected benchmark and State-selected benchmark are
unlikely to be actuarially significant. We are not aware of any
compelling evidence that multiple benchmarks would lead to adverse
selection or consumer confusion, nor did the commenters produce any
evidence of adverse selection or consumer confusion. Accordingly, we
are adopting as final the proposed provision to allow an MSPP issuer to
offer a benefits package in all States that is substantially equal to
either the EHB-benchmark plan in each State in which it proposes to
offer an MSP or any EHB-benchmark plan selected by OPM.
Comments: Several commenters discussed the need for national MSPs
for American Indians/Alaska Natives.
Response: We acknowledge that consistency among States would be
helpful for I/T/Us that may consider purchasing plans for tribes that
are in multiple States. Members of tribes would still need to access
the Exchanges in their States to determine their eligibility and
enrollment for products available through the Exchange, including an
MSP. While the MSPP is not a national plan, reciprocity of coverage
among MSPs in States is an issue we intend to take up in contract
negotiations with MSPP issuers. We look forward to conferring with
tribes on this approach and engaging them in how the MSPP may best meet
their needs.
Comments: Several commenters asked us to eliminate or provide
additional guidance regarding the ``substantially equal'' standard.
[[Page 15566]]
Response: Because HHS is defining the standard for the term
``substantially equal,'' we expect MSPP issuers to follow HHS guidance
relating to this term.
OPM also proposed that even if an MSPP issuer chooses to use an
EHB-benchmark plan selected by OPM in all States, the MSPP issuer must
still use a State-selected benchmark in States that do not allow any
substitution for services within the benchmark benefits. The reason for
this is if an MSPP issuer were to use an OPM-selected benchmark in
States that require all plans to offer the same set of benefits, then
the MSP in that State would be different from all of the other plans
offered on the market, which could potentially lead to market
disruption, adverse selection, or consumer confusion could occur.
Comments: Many commenters supported the policy that OPM-selected
benchmarks and substitutions not be allowed in States having standard
benefit designs.
Response: We are adding a paragraph (b)(3) to Sec. 800.105 to
clarify that an MSPP issuer must comply with any State standards
relating to substitution of benchmark benefits or standard benefit
designs. Accordingly, in a State that does not allow substitution of
benchmark benefits, or that has standard benefit designs, an MSPP
issuer that has chosen to use an OPM-selected EHB-benchmark plan under
paragraph (b)(2)(ii) must use the State's EHB-benchmark plan.
No matter which option an MSPP issuer chooses, it must apply that
option uniformly in each State in which the MSPP issuer proposes to
offer MSPs. This means that, except as discussed above, our approach
will not permit an issuer to use a State benchmark plan in some States
in which it operates and an OPM-chosen benchmark plan in others.
In Sec. 800.105(c)(1), OPM proposed selecting, as EHB-benchmark
plans, the three largest FEHBP plan options by enrollment that are open
to Federal employees and annuitants, which were identified by HHS
pursuant to section 1302(b) of the Affordable Care Act. On July 3,
2012, HHS identified the three largest FEHBP plan options (as of March
31, 2012) as Blue Cross Blue Shield (BCBS) Standard Option; BCBS Basic
Option; and Government Employees Health Association (GEHA) Standard
Option.\1\ An MSPP issuer that selects one of these benchmarks must
offer this benefits package in all States in which it operates an MSP.
---------------------------------------------------------------------------
\1\ Centers for Medicare and Medicaid Services, Essential Health
Benefits: List of the Largest Three Small Group Products by State,
available at https://cciio.cms.gov/resources/files/largest-smgroup-products-7-2-2012.pdf.PDF (July 3, 2012).
---------------------------------------------------------------------------
Several commenters urged OPM to be judicious in evaluating all
proposed benchmarks. Based on initial comparative research, it appears
that the proposed OPM-selected EHB-benchmark plans are largely similar
in scope of benefits covered to those benchmark-eligible plans in the
small group markets.\2\ This research also indicates that the OPM-
selected EHB-benchmark plans, like other benchmark-eligible plans, may
lack coverage for pediatric oral services, pediatric vision services,
and habilitative services and devices. Moreover, the EHB-benchmark may
also lack State-required benefits. Accordingly, OPM proposed standards
to supplement the OPM-selected EHB-benchmark plans in Sec.
800.105(c)(2)-(c)(4).
---------------------------------------------------------------------------
\2\ U.S. Department of Health and Human Services, Office of the
Assistant Secretary for Planning and Evaluation, ASPE Research
Brief, Essential Health Benefits: Comparing Benefits in Small Group
Products and State and Federal Employee Plans, available at https://aspe.hhs.gov/health/reports/2011/MarketComparison/rb.pdf (December
2011).
---------------------------------------------------------------------------
In Sec. 800.105(c)(2), we proposed that any OPM-selected EHB-
benchmark plan lacking coverage of pediatric oral services or pediatric
vision services must be supplemented by the addition of the entire
category of benefits from the largest Federal Employee Dental and
Vision Insurance Program (FEDVIP) dental or vision plan option,
respectively, pursuant to 45 CFR 156.110(b) and section 1302(b) of the
Affordable Care Act. On July 3, 2012, HHS identified the largest FEDVIP
dental and vision plan options, as of March 31, 2012, to be,
respectively, MetLife Federal Dental Plan High Option and FEP
BlueVision High Option.
We also solicited comments on the provision of pediatric oral
services by MSPs in order to meet the requirements of section
1302(b)(1)(J) of the Affordable Care Act. Under one proposed approach,
an MSP would include pediatric oral services in its benefit package.
Finally, we solicited comments on how stand-alone dental plans offered
on the Exchanges should affect this requirement, if at all.
Comments: While some commenters favored offering stand-alone dental
plans, others expressed concern that the expense of separate out-of-
pocket maximums might discourage families from purchasing separate
coverage for pediatric oral services. Some commenters proposed to
require all MSPs to offer both a complete medical package and an
identical plan without pediatric oral services in areas where stand-
alone pediatric dental coverage is available.
Response: Given the range of possible benefit designs, we are not
promulgating any further regulatory provisions regarding coverage of
pediatric oral services. Instead, we will keep these comments in mind
during MSPP contract negotiations, which would allow greater
flexibility on benefit designs.
In Sec. 800.105(c)(3), we proposed that an MSPP issuer must follow
State definitions for habilitative services and devices where the State
chooses to specifically define this category pursuant to 45 CFR
156.110(f). When a State chooses not to define this category and any
OPM-selected EHB-benchmark plan lacks coverage of habilitative services
and devices, OPM may determine what to include in this category.
Comments: All commenters supported OPM's intention to include
habilitative services and devices in the MSPs. However, they disagreed
on whether we should defer to State definitions or have OPM define a
specific set of habilitative services and devices that each MSP must
cover. Some asked that we require parity in scope, amount, and duration
for habilitative and rehabilitative services. Other commenters
supported our proposed approach for when a State chooses not to define
the category of habilitation. When this happens, we will determine what
habilitative services and devices must be included in an OPM-selected
EHB-benchmark plan. One commenter suggested that we refer to both
habilitative ``services and devices'' in Sec. 800.105(c)(3) as we do
in Sec. 800.105(c)(4).
Response: Based on the comments, we will direct MSPP issuers to
follow State definitions of habilitative services and devices where
they exist and, where they do not exist, OPM will consider these
comments during MSPP contract negotiation. We are adopting proposed
Sec. 800.105(c)(3) as final, with the one technical correction
mentioned above.
In Sec. 800.105(c)(4), OPM proposed that, at least for years 2014
and 2015, OPM's EHB-benchmark plans would also include, for each State,
any State-required benefits enacted by December 31, 2011, that are
included in a State's EHB-benchmark plan or specific to the market in
which the MSPP issuer offers coverage. Accordingly, these State-
required benefits would be treated as part of the EHB. However,
consistent with 45 CFR 155.170, OPM proposed that State-required
benefits enacted after December 31, 2011, would be in addition to the
EHB. Under section
[[Page 15567]]
1334(c)(4) of the Affordable Care Act, a State must assume the cost of
such additional benefits over the EHB by making payments either to the
enrollee or on behalf of the enrollee to the MSPP issuer, if
applicable. An MSPP issuer must calculate and report the costs of
additional State-required benefits pursuant to Sec. 800.105(e). This
standard is also consistent with 45 CFR 155.170.
Comments: Most commenters supported the inclusion of State-required
benefits before December 31, 2011. However, one commenter opposed the
inclusion of State-required benefits. Another commenter stated that the
cutoff date for inclusion of State-required benefits should be November
26, 2012, the date when the proposed EHB rule was published.
Response: We are making no changes to Sec. 800.105(c)(4), because
it is consistent with standards applicable to QHPs at 45 CFR 155.170.
Comments: Several commenters recommended that State payments for
State-required benefits above the EHB benchmark be made only to issuers
instead of allowing States the option of making payments to either
issuers or enrollees.
Response: We are making no changes to proposed Sec. 800.105(e),
because it is consistent with section 1334(c)(4) of the Affordable Care
Act, as well as standards applicable to QHPs at 45 CFR 155.170.
In Sec. 800.105(d), OPM proposed that an MSPP issuer's benefits
package, including its prescription drug list, must be submitted to and
approved by OPM, which will determine whether a benefits package
proposed by an MSPP issuer is substantially equal to an EHB-benchmark
plan, in accordance with the requirements set forth by HHS in the
proposed EHB rule. In determining whether an MSPP issuer's benefits
package should be approved, OPM proposed to follow the HHS approach set
forth at 45 CFR 156.115, 156.122, and 156.125. Section 156.115(b) of
title 45, Code of Federal Regulations, allows issuers to make benefit
substitutions within each EHB category and directs issuers to submit
evidence of actuarial equivalence of substituted benefits to a State.
We requested comments on whether MSPP issuers should submit evidence of
actuarial equivalence of substituted benefits to OPM in addition to, or
in lieu of, their submission to a State.
Comments: Many commenters recommended that, if MSPP issuers are
allowed to make actuarially equivalent substitutions, evidence should
be submitted to both States and OPM.
Response: We are adopting the proposed Sec. 800.105(d), and we
will work collaboratively with State regulatory officials during the
MSPP application process to ensure they receive evidence of actuarial
equivalence of substituted benefits.
In reviewing an MSPP issuer's proposed benefit design, OPM plans to
review an MSPP issuer's benefits package for discriminatory benefit
design, consistent with section 1302(b)(4) of the Affordable Care Act
and 45 CFR 156.110(d), 156.110(e), and 156.125, and will work closely
with States and HHS to identify and investigate any potentially
discriminatory benefit design in MSPs.
In summary, we are adopting proposed Sec. 800.105 as final, with
the change described above relating to standardized benefit designs. We
also are making minor technical corrections, including by inserting a
reference to both habilitative ``services and devices'' in Sec.
800.105(c)(3) to be consistent with Sec. 800.105(c)(4).
Cost-Sharing Limits, Premium Tax Credits, and Cost-Sharing Reductions
(Sec. 800.106)
In Sec. 800.106(a), OPM proposed that, for each MSP it offers, an
MSPP issuer must ensure that the cost-sharing provisions of the MSP
comply with section 1302(c) of the Affordable Care Act as well as any
applicable standards set by OPM or HHS in regulations. The HHS
standards are set forth in 45 CFR 156.130. In Sec. 800.106(b), OPM
proposed that an MSPP issuer, for each MSP it offers, must ensure that
an eligible individual receives advance payments of premium tax credits
under section 36B of the Internal Revenue Code (the Code) and cost-
sharing reductions under section 1402 of the Affordable Care Act. This
provision would establish MSPP issuer responsibilities under section
1334(c)(3)(A) of the Affordable Care Act, which specifies that an
individual enrolled in an MSP is eligible for the premium tax credits
and cost-sharing reductions in the same manner as an individual who is
enrolled in a QHP. We clarify that under Sec. 800.106(b), MSPP issuers
must comply with the same standards as QHP issuers, including
applicable provisions of sections 1402(a)(2) and 1412(c)(2)(B) of the
Affordable Care Act and 45 CFR part 156, subpart E. OPM may issue
additional guidance regarding any unique issues faced by MSPs.
We received comments on this section from a broad spectrum of
consumer and professional organizations and a few individual States. In
general, our intention is to require MSPP issuers to comply with
Exchange rules to ensure that MSPs operate on a level playing field
with other issuers operating in the Exchanges. To the extent any rules
governing MSPs differ from those governing QHPs, OPM will design them
to afford the MSPs and MSPP issuers neither a competitive advantage nor
a disadvantage with respect to other plans offered on the Exchange.
Comments: Some commenters requested that OPM clarify its
requirement that MSPPs must comply with State cost-sharing
restrictions.
Response: It is our intention to require MSPP issuers to follow HHS
rules regarding cost-sharing except when State laws impose stricter
requirements for their Exchanges. In the event a State standardizes
cost-sharing arrangements and these standards comply with HHS
regulations, an MSPP issuer will also be required to comply with State
standards for cost-sharing.
Comments: One group of commenters suggested that OPM require an MSP
to cover out-of-network subspecialty care with the same cost-sharing
arrangements as in-network.
Response: As acknowledged in our final application for the MSPP, we
may, in some circumstances, also require MSPP issuers to provide in-
network benefits for services from certain out-of-network providers;
however, this would not be done through rulemaking. We will take these
comments under consideration during our contract negotiation with MSPP
issuers.
Concerns about the cost-sharing variation for American Indian/
Alaska Native families who want to purchase child-only coverage are not
within the scope of OPM's rulemaking authority. The Exchanges and HHS
will facilitate all plan variations between MSPP issuers and potential
enrollees just as they will do for families participating in the QHPs.
However, where appropriate, OPM will coordinate closely with HHS on
areas of special concern for American Indian/Alaska Native adults and
children.
We are adopting proposed Sec. 800.106(a) as final, with no
changes, and we are making technical changes to Sec. 800.106(b).
Levels of Coverage (Sec. 800.107)
In Sec. 800.107, we proposed that an MSPP issuer, like a QHP
issuer participating in Exchanges, must offer at least one plan at the
silver level of coverage and one plan at the gold level of coverage in
each Exchange in which the issuer is certified to offer an MSP pursuant
to a contract with OPM. OPM will use its discretion about whether an
MSPP issuer may offer products in
[[Page 15568]]
addition to the required gold and silver products.
We also proposed that an MSPP issuer must offer a child-only plan
at the same level of coverage as any health insurance coverage offered
to individuals who, as of the beginning of the plan year, have not
attained the age of 21. OPM proposed that MSPP issuers must comply with
applicable HHS requirements to offer plan variations that will reduce
or eliminate cost-sharing for eligible enrollees pursuant to section
1402 of the Affordable Care Act. Any MSP plan variations will be
submitted to OPM for review and approval, and OPM will coordinate its
approach to them with the final HHS notice of benefit and payment
parameters for 2014. OPM will exercise this discretion to promote the
best interests of enrollees and potential enrollees in the MSPP and to
ensure adequate administrative oversight of each MSP and MSPP issuer.
A number of comments, although informative, relate to issues that
do not fall within the scope of OPM's rulemaking. In general, our
intention is to direct MSPP issuers to comply with State requirements
related to the offering of levels of coverage, including but not
limited to standardized benefit designs and tiers.
Comments: Some commenters recommended that OPM require or encourage
MSPP issuers to offer coverage beyond gold and silver plans. The
suggestions included requiring MSPP issuers to offer one or more of the
following: At least one bronze plan; a plan in both the MSP and State
Medicaid program; and catastrophic coverage.
Response: The Affordable Care Act requires each MSPP issuer to
offer both a gold and silver plan. OPM will not require bronze coverage
through this regulation, but has the discretion to approve other levels
of coverage through contract negotiation with issuers. Therefore, where
a State allows it, we will consider plans that offer catastrophic or
bronze levels of coverage. We will also consider applicants to the MSPP
that propose to offer an MSP in the Exchange and simultaneously provide
coverage through a State Medicaid program. We agree with commenters
that this would reduce the potential for gaps as consumers transition
between Medicaid and Exchange eligibility. However, we do not have
authority to require MSPP issuers to participate in Medicaid.
No changes are needed in Sec. 800.107 in light of the comments we
received. Therefore, we are adopting proposed Sec. 800.107 as final,
with no changes.
Assessments and User Fees (Sec. 800.108)
The proposed rule provides OPM discretion to collect an assessment
or user fee from MSPP issuers as a condition of participating in the
MSPP. The proposed rule also describes, generally, that any OPM-
collected assessments and user fees would be to cover the
administrative costs of performing the contracting and certification of
MSPs and of operating the program, functions typically conducted
through an Exchange for QHPs.
Comments: Some commenters asked OPM to confirm that MSPP issuers
would pay any State-based Exchange user fees in addition to the MSPP-
specific assessments or user fees. These commenters were concerned that
any administrative fee above and beyond the Exchange fee charged to QHP
issuers is duplicative and could lead to a competitive disadvantage for
MSPP issuers. One commenter asked how the process for paying
assessments and user fees to OPM would work.
Response: In this final rule, OPM is preserving its discretion to
collect an MSPP assessment or user fee, and clarifies that it may begin
collecting the fee in 2015; OPM does not intend to collect an
assessment or user fee in 2014. The user fee could be used to fund OPM
activities directly related to MSPP certification and administration.
We currently estimate that any future assessment or fee would be no
more than 0.2 percent of premiums.
The MSPP user fee would not be a substitute for any user fee or
assessment imposed by a State-based Exchange or Federally-facilitated
Exchange. Rather, OPM intends for any MSPP user fee it collects to be
offset against any State-based Exchange or Federally-facilitated
Exchange user fee that the MSPP issuer must pay. This offset would
preserve a level playing field for MSPP issuers. Under this approach,
the MSPP issuers would pay the same total assessment or user fee to
participate in an Exchange as all other QHPs participating in that
Exchange. In addition, this process would allow the Exchanges to
receive the bulk of the user fee from MSPP issuers to cover the
Exchange costs, while also providing a marginal amount to fund the
certification activities that OPM will perform in the place of an
Exchange with respect to the MSPs.
OPM would issue further guidance in advance of collecting any user
fees in 2015. For example, OPM would provide instructions on whether
MSPP issuers should pay the MSPP portion of the user fee to OPM and pay
separately the balance of the State-based or Federally-facilitated
Exchange user fee to the State or HHS, as appropriate.
Comments: Several commenters wanted more detail about OPM's costs
for certifying and administering the MSPP and to what use the
assessment or user fee would be put. One commenter suggested
eliminating the assessment or user fee since MSPP administration is a
function of OPM.
Response: As stated in the proposed rule, the MSPP assessment or
user fee would be used for OPM's MSPP functions for administration,
including entering into contracts with, certifying, recertifying,
decertifying, and overseeing MSPs and MSPP issuers for that plan year.
OPM will communicate such costs to MSPP issuers and Exchanges when
available. The MSPP user fee is similar to a fee that OPM collects and
uses to administer contracts for the FEHBP and will only be used to
administer the MSPP as it performs plan management functions similar to
State-based and Federally-facilitated Exchanges.
Network Adequacy (Sec. 800.109)
OPM proposed, in Sec. 800.109, a standard for network adequacy for
the MSPP that mirrors the HHS standard set forth in 45 CFR 156.230 and
is intended to ensure that an MSP's services are available to all
enrollees. Consistent with the Exchange final rule's alignment with the
NAIC Model Act, OPM proposed directing an MSPP issuer to (1) maintain a
network that is sufficient in the number and types of providers to
ensure that all services will be accessible without reasonable delay
for enrollees; (2) offer a provider network that is consistent with
network adequacy provisions set forth in section 2702(c) of the PHS
Act; and (3) offer a provider network that includes essential community
providers in compliance with 45 CFR 156.235. OPM intends for an MSPP
issuer to make its provider directory available to the Exchange for
online publication and to potential enrollees in hard copy, upon
request. The proposed regulation stated that OPM would issue guidance
containing the criteria and standards that OPM will use to determine
the adequacy of a provider network. In addition, we solicited comment
on State licensure and any issues for MSPs with respect to State-
specific network adequacy requirements.
Comments: Some commenters recommended that network adequacy
provisions include specific provider types, such as certified
registered nurse anesthetists, tribal health care providers,
chiropractic physicians, optometrists, and Christian Science providers.
Some
[[Page 15569]]
commenters also stated that OPM should prohibit discrimination against
specific provider types. A few commenters recommended that OPM require
MSPP issuers to adopt a standard Indian Addendum for contracting with
tribal health care providers.
Response: While the MSP network adequacy standard should provide
access to a range of health care providers, specifying the inclusion of
specified provider types, beyond what is required under the Affordable
Care Act for QHPs (e.g., essential community providers), would detract
from the larger issue of broadly ensuring affordable access to the full
range of covered services. Accordingly, the final rule retains the
language in proposed Sec. 800.109(a) that requires MSPP issuers to
maintain networks that include sufficient numbers and types of
providers to ensure all services will be accessible without
unreasonable delay. This includes providers representing medical,
surgical, pediatric, mental health, and allied health disciplines to
meet the anticipated health care needs of a diverse patient population.
We acknowledge the importance of having standards in place to prevent
discrimination against specific provider types, because a variety of
providers is important for accessing services. However, we believe that
the non-discrimination standards set forth in Sec. Sec. 800.101 and
800.102 adequately prohibit discrimination against specific provider
types. OPM will reinforce these protections through its contract
negotiations with MSPP issuers.
With regard to the comments on the standard Indian Addendum, OPM
recognizes that furnishing MSPP issuers with a standard Indian Addendum
to a provider contract may make it easier for MSPP issuers to contract
with Indian providers. We are aware that the Centers for Medicare and
Medicaid Services (CMS) has partnered with the Indian Health Service to
develop a Draft Model Qualified Health Program Addendum for contracting
between QHP issuers and tribal health care providers. However, CMS has
not required that QHP issuers use the Addendum in the Exchange rule. We
think it more appropriate to address this issue in our contract
negotiations. We will continue to coordinate closely with CMS on the
use of the standard Indian Addendum by MSPP issuers when contracting
with Indian providers.
Comments: A few commenters recommended that OPM require MSPP
issuers to contract with ``any willing essential community provider.''
Similarly, a few commenters suggested that OPM require MSPP issuers to
comply with any State laws concerning ``any willing provider'' or ``any
willing pharmacy.''
Response: In proposed Sec. 800.109(a)(3), OPM adopted an approach
that mirrors that of HHS regarding inclusion of essential community
providers for QHPs. OPM intends for MSPP issuers to contract with
essential community providers. We do not intend to change this
provision of the proposed regulation, but we wish to assure commenters
that we consider Sec. Sec. 800.109(a) and 800.114 to require MSPP
issuers to comply with State ``any willing provider'' laws.
Comments: We received some comments related to standards for
provider directories under proposed Sec. 800.109(b). Overall,
commenters supported the proposed standards, which mirrored the HHS
standards in the Exchange final rule. However, one commenter suggested
that OPM require MSPP issuers to maintain a dedicated email address
that providers and consumers could use to submit inaccurate provider
directory information for correction. In addition, another commenter
requested that OPM streamline requirements for provider directories by
allowing downloadable electronic versions in place of hard copy and
avoiding requiring regular updates of providers accepting new patients.
Response: The proposed Sec. 800.109(c) mirrors the HHS approach to
provider directories for QHPs. We will consider, during the MSPP
contract negotiations, the comment on an MSPP issuer maintaining a
dedicated email address for changes in provider directory information.
With regard to the commenter who suggested that MSPP issuers not be
required to provide a hard copy of the provider directory to potential
enrollees upon request, this suggestion conflicts with HHS standards.
Comments: We received numerous comments related to establishing a
uniform MSPP network adequacy standard. Many commenters did not support
OPM developing a uniform standard for the MSPP. These commenters
suggested that not applying the same standards to all QHPs and MSPs
within a State would lead to adverse selection and market dislocation,
and would not be in the best interests of consumers, though they did
not submit any evidence to support these contentions. Specifically, two
commenters identified States that had existing network adequacy
standards for managed care products and recommended that an MSPP issuer
comply with those standards. Conversely, many other commenters
recommended that OPM establish a national, uniform standard for network
adequacy for the MSPP. These commenters indicated that a uniform
standard would be considered a critical component of the MSPP and is
especially important in ensuring that MSPs provide reasonable and
timely access to health care.
Response: OPM recognizes that many, though not all, States direct
health insurance issuers to evaluate the adequacy of their provider
networks on an ongoing basis and monitor network adequacy in their
traditional role of regulating health insurance. Based on comments
received on the proposed rule, and informed by previous comments
concerning the RFI and the draft application, we have adopted an
approach under which the MSPP will establish a uniform standard for
network adequacy using time and distance standards that are based on
those published by CMS for Medicare Advantage plans (for providers and
facilities) and Medicare Part D (for retail pharmacies), which we note
meet the QHP network standards in 45 CFR 156.230. For 2014, we will
assess MSPP issuers' compliance with these time and distance standards
for a broad, diverse list of provider types and facility types, which
we believe adequately reflects the ability of an MSPP issuer to assure
that all services will be accessible without unreasonable delay for
enrollees. More information is available in our final MSPP application
that was published on January 18, 2013, on the Federal Business
Opportunities Web site at www.FBO.gov under solicitation number OPM35-
12-R-0006, Multi-State Plan Program.
In the first year of the MSPP, we will apply only the MSPP standard
for MSPP issuer networks, and in future years may require an MSPP
issuer to meet State network standards, if appropriate and in the best
interest of MSP enrollees. Accordingly, we are adopting proposed Sec.
800.109 as final, with no changes; however, we will continue to
consider these comments during the MSPP contract negotiations.
Service Area (Sec. 800.110)
In Sec. 800.110, OPM proposed that MSPP issuers comply with the
service areas defined by Exchanges, but this does not necessarily
require that an MSP be offered in all defined service areas. We also
proposed that for each State in which the MSPP issuer does not offer
coverage in all service areas, the MSPP issuer's application for
participation in the MSPP and the information it submits to support
[[Page 15570]]
renewal of a contract must include a plan for offering coverage
throughout the State. We sought comment on whether MSPP issuers should
be required to offer MSPs in all service areas by the fourth year of
participation in the MSPP.
Comments: We received some support for our proposal on service
areas from a commenter stating that our policy allows MSPP issuers time
to develop the capacity to offer coverage throughout a service area and
this will enhance competition. Several commenters were concerned about
MSPP issuers' ability to cherry-pick the areas where they offer plans.
Some commenters recommended that MSP service and rating areas be
aligned to prevent issuers from cherry-picking. Another commenter
recommended that MSPs be required to comply with the service area
requirements applicable to all other issuers in a State. One commenter
recommended that MSPs be required to cover geographic service areas in
a particular State where they are licensed if their license is other
than statewide, and the commenter also recommended that MSPs should
follow the same rules as QHPs, concerning partial rating regions.
Finally, several commenters were concerned that our proposed policy may
not ensure access in a meaningful way or promote competition.
Response: Similar to our response to comments on Sec. 800.104, we
are not prohibiting MSPP issuers from offering coverage in all service
areas; on the contrary, we encourage them to do so if they have the
capacity. We are clarifying in the final rule that MSPs will be
required to comply with the service area requirements applicable to all
QHPs in a State. We are not making any additional requirements
regarding partial rating regions or geographic service areas in States
with certain licensure laws that determine service area. We acknowledge
the commenters' concern that issuers may cherry-pick certain service
areas. However, we believe that requiring that MSPs be subject to the
same service area requirements as QHPs will create a level playing
field and prevent issuers from cherry-picking. In addition, we intend
to pay special attention to whether service areas include rural areas
and American Indian/Alaska Natives during MSPP contract negotiations.
We will evaluate the service area of an MSP to ensure that it has been
established without regard to racial, ethnic, language, health status-
related factors specified under section 2705(a) of the PHS Act, or
other factors that exclude specific high-utilizing, high-cost or
medically-underserved populations.
Similar to our changes under Sec. 800.104, we are removing the
requirement in the proposed rule that, for each State in which the MSPP
issuer does not offer coverage in all service areas, the MSPP issuer
would submit a plan on expanding coverage throughout the State. For
reasons described in our responses to comments on Sec. 800.104 related
to statewide coverage, we intend to encourage MSPP issuers to expand
coverage and will assess their capacity to do so through the MSPP
contract negotiations.
Accreditation Requirement (Sec. 800.111)
In Sec. 800.111, OPM proposed a requirement that MSPP issuers be
or become accredited consistent with the HHS standards for QHP issuers.
We also proposed that the MSPP issuer must authorize the accrediting
entity to release to OPM and to Exchanges a copy of the MSPP issuer's
most recent accreditation survey, along with any survey-related
information that OPM or an Exchange may require. OPM also proposed that
an issuer that is not accredited as of the date that it enters into a
contract with OPM must become accredited within the timeframe
established by OPM in accordance with 45 CFR 155.1045.
Comments: Several commenters recommended that OPM set a timeframe
for accreditation that meets the accreditation timeframe set for QHP
issuers either participating in Federally-facilitated Exchanges or in
State-based Exchanges. Some commenters supported a unique timeline for
MSPP issuer accreditation.
Response: OPM intends to follow the timeframe for accreditation in
45 CFR 155.1045 and similar provisions adopted by State-based
Exchanges, though we are reserving the authority to set our own
timeframe under narrow circumstances that take into account the unique
nature of the MSPP. Due to the broad geographic coverage required for
the MSPP, MSPP issuers may need additional time to collect data on
local performance for accreditation. Similarly, a group of issuers
coming together to contract as an MSPP issuer under a common service
mark may need additional time to coordinate between accrediting
entities or among component plans. Additional time may also be required
if a component plan has previously been accredited by an entity other
than the accrediting entities recognized by the Secretary. Therefore,
in accordance with our authority under 45 CFR 155.1045, we are adopting
our proposed approach in the final regulation, with no changes.
Comment: One commenter recommended that the MSPP issuer must have a
schedule for a review of policies and procedures with a recognized
accrediting agency during that initial year and have documentation that
a readiness review for accreditation has been completed.
Response: OPM will consider this comment in creating contract
language for MSPP issuers who are obtaining accreditation in accordance
with Sec. 800.111(c).
Comment: One commenter asked OPM to clarify how consumers will be
educated about the differences between an accredited and unaccredited
plan; another commenter requested that accreditation surveys be made
public.
Response: Accreditation status of MSPP issuers (as well as all QHP
issuers) will be made available to consumers through Exchange systems.
No change in the regulation is needed.
Comment: One commenter suggested that to allow a group of
independent insurance issuers to jointly offer an MSP, accreditation
must be required at the State level rather than at a national level.
Response: MSPP issuers will be accredited on the basis of local
performance in accordance with the requirements for QHP issuers
specified in section 1311 of the Affordable Care Act and 45 CFR
156.275(a). No change is required in the proposed rule.
Reporting Requirements (Sec. 800.112)
The proposed Sec. 800.112(a) specified that OPM may collect such
data and information as are permitted or required by the Affordable
Care Act to be collected from an MSPP issuer. OPM has also proposed to
collect such other data and information as it determines necessary for
the oversight and administration of the MSPP.
OPM will use its FEHBP contract administration as a model for
reporting requirements. Examples of reporting that is currently
required for FEHBP carriers and that may be required for the MSPP
include financial reports, premium payment information, enrollment
reporting, and quality assurance information.\3\ OPM will determine the
data and information that MSPP issuers report and the frequency and
process for submitting such reports to be published in future guidance.
Reporting of certain types of information is critical for OPM to
[[Page 15571]]
implement and administer the MSPP. To oversee MSPP contracts, OPM will
need to collect certain information to ensure the integrity of the
MSPP, to protect enrollees, to prevent fraud and abuse, to monitor
quality and quality improvement, and for other purposes.
---------------------------------------------------------------------------
\3\ OPM's Routine Reports and Submissions required for FEHB
carriers is available at https://www.opm.gov/carrier/reports/index.asp.
---------------------------------------------------------------------------
Comments: Commenters raised several issues with regard to MSPP
reporting requirements. Many commenters noted that MSPP issuers should
comply with applicable State and Exchange standards.
Response: We note that Sec. 800.115(e) requires MSPP issuers to
comply with all Federal and State quality improvement and reporting
requirements.
Comments: Many commenters also urged that we coordinate with States
on data collection to avoid duplicative efforts. Some also asked us to
share data with the public. A couple of commenters stated that OPM
should not use a centralized health claims data warehouse for the MSPP,
but adopt a decentralized approach.
Response: We agree with commenters that our approach to data
collection should be coordinated with States. OPM intends to enter into
MOUs with States to streamline data collection and reduce duplicate
reporting requirements. This rule does not address specifics of how OPM
will collect data, and our method for data collection will be developed
in future policy guidance, in consultation with HHS.
Comment: One commenter stated that the MSPP should adopt the
pharmacy benefit manager (PBM) transparency standards that OPM has
established for the FEHBP, while another commenter opposed such an
approach.
Response: PBM transparency standards will be established through
the MSPP contract, and we will consider these comments in developing
contract language.
Comments: Several commenters urged us to adopt specific data
collection requirements, such as annual reports on each health plan,
including data on the number of enrollees receiving treatment for drug
and alcohol abuse and MSPP issuer definitions of medical necessity and
rider policies.
Response: Specific reporting requirements may change from year to
year based on the needs of the program. Accordingly, such issues are
more appropriately addressed through contract negotiations, rather than
this regulation.
Comments: The preamble of the proposed rule also suggested that OPM
may collect demographic data. Several commenters supported data
collection on demographics. A couple of commenters noted that issuers
may not currently collect demographic data and, in some States,
demographic data collection could be prohibited by law. One commenter
opposed all demographic data collection.
Response: Although we are not finalizing any specific demographic
data collection in this rule, our authority to administer MSPP
contracts includes collection of demographic data, if we decide to do
so in the future. In that event, we will consult with any States that
have laws prohibiting collection of demographic data.
Section 800.112(b) specifies quality and quality improvement
standards. With respect to quality reporting, under the FEHBP, OPM
requires all health plans to report their performance through
Healthcare Effectiveness Data and Information Set (HEDIS) metrics and
Consumer Assessment of Healthcare Providers and Systems (CAHPS)
surveys, independent of the source of plan accreditation. This allows
for comparison among plans in a consistent manner. OPM expects to begin
with a similar approach to performance measurement in MSPs to
facilitate oversight. We expect our approach to evolve as HHS sets
forth further guidance on quality reporting standards for QHPs.
Comments: Several commenters supported our proposed approach
regarding quality and quality improvement standards. One commenter was
concerned that requiring HEDIS reporting, which is proprietary to one
accrediting entity, would be an undue burden to other accrediting
entities. One commenter recommended that we immediately use the eValue8
quality reporting tool. Another commenter noted that we include
measures applicable to children, including specific modules for
children with special health care needs across the entire breadth of
conditions and domains (preventive care, mental health, and chronic
care).
Response: We are adopting in this final regulation our proposed
approach to quality and quality improvement standards, because it
reflects current FEHBP policies and Federal standards for QHPs. We
anticipate that quality reporting standards will evolve over time, and
we will consider these comments as the standards develop.
Benefit Plan Material or Information (Sec. 800.113)
In proposed Sec. 800.20, OPM defined the term ``benefit plan
material or information'' to include explanations or descriptions,
whether printed or electronic, that describe a health insurance
issuer's products. The term does not include a policy or contract for
health insurance coverage. As it does in the FEHBP, OPM will review and
approve the policy or contract for health insurance coverage. We view
oversight of such contractual documents as uniquely within OPM's
responsibilities under section 1334(a)(4) to implement the MSPP in a
manner similar to the manner in which we implement the contracting
provisions with respect to carriers under the FEHBP. OPM cannot manage
MSPP contracts similarly to FEHBP contracts without the authority to
review and revise these documents. See the discussion of Sec. 800.20
for our responses to comments on the definition of ``benefit plan
material or information.''
Section 800.113(a) states that MSPP issuers must comply with
Federal and State laws related to benefit plan material or information.
An MSPP issuer must also comply with OPM guidance specifying OPM
standards, process, and timeline for approval of benefit plan material
or information.
Comments: We received many comments about the proposed policy on
compliance with Federal and State law. Several commenters supported the
requirement that MSPP issuers comply with both Federal and State laws
relating to benefit plan material or information. Several commenters
wanted OPM to clarify that State approval of a policy form is a
precondition of OPM approval. One commenter wanted OPM to defer to
States for approval of policy forms, except where a State's action or
inaction prevents an MSP from being offered on an exchange.
Response: While OPM intends to review and approve policy forms for
health insurance coverage, OPM expects MSPP issuers to comply with
related State law requirements for form review. Accordingly, an MSPP
issuer's requirement to comply with State law includes the requirement
to comply with form review laws. However, State approval of a policy
form is not a precondition of OPM approval. OPM expects that few
disagreements will arise between OPM and a State regarding form review
and, if they do, we will work with the State to successfully resolve
the discrepancy in a manner that is acceptable to both OPM and the
particular State.
Proposed Sec. 800.113(b) states that all MSP enrollee notices must
meet minimum access standards for individuals with limited English
proficiency (LEP) and for individuals with disabilities as described in
45 CFR 155.205(c). As stated in the final
[[Page 15572]]
Exchange rule, HHS intends to issue further guidance on minimum
standards to address language access and coordinate HHS accessibility
standards with insurance affordability programs, and across HHS
programs, as appropriate. OPM expects MSPP issuers to comply with these
minimum access standards once HHS publishes this guidance. OPM may also
establish additional standards for MSPP applications and notices.
Comments: Several commenters wanted OPM to clarify that obligations
to provide materials in different languages be calculated by State or
service area, not nationwide. Two commenters wanted us to provide
clearer guidance on our language access policies. They suggested that,
to start with, OPM clarify that LEP guidance set forth by HHS' Office
of Civil Rights, which is referenced in footnote 48 of the HHS proposed
rule with respect to appeals, will also apply to other benefit material
or information.
Response: Such guidance will be addressed through the contract
negotiation process.
Section 800.113(c) states that an MSPP issuer is responsible for
the accuracy of its benefit plan material or information. Section
800.113(d) states that benefit plan material or information must also
be in plain language, be truthful, not be misleading, and have no
material omissions.
QHPs must comply with the provisions of section 2715 of the PHS Act
and its implementing regulations at 45 CFR 147.200 on Summary of
Benefit and Coverage and Uniform Glossary requirements. Under Sec.
800.113(e), OPM also will require MSPs to comply with the statute and
regulations. Additionally, OPM expects that MSPP issuers will meet any
requirements that allow standardized benefit information to be
displayed on HHS or Exchange web portals.
Section 800.113(f) states that OPM will review and approve certain
benefit plan material or information as defined in Sec. 800.20 of the
proposed regulation. OPM may not necessarily review all benefit plan
material or information. It may request from MSPP issuers those
materials that it wishes to review and approve. OPM's review will focus
on the MSPP issuer's compliance with the standards promulgated by OPM
with respect to benefit plan material or information.
Comments: One commenter did not want OPM to review and approve
benefit plan material or information. One commenter was concerned about
the practical difficulties for both issuers and regulators with respect
to the dual requirement that OPM review and approve policy forms and
that issuers also comply with State requirements. One commenter wanted
more clarity on the interplay between Federal and State review. One
commenter stated that OPM review of communication materials, and its
discussion with States, should be concluded no later than 90 days prior
to the beginning of the annual enrollment period.
Response: OPM cannot entirely cede responsibility for the review of
benefit plan material or information since such review is important to
oversight. Nonetheless, in order to avoid unnecessary duplication and
burden, OPM will work with States concerning the review of benefit plan
material or information and may work with States to define respective
roles through MOUs. OPM will also aim for prompt review of benefit plan
material or information.
Section 800.113(g) states that OPM will allow an MSPP issuer to
state that OPM has certified a plan as an MSP and will oversee its
administration. OPM is aware that many States have adopted laws or
regulations prohibiting issuers from using advertisements that ``may
lead the public to believe that the advertised coverages are somehow
provided by or endorsed by [a] governmental agenc[y].'' \4\ However,
because OPM will have certified an MSPP issuer and an MSP as meeting
certain standards, potential issuers may wish to include this fact in
materials they distribute to the public subject to review by OPM. OPM
does not view this as a violation of State law anti-endorsement
provisions because it is not misleading, but rather a recitation of the
fact that the issuer is providing coverage pursuant to a contract with
OPM.
---------------------------------------------------------------------------
\4\ These State law prohibitions derive from the NAIC's
Advertisements of Accident and Sickness Insurance Model Regulation
Sec. 13.C. (Apr. 1999).
---------------------------------------------------------------------------
Comment: One commenter did not want MSPP issuers to include a
statement on certification by OPM.
Response: For the reasons set forth above, we are adopting the
proposed policy regarding statement of certification.
Comments: Several commenters stated that it is critical that the
information about the special protections for American Indians/Alaska
Natives be clearly stated in all plan materials so that they are
informed about the cost-sharing plan variations that may apply to them
so they can enroll in the correct plan. The commenters also stated that
American Indians/Alaska Natives should know whether a plan network
includes their I/T/U provider.
Response: We acknowledge that certain American Indians/Alaska
Natives should be made aware of special protections and whether a plan
includes I/T/U providers. We encourage MSPP issuers to make this
information available to MSPP plan participants. We will continue to
work with CMS and the Indian Health Service to make sure American
Indians/Alaska Natives are informed about the cost-sharing plan
variations.
Because no changes are required based on the comments received, OPM
is adopting proposed Sec. 800.113 as final, with no changes.
Compliance With Applicable State Law (Sec. 800.114)
As proposed, Sec. 800.114 would require MSPP issuers generally to
comply with State law. Paragraph (a) of the proposed regulation
restated the requirement set forth in section 1334(b)(2) of the
Affordable Care Act, including the three categories of State laws with
which MSPP issuers need not comply: (1) State laws that are
inconsistent with section 1334; (2) State laws that prevent the
application of a requirement of part A of title XXVII of the PHS Act;
and (3) State laws that prevent the application of a requirement of
title I of the Affordable Care Act. We have made a technical edit in
paragraph (a) to make it more consistent with Sec. 800.116.
In paragraph (b) of proposed Sec. 800.114, we provided greater
detail on the methods OPM would use to determine whether a State law
fits into one of the above categories. Specifically, we proposed that
OPM would use a list of four factors: (1) Whether the law in question
imposes a requirement that differs from those applicable to QHPs and
QHP issuers on one or more Exchanges in the State; (2) whether the law
creates responsibilities, administrative burdens, or costs that would
significantly deter or impede the MSPP issuer from offering a viable
product on one or more Exchanges; (3) whether the law creates
responsibilities, administrative burdens, or costs that significantly
deter or impede OPM's effective implementation of the MSPP; or (4)
whether the law prevents an MSPP issuer from offering an MSP on one or
more Exchanges in the State.
Comments: Many commenters found the factors listed in paragraph (b)
to be too broad and vague. A few commenters noted that paragraph (b)(1)
compares MSP requirements to QHP requirements, whereas (b)(2) appears
to lack an analog against which to measure responsibilities,
administrative burdens,
[[Page 15573]]
or costs that apply to MSPs and MSPP issuers. A few commenters
expressed specific concern about the use of the words ``significantly
deter or impede'' in paragraphs (b)(2) and (b)(3). A few commenters
requested that the word ``unreasonable'' be added to paragraph (b)(2)
to modify ``responsibilities, administrative burdens, or costs.'' A few
commenters generally opposed OPM's authority to find that a State law
is inconsistent with Federal law, and one commenter questioned OPM's
legal authority to preempt State law through a determination of
inconsistency.
Response: At proposed Sec. 800.114(a), we listed the
justifications for nonapplicability of a State law to the MSPP, as set
forth at section 1334(b)(2) of the Affordable Care Act, which provides
that an MSPP issuer must be ``subject to all requirements of State law
not inconsistent with this section, including the standards and
requirements that a State imposes that do not prevent the application
of a requirement of part A of title XXVII of the [PHS] Act, or a
requirement of this title [I of the Affordable Care Act.]'' In proposed
paragraph (b), we listed factors that may inform OPM's analysis under
paragraph (a). Although these listed elements would be considered
relevant to the analysis, OPM would only be authorized to excuse an
MSPP issuer from compliance with a State law that is inconsistent with
section 1334 of the Affordable Care Act, prevents the application of a
provision of part A of title XXVII of the PHS Act, or prevents the
application of a requirement of title I of the Affordable Care Act.
In light of the concerns expressed concerning the regulatory
factors identified in the proposed regulation, we have amended the
regulatory text to remove the list of factors. By removing these
factors from the regulation, we do not disavow them as relevant
considerations in evaluating whether the statutory standard for
preemption has been satisfied. Rather, we do not wish to give the
impression that they are any more or less important than any other
factors that may be relevant in a specific circumstance to a
determination of whether a State law should be preempted.
Comment: One commenter recommended that OPM consider the
seamlessness of a consumer's experience purchasing health insurance on
an Exchange and the avoidance of consumer confusion in evaluating State
laws under this section.
Response: We will consider all relevant information, including
consumers' experiences in shopping on Exchanges, when determining
whether a State law must be preempted under the statutory standards
listed in paragraph (a). Each determination under this section will
depend on specific facts and circumstances.
Comments: A few commenters recommended that OPM consult with States
and Exchanges prior to making a determination of inconsistency under
this section.
Response: We agree that OPM should work collaboratively with
States, particularly in making determinations regarding State laws. OPM
intends to continue to establish and cultivate working relationships
with officials in State regulatory agencies and Exchanges. Such
relationships may exist informally, or may eventually be reflected in
MOUs, as OPM intends to pursue MOUs with each State in which the MSPs
are being offered. In either case, OPM would consult with States during
the process of making a determination of inconsistency regarding a
State law. We have changed paragraph (b) to state expressly our
intention to engage in such consultation.
Comments: Some commenters expect that OPM's ability to render a
determination of inconsistency under this section will create
competitive advantages for MSPs over QHPs. A few commenters stated that
``double regulation,'' by both OPM and each State, will competitively
disadvantage MSPs.
Response: We are sensitive to concerns that the MSPP will create
disruptions in different markets, and this regulation has been designed
to comply with the statutory directives of the Affordable Care Act
while minimizing any such disruptions. The proposed rule reflects a
balanced approach under which an MSPP issuer will comply with all State
laws except any with respect to which OPM has determined that such
State law is contrary to Federal law. This approach will keep each MSP
in relative balance with QHPs offered on the same Exchange. No evidence
has been offered to support the commenters' assertion that OPM's
reservation and potential exercise of this authority creates a
competitive advantage for the MSPs or MSPP issuers.
Moreover, OPM's proposed framework for MSPP compliance incorporates
State law and sets standards and requirements similar to those used
successfully under the FEHBP. We designed this regulatory framework to
ensure that the program is capable of sufficient flexibility to
facilitate its implementation. We intend to employ that flexibility to
take any appropriate action to ensure that MSPs are neither
unreasonably competitively advantaged nor disadvantaged.
Comments: Some commenters recommended that we require compliance
not only with State law but also with QHP standards set by States and
Exchange authorities. A few commenters recommended that OPM require
MSPP issuers to enter into contracts with Exchanges that will actively
or selectively contract with QHP issuers. One commenter requested
clarification that MSPP issuers would be required to comply with
technical requirements for QHPs, such as data submission formatting.
Response: As noted in the preamble to the proposed rule, we intend
that MSPs and MSPP issuers be subject to all of the same standards and
requirements as QHPs and QHP issuers, except where deviations are
authorized by law. We look forward to working collaboratively with
States to ensure that we are aware of all relevant standards, including
those of a technical nature, to ensure that MSPs and MSPP issuers
comply with such standards.
Requiring MSPP issuers to enter into a contract with Exchanges
would circumvent section 1334(d) of the Affordable Care Act, which
vests certification authority for MSPs in OPM rather than Exchanges by
providing that MSPs offered under a contract with OPM are deemed to be
certified by an Exchange. We consider active or selective contracting
models employed by Exchanges to be operational processes rather than
QHP standards, and we will not direct MSPP issuers to participate in
such processes, consistent with statute.
Comment: One commenter requested clarification that OPM's
determination of inconsistency under this section would only apply to
MSPs and MSPP issuers in Exchanges in one State, as opposed to
throughout all States.
Response: A determination of inconsistency under this section would
be limited to the State in which the State law in question exists. OPM
recognizes that some State laws are based on model acts, and that
several States may employ the same or similar language in State laws.
However, we also realize that the facts and circumstances that give
rise to a determination of inconsistency may vary from one State to
another. OPM will evaluate State laws carefully, and will refer to
previous determinations as precedent when determining the applicability
of a State law, but will not automatically apply a determination of
inconsistency to more than one State law without consulting with the
State
[[Page 15574]]
regulatory agencies and Exchange(s), and thoroughly evaluating the
unique facts and circumstances in each State.
Comment: One commenter requested clarification as to whether OPM
would conduct independent research or rely on a complaint-driven
process to select which State laws may be subject to a determination of
inconsistency under this section.
Response: We intend to use all available information to assess the
compatibility of State laws with the MSPP, including complaints from
enrollees, communication with issuers, collaboration with States, and
additional research.
Comment: One commenter recommended that OPM adopt a standard for
noncompliance with State law where only a ``compelling national goal''
would justify a finding that a State law does not apply to MSPP
issuers.
Response: The standards we have adopted are those set forth in the
statute.
Comment: One commenter supported the proposed approach, but
requested acknowledgement that OPM would assume responsibility for
enforcement of State law with respect to MSPP issuers.
Response: Although we intend to communicate closely with States to
ensure compliance with State and Federal laws, OPM is not authorized to
assume responsibility for enforcement of State law. The same vehicles
available to States to enforce their laws against QHPs would also be
available to enforce them against MSPs. As noted above, we look forward
to working collaboratively with States to ensure that consumers receive
high-quality coverage.
Comment: One commenter supported our proposal, but requested
clarification that OPM would decide whether a State law applies, as
opposed to an issuer or another party.
Response: As reflected in the proposed regulatory text, we agree
that OPM should decide whether a State law meets one of the three
standards in paragraph (a). This responsibility flows from the
statutory authority granted to OPM by section 1334 of the Affordable
Care Act to implement and administer the MSPP.
Comments: A few commenters recommended that Federal Indian law be
recognized separately from State law.
Response: The requirement for MSPP issuer compliance with State law
set forth in Sec. 800.114 is included in the final regulation to
implement section 1334(b)(2) of the Affordable Care Act, which
specifies that an MSPP issuer ``is subject to all requirements of State
law not inconsistent with this section [1334], including the standards
and requirements that a State imposes that do not prevent the
application of a requirement of'' part A of title 27 of the PHS Act or
title I of the Affordable Care Act. We acknowledge the unique concerns
of I/T/Us, including concerns that involve the interaction of State law
and Federal Indian law, and we intend to address them, to the extent
practicable, through contractual terms.
Level Playing Field (Sec. 800.115)
In Sec. 800.115, we proposed that an MSPP issuer would comply with
Federal and State laws involving guaranteed renewal, rating,
preexisting conditions, non-discrimination, quality improvement and
reporting, fraud and abuse, licensure, solvency and financial
requirements, market conduct, prompt payment, appeals and grievances,
privacy and confidentiality, and benefit plan material or information.
This section addresses compliance directly involving these areas of
law, which are expressly listed at section 1324 of the Affordable Care
Act. Section 1324 states that, if an MSP is not subject to a Federal or
State law that falls into one of the 13 categories listed, no private
health insurance coverage would be subject to such law. We received
comments from States, Exchanges, consumer groups, providers and
provider groups, pharmaceutical companies, and professional
associations.
Comments: A few commenters, while generally supporting OPM's
proposed approach, expressed concern that our approaches to rate
review, benefit plan material and information, and external review may
trigger section 1324 (i.e., that they would cause private insurance
plans to be exempt from laws listed in that section).
Response: As explained in the preamble to the proposed rule and in
the responses to comments regarding Sec. Sec. 800.201, 800.501-504,
and 800.113, our approach to rate review, benefit plan material or
information, and external review would not excuse private health
insurance coverage from compliance under section 1324. First, laws
involving rate review do not fall within a category listed in section
1324 of the Affordable Care Act.
Second, our proposed rule explicitly requires MSPP issuers to
comply with Federal and State laws related to benefit plan material or
information. As set forth in Sec. 800.20, and as discussed in
responses to comments regarding that section and Sec. 800.113, the
definition of ``benefit plan material and information'' does not
include a policy or contract for health insurance coverage.
Finally, as we indicated in the proposed rule, we believe that our
approach to external review is required by section 1334 of the
Affordable Care Act and does not trigger the level playing field
provisions of section 1324 because our approach will comply with
external review requirements.
Specifically, we believe our approach to external review is
required by section 1334(a)(4), which directs OPM to implement the MSPP
in a manner similar to the manner in which we implement the contracting
provisions with respect to carriers under the FEHBP. External review is
part of the contracting process. Through the external review process,
matters of contract coverage are resolved.
As noted in the proposed rule, section 2719 of the PHS Act and its
implementing regulations apply to all non-grandfathered group health
plans and health insurance issuers, including MSPP issuers, with
respect to internal claims and appeals and external review. We
understand that the Departments of HHS, Labor, and the Treasury (the
tri-Departments) intend to amend those regulations at 45 CFR 147.136 to
clarify that the MSPP external review process is governed by section
2719(b)(2)(B). Under section 2719(b)(2), the external review
requirements that must be met are established by the tri-Departments,
which have made the judgment that the external review process adopted
in this rule satisfies the requirements under that section. Thus, the
level playing field provisions of section 1324 of the Affordable Care
Act would not be triggered because MSPs and MSPP issuers would comply
with the external review requirements in section 2719(b) of the PHS
Act, just as other health insurance issuers in the group and individual
markets are required to do. As noted in the DATES section of this
notice of final rulemaking, rulemaking by the tri-Departments
interpreting section 2719 in this manner has not yet been completed. We
are making the provisions of this regulation on external review
effective on the date that such tri-Department regulations become
effective.
In addition, our approach to external review does not afford the
MSPs any competitive advantage. Although OPM--instead of the States--
will administer the external review process for MSPs, that process
provides for application of the standards and requirements with which
other issuers must comply under section 2719(b)(2) of the PHS Act.
Thus, MSPs will in fact be
[[Page 15575]]
subject to, and comply with, the same law on external review as other
issuers.
No commenter identified any State external review law that imposes
higher standards than does the Federal external review law proposed for
the MSPP. Based on our experience with the disputed claims process
under the FEHBP, we believe that our external review process is
comparable to any State external review process. We look forward to
working collaboratively with States to ensure that our external review
process is no less protective than the most protective State standards.
Comment: One commenter recommended the expansion of the scope of
``licensure'' under this section.
Response: We recognize that licensure laws in some States may
impose varying requirements on health insurance issuers. Compliance
with a broader range of State laws that may be conditions of licensure
would be required under Sec. 800.114 of this regulation, subject to
the exceptions listed there. However, for purposes of analysis under
this section, an MSPP issuer complies with laws ``relating to''
licensure by being licensed in each State in which the issuer offers an
MSP.
Comment: One commenter requested clarification as to whether the
inverse of section 1324 would also be required, i.e., whether the other
private health insurance coverage in a State would be subject to a
State law to which an MSP is subject.
Response: States typically regulate health insurance markets, and
the MSPs will operate within those markets. As set forth in Sec.
800.114, MSPs and MSPP issuers generally are subject to the same laws
to which the rest of the health insurance market is subject.
Comments: A few commenters expressed concern that OPM would prompt
a ``race to the bottom'' by circumventing, through the MSPP, consumer
protections provided by State laws.
Response: The MSPP will promote uniformly high standards for MSPs
to be made available to consumers. As noted in the proposed rule, we
will deviate from State standards only when the standards are
inconsistent with the implementation of OPM's statutory directive to
implement this program. Like plans offered through the FEHBP, MSPs will
be high-quality products that are subject to the experienced oversight
of OPM.
We are adopting proposed Sec. 800.115 as final, with no changes.
Process for Dispute Resolution (Sec. 800.116)
In Sec. 800.116, we proposed a process by which a State may
request that OPM reconsider a determination under Sec. 800.114 that a
State law does not apply to MSPs or MSPP issuers. The proposed process
calls for a State to demonstrate that the State law at issue is not
inconsistent with section 1334 of the Affordable Care Act, does not
prevent the application of a requirement of part A of title XXVII of
the PHS Act, and does not prevent the application of a requirement of
title I of the Affordable Care Act. This section goes on to set forth
the procedural framework for the process, including the form of the
request, permissible supporting information and documentation, the
timeframe for resolution, and the nature of OPM's written decision as
final agency action. Most of the comments we received regarding this
section were from States and Exchanges, and a few additional comments
were submitted by consumer groups, issuers, and professional
organizations.
Comments: A few commenters recommended that this process be
conducted by a third party outside of OPM. One commenter suggested that
disputes over the applicability of State law be conducted through State
administrative and judicial processes.
Response: OPM cannot cede authority to make these determinations to
an outside entity, because Congress directed OPM to implement and
administer the MSPP.
The process outlined in this section offers a formal route to seek
resolution of a complaint without having to initiate costly,
contentious litigation over the applicability of State laws under the
MSPP. Thus, review under this section would be conducted by a different
official within OPM than the official who made an initial determination
under Sec. 800.114. Similar review is conducted under certain
circumstances in the FEHBP when a dispute arises between OPM and a
carrier. OPM's experience with such review has shown that it is an
effective means of resolving disputes.
Comments: One commenter requested a shorter timeframe than the 60
days proposed in paragraph (c)(3). Another commenter recommended that
OPM ensure the resolution of all potential disputes involving a State's
law prior to an MSP being offered on an Exchange within that State.
Response: Sixty days is an appropriate period within which written
decisions must be issued, but we intend to resolve each dispute under
this section as quickly as possible after it arises.
We have attempted, through the provisions of this regulation, to
anticipate potential Exchange approaches to substantive standards and
requirements. However, we are aware that new State laws may be enacted
or QHP standards established subsequent to the promulgation of this
regulation. This process is necessitated in part by the evolving nature
of health insurance regulation and QHP standards. In addition, we
anticipate that any inconsistencies between State laws and section 1334
of the Affordable Care Act may not become apparent until after MSPP
operations have begun. We intend to work collaboratively with States to
mitigate or avoid any potential disruptions that may result from the
ongoing nature of this process.
Comments: A few commenters recommended that a de novo review be
conducted under this section, that State law applicability be presumed,
or that OPM bear the ``burden'' of demonstrating that a determination
of inconsistency is supported.
Response: This process is designed to create an avenue for a State
to show that OPM's considered determination under Sec. 800.114 was
made in error, which would present an opportunity to avoid potential
litigation that could arise from such a determination. As such, the
State is responsible for demonstrating consistency between Federal and
State law.
Comments: A few commenters recommended that determinations
regarding laws under both Sec. Sec. 800.114 and 800.115 be subject to
the process for dispute resolution under this section. Other commenters
requested clarification as to whether the dispute resolution applied to
all State laws or only to State laws that do not fit into the list of
categories under section 1324(b) of the Affordable Care Act.
Response: We agree that a State should have an opportunity to
request reconsideration of a determination of inconsistency regarding
any State law and we are revising paragraph (a) accordingly.
Comment: One commenter recommended that the record for judicial
review under paragraph (c)(4) include all relevant information, not
only the record that was before OPM when a decision was rendered.
Response: The Administrative Procedure Act permits judicial review
of final agency action, and limits such review to the record that was
before the agency when it took the action being reviewed. This
regulation neither restricts nor expands that limitation.
[[Page 15576]]
Comments: A few commenters recommended that parties other than
States be permitted to seek dispute resolution under this section. One
commenter recommended that MSPP issuers bear the burden of
demonstrating that State laws should not apply to them.
Response: This process is designed to assist States in working with
OPM to prevent and mitigate market disruptions. State health insurance
laws are regulatory by nature; the most expert entities to address them
are therefore the regulatory agency and/or Exchange charged with their
implementation. Regulatory agencies and Exchanges are well-equipped to
represent the interests of the issuers with which they work and the
consumers they serve.
We are amending paragraph (a) of Sec. 800.116 as indicated above,
to reflect that a determination of inconsistency involving any State
law may be the subject of the process outlined in this section. We are
also making a technical correction in paragraph (b) and inserting a
technical amendment in paragraph (c)(3) for greater clarity.
Subpart C--Premiums, Rating Factors, Medical Loss Ratios, and Risk
Adjustment
General Requirements (Sec. 800.201)
Under Sec. 800.201, OPM proposed a number of standards for setting
rates in the MSPP. First, we proposed that OPM would negotiate
premiums, as provided in section 1334(a)(4) of the Affordable Care Act,
in a similar manner to the way we negotiate with FEHBP carriers each
year.
Second, the proposed rule included a provision that required MSPP
rates to remain in effect for the 12-month plan year.
Third, OPM proposed to issue rating guidance for the MSPP, similar
to the way OPM communicates with FEHBP carriers.
Fourth, we proposed that MSPP issuers comply with standards in HHS
guidance for calculating actuarial value (AV), specifically those
standards proposed in 45 CFR 156.135.
Fifth, OPM proposed a process for rate setting and review that
requires an MSPP issuer to follow State rating standards with respect
to rating factors generally applicable in a State. With respect to rate
review, OPM's proposal reflected that some States have a prior approval
process for rates and the authority to reject rates. Therefore, we
proposed to work closely with each State in approving a rate for the
MSPs in that State and to consult with that State about patterns in its
markets and about other rates that an MSPP issuer might be proposing in
that State for non-MSPs. In doing so, MSPP issuers would be required to
file rates with a State, but the final decision regarding rates for
MSPs would rest with OPM, as required by the statute. As described in
proposed Sec. 800.201(e) and (f), with respect to rate review, OPM's
rate process and analysis will be transparent to States in which the
MSP is operating. MSPP issuers will be subject to a State's rate review
process, including a State's Effective Rate Review Program established
by HHS pursuant to section 2794 of the PHS Act and 45 CFR part 154. OPM
proposed that, for States with Effective Rate Review Programs under
section 2794 of the PHS Act, the MSPP issuer would comply with the
State standards. In addition, OPM proposed that in States where HHS is
reviewing rates, HHS would accept the judgment of OPM for MSP rates.
Furthermore, MSPP issuers must comply with the reporting and disclosure
requirements for all rate justifications to HHS, States, and Exchanges,
such as the requirements set forth in 42 CFR 156.210(c). In the event
that a State withholds approval of an MSP rate for reasons that OPM
determines, in its discretion, to be arbitrary, capricious, or an abuse
of discretion, the Act authorizes the Director to make the final
decision to approve rates for participation in the MSPP,
notwithstanding the absence of State approval.
Finally, OPM proposed that MSPP issuers must comply with section
1312(c)(1) and (2) of the Affordable Care Act and implementing
regulations, which provide that a health insurance issuer consider all
enrollees in all non-grandfathered health plans in the individual
market to be members of a single risk pool and all enrollees in non-
grandfathered health plans in the small group market to be members of a
single risk pool within a State. With proposed Sec. 800.201(g), OPM
clarified that an MSPP issuer must consider MSP enrollees to be members
of the same risk pool as all other enrollees of the issuer in non-
grandfathered health plans in the individual and small group markets,
respectively. OPM received several comments on our general standards
related to MSPP rate setting and review policies applicable to an MSPP
issuer and related to compliance with sections 2701 and 2794 of the PHS
Act.
Comments: Many commenters supported the general rate review
approach set out for the MSPP, such as compliance with State rate
review processes, single risk pool, calculation of AV, and State-based
rating. Most of these commenters were concerned about OPM retaining
discretion to negotiate premiums and having final approval of rates. A
few commenters noted that there are administrative and judicial
remedies available under State law for issuers who believe that rate
approval has been withheld for reasons that are ``arbitrary,
capricious, or an abuse of discretion'' and generally a State would be
violating its own laws if it were to withhold for reasons that are
``arbitrary, capricious, or an abuse of discretion.'' The commenters
also noted that this standard is broad and asked OPM to narrow its
scope. One commenter suggested that if OPM were to bypass these
remedies, MSPs would be given an unfair advantage over QHPs and would
be violating State law. A few commenters recommended that OPM not
reserve discretion in States with Effective Rate Review Programs. One
commenter believed OPM's authority to negotiate rates in section 1334
of the Affordable Care Act is constrained by sections 1324 and 1252.
Response: Based on support from some commenters on our proposed
approach, we are adopting this section as final, with modifications.
Section 1334(a)(4) of the Affordable Care Act explicitly authorizes the
Director to make the final decision to approve rates for participation
in the MSPP, notwithstanding the existence or absence of State
approval. We are fully aware of the complexities of rate review in 2014
and subsequent years, and we intend to collaborate closely with HHS and
States on MSP rates. We agree with comments that MSPP issuers should
use the remedies available under State laws related to rate review
decisions. OPM will require MSPP issuers to allow the rate review
process in States, including administrative and judicial remedies, to
proceed unless the timeline for administration of the MSPP is
threatened. In order to give MSPP issuers adequate time to prepare for
open enrollment periods, we maintain our discretion to issue final
decisions on MSP rates. For this reason, we are revising Sec.
800.201(f) to clarify that OPM would exercise its discretion only in
the event that the State's action would impede the Federal objective by
preventing OPM from operating the MSPP. In addition, we are removing
from the final regulation the ``arbitrary, capricious, or an abuse of
discretion'' language, based on the comments we received. We expect
that the Director will rarely, if ever, have to exercise this authority
to disapprove or approve MSP rates over the approval or non-approval of
a State.
We disagree with the interpretation that sections 1324 and 1252
constrain
[[Page 15577]]
OPM's authority to negotiate premiums. Were we to interpret these
sections in the manner suggested by the commenter, section 1334(a)(4)
of the Affordable Care Act, which requires the Director to
``negotiate[] * * * with each multi-state plan * * * the premiums to be
charged,'' would be rendered inoperative. Section 1324(b)(2) refers to
``rating.'' OPM has defined ``rating'' for purposes of section
1324(b)(2) to require compliance with the rating factors permitted by
the PHS Act as detailed in Sec. 800.202. Rating factors refer to the
factors issuers must use to develop their premiums. With regard to the
MSPP, we do not consider ``rating'' to be the same as ``rate review.''
Rate review is a broader concept and is a necessary component of
premium negotiation. As mentioned above, we intend to conduct our own
process to review rates, and each State will have the opportunity to
review the MSP rates under its own procedures. We intend to work
cooperatively with the States, and have coordinated our policy with
HHS.
In addition, the MSPP will comply with section 1252 of the
Affordable Care Act. That section, entitled ``Rating Reforms Must Apply
Uniformly * * *'' requires rating reforms adopted by a State pursuant
to title I of the Affordable Care Act to apply uniformly within a
market. Rating reforms, again, do not equate to ``rate review''
processes. Rather, consistent with OPM's interpretation of ``rating''
for purposes of section 1324(b)(2), rating reforms refer to reforms
that constrain the factors upon which issuers rely to develop their
premiums. Section 1252 does not constrain the Director's power to
negotiate rates with MSP issuers under section 1334(a)(4).
Comment: In addition, the same commenter indicated its view that
section 1252 constrains network adequacy rules.
Response: OPM does not agree with this comment, as section 1252 is
limited in its scope to rating reforms.
Comment: This commenter further indicated that section 1301(a)(2)
applies with ``equal force'' to MSPP issuers.
Response: While OPM acknowledges that QHP standards generally apply
to the MSPP, section 1334(c) specifically reserves to the Director the
discretion to determine whether QHP rules are satisfied in the context
of the MSPP. Therefore, OPM does not agree that section 1301(a)(2)
causes QHP rules to apply to MSPP ``with equal force,'' as they do not
apply in the same manner with respect to enforcement.
Comment: One commenter asked OPM to clarify that the single risk
pool standard proposed in the rule applies to MSPP issuers' pools
within a State and not across States.
Response: Our intent was for an MSPP issuer to consider all
enrollees in an MSP to be in the same risk pool as all enrollees in all
other non-grandfathered health plans in the individual market or small
group market, respectively, in compliance with section 1312(c) of the
Affordable Care Act as well as HHS regulations implementing that
section. Consistent with HHS guidance, we affirm that MSPP issuers will
pool risk within a State and not across States, but we do not believe a
change in the regulatory text is needed.
Comments: Some commenters suggested that OPM establish rules and
conditions that will facilitate tribal sponsorship, to allow tribes to
perform premium aggregation for individuals to enroll in MSPs.
Response: We are exploring whether potential issuers have the
capacity to perform premium aggregation and/or accept aggregated
premiums. In the MSPP issuer application, OPM will ask applicants to
indicate whether they have this capacity and will take the applicants'
responses into consideration when negotiating contracts.
Rating Factors (Sec. 800.202)
The proposed Sec. 800.202 required MSPP issuers to comply with
section 2701 of the PHS Act, as amended by the Affordable Care Act. We
proposed in Sec. 800.202(a) that MSPP issuers must comply with
requirements setting standards for fair health insurance premiums
appearing in HHS regulations. In addition, we proposed that MSPP
issuers must follow standards set for rating areas in a State
established under any HHS or State regulations implementing section
2701 of the PHS Act. OPM received numerous comments related to rating
standards and factors from States, consumer organizations, and issuers.
Comments: Many commenters supported the general approach we
proposed that MSPP issuers must comply with Federal standards and more
narrow State standards for rating factors. A few commenters asked OPM
to clarify the requirement that MSPP issuers use the age curves
established under Federal regulations implementing section 2701(a),
including that an MSPP issuer must also use any age curve established
by a State pursuant to 45 CFR 147.103(e).
Response: We clarify that our intent is for an MSPP issuer to use
any age curve established by a State pursuant to 45 CFR 147.103(e). In
the event that a State does not establish an age curve, the MSPP issuer
would use the standard age curve established by HHS. We are amending
proposed Sec. 800.202(c)(2) to reference State-established age curves.
Comments: A few commenters requested that OPM have MSPP issuers
comply with PHS Act section 2705 and its implementing regulations on
incentives for nondiscriminatory wellness programs in group health
plans pursuant to 45 CFR parts 146 and 147, 29 CFR part 2590, and 26
CFR part 54.
Response: We agree with the commenters and their suggestion.
Accordingly, we have added a paragraph (f) to Sec. 800.202 to require
MSPP issuers offering group health plans to comply with section 2705 of
the PHS Act and any implementing Federal or State regulations. We
believe this appropriately resolves the concerns of commenters.
Comments: Some commenters urged OPM to clarify how MSPP issuers
will define ``family'' as it applies to coverage and rating.
Specifically, commenters recommended OPM coordinate with HHS to ensure
that the coverage and rating requirements established by HHS under
section 2701 clearly apply to MSPs, adopt broad definitions for minimum
categories for family policies, and adopt four types of family coverage
categories: Individual; two adults; adult plus child(ren); and two-
adult with child(ren) or other family composition.
Response: The proposed rule did not require specific standards
around categories of family members, and intended to coordinate MSPP
standards with HHS standards published at 45 CFR part 147. Therefore,
the final rule does not specify the minimum categories of family
members that must be rated in a family policy.
However, we encourage MSPs to provide the same benefits for all
family compositions, including but not limited to same-sex domestic
partners and their children. We note that individuals not eligible for
family coverage will be able to purchase individual coverage on a
guaranteed issue basis.
While we intend to administer the MSPP in a manner that supports a
broad definition of family coverage categories, we are finalizing the
proposed provision without a change. We must coordinate our approach in
applying rating factors consistent with HHS guidance and State law, and
as a result will implement the policy for extending coverage rules so
that they apply to a broad definition of family coverage categories
through the MSPP contract negotiation process.
Medical Loss Ratio (Sec. 800.203)
The proposed rule requires MSPP issuers to attain the medical loss
ratio
[[Page 15578]]
(MLR) in section 2718 of the PHS Act. The proposed rule also codifies
section 1334(a)(4) of the Affordable Care Act, which gives OPM the
explicit authority to negotiate premiums, profit margins, and an MLR by
allowing OPM to set an MSP-specific MLR that is either in the interest
of MSP enrollees or conforms to State MLR standards. Failure to attain
the MLR could result in intermediate sanctions, which include, but are
not limited to, suspension of marketing, decertification in one or more
States, or termination of an MSPP issuer's contract.
Comments: Several commenters expressed support for OPM's approach.
Commenters supported an MLR calculation that was State-based, rather
than nationwide. Commenters also supported pooling MSP and non-MSP
experience in MLR calculation.
Response: OPM is retaining in the final rule its approach to have
MSPP issuers calculate MLR on a State-by-State basis as well as pool
MSP and non-MSP experience within a State.
Comments: Several commenters expressed concern that OPM having
authority to set an MSP-specific MLR different from the State or
Federal standard could give MSPs an advantage over QHPs.
Response: OPM recognizes the concerns of States and other
stakeholders regarding authority to set an MLR standard for the MSPP.
However, section 1334(a)(4)(B) of the Affordable Care Act explicitly
grants OPM legal authority to negotiate an MLR with each MSP. As a
matter of policy, however, OPM does not foresee exercising the
authority to set an MSP-specific MLR. If OPM were to consider
implementing an MSP-specific MLR, it would only be under extraordinary
and rare circumstances, and after consulting with the State.
Comment: A commenter was concerned that OPM may decertify an MSP
mid-year for failing to meet the applicable MLR standard.
Response: While OPM has the authority to decertify an MSP at any
time, we do not want to disrupt State insurance markets or harm
consumers. Decertifying an MSP is one of many compliance actions OPM
proposed in the rule. We want to clarify that OPM would only decertify
an MSP mid-year under unusual circumstances, such as widespread and
repeated failure to comply with the legal or MSPP contractual
requirements. Before decertifying an MSP, we would consult with a State
and/or HHS, as appropriate, to avoid market disruption and protect
consumers. Our approach to compliance actions is discussed in more
detail in relation to Sec. 800.404.
Comment: One commenter requested that MSPP issuers pay a rebate in
addition to other MLR sanctions.
Response: MSPP issuers, like all health insurance issuers regulated
by HHS, are subject to the MLR rebate requirements under the Affordable
Care Act, and OPM will not require additional rebates.
Comment: One commenter wants MSPP user fees to qualify for MLR
inclusion.
Response: This final rule clarifies in Sec. 800.108 that MSPP user
fees will be part of the State-based Exchange or Federally-facilitated
Exchange user fee. According to technical guidance document CCIIO 2012-
002, released April 20, 2012, by HHS, Exchange user fees are subtracted
from premiums in the MLR calculation, as are all other Federal and
State regulatory and licensing fees. MSPP user fees, therefore, will
not be included in the MLR calculation.
We are adopting Sec. 800.203 of the proposed rule as final, with
one technical correction in paragraph (b), relating to the sanctions
for not attaining the required medical loss ratio.
Reinsurance, Risk Corridors, and Risk Adjustment (Sec. 800.204)
The proposed Sec. 800.204 would require MSPP issuer participation
in the transitional reinsurance program in the individual market, risk
adjustment program, and temporary risk corridors program to ensure that
all issuers have the same fiscal responsibilities and protections. OPM
proposed that MSPP issuers be required to participate in the
transitional reinsurance program for the individual market established
pursuant to section 1341 of the Affordable Care Act, and comply with
HHS standards set forth in 45 CFR part 153 and, if applicable, any
State regulations implementing the program. OPM also proposed that an
MSPP issuer must participate in the temporary risk corridors program
established pursuant to section 1342 of the Affordable Care Act and
comply with 45 CFR part 153, as well as any additional HHS standards
implementing the program. Finally, OPM proposed that an MSPP issuer
must participate in the risk adjustment program established pursuant to
section 1343 of the Affordable Care Act and comply with HHS standards
set forth in 45 CFR part 153 and, if applicable, any State standards
implementing the program.
Comments: The majority of the comments we received supported OPM's
approach to requiring MSPP issuers to participate, like QHP issuers, in
the transitional reinsurance program, risk adjustment program, and
temporary risk corridors program. States, consumer organizations, and
issuers supported the general approach OPM proposed that MSPP issuers
must comply with Federal standards and State standards, if applicable,
in the administration of the reinsurance program and risk adjustment
program. One commenter suggested OPM has legal discretion to allow a
church health plan offered through the MSPP to vary premiums to adjust
for risk across its enrollees, using risk adjustment criteria related
to Medicare Part D and Medicare Advantage plans.
Response: OPM appreciates the comments and is adopting the proposed
regulation as final, with two technical corrections. First, in Sec.
800.204(b), we are changing ``any applicable Federal or State
regulations under that section'' to ``any applicable Federal
regulations under that section'' because HHS will be operating the
temporary risk corridors program. Second, we are correcting an
editorial error in paragraph (c) of Sec. 800.204 by changing ``An MSPP
issuer must comply with participate in the risk adjustment program
established pursuant to section 1343 of the Affordable Care Act'' to
``An MSPP issuer must comply with section 1343 of the Affordable Care
Act''.
Finally, we do not agree with the commenter's analysis that OPM
would have legal discretion to allow a church health plan offered
through the MSPP to vary premiums to adjust for risk across its
enrollees, using risk adjustment criteria related to Medicare Part D
and Medicare Advantage plans. Therefore, we are not adopting this
suggestion.
Subpart D--Application and Contracting Procedures
In subpart D of proposed 45 CFR part 800, OPM set forth proposed
processes for accepting and evaluating applications to participate in
the MSPP and for executing contracts to offer coverage under the MSPP.
In general, these processes were designed based on OPM's experience in
the operation of the FEHBP while reflecting the unique aspects of the
MSPP, as directed in section 1334 of the Affordable Care Act. Subpart D
includes sections relating to an application process, review of
applications, MSPP contracting, term of the contract, contract renewal
process, and nonrenewal. OPM received both general comments on this
subpart and specific comments on several sections. We address first the
general comments on the subpart, followed by comments on specific
sections within the subpart.
[[Page 15579]]
Any regulatory changes are noted within the discussion of each section.
Comment: One commenter requested additional information on the
application and contracting procedures, including form, manner, and
timeline for submission and review of applications, contracting, and
renewal of contracts.
Response: OPM has released a final paper application setting forth
the information that we will collect from health insurance issuers that
apply to become MSPP issuers, available on the Federal Business
Opportunities Web site at www.FBO.gov under solicitation number OPM35-
12-R-0006, Multi-State Plan Program. The final paper application was
posted on January 18, 2013. The solicitation notes that OPM expects to
begin receiving application material from issuers in February 2013, and
instructs issuers to submit a notice of intent to apply to receive
access to the MSPP Portal, through which issuers will submit the
requested information to OPM electronically.
Due to the generally compressed deadlines for the first year of
this program and the first years of operation of many Exchanges,
timelines may vary from one year to the next. We therefore will not
establish rigid timelines in this regulation, but will evaluate MSPP
timelines and address them through guidance. Similarly, we intend to
share additional information on initial execution and renewal of
contracts through guidance.
Comments: A few commenters recommended that OPM incorporate States
and Exchanges into the process of evaluating applicants and negotiating
contracts with issuers. Specifically, commenters noted that some
Exchanges will employ an ``active purchaser'' model, whereby QHP
certification will depend on a contract between a QHP issuer and the
Exchange, and recommended that OPM address this model in its
application and contracting procedures. Other commenters voiced concern
that the absence of State representation in application and contracting
procedures, including evaluation of rate and benefit proposals, would
result in inconsistent application of State insurance laws and
regulations.
Response: OPM is directed by section 1334 of the Affordable Care
Act to enter into contracts with health insurance issuers, and to do so
in a manner similar to the manner in which contracting provisions under
the FEHBP are implemented. The Affordable Care Act also provides for
deemed certification of MSPs by virtue of an MSPP contract. We
acknowledge that States will retain responsibility for the enforcement
of their insurance laws and regulations, and we will continue to
develop relationships with States' Departments of Insurance and
Exchange authorities to collaborate to ensure that MSPs may be offered
on Exchanges without creating market disruptions.
Based on the phased expansion provisions of section 1334 of the
Affordable Care Act and of Sec. 800.104 of this regulation, we do not
expect each MSPP issuer to offer an MSP on each Exchange in 2014. We
will communicate with appropriate State officials on an ongoing basis
regarding the MSPs that we expect to certify.
Application and Contracting Procedures (Sec. 800.301)
In Sec. 800.301, we proposed that a health insurance issuer may
submit an application to OPM to participate in the MSPP. We specified
that such applications would meet guidelines to be released regarding
the form and manner of applications, and the timeline for submission.
OPM received a few comments specifically addressing this section.
Comment: One commenter noted the absence of specific timeframes in
the proposed regulation and requested that such timeframes allow each
State to perform its ``traditional role'' in regulating health
insurance products.
Response: As discussed in greater depth regarding subpart C of this
regulation, OPM intends to collaborate with appropriate State officials
regarding the review and approval of rates and benefits. We intend to
be as flexible as possible to ensure that each State has adequate
opportunity to review MSP documentation as appropriate.
Comment: One commenter recommended that OPM ensure that issuers'
proprietary information be protected from information requests,
including under the Freedom of Information Act (FOIA).
Response: We acknowledge that certain information given to OPM by
applicant issuers may be proprietary, and should therefore not be
subject to public inspection. Applicants will be given an opportunity
to mark submitted information as confidential, pursuant to instructions
that will accompany the application in the MSPP Portal, subject to the
limits of FOIA and its implementing regulations.
OPM does not believe that any of these comments require any changes
in the regulatory text. Therefore, we are adopting proposed Sec.
800.301 as final, with no changes.
Review of Applications (Sec. 800.302)
Proposed Sec. 800.302 provided that an issuer that has applied
under Sec. 800.301 may be accepted to enter into contract negotiations
if OPM determines that the applicant meets the requirements of part
800; that OPM may request additional information from issuers in making
such a determination; that OPM will inform the applicant in writing if
OPM declines to enter into contract negotiations with the applicant;
that OPM alone may determine whether an application is to be accepted
or declined; and that a declined applicant may apply for a subsequent
year. OPM received no specific comments on this section. Therefore, we
are adopting proposed Sec. 800.302 as final, with no changes.
MSPP Contracting (Sec. 800.303)
In proposed Sec. 800.303, OPM provided that, to become an MSPP
issuer, an applicant must execute a contract with OPM; that OPM would
establish a standard contract for the MSPP; that OPM and an applicant
would negotiate premiums for each plan year; that OPM would review for
approval an applicant's benefit packages; that OPM may negotiate
additional contractual terms and conditions; and that MSPP issuers
would be certified to offer MSP coverage on Exchanges.
Comments: Several commenters recommended that I/T/Us be
contractually allowed to participate in MSP networks as providers, and
that MSPP issuers comply with Federal laws governing I/T/Us.
Response: OPM will address the specific terms of the MSPP standard
contract through a development process following the publication of
this final rule. We acknowledge the unique concerns of I/T/Us, and we
intend to address them, to the extent practicable, through contractual
terms.
Comment: One commenter recommended that OPM adopt for the MSPP the
same transparency and pass-through pricing standards and requirements
that exist under the FEHBP for PBMs.
Response: As noted above, OPM will address specific contract terms
through a process following the publication of this rule. Such terms
will include standards and requirements for PBMs.
Comments: A few commenters suggested that OPM's proposed
contracting process would be duplicative of State regulatory or
Exchange processes or would circumvent such processes. One commenter
recommended that MSPP issuers be required to attest to compliance with
all State laws as a
[[Page 15580]]
condition of certification. Another commenter recommended that issuers
be required to attest to understanding and compliance with a specific
State law as a condition of contracting. One commenter recommended that
MSPP contracts incorporate consultation with State-based Exchanges to
measure performance and compliance.
Response: In general, MSPP issuers will be expected to comply with
State laws and regulations. Although we intend to monitor such
compliance and to evaluate contract performance in part on such
compliance, we decline to specifically list State laws with which
issuers must comply. Specifically listing laws with which an issuer
must comply may have the unintended result of implying that an issuer
need not comply with unlisted laws and regulations, and OPM cannot list
every relevant State law with which an MSPP issuer must comply.
We intend to promote information sharing between OPM and States,
and OPM will measure MSP performance using standards similar to those
measured under the FEHBP. Sharing information with States will help
ensure that MSPs meet comparable standards to QHPs in the same markets
and that issuers comply with State laws. By measuring contract quality
assurance standards across MSPs, OPM will be able to ensure that MSPs
are of comparably high quality across States. We will set forth the
specific standards that MSPs will be expected to meet in the model MSPP
contract.
We are adopting proposed Sec. 800.303 as final, with the inclusion
of a minor editorial correction.
Term of the Contract (Sec. 800.304)
In Sec. 800.304, we proposed that the term of an MSPP contract be
for a period of at least 12 consecutive months, as set forth in the
MSPP contract; that a plan year be a consecutive 12-month period during
which an MSP provides coverage for health benefits; and that a plan
year may be a calendar year or other 12-month period.
Comment: One commenter recommended that the term of the MSPP
contract coincide with the calendar year so that MSP plan years and
open enrollment periods would coincide with those of QHPs, which would
preserve a level playing field.
Response: In Sec. 800.20, we are adopting the definition of ``plan
year'' established by HHS at 45 CFR 155.20. Section 800.101 states that
MSPs will comply with the same standards for eligibility, enrollment,
and termination of coverage as QHPs on the same Exchange. Open
enrollment periods for MSPs, therefore, will coincide with those of
QHPs.
Comment: One commenter recommended that OPM adopt an initial
contract term of 3 to 5 years, rather than 1 year.
Response: We acknowledge that participation in the MSPP may require
significant initial investment on the part of MSPP issuers, and that a
longer contract term may assure issuers that such investment may
require several years of participation in the program to become cost-
effective. OPM has modeled the application and contracting procedures
in subpart D after those used in the FEHBP, including the automatically
renewable nature of contracts. We anticipate that all MSPP issuers will
participate in the program for many contract terms. However, rates and
benefits will be revised each year, and some terms of the MSPP contract
may need to be updated from one term to the next. Therefore, the
contract term will be 1 year.
We are adopting proposed Sec. 800.304 as final, with no changes.
Contract Renewal Process (Sec. 800.305)
In proposed Sec. 800.305, we set forth a process by which OPM and
an MSPP issuer would renew an MSPP contract, including the issuer's
submission of information to OPM and criteria for a determination by
OPM of whether to renew the contract. This section also provides that
if OPM and the issuer fail to agree to premiums and/or benefits with
respect to an MSP on an Exchange, the contract may nevertheless be
renewed with the same premiums and benefits in effect for the previous
term. OPM received no comments directly addressing this section.
Therefore, we are adopting proposed Sec. 800.305 as final, with no
changes.
Nonrenewal (Sec. 800.306)
In Sec. 800.306, we proposed that either OPM or an issuer could
decline to renew an MSPP contract at the end of a plan year by timely
notifying the other party and MSP enrollees.
Comments: Some commenters recommended lengthening the period of
notice to enrollees of nonrenewal from 90 days to 180 days.
Response: OPM proposed that issuers would be required to notify
enrollees of nonrenewal of an MSPP contract no fewer than 90 days prior
to the date on which coverage would end. The proposed 90-day period was
taken from the same requirement in the FEHBP. Conversely, Exchanges may
have notice periods as short as 30 days. As noted at Sec. 800.306(c),
the 90-day requirement would only take effect in the absence of an
Exchange rule requiring a different notice period.
Comments: Some commenters recommended that OPM require issuers to
assist MSP enrollees who will lose their coverage to find new coverage.
One commenter recommended that OPM defer to a determination by the
Centers for Medicare and Medicaid Services that a QHP issuer must
continue to offer coverage outside of an Exchange.
Response: Enrollment of individuals in QHPs following nonrenewal of
an MSPP contract falls outside of the responsibilities set forth at
section 1334 of the Affordable Care Act. However, as noted throughout
this regulation, we look forward to working collaboratively with States
and Exchanges to best serve consumers, including by ensuring
cooperation with efforts to assist enrollees who lose MSP coverage.
Comments: A few commenters recommended that OPM clarify the
language of paragraph (c) to require issuers to comply with any State
law requirements relating to nonrenewal of coverage and withdrawal from
an Exchange market.
Response: Proposed Sec. 800.306(c) states that an MSPP issuer must
comply with ``any requirements imposed by an Exchange with respect to
the termination of a QHP * * *'' Such requirements would include a
State law requirement relating to nonrenewal of coverage or withdrawal
from an Exchange market. Therefore, no change to Sec. 800.306 is
necessary.
Comment: One commenter noted that Sec. 800.404(d), like Sec.
800.306(c), addresses notice to enrollees who will lose coverage due to
an MSP ceasing to be offered on an Exchange, and recommended using the
same language in both sections.
Response: We agree that the language should be the same in both
sections.
OPM is adopting proposed Sec. 800.306 as final, with one change.
Paragraph (c) will be revised as follows, to include a technical,
clarifying edit: ``The MSPP issuer's written notice of nonrenewal must
be made in accordance with its MSPP contract with OPM. The MSPP issuer
also must comply with any requirements regarding the termination of a
plan that are applicable to a QHP offered on an Exchange on which the
MSP was offered, including a requirement to provide advance written
notice of termination to enrollees. If an Exchange does not have
requirements about advance written notice of termination to enrollees,
the MSPP issuer must inform current MSP enrollees in writing of the
nonrenewal of the MSP no later than 90 days prior
[[Page 15581]]
to termination of coverage, unless OPM determines that good cause
justifies less than 90 days' notice.'' We will also revise Sec.
800.404(d) to mirror this language.
Subpart E--Compliance
In subpart E of the proposed rule, OPM set forth standards and
requirements with which MSPP issuers must comply and a non-exhaustive
list of actions OPM may take to enforce provisions of an MSPP contract.
Like subpart D, these standards, requirements, and compliance actions
have been designed based on OPM's experience in the operation of the
FEHBP, while reflecting the unique aspects of the MSPP, as required by
section 1334 of the Affordable Care Act. Subpart E addresses contract
performance, contract quality assurance, fraud and abuse, compliance
actions, and a process for reconsideration of compliance actions. OPM
received both general comments on this subpart and specific comments on
several sections. We address first the general comments on this
subpart, followed by comments on specific sections within this subpart.
Any regulatory changes are noted within the discussion of each
individual section.
Commenters on this subpart included States and State Exchange
authorities, plan/issuer associations, consumer advocacy organizations,
and a public policy advocacy organization. Comments on this subpart
generally supported the overall structure of contract compliance under
the MSPP, and several offered specific suggestions for improvement. We
received one comment regarding cost accounting systems that is outside
the scope of this rulemaking.
Comments: Some commenters recommended adding specific requirements,
such as network adequacy, to one of the sections of this subpart as a
contract performance standard, a contract quality assurance standard,
or a basis for a compliance action.
Response: OPM acknowledges the importance of requirements and
consumer protections like network adequacy, and addressed network
adequacy in Sec. 800.109 of the proposed rule. We have set forth other
provisions in this regulation that we intend to enforce through
contractual measures and compliance actions; this subpart is structured
to provide OPM the authority to do so in a manner similar to the
administration of the FEHBP. In particular, Sec. 800.404(a)(1) lists
as a cause for OPM to impose a compliance action a failure by the MSPP
issuer to meet the requirements of Sec. 800.401(a), which includes any
violation of section 1334 of the Affordable Care Act or these
regulations. Therefore, a violation of network adequacy standards, or
any other MSPP standard or requirement, would constitute cause for a
compliance action.
Comments: A few commenters recommended that review of financial
resources, records, novation and change of name agreements, and claims
processing practices be left solely to States, and that OPM rely on
States to communicate findings regarding these matters. One commenter
noted States' experience in measurements of these kinds. Another
commenter recommended establishing a notice and communication process
between OPM and the States and Exchanges to ensure MSPP issuers comply
with State laws as well as OPM's standards and requirements.
Response: We acknowledge States' expertise in measuring performance
and compliance, and, as noted above in our responses to comments on
subpart D, we look forward to working with States to ensure compliance
and comparability within States as well as across States. We also note
that OPM has more than 50 years of experience administering the FEHBP,
which includes measurement of numerous performance standards, contract
quality assurance measures, and compliance actions. Section 1334 of the
Affordable Care Act directs OPM to implement this program in a manner
similar to the manner in which the contracting provisions of the FEHBP
are implemented, which includes the compliance measures set forth in
subpart E.
Contract Performance (Sec. 800.401)
In proposed Sec. 800.401, we set forth requirements for MSPP
issuers, including that the issuer must comply with section 1334 of the
Affordable Care Act and with the provisions of this regulation; that it
must meet minimum threshold issuer standards; that it must demonstrate
specified prudent business practices; that it must not engage in
specified poor business practices; and that OPM may collect an
assessment to a performance escrow account. OPM received several
comments specifically addressing this section.
Comment: One commenter recommended that these regulations reflect
OPM's commitment to the protection of enrollees' private and
confidential information. Specifically, the commenter recommended that
we require issuers to comply with Fair Information Practice Principles
by listing failure to comply with such Principles as a poor business
practice.
Response: We appreciate the need to protect private and
confidential information in the MSPP. Personally identifiable
information (PII) and protected health information (PHI) are protected
by the Health Insurance Portability and Accountability Act (HIPAA) and
the Privacy Act of 1974, as well as contractual provisions that will
mirror those used under the FEHBP. By ensuring compliance with these
laws and provisions, OPM will adequately protect PII and PHI.
Comments: Several commenters recommended adding to the list of
``poor business practices'' failure to properly pay I/T/Us in
compliance with 25 U.S.C. 1621e and the cost-sharing protections under
section 1402 of the Affordable Care Act.
Response: The list of ``poor business practices'' does not include
failures to comply with specific laws. This regulation, at Sec.
800.102, addresses compliance with Federal and State laws. Section
800.404(a)(4) permits OPM to impose a compliance action for any
violation of law or regulation. We will address compliance more
specifically in the terms of MSPP contracts.
Comment: One commenter interpreted the list of ``poor business
practices'' to include innovative payment arrangements or delivery
models such as Accountable Care Organizations (ACOs) or Patient-
Centered Medical Homes (PCMHs), and recommended that such models not be
prohibited.
Response: The list of ``poor business practices'' does not address
health care delivery models. The list includes ``[e]ntering into
contracts or employment agreements * * * that include provisions or
financial incentives that directly or indirectly create an inducement
to limit or restrict communication about medically necessary services
to any individual covered under the MSPP.'' Limitation of communication
about medically necessary services to enrollees is not an innovative
payment arrangement or delivery model, and is not a feature of an ACO
or PCMH.
Comments: A few commenters recommended against requiring issuers to
contribute to a performance escrow account. One commenter requested
clarification that OPM's proposal to reserve authority to require MSPP
issuers to contribute to a performance escrow account is limited to
MSPP issuers, presumably as opposed to QHP issuers; that contributions
would be based on premiums rather than a flat fee; that contributions
be assessed at the
[[Page 15582]]
beginning of the year; and that any refunds be remitted to consumers
similarly to MLR rebates.
Response: We continue to explore establishing a performance escrow
account to use in enforcement of MSPP contracts. OPM may develop more
specific policies to begin using such an account no sooner than 2015.
We will issue specific guidance on the operations of a performance
escrow account well in advance of the date on which it takes effect.
We are adopting proposed Sec. 800.401 as final, with no changes
except for minor technical edits.
Contract Quality Assurance (Sec. 800.402)
In proposed Sec. 800.402, we set forth general policies and
procedures to ensure that MSPP contracts conform to quality standards
and requirements, specifically with respect to the issuer's internal
controls and performance standards to be set by OPM.
Comment: One commenter recommended that OPM require MSPP issuers to
meet and comply with States' quality assurance standards and
requirements. The commenter suggested that OPM ensure such compliance
by requiring MSPP issuers to contract with each State, in addition to
contracting with OPM, or by inserting regulatory text.
Response: As noted throughout our responses to comments, we
appreciate the need for coordination with States to ensure that MSPs
are comparable to a QHP offered on the same Exchange. Requiring MSPP
issuers to enter into a contract with Exchanges would circumvent
section 1334(d) of the Affordable Care Act, which vests certification
authority for MSPs in OPM rather than State Exchanges by providing that
MSPs offered under a contract with OPM are deemed to be certified by an
Exchange. We intend to hold MSPs to performance standards that are
comparable to those set for QHPs by States and Exchanges. OPM will
establish and enforce these standards through contractual negotiation
and compliance.
We are adopting proposed Sec. 800.402 as final, with no changes.
Fraud and Abuse (Sec. 800.403)
In proposed Sec. 800.403, we required MSPP issuers to maintain a
program to assess and address vulnerabilities to fraud and abuse, to
maintain a system to detect and eliminate fraud and abuse, and to
provide certain information to OPM. One commenter specifically
addressed this section, requesting further information on the required
fraud detection system. We intend to set forth specific standards and
requirements for systems to detect and eliminate fraud and abuse in the
model MSPP contract. This does not require a change in the proposed
rule; therefore, we are adopting Sec. 800.403 of the proposed
regulation as final, with no changes.
Compliance Actions (Sec. 800.404)
In Sec. 800.404 of the proposed rule, we set forth the bases for
OPM to impose a compliance action; the compliance actions that OPM may
impose; the notices that OPM will send to issuers upon imposition of a
compliance action; and the notices that issuers must send to enrollees
upon imposition of certain compliance actions.
Comment: One commenter noted that mid-year decertification of MSPs
may disrupt markets and harm consumers and recommended that OPM clarify
that such a compliance action would be used only when it is strictly
necessary.
Response: We agree that mid-year decertification creates potential
for disruption, and OPM would only terminate or decertify an MSP if, in
the discretion of the Director, such action was necessary. However,
compliance actions are discretionary, so the regulatory text need not
be modified to reflect that those particular compliance actions would
not be routinely imposed.
Comment: One commenter recommended using State performance
evaluations in reviewing MSP performance and developing processes to
communicate with States and Exchanges regarding compliance actions.
Response: As noted above, we look forward to working with States
and Exchanges to ensure that MSPs meet appropriate standards within
States and across States. Because some compliance actions directly
affect Exchange markets, we agree that Exchanges should receive notice
of such compliance actions. Specifically, regulatory text will be
amended to provide that OPM will notify State and/or Exchange officials
when we reduce the service area or areas of an MSP in the State,
withdraw certification for an MSP in the State, decline to renew the
MSPP contract under which an MSP is offered in the State, or terminate
the MSPP contract under which an MSP is offered in the State.
Section 800.404 of the proposed rule is adopted as final, with two
changes:
First, the following new paragraph will be added after paragraph
(c)(2): ``(3) Upon imposition of a compliance action listed in
paragraphs (b)(2)(iv) through (b)(2)(vii) of this section, OPM must
notify the State Insurance Commissioner(s) and Exchange officials in
the State or States in which the compliance action is effective.''
Second, pursuant to a comment on subpart D of this regulation, we
are inserting language in paragraph (d) of this section to add clarity
and to conform to the wording of Sec. 800.306(c), which sets forth a
similar notice requirement. The revised paragraph (d) will read as
follows: ``If OPM terminates an MSPP issuer's MSPP contract with OPM,
or OPM withdraws the MSPP issuer's certification to offer the MSP on an
Exchange, the MSPP issuer must comply with any requirements regarding
the termination of a plan that are applicable to a QHP offered on an
Exchange on which the MSP was offered, including a requirement to
provide advance written notice of termination to enrollees. If an
Exchange does not have requirements about advance written notice of
termination to enrollees, the MSPP issuer must inform current MSP
enrollees in writing of the nonrenewal of the MSP no later than 90 days
prior to termination of coverage, unless OPM determines that good cause
justifies less than 90 days' notice.''
Reconsideration of Compliance Actions (Sec. 800.405)
In proposed Sec. 800.405, we set forth the right of an MSPP issuer
to request reconsideration of the imposition of certain compliance
actions, the form and manner of such a request, and OPM's notice to the
issuer of a decision upon reconsideration. One commenter specifically
addressed this section, recommending that OPM notify States of requests
for reconsideration under this section. As noted above, we intend to
communicate extensively with States and Exchanges to ensure that MSPs
meet appropriate standards. No change is needed in the wording of
proposed Sec. 800.405; therefore, we are adopting it as final, with no
changes.
Subpart F--Appeals by Enrollees for Denials of Claims for Payment or
Service
In subpart F, we proposed a process by which MSP enrollees (and
individuals acting on behalf of enrollees) could seek an internal
appeal and external review of an adverse benefit determination. The
proposed subpart included sections on general requirements, MSPP issuer
internal claims and appeals processes, MSPP issuer internal claims and
appeals timeframes and notice of determination, external review, and
judicial review. The proposed regulation adopted the standards and
timeframes established under section 2719 of the PHS Act, and
[[Page 15583]]
will be administratively similar to the disputed claims process
employed within the FEHBP. By adopting the standards and timeframes
applicable to health insurance issuers under the PHS Act, we proposed
to provide MSP enrollees with comparable processes to those that will
apply to QHPs and other coverage. In particular, the MSPP external
review process will include binding final decisions by independent
review organizations (IRO) on enrollee disputes that involve medical
judgment (including, but not limited to, those based on medical
necessity, appropriateness, health care setting, level of care, or
effectiveness of a covered benefit). The preamble to our proposed rule
noted that we intend to issue further guidance explaining the details
of these processes.
As indicated in the proposed rule, OPM has considerable experience
in resolving disputed claims pursuant to OPM's statutory authority
under 5 U.S.C. 8902(j). Claims disputed by FEHBP enrollees, generally
governed by 5 CFR 890.105, are first submitted to FEHBP carriers for an
internal level of reconsideration, and FEHBP carriers are required to
comply with the same timeframes that are contained in section 2719 of
the PHS Act. OPM then externally reviews any FEHBP carrier
reconsideration decisions that enrollees submit for OPM's review--
including decisions related to medical judgment, as well as decision
related to interpretation of contract coverage. This process is central
to OPM's contractual oversight of FEHBP carriers, allowing OPM to
determine whether the health plan's daily operations are functioning
appropriately and whether the plan's benefits are meeting enrollees'
needs, which informs the following benefit negotiation cycle. OPM
reviews claims efficiently; in 2012, 97 percent of all FEHB disputed
claims reviewed by OPM were resolved by OPM within 60 days of being
received.
Accordingly, in addition to engaging an independent review
organization for final, binding decisions on MSPP claims disputes
involving medical judgments, we have designed the external review
process for the MSPP to accommodate final, binding decisions by OPM on
claims disputes involving interpretation of contract coverage that does
not involve medical judgments.
Commenters on this subpart included States, Exchanges, State
associations, consumer groups, provider groups, pharmaceutical
companies, and plan and issuer groups. Several comments were generally
supportive of the proposed approach, whereas some commenters generally
preferred specific compliance with each separate State process in each
State. Some commenters expressed support for the adoption of the
standards and timeframes applicable under section 2719 of the PHS Act.
A few commenters recommended specific changes. Below, we address first
the general comments on the approach proposed in this subpart, followed
by the specific content of each section of the final regulation.
Comments: Some commenters suggested that consumers would be
confused by OPM's approach, noting that MSPs in some States would seek
an internal appeal or external review by following a different process
than a QHP on the same Exchange. A few commenters recommended that
notices to enrollees include contact information for Consumer
Assistance Programs (CAPs) or Ombudsman offices available to assist
consumers in filing appeals.
Response: We believe the proposed process adequately addresses the
potential for confusion in several ways. First, MSP issuers must comply
with the internal claims and appeals process under 45 CFR 147.136(b).
Regarding external review, MSP enrollees would send any request for
external review, whether of a determination based on medical judgment
or otherwise, to OPM. Some processes may call for resolution of medical
judgment determinations separately from, for example, determinations of
whether a benefit is covered under a plan. OPM plans to ensure that
this process will be explained clearly in plan documents and enrollee
notices. Second, the process will be administratively operated based on
the existing disputed claims process under the FEHBP. We have operated
this process for more than 35 years across the country, alongside
health coverage that has been subject to different appeals processes,
(for example, separate processes applicable to ERISA plans, commercial
insurance products, non-Federal governmental plans, or church plans).
OPM has nevertheless guided consumers through the disputed claims
process. Finally, we will ensure that notices to enrollees are
accessible and meet the standards established under section 2719 of the
PHS Act and its implementing regulations.
We agree that notices should include contact information for CAPs
and Ombudsman offices. Proposed Sec. Sec. 800.502 and 800.503 state
that MSPP issuers must comply with 45 CFR 147.136(b), which includes
the following provision at Sec. 147.136(b)(2)(ii)(E)(4): issuers
``must disclose the availability of, and contact information for, any
applicable office of health insurance consumer assistance or ombudsman
established under PHS Act section 2793 to assist individuals with the
internal claims and appeals and external review processes.''
Comments: Some commenters objected to the proposed process in
general, preferring instead that MSP enrollees be limited to the
processes available in their State. A few of those commenters suggested
that the proposed approach may trigger the ``level playing field''
provision at section 1324 of the Affordable Care Act, as discussed
under Sec. 800.115 of this regulation.
Response: As noted in the preamble to the proposed rule, our
primary objectives in establishing the internal appeals and external
review processes are to ensure that (1) enrollees have adequate access
to review of adverse benefit determinations and (2) OPM collects the
information necessary for the enforcement of MSPP contracts and
implementation of the program. We consider both objectives integral to
the implementation of the MSPP, and therefore required under section
1334 of the Affordable Care Act.
We have addressed the applicability of the ``level playing field''
provision in our responses to comments relating to Sec. 800.115 of
this regulation. As explained in that discussion, our approach to
external appeals will not trigger the level playing field provision
because MSPP issuers will be subject to the same rules as other
issuers: Section 2719 of the PHS Act and its implementing regulations.
Comments: A few commenters recommended that OPM require MSPP
issuers to comply with our proposed process unless a State's process is
more protective, in which case the more protective State provisions
would take effect for MSP enrollees.
Response: Our proposed process protects consumers by allowing us to
ensure that all MSP enrollees are able to seek review of a broad range
of determinations, and that requests for external review are resolved
consistently across the States. Although States' appeals processes, in
many cases, offer a different approach to consumer protection, we
believe that our processes provide a comparable or greater degree of
protection, which would apply uniformly across the States for MSP
enrollees.
Comments: A few commenters noted that State regulatory agencies
often use external review as a means of ascertaining information
regarding compliance with laws and regulations, and recommended that we
therefore decline to establish a process that would preclude States'
collection of such
[[Page 15584]]
information. Of those commenters, two suggested that States provide OPM
with data and information to use for the MSPP, and one requested that
OPM develop a process to share information with States and Exchanges to
facilitate enforcement of State laws and standards.
Response: As noted above, OPM intends to use these processes to
monitor and enforce MSPP contracts. We consider our ability to resolve
disputes arising under MSPP contracts integral to our implementation of
this program. However, we recognize that external review data and
information may also be important to State regulatory agencies and
Exchanges, and we intend to share information collected through this
process, to the extent that it is legally and operationally feasible,
with States and Exchanges. We look forward to working in collaboration
with States and Exchanges to ensure that the appropriate information is
shared seamlessly.
General Requirements (Sec. 800.501)
In this section, we set forth definitions, and provide that an MSP
enrollee or a person acting on behalf of an MSP enrollee may seek
review of an adverse determination under this program. We are adopting
proposed Sec. 800.501 as final, with no changes.
MSPP Issuer Internal Claims and Appeals Processes (Sec. 800.502) and
MSPP Issuer Internal Claims and Appeals Timeframes and Notice of
Determination (Sec. 800.503)
In Sec. 800.502, we provided that an MSPP issuer must comply with
internal claims and appeals processes applicable under 45 CFR
147.136(b). In Sec. 800.503, we provide that an MSPP issuer must
comply with notice requirements under 45 CFR 147.136(b) and (e) upon
rendering a determination on a claim under Sec. 800.502. We are not
making any substantive changes in these sections; however, because they
are so closely related, we have decided to combine Sec. Sec. 800.502
and 800.503 into a single section numbered 800.502, with paragraph (a)
of Sec. 800.502 containing the content of proposed Sec. 800.502, and
paragraph (b) of Sec. 800.502 containing the content of proposed Sec.
800.503.
External Review (Sec. 800.504)
In Sec. 800.504, we proposed an external review process under
which OPM would conduct external review of adverse benefit
determinations under the MSPP, enrollees would receive notices pursuant
to 45 CFR 147.136(e), and MSPP issuers would be required to pay a claim
or provide a service pursuant to a final decision by OPM or an IRO. In
the proposed rule, we referred to the State external review process
under standards in paragraph (c)(2) of the appeals regulation, 45 CFR
147.136(c)(2). The standards outlined in paragraph (c)(2), however,
expressly apply only to a State external review process, and would be
inconsistent with the national approach OPM was proposing. OPM's
national approach more appropriately falls under 45 CFR 147.136(d). We
therefore wish to clarify that we intended the State external review
standards in paragraph (c)(2) to serve as a model for the consumer
protections that OPM would incorporate into its proposed external
review process. Accordingly, the change in citation from 45 CFR
147.136(c)(2) to 45 CFR 147.136(d) has been made.
Judicial Review (Sec. 800.505)
In proposed Sec. 800.505, we provided that OPM's written decision
pursuant to completed external review of an adverse benefit
determination would constitute final agency action under the
Administrative Procedure Act, and that review of such a decision in the
appropriate U.S. district court would be limited to the record that was
before OPM when it made its decision. We are adopting proposed Sec.
800.505 as final, with one change, and renumbering it as Sec. 800.504.
Although OPM will conduct external review under the MSPP, final
decisions on adverse benefit determinations related to medical judgment
will be made by IROs, in accordance with section 2719 of the PHS Act.
Decisions made by IROs will be final, and OPM will not be responsible
for their approval. Such decisions therefore cannot be considered final
agency action. The regulation will provide that a decision by an IRO on
external review of an adverse benefit determination related to medical
judgment will not be considered final agency action.
Subpart G--Miscellaneous
Reservation of Authority (Sec. 800.601)
We received no comment on this section of the proposed rule, which
simply provides that OPM reserves the right to implement and supplement
its regulations with written operational guidelines. Therefore, we are
adopting this section as final, with no changes.
Consumer Choice With Respect to Certain Services (Sec. 800.602)
Section 800.602 of the proposed rule requires that at least one MSP
on each Exchange not offer services described at section
1303(b)(1)(B)(i) of the Affordable Care Act. Further, MSPs in States
that prohibit these services must comply with State law.
Comments: Several commenters expressed concern that OPM is
proposing to preempt State law regarding coverage of services described
in section 1303(b)(1)(B)(i) of the Affordable Care Act. Some commenters
expressed a preference that at least one MSP in each Exchange be
required to provide coverage for these services. In particular, there
was concern that, since FEHBP plans do not generally cover services
described at section 1303(b)(1)(B)(i), the FEHBP benchmark plan would
exclude these services for an MSP. One commenter was concerned that
requiring enrollees to make separate payments for these services would
be burdensome.
Response: OPM is complying with section 1334(a)(6) of the
Affordable Care Act, which directs that at least one of the MSPs in a
State not offer services described in section 1303(b)(1)(B)(i). If an
MSP is offered in a State that requires coverage of the services
described in section 1303(b)(1)(B)(i), OPM will discuss options for
compliance with State and Federal laws in contract negotiations with
MSPP applicants. Although an FEHBP benchmark would not include services
described in section 1303(b)(1)(B)(i), MSPP issuers can include
services permitted by law as long as the EHB benefits are substantially
equal. OPM will require MSPs to comply with HHS rules about segregation
of funds as described in 45 CFR part 156.
We are adopting as final proposed subpart G, with a technical
correction to Sec. 800.602, which included an incorrect reference to
the Affordable Care Act provision describing the services in section
1303(b)(1)(B)(i).
Executive Orders 13563 and 12866; Regulatory Review
OPM has examined the impact of this rule as required by Executive
Order 12866 on Regulatory Planning and Review (September 30, 1993) and
Executive Order 13563 on Improving Regulation and Regulatory Review
(January 18, 2011). Executive Orders 12866 and 13563 direct agencies to
assess all costs and benefits of available regulatory alternatives and,
if regulation is necessary, to select regulatory approaches that
maximize net benefits (including potential economic, environmental,
public health and safety effects, distributive impacts, and equity). A
regulatory impact analysis must be prepared for major rules with
economically significant effects ($100 million or more in any one year,
[[Page 15585]]
adjusted for inflation). Section 3(f) of Executive Order 12866 defines
a ``significant regulatory action'' as an action that is likely to
result in a rule that may:
(1) Have an annual effect on the economy of $100 million or more in
any one year or adversely affect in a material way a sector of the
economy, productivity, competition, jobs, the environment, public
health or safety, or State, local, or tribal government or communities;
(2) Create a serious inconsistency or otherwise interfere with an
action taken or planned by another agency;
(3) Materially alter the budgetary impacts of entitlement grants,
user fees, or loan programs, or the rights and obligations of
recipients thereof; or
(4) Raise novel legal or policy issues arising out of legal
mandates, the President's priorities, or the principles set forth in
Executive Order 12866.
The economic impact of this rule may exceed the $100 million
threshold for at least one year; we therefore assess costs and benefits
as required by the Executive order.
This rule gives health insurance issuers the opportunity to
contract with OPM to offer a product on the Affordable Insurance
Exchanges, but does not require those issuers to outlay funds. In 2013,
the Congressional Budget Office (CBO) and the Joint Committee on
Taxation (JCT) estimated the effects of the Affordable Care Act on
nationwide insurance enrollment and on the Federal budget.\5\ CBO and
JCT estimated that from 2016 on, between 24 million and 27 million
people will receive individually purchased coverage through the
Exchanges, and another 3-4 million people will receive employment-based
coverage through the Exchanges. In the preamble to the proposed rule,
we noted that OPM lacks the information necessary to make assumptions
about the potential enrollment penetration for MSPs on the Exchanges.
We sought comments on the number of States where MSPs will participate
and the influence of current market dynamics on enrollment in MSPs, but
received none. As we have not yet begun contract negotiations or closed
the application process, we do not have any more information on
projected enrollment than we had at the time of the proposed rule. As
such, this analysis will continue to largely reflect qualitative
analysis, with quantitative analysis where possible.
---------------------------------------------------------------------------
\5\ Congressional Budget Office, Effects of the Affordable Care
Act on Health Insurance Coverage--February 2013 Baseline, available
at https://www.cbo.gov/publication/43900 (February 5, 2013).
---------------------------------------------------------------------------
One primary benefit of health insurance coverage would be an
increase in longevity or health for newly-enrolled individuals.
Improved access to health care services has been shown to lead to
higher use of preventive services and health improvements, such as
reduced hypertension, improved vision and better self-reported health
status, as well as better clinical outcomes and lower
mortality.6 7
---------------------------------------------------------------------------
\6\ Brook, Robert H., John E. Ware, William H. Rogers, Emmett B.
Keeler, Allyson Ross Davies, Cathy D. Sherbourne, George A.
Goldberg, Kathleen N. Lohr, Patricia Camp and Joseph P. Newhouse.
The Effect of Coinsurance on the Health of Adults: Results from the
RAND Health Insurance Experiment. Santa Monica, CA: RAND
Corporation, 1984. Finkelstein, A. et al. ``The Oregon Health
Insurance Experiment: Evidence from the First Year.'' NBER Working
Paper No. 17190, July 2011. Doyle, J.J. ``Health Insurance,
Treatment and Outcomes: Using Auto Accidents and Health Shocks.''
National Bureau of Economic Research. NBER Working Paper No. 11099,
February 2005.
\7\ See the regulatory impact analysis developed by HHS for the
Exchange Establishment final rule, available at https://cciio.cms.gov
under ``Regulations and Guidance'', for a comprehensive overview of
the empirical evidence on the benefits of enhanced availability of
quality, affordable health insurance, which to great extent applies
to the MSPP program and this proposed rule as well.
---------------------------------------------------------------------------
Additional benefits would be generated for newly-enrolled
individuals in the form of improved financial security. There is
evidence that bankruptcy filings, for instance, decrease in response to
increases in Medicaid eligibility.\8\ Furthermore, a 2011 analysis by
the Office of the Assistant Secretary for Planning and Evaluation
(ASPE) found that most of the uninsured were unable to afford a single
hospitalization, because 90 percent of the uninsured reported having
total financial assets below $13,000.\9\ A related benefit would be
generated by increased access to non-employment-based health insurance,
which can give individuals greater flexibility to take positions that
better match their skills or interests.
---------------------------------------------------------------------------
\8\ Gross, T., Notowidigdo, M. ``Health Insurance and the
Consumer Bankruptcy Decision: Evidence from Medicaid Expansions.''
Journal of Public Economics 95 (7-8): 2011.
\9\ Assistant Secretary for Planning and Evaluation The Value of
Health Insurance: Few of the Uninsured Have Adequate Resources to
Pay Potential Hospital Bills: 2011. Washington, DC: U.S. Department
of Health and Human Services.
---------------------------------------------------------------------------
Expansion of health insurance coverage leads to many benefits, such
as improved access to health care and improved financial security for
the newly insured. However, insurance coverage can lead to increased
utilization of health services for individuals who become newly
insured. While a portion of this increased utilization may be
economically inefficient, studies that estimated the effects of
Medicare found that the cost of this inefficiency is likely more than
offset by the benefit of risk reduction.10 11
---------------------------------------------------------------------------
\10\ Finkelstein, A, McKnight R: ``What Did Medicare Do? The
Initial Impact of Medicare on Mortality and Out Of Pocket Medical
Spending '' Journal of Public Economics 2008, 92:1644-1668.
\11\ Finkelstein, A., ``The Aggregate Effects of Health
Insurance: Evidence from the Introduction of Medicare,'' National
Bureau of Economic Research. Working Paper No. 11619, Sept, 2005.
---------------------------------------------------------------------------
Administrative costs of the rule would be generated both within OPM
and by issuers deciding to offer MSPs. The costs that MSPP issuers may
incur are the same as those of QHPs and, as stated in 45 CFR part 157,
will include accreditation, network adequacy standards, and quality
improvement strategy reporting. The costs associated with MSP
certification offset the costs that issuers would face were they to be
certified by the State, or HHS on behalf of the State, to offer QHPs
through the Exchange.
Finally, some of the most notable effects of Exchanges in general,
and MSPs in particular, may not be net social costs or benefits, but
would instead be transfers between members of society--in particular,
decreases in uncompensated care.
OPM lacks data to quantify most of these benefits, costs and
transfers. Perhaps most notably, OPM cannot isolate the effects of MSPs
from forecasts of the overall effects of the Affordable Care Act
coverage provisions. We requested comments on our cost-benefit
analysis, but received no comments.
Paperwork Reduction Act
The Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35; see 5
CFR part 1320) requires that OMB approve all collections of information
by a Federal agency from the public before they can be implemented.
Respondents are not required to respond to any collection of
information unless it displays a current valid OMB control number. OPM
will have several collections from MSPP issuers or applicants seeking
to become MSPP issuers, but we have determined that they are exempt
from the requirements of the Paperwork Reduction Act. For example, we
seek to collect information in connection with the MSPP application
process and reporting requirements under Sec. 800.112. We are also
requiring issuers to authorize accrediting entities to send
documentation to OPM under Sec. 800.111. We are setting up a process
under
[[Page 15586]]
Sec. 800.116 for States to request that OPM reconsider a standard
applicable to MSPs or MSPP issuers that does not comply with that
State's laws for QHPs. Under Sec. 800.503, MSPP issuers are directed
to provide certain written notices, which are third-party disclosures
under the Paperwork Reduction Act. These collections would generally be
considered reporting requirements under the Paperwork Reduction Act.
Moreover, based on responses to the RFI, subsequent conversations with
both responding health insurance issuers and other health insurance
issuers subsequent to the RFI, and other practical considerations, OPM
expects fewer than ten responsible entities to respond to all of the
collections noted above. For that reason alone, the collections are
exempt from the Paperwork Reduction Act under 44 U.S.C. 3502(3)(A)(i).
There may also be other reasons why these collections are exempt from
these requirements. We sought comments on these assumptions but
received none.
Regulatory Flexibility Act
The Regulatory Flexibility Act (RFA) \12\ requires agencies to
prepare an initial regulatory flexibility analysis to describe the
impact of the final rule on small entities, unless the head of the
agency can certify that the rule would not have a significant economic
impact on a substantial number of small entities. The RFA generally
defines a ``small entity'' as (1) a proprietary firm meeting the size
standards of the Small Business Administration (SBA); (2) a not-for-
profit organization that is not dominant in its field; or (3) a small
government jurisdiction with a population of less than 50,000. States
and individuals are not included in the definition of ``small entity.''
---------------------------------------------------------------------------
\12\ 5 U.S.C. 601 et seq.
---------------------------------------------------------------------------
The RFA requires agencies to analyze options for regulatory relief
of small businesses, if a rule has a significant impact on a
substantial number of small entities. For purposes of the RFA, small
entities include small businesses, small non-profit organizations, and
small government jurisdictions. Small businesses are those with sizes
below thresholds established by the SBA. With respect to health
insurers, the SBA size standard is $7.0 million in annual receipts.\13\
---------------------------------------------------------------------------
\13\ According to the SBA size standards, entities with average
annual receipts of $7 million or less would be considered small
entities for North American Industry Classification System (NAICS)
Code 524114 (Direct Health and Medical Insurance Carriers) (for more
information, see ``Table of Size Standards Matched To North American
Industry Classification System Codes,'' effective March 26, 2012,
U.S. Small Business Administration, available at https://www.sba.gov).
---------------------------------------------------------------------------
OPM does not think that small businesses with annual receipts less
than $7.0 million would likely have sufficient economies of scale to
become MSPP issuers or be part of a group of MSPP issuers. Similarly,
while the Director must enter into an MSPP contract with at least one
non-profit entity, OPM does not think that small non-profit
organizations would likely have sufficient economies of scale to become
MSPP issuers or be part of a group of MSPP issuers.
OPM does not think that these regulations will have a significant
economic impact on a substantial number of small businesses with annual
receipts less than $7.0 million, because there are only a few health
insurance issuers that could be considered small businesses. Moreover,
while the Director must enter into an MSPP contract with at least one
non-profit entity, OPM does not think that these regulations will have
a significant economic impact on a substantial number of small non-
profit organizations, because few health insurance issuers are small
non-profit organizations.
OPM incorporates by reference previous analysis by HHS, which
provides some insight into the number of health insurance issuers that
could be small entities. Particularly, as discussed by HHS in the
Medical Loss Ratio interim final rule (75 FR 74918), few, if any,
issuers are small enough to fall below the size thresholds for small
business established by the SBA. In that rule, HHS used a data set
created from 2009 NAIC Health and Life Blank annual financial statement
data to develop an updated estimate of the number of small entities
that offer comprehensive major medical coverage in the individual and
group markets. For purposes of that analysis, HHS used total Accident
and Health earned premiums as a proxy for annual receipts. HHS
estimated that there are 28 small entities with less than $7 million in
accident and health earned premiums offering individual or group
comprehensive major medical coverage. OPM concurs with this HHS
analysis, and, thus, does not think that these regulations will have a
significant economic impact on a substantial number of small entities.
Based on the foregoing, OPM is not preparing an analysis for the
RFA because OPM has determined, and the Director certifies, that these
regulations will not have a significant economic impact on a
substantial number of small entities.
Unfunded Mandates
Section 202 of the Unfunded Mandates Reform Act of 1995 (UMRA) \14\
requires that agencies assess anticipated costs and benefits and take
certain other actions before issuing a final rule that includes any
Federal mandate that may result in expenditures in any one year by a
State, local, or tribal government, in the aggregate, or by the private
sector, of $100 million in 1995 dollars, updated annually for
inflation. In 2013, that threshold is approximately $150 million. UMRA
does not address the total cost of a rule. Rather, it focuses on
certain categories of costs, mainly those ``Federal mandate'' costs
resulting from (1) imposing enforceable duties on State, local, or
tribal governments, or on the private sector; or (2) increasing the
stringency of conditions in, or decreasing the funding of, State,
local, or tribal governments under entitlement programs.
---------------------------------------------------------------------------
\14\ Public Law 104-4.
---------------------------------------------------------------------------
These regulations do not place any Federal mandates on State,
local, or tribal governments, or on the private sector. This final rule
would establish the MSPP, a voluntary Federal program that provides
health insurance issuers the opportunity to contract with OPM to offer
MSPs on the Exchanges. Section 3 of UMRA excludes from the definition
of ``Federal mandate'' duties that arise from participation in a
voluntary Federal program. Accordingly, no analysis under UMRA is
required.
Federalism
Executive Order 13132 outlines fundamental principles of
federalism, and requires the adherence to specific criteria by Federal
agencies in the process of their formulation and implementation of
policies that have ``substantial direct effects'' on the States, the
relationship between the national government and States, or on the
distribution of power and responsibilities among the various levels of
government. Federal agencies promulgating regulations that have these
federalism implications must consult with State and local officials,
and describe the extent of their consultation and the nature of the
concerns of State and local officials in the preamble to the
regulation.
These regulations have federalism implications, because they have
direct effects on the States, the relationship between the national
government and States, or on the distribution of power
[[Page 15587]]
and responsibilities among various levels of government. In particular,
under Sec. 800.114, OPM may deem a State law to be inconsistent with
section 1334 of the Affordable Care Act, and, thus, inapplicable to an
MSP or MSPP issuer. However, in OPM's view, the federalism implications
of these regulations are substantially mitigated because OPM expects
that the vast majority of States have laws that are consistent with
section 1334 of the Affordable Care Act. Furthermore, Sec. 800.116
sets forth a process for dispute resolution if a State seeks to
challenge OPM's determination that a State law is inapplicable to an
MSP or MSPP issuer.
We received one comment that OPM is not in compliance with
Executive Order 13132, because we do not defer to more consumer-
protective State standards. However, we respectfully disagree because,
as noted throughout this rule, OPM defers to more consumer-protective
State standards. Moreover, in compliance with the requirement of
Executive Order 13132 that agencies examine closely any policies that
may have federalism implications or limit the policy-making discretion
of the States, OPM has engaged in efforts to consult with and work
cooperatively with affected State and local officials, including
attending meetings of the NAIC and consulting with State insurance
officials on an individual basis. OPM expects to act in a similar
fashion in enforcing the Affordable Care Act requirements. Throughout
the process of developing these final regulations, OPM has attempted to
balance the States' interests in regulating health insurance issuers,
and the statutory requirement to provide two MSPs in all Exchanges in
the 50 States and the District of Columbia. By doing so, it is OPM's
view that it has complied with the requirements of Executive Order
13132.
Pursuant to the requirements set forth in section 8(a) of Executive
Order 13132, and by the signature affixed to these regulations, OPM
certifies that it has complied with the requirements of Executive Order
13132 for the attached regulations in a meaningful and timely manner.
Congressional Review Act
This final rule is subject to the Congressional Review Act
provisions of the Small Business Regulatory Enforcement Fairness Act of
1996 (5 U.S.C. 801, et seq.), which specifies that before a rule can
take effect, the Federal agency promulgating the rule must submit to
each House of Congress and to the Comptroller General a report
containing a copy of the rule along with other specified information.
In accordance with this requirement, OPM has transmitted this rule to
Congress and the Comptroller General for review.
List of Subjects in 5 CFR Part 800
Administrative practice and procedure, Health facilities, Health
insurance, Health professions, Reporting and recordkeeping
requirements.
U.S. Office of Personnel Management.
John Berry,
Director.
Accordingly, the U.S. Office of Personnel Management is adding part
800 to title 45, chapter VIII, Code of Federal Regulations, as follows:
PART 800--MULTI-STATE PLAN PROGRAM
Subpart A--General Provisions and Definitions
Sec.
800.10 Basis and scope.
800.20 Definitions.
Subpart B--Multi-State Plan Program Issuer Requirements
800.101 General requirements.
800.102 Compliance with Federal law.
800.103 Authority to contract with issuers.
800.104 Phased expansion.
800.105 Benefits.
800.106 Cost-sharing limits, advance payments of premium tax
credits, and cost-sharing reductions.
800.107 Levels of coverage.
800.108 Assessments and user fees.
800.109 Network adequacy.
800.110 Service area.
800.111 Accreditation requirement.
800.112 Reporting requirements.
800.113 Benefit plan material or information.
800.114 Compliance with applicable State law.
800.115 Level playing field.
800.116 Process for dispute resolution.
Subpart C--Premiums Rating Factors, Medical Loss Ratios, and Risk
Adjustment
800.201 General requirements.
800.202 Rating factors.
800.203 Medical loss ratio.
800.204 Reinsurance, risk corridors, and risk adjustment.
Subpart D--Application and Contracting Procedures
800.301 Application process.
800.302 Review of applications.
800.303 MSPP contracting.
800.304 Term of the contract.
800.305 Contract renewal process.
800.306 Nonrenewal.
Subpart E--Compliance
800.401 Contract performance.
800.402 Contract quality assurance.
800.403 Fraud and abuse.
800.404 Compliance actions.
800.405 Reconsideration of compliance actions.
Subpart F--Appeals by Enrollees of Denials of Claims for Payment or
Service
800.501 General requirements.
800.502 MSPP issuer internal claims and appeals.
800.503 External review.
800.504 Judicial review.
Subpart G--Miscellaneous
800.601 Reservation of authority.
800.602 Consumer choice with respect to certain services.
Authority: Sec. 1334 of Pub. L. 111-148, 124 Stat. 119; Pub. L.
111-152, 124 Stat. 1029.
Subpart A--General Provisions and Definitions
Sec. 800.10 Basis and scope.
(a) Basis. This part is based on the following sections of title I
of the Affordable Care Act:
1001. Amendments to the Public Health Service Act.
1302. Essential Health Benefits Requirements.
1311. Affordable Choices of Health Benefit Plans.
1324. Level Playing Field.
1334. Multi-State Plans.
1341. Transitional Reinsurance Program for Individual Market in
Each State.
1342. Establishment of Risk Corridors for Plans in Individual and
Small Group Markets.
1343. Risk Adjustment.
(b) Scope. This part establishes standards for health insurance
issuers to contract with the United States Office of Personnel
Management (OPM) to offer multi-State plans to provide health insurance
coverage on Exchanges for each State. It also establishes standards for
appeal of a decision by OPM affecting the issuer's participation in the
Multi-State Plan Program (MSPP) and standards for an enrollee in a
multi-State plan (MSP) to appeal denials of payment or services by an
MSPP issuer.
Sec. 800.20 Definitions.
For purposes of this part:
Actuarial value (AV) has the meaning given that term in 45 CFR
156.20.
Affordable Care Act means the Patient Protection and Affordable
Care Act (Pub. L. 111-148), as amended by the Health Care and Education
Reconciliation Act of 2010 (Pub. L. 111-152).
Applicant means an issuer or group of issuers that has submitted an
application to OPM to be considered for participation in the Multi-
State Plan Program.
Benefit plan material or information means explanations or
descriptions, whether printed or electronic, that
[[Page 15588]]
describe a health insurance issuer's products. The term does not
include a policy or contract for health insurance coverage.
Cost sharing has the meaning given that term in 45 CFR 155.20.
Director means the Director of the United States Office of
Personnel Management.
EHB-benchmark plan has the meaning given that term in 45 CFR
156.20.
Exchange means a governmental agency or non-profit entity that
meets the applicable requirements of 45 CFR part 155 and makes
qualified health plans (QHPs) and MSPs available to qualified
individuals and qualified employers. Unless otherwise identified, this
term refers to State Exchanges, regional Exchanges, subsidiary
Exchanges, and a Federally-facilitated Exchange.
Federal Employees Health Benefits Program or FEHBP means the health
benefits program administered by the United States Office of Personnel
Management pursuant to chapter 89 of title 5, United States Code.
Group of issuers means:
(1) A group of health insurance issuers who are affiliated either
by common ownership and control or by common use of a nationally
licensed service mark (as defined in this paragraph); or
(2) An affiliation of health insurance issuers and an entity that
is not an issuer but that owns a nationally licensed service mark (as
defined in this paragraph).
Health insurance coverage means benefits consisting of medical care
(provided directly, through insurance or reimbursement, or otherwise)
under any hospital or medical service policy or certificate, hospital
or medical service plan contract, or HMO contract offered by a health
insurance issuer. Health insurance coverage includes group health
insurance coverage, individual health insurance coverage, and short-
term, limited duration insurance.
Health insurance issuer or issuer means an insurance company,
insurance service, or insurance organization (including an HMO) that is
required to be licensed to engage in the business of insurance in a
State and that is subject to State law that regulates insurance (within
the meaning of section 514(b)(2) of the Employee Retirement Income
Security Act (ERISA)). This term does not include a group health plan
as defined in 45 CFR 146.145(a).
HHS means the United States Department of Health and Human
Services.
Level of coverage means one of four standardized actuarial values
of plan coverage as defined by section 1302(d)(1) of the Affordable
Care Act.
Licensure means the authorization obtained from the appropriate
State official or regulatory authority to offer health insurance
coverage in the State.
Multi-State Plan or MSP means a health plan that is offered under a
contract between OPM and the MSPP issuer pursuant to section 1334 of
the Affordable Care Act and that meets the requirements of this part.
Multi-State Plan Program or MSPP means the program administered by
OPM pursuant to section 1334 of the Affordable Care Act.
Multi-State Plan Program issuer or MSPP issuer means a health
insurance issuer or group of issuers (as defined in this section) that
has a contract with OPM to offer health plans pursuant to section 1334
of the Affordable Care Act and meets the requirements of this part.
Nationally licensed service mark means a word, name, symbol, or
device, or any combination thereof, that an issuer or group of issuers
uses consistently nationwide to identify itself.
Non-profit entity means:
(1) An organization that is incorporated under State law as a non-
profit entity and licensed under State law as a health insurance
issuer; or
(2) A group of health insurance issuers licensed under State law, a
substantial portion of which are incorporated under State law as non-
profit entities.
OPM means the United States Office of Personnel Management.
Percentage of total allowed cost of benefits has the meaning given
that term in 45 CFR 156.20.
Plan year means a consecutive 12-month period during which a health
plan provides coverage for health benefits. A plan year may be a
calendar year or otherwise.
Prompt payment means a requirement imposed on a health insurance
issuer to pay a provider or enrollee for a claimed benefit or service
within a defined time period, including the penalty or consequence
imposed on the issuer for failure to meet the requirement.
Qualified Health Plan or QHP means a health plan that has in effect
a certification that it meets the standards described in subpart C of
45 CFR part 156 issued or recognized by each Exchange through which
such plan is offered pursuant to the process described in subpart K of
45 CFR part 155.
Rating means the process, including rating factors, numbers,
formulas, methodologies, and actuarial assumptions, used to set
premiums for a health plan.
Secretary means the Secretary of the Department of Health and Human
Services.
SHOP means a Small Business Health Options Program operated by an
Exchange through which a qualified employer can provide its employees
and their dependents with access to one or more qualified health plans
(QHPs).
Silver plan variation has the meaning given that term in 45 CFR
156.400.
Small employer means, in connection with a group health plan with
respect to a calendar year and a plan year, an employer who employed an
average of at least one but not more than 100 employees on business
days during the preceding calendar year and who employs at least one
employee on the first day of the plan year. In the case of plan years
beginning before January 1, 2016, a State may elect to define small
employer by substituting ``50 employees'' for ``100 employees.''
Standard plan has the meaning given that term in 45 CFR 156.400.
State means each of the 50 States or the District of Columbia.
State Insurance Commissioner means the commissioner or other chief
insurance regulatory official of a State.
Subpart B--Multi-State Plan Program Issuer Requirements
Sec. 800.101 General requirements.
An MSPP issuer must:
(a) Licensed. Be licensed as a health insurance issuer in each
State where it offers health insurance coverage;
(b) Contract with OPM. Have a contract with OPM pursuant to this
part;
(c) Required levels of coverage. Offer levels of coverage as
required by Sec. 800.107;
(d) Eligibility and enrollment. MSPs and MSPP issuers must meet the
same requirements for eligibility, enrollment, and termination of
coverage as those that apply to QHPs and QHP issuers pursuant to 45 CFR
part 155, subparts D, E, and H, and 45 CFR 156.250, 156.260, 156.265,
156.270, and 156.285;
(e) Applicable to each MSP. Ensure that each of its MSPs meets the
requirements of this part;
(f) Compliance. Comply with all standards set forth in this part;
(g) OPM direction and other legal requirements. Timely comply with
OPM instructions and directions and with other applicable law; and
(h) Other requirements. Meet such other requirements as determined
appropriate by OPM, in consultation with HHS, pursuant to section
1334(b)(4) of the Affordable Care Act.
[[Page 15589]]
(i) Non-discrimination. MSPs and MSPP issuers must comply with
applicable Federal and State non-discrimination laws, including the
standards set forth in 45 CFR 156.125 and 156.200(e).
Sec. 800.102 Compliance with Federal law.
(a) Public Health Service Act. As a condition of participation in
the MSPP, an MSPP issuer must comply with applicable provisions of part
A of title XXVII of the PHS Act. Compliance shall be determined by the
Director.
(b) Affordable Care Act. As a condition of participation in the
MSPP, an MSPP issuer must comply with applicable provisions of title I
of the Affordable Care Act. Compliance shall be determined by the
Director.
Sec. 800.103 Authority to contract with issuers.
(a) General. OPM may enter into contracts with health insurance
issuers to offer at least two MSPs on Exchanges and SHOPs in each
State, without regard to any statutes that would otherwise require
competitive bidding.
(b) Non-profit entity. In entering into contracts with health
insurance issuers to offer MSPs, OPM will enter into a contract with at
least one non-profit entity as defined in Sec. 800.20 of this part.
(c) Group of issuers. Any contract to offer an MSP may be with a
group of issuers as defined in Sec. 800.20.
(d) Individual and group coverage. The contracts will provide for
individual health insurance coverage and for group health insurance
coverage for small employers.
Sec. 800.104 Phased expansion.
(a) Phase-in. OPM may enter into a contract with a health insurance
issuer to offer an MSP if the health insurance issuer agrees that:
(1) With respect to the first year for which the health insurance
issuer offers an MSP, the health insurance issuer will offer the MSP in
at least 60 percent of the States;
(2) With respect to the second such year, the health insurance
issuer will offer the MSP in at least 70 percent of the States;
(3) With respect to the third such year, the health insurance
issuer will offer the MSP in at least 85 percent of the States; and
(4) With respect to each subsequent year, the health insurance
issuer will offer the MSP in all States.
(b) Partial coverage within a State. OPM may enter into a contract
with an MSPP issuer even if the MSPP issuer's MSPs for a State cover
fewer than all the service areas specified for that State pursuant to
Sec. 800.110. For each State in which the MSPP issuer offers partial
coverage, the MSPP issuer must submit a plan for offering coverage
throughout the State. OPM will monitor the MSPP issuer's progress in
implementing the plan as part of its contract compliance activities
under subpart E of this part.
(c) Participation in SHOPs. (1) An MSPP issuer's participation in
the Federally-facilitated SHOP must be consistent with the requirements
for QHP issuers specified in 45 CFR 156.200(g).
(2) An MSPP issuer must comply with State standards governing
participation in State-based SHOPs, consistent with Sec. 800.114. For
these State-based SHOP standards, OPM retains discretion to allow an
MSPP issuer to phase-in SHOP participation in States pursuant to
section 1334(e) of the Affordable Care Act.
(d) Licensed where offered. OPM may enter into a contract with an
MSPP issuer who is not licensed in every State, provided that the
issuer is licensed in every State where it offers MSP coverage through
any Exchanges in that State and demonstrates to OPM that it is making a
good faith effort to become licensed in every State consistent with the
timeframe in paragraph (a) of this section.
Sec. 800.105 Benefits.
(a) Benefits package. (1) An MSPP issuer must offer a uniform
benefits package, including the essential health benefits (EHB)
described in section 1302 of the Affordable Care Act, for each MSP
within a State.
(2) The benefits package referred to in paragraph (a)(1) of this
section must comply with section 1302 of the Affordable Care Act, as
well as any applicable standards set by OPM or HHS.
(b) Benefits package options. (1) An MSPP issuer must offer a
benefits package, in all States, that is substantially equal to:
(i) The EHB-benchmark plan in each State in which it operates; or
(ii) Any EHB-benchmark plan selected by OPM under paragraph (c) of
this section.
(2) An issuer applying to participate in the MSPP must select one
of the two benefits package options described in paragraph (b)(1) of
this section in its application.
(3) An issuer must comply with any State standards relating to
substitution of benchmark benefits or standard benefit designs.
(c) OPM selection of benchmark plans. (1) The OPM-selected EHB-
benchmark plans are the three largest Federal Employees Health Benefits
Program (FEHBP) plan options, as identified by HHS pursuant to section
1302(b) of the Affordable Care Act, and as supplemented pursuant to
paragraphs (c)(2) through (c)(4) of this section.
(2) Any EHB-benchmark plan selected by OPM under paragraph (c)(1)
of this section lacking coverage of pediatric oral services or
pediatric vision services must be supplemented by the addition of the
entire category of benefits from the largest Federal Employee Dental
and Vision Insurance Program (FEDVIP) dental or vision plan options,
respectively, pursuant to 45 CFR 156.110(b) and section 1302(b) of the
Affordable Care Act.
(3) An MSPP issuer must follow State definitions where the State
chooses to specifically define the habilitative services and devices
category pursuant to 45 CFR 156.110(f). In the case of any State that
chooses not to define this category, if any OPM-selected EHB-benchmark
plan lacks coverage of habilitative services and devices, OPM may
determine what habilitative service and devices are to be included in
that EHB-benchmark plan.
(4) Any EHB-benchmark plan selected by OPM under paragraph (c)(1)
of this section must include, for each State, any State-required
benefits enacted before December 31, 2011, that are included in the
State's EHB-benchmark plan as described in paragraph (b)(1)(i) of this
section, or specific to the market in which the plan is offered.
(d) OPM approval. An MSPP issuer's benefits package, including its
prescription drug list, must be submitted for approval by OPM, which
will review a benefits package proposed by an MSPP issuer and determine
if it is substantially equal to an EHB-benchmark plan described in
paragraph (b)(1) of this section, pursuant to standards set forth by
OPM or HHS, including 45 CFR 156.115, 156.122, and 156.125.
(e) State payments for additional State-required benefits. If a
State requires that benefits in addition to the benchmark package be
offered to MSP enrollees in that State, then pursuant to section
1334(c)(2) of the Affordable Care Act, the State must assume the cost
of such additional benefits by making payments either to the enrollee
or on behalf of the enrollee to the MSPP issuer.
Sec. 800.106 Cost-sharing limits, advance payments of premium tax
credits, and cost-sharing reductions.
(a) Cost-sharing limits. For each MSP it offers, an MSPP issuer
must ensure that the cost-sharing provisions of the
[[Page 15590]]
MSP comply with section 1302(c) of the Affordable Care Act, as well as
any applicable standards set by OPM or HHS.
(b) Advance payments of premium tax credits and cost-sharing
reductions. For each MSP it offers, an MSPP issuer must ensure that an
eligible individual receives the benefit of advance payments of premium
tax credits under section 36B of the Internal Revenue Code and the
cost-sharing reductions under section 1402 of the Affordable Care Act.
An MSPP issuer must also comply with any applicable standards set by
OPM or HHS.
Sec. 800.107 Levels of coverage.
(a) Silver and gold levels of coverage required. An MSPP issuer
must offer at least one MSP at the silver level of coverage and at
least one MSP at the gold level of coverage on each Exchange in which
the issuer is certified to offer an MSP pursuant to a contract with
OPM.
(b) Bronze or platinum metal levels of coverage permitted. Pursuant
to a contract with OPM, an MSPP issuer may offer one or more MSPs at
the bronze level of coverage or the platinum level of coverage, or
both, on any Exchange or SHOP in any State.
(c) Child-only plans. For each level of coverage, the MSPP issuer
must offer a child-only plan at the same level of coverage as any
health insurance coverage offered to individuals who, as of the
beginning of the plan year, have not attained the age of 21.
(d) Plan variations for the reduction or elimination of cost-
sharing. An MSPP issuer must comply with section 1402 of the Affordable
Care Act, as well as any applicable standards set by OPM or HHS.
(e) OPM approval. An MSPP issuer must submit the levels of coverage
plans and plan variations to OPM for review and approval by OPM.
Sec. 800.108 Assessments and user fees.
(a) Discretion to charge assessment and user fees. Beginning in
2015, OPM may require an MSPP issuer to pay an assessment or user fee
as a condition of participating in the MSPP.
(b) Determination of amount. The amount of the assessment or user
fee charged by OPM for a plan year is the amount determined necessary
by OPM to meet the costs of OPM's functions under the Affordable Care
Act for a plan year, including but not limited to such functions as
entering into contracts with, certifying, recertifying, decertifying,
and overseeing MSPs and MSPP issuers for that plan year. The amount of
the assessment or user fee charged by OPM will be offset against the
assessment or user fee amount required by any State-based Exchange or
Federally-facilitated Exchange such that the total of all assessments
and user fees paid by the MSPP issuer for the year for the MSP shall be
no greater than nor less than the amount of the assessment or user fee
paid by QHP issuers in that State-based Exchange or Federally-
facilitated Exchange for that year.
(c) Process for collecting MSPP assessment or user fees. OPM may
require an MSPP issuer to make payment of the MSPP assessment or user
fee amount directly to OPM, and the MSPP issuer will deduct the MSPP
assessment or user fee required under paragraph (a) of this section
from the amount for any State-based Exchange or Federally-facilitated
Exchange and the MSPP issuer would forward the remainder of the payment
to the State or to HHS, as appropriate.
Sec. 800.109 Network adequacy.
(a) General requirement. An MSPP issuer must ensure that the
provider network of each of its MSPs, as available to all enrollees,
meets the following standards:
(1) Maintains a network that is sufficient in number and types of
providers to assure that all services will be accessible without
unreasonable delay;
(2) Is consistent with the network adequacy provisions of section
2702(c) of the Public Health Service Act; and
(3) Includes essential community providers in compliance with 45
CFR 156.235.
(b) Provider directory. An MSPP issuer must make its provider
directory for an MSP available to the Exchange for publication online
pursuant to guidance from the Exchange and to potential enrollees in
hard copy, upon request. In the provider directory, an MSPP issuer must
identify providers that are not accepting new patients.
(c) OPM guidance. OPM will issue guidance containing the criteria
and standards that it will use to determine the adequacy of a provider
network.
Sec. 800.110 Service area.
An MSPP issuer must offer an MSP within one or more service areas
in a State defined by each Exchange pursuant to 45 CFR 155.1055. If an
Exchange permits issuers to define their service areas, an MSPP issuer
must obtain OPM's approval for its proposed service areas. Pursuant to
Sec. 800.104, OPM may enter into a contract with an MSPP issuer even
if the MSPP issuer's MSPs for a State cover fewer than all the service
areas specified for that State. MSPs will follow the same standards for
service areas for QHPs pursuant to 45 CFR 155.1055. As part of its
contract compliance activities under subpart E of this part, OPM will
consult with State regulators and the State Exchange to monitor the
MSPP issuer's progress expanding coverage statewide and will ensure
that MSPs meet QHP requirements in 45 CFR 155.1055(b).
Sec. 800.111 Accreditation requirement.
(a) General requirement. An MSPP issuer must be or become
accredited consistent with the requirements for QHP issuers specified
in section 1311 of the Affordable Care Act and 45 CFR 156.275(a).
(b) Release of survey. An MSPP issuer must authorize the
accrediting entity that accredits the MSPP issuer to release to OPM and
to the Exchange a copy of its most recent accreditation survey,
together with any survey-related information that OPM or an Exchange
may require, such as corrective action plans and summaries of findings.
(c) Timeframe for accreditation. An MSPP issuer that is not
accredited as of the date that it enters into a contract with OPM must
become accredited within the timeframe established by OPM as authorized
by 45 CFR 155.1045.
Sec. 800.112 Reporting requirements.
(a) OPM specification of reporting requirements. OPM will specify
the data and information that must be reported by an MSPP issuer,
including data permitted or required by the Affordable Care Act and
such other data as OPM may determine necessary for the oversight and
administration of the MSPP. OPM will also specify the form, manner,
processes, and frequency for the reporting of data and information. The
Director may require that MSPP issuers submit claims payment and
enrollment data to facilitate OPM's oversight and administration of the
MSPP in a manner similar to the FEHBP.
(b) Quality and quality improvement standards. An MSPP issuer must
comply with any standards required by OPM for reporting quality and
quality improvement activities, including but not limited to
implementation of a quality improvement strategy, disclosure of quality
measures to enrollees and prospective enrollees, reporting of pediatric
quality measures, and implementation of rating and enrollee
satisfaction surveys, which will be similar to standards under section
1311(c)(1)(E), (H), and (I), (c)(3), and (c)(4) of the Affordable Care
Act.
[[Page 15591]]
Sec. 800.113 Benefit plan material or information.
(a) Compliance with Federal and State law. An MSPP issuer must
comply with Federal and State laws relating to benefit plan material or
information, including the provisions of this section and guidance
issued by OPM specifying its standards, process, and timeline for
approval of benefit plan material or information.
(b) General standards for MSP applications and notices. An MSPP
issuer must provide all applications and notices to enrollees in
accordance with the standards described in 45 CFR 155.205(c). OPM may
establish additional standards to meet the needs of MSP enrollees.
(c) Accuracy. An MSPP issuer is responsible for the accuracy of its
benefit plan material or information.
(d) Truthful, not misleading, no material omissions, and plain
language. All benefit plan material or information must be:
(1) Truthful, not misleading, and without material omissions; and
(2) Written in plain language, as defined in section 1311(e)(3)(B)
of the Affordable Care Act.
(e) Uniform explanation of coverage documents and standardized
definitions. An MSPP issuer must comply with the provisions of section
2715 of the PHS Act and regulations issued to implement that section.
(f) OPM review and approval of benefit plan material or
information. OPM may request an MSPP issuer to submit to OPM benefit
plan material or information, as defined in Sec. 800.20. OPM reserves
the right to review and approve benefit plan material or information to
ensure that an MSPP issuer complies with Federal and State laws, and
the standards prescribed by OPM with respect to benefit plan material
or information.
(g) Statement on certification by OPM. An MSPP issuer may include a
statement in its benefit plan material or information that:
(1) OPM has certified the MSP as eligible to be offered on the
Exchange; and
(2) OPM monitors the MSP for compliance with all applicable law.
Sec. 800.114 Compliance with applicable State law.
(a) Compliance with State law. An MSPP issuer must, with respect to
each of its MSPs, generally comply with State law pursuant to section
1334(b)(2) of the Affordable Care Act. However, the MSPs and MSPP
issuers are not subject to State laws that:
(1) Are inconsistent with section 1334 of the Affordable Care Act
or this part;
(2) Prevent the application of a requirement of part A of title
XXVII of the PHS Act; or
(3) Prevent the application of a requirement of title I of the
Affordable Care Act.
(b) Determination of inconsistency. After consultation with the
State and HHS, OPM reserves the right to determine, in its judgment, as
effectuated through an MSPP contract, these regulations, or OPM
guidance, whether the standards set forth in paragraph (a) of this
section are satisfied with respect to particular State laws.
Sec. 800.115 Level playing field.
An MSPP issuer must, with respect to each of its MSPs, meet the
following requirements in order to ensure a level playing field:
(a) Guaranteed renewal. Guarantee that an enrollee can renew
enrollment in an MSP in compliance with sections 2703 and 2742 of the
PHS Act;
(b) Rating. In proposing premiums for OPM approval, use only the
rating factors permitted under section 2701 of the PHS Act and State
law;
(c) Preexisting conditions. Not impose any preexisting condition
exclusion and comply with section 2704 of the PHS Act;
(d) Non-discrimination. Comply with section 2705 of the PHS Act;
(e) Quality improvement and reporting. Comply with all Federal and
State quality improvement and reporting requirements. Quality
improvement and reporting means quality improvement as defined in
section 1311(h) of the Affordable Care Act and quality improvement
plans or strategies required under State law, and quality reporting as
defined in section 2717 of the PHS Act and section 1311(g) of the
Affordable Care Act. Quality improvement also includes activities such
as, but not limited to, implementation of a quality improvement
strategy, disclosure of quality measures to enrollees and prospective
enrollees, and reporting of pediatric quality measures, which will be
similar to standards under section 1311(c)(1)(E), (H), and (I) of the
Affordable Care Act;
(f) Fraud and abuse. Comply with all Federal and State fraud and
abuse laws;
(g) Licensure. Be licensed in every State in which it offers an
MSP;
(h) Solvency and financial requirements. Comply with the solvency
standards set by each State in which it offers an MSP;
(i) Market conduct. Comply with the market conduct standards of
each State in which it offers an MSP;
(j) Prompt payment. Comply with applicable State law in negotiating
the terms of payment in contracts with its providers and in making
payments to claimants and providers;
(k) Appeals and grievances. Comply with Federal standards under
section 2719 of the PHS Act for appeals and grievances relating to
adverse benefit determinations, as described in subpart F of this part;
(l) Privacy and confidentiality. Comply with all Federal and State
privacy and security laws and requirements, including any standards
required by OPM in guidance or contract, which will be similar to the
standards contained in 45 CFR part 162 and applicable State law; and
(m) Benefit plan material or information. Comply with Federal and
State law, including Sec. 800.113.
Sec. 800.116 Process for dispute resolution.
(a) Determinations about applicability of State law under section
1334(b)(2) of the Affordable Care Act. In the event of a dispute about
the applicability to an MSP or MSPP issuer of a State law, the State
may request that OPM reconsider a determination that an MSP or MSPP
issuer is not subject to such State law.
(b) Required demonstration. A State making a request under
paragraph (a) of this section must demonstrate that the State law at
issue:
(1) Is not inconsistent with section 1334 of the Affordable Care
Act or this part;
(2) Does not prevent the application of a requirement of part A of
title XXVII of the PHS Act; and
(3) Does not prevent the application of a requirement of title I of
the Affordable Care Act.
(c) Request for review. The request must be in writing and include
contact information, including the name, telephone number, email
address, and mailing address of the person or persons whom OPM may
contact regarding the request for review. The request must be in such
form, contain such information, and be submitted in such manner and
within such timeframe as OPM may prescribe.
(1) The requester may submit to OPM any relevant information to
support its request.
(2) OPM may obtain additional information relevant to the request
from any source as it may, in its judgment, deem necessary. OPM will
provide the requester with a copy of any additional information it
obtains and provide an opportunity for the requester to respond
(including by submission of additional information or explanation).
(3) OPM will issue a written decision within 60 calendar days after
receiving the written request, or after the due date
[[Page 15592]]
for a response under paragraph (c)(2) of this section, whichever is
later, unless a different timeframe is agreed upon.
(4) OPM's written decision will constitute final agency action that
is subject to review under the Administrative Procedure Act in the
appropriate U.S. district court. Such review is limited to the record
that was before OPM when OPM made its decision.
Subpart C--Premiums, Rating Factors, Medical Loss Ratios, and Risk
Adjustment
Sec. 800.201 General requirements.
(a) Premium negotiation. OPM will negotiate annually with an MSPP
issuer, on a State by State basis, the premiums for each MSP offered by
that issuer in that State. Such negotiations may include negotiations
about the cost-sharing provisions of an MSP.
(b) Duration. Premiums will remain in effect for the plan year.
(c) Guidance on rate development. OPM will issue guidance
addressing methods for the development of premiums for the MSPP. That
guidance will follow State rating standards generally applicable in a
State, to the greatest extent practicable.
(d) Calculation of actuarial value. An MSPP issuer must calculate
actuarial value in the same manner as QHP issuers under section 1302(d)
of the Affordable Care Act, as well as any applicable standards set by
OPM or HHS.
(e) OPM rate review process. An MSPP issuer must participate in the
rate review process established by OPM to negotiate rates for MSPs. The
rate review process established by OPM will be similar to the process
established by HHS pursuant to section 2794 of the PHS Act and
disclosure and review standards established under 45 CFR part 154.
(f) State Effective Rate Review. With respect to its MSPs, an MSPP
issuer is subject to a State's rate review process, including a State's
Effective Rate Review Program established by HHS pursuant to section
2794 of the PHS Act and 45 CFR part 154. In the event HHS is reviewing
rates for a State pursuant to section 2794 of the PHS Act, HHS will
defer to OPM's judgment regarding the MSPs' proposed rate increase. If
a State withholds approval of an MSP and OPM determines, in its
discretion, that the State's action would prevent OPM from operating
the MSPP, OPM retains authority to make the final decision to approve
rates for participation in the MSPP, notwithstanding the absence of
State approval.
(g) Single risk pool. An MSPP issuer must consider all enrollees in
an MSP to be in the same risk pool as all enrollees in all other health
plans in the individual market or the small group market, respectively,
in compliance with section 1312(c) of the Affordable Care Act, 45 CFR
156.80, and any applicable Federal or State laws and regulations
implementing that section.
Sec. 800.202 Rating factors.
(a) Permissible rating factors. In proposing premiums for each MSP,
an MSPP issuer must use only the rating factors permitted under section
2701 of the PHS Act.
(b) Application of variations based on age or tobacco use. Rating
variations permitted under section 2701 of the PHS Act must be applied
by an MSPP issuer based on the portion of the premium attributable to
each family member covered under the coverage in accordance with any
applicable Federal or State laws and regulations implementing section
2701(a) of the PHS Act.
(c) Age rating. For age rating, an MSPP issuer must use the ratio
established by the State in which the MSP is offered, if it is less
than 3:1.
(1) Age bands. An MSPP issuer must use the uniform age bands
established under HHS regulations implementing section 2701(a) of the
PHS Act.
(2) Age curves. An MSPP issuer must use the age curves established
under HHS regulations implementing section 2701(a) of the PHS Act, or
age curves established by a State pursuant to HHS regulations.
(d) Rating areas. An MSP must use the rating areas appropriate to
the State in which the MSP is offered and established under HHS
regulations implementing section 2701(a) if the PHS Act.
(e) Tobacco rating. An MSPP issuer must apply tobacco use as a
rating factor in accordance with any applicable Federal or State laws
and regulations implementing section 2701(a) of the PHS Act.
(f) Wellness programs. An MSPP issuer must comply with any
applicable Federal or State laws and regulations implementing section
2702 of the PHS Act.
Sec. 800.203 Medical loss ratio.
(a) Required medical loss ratio. An MSPP issuer must attain:
(1) The medical loss ratio (MLR) required under section 2718 of the
PHS Act and regulations promulgated by HHS; and
(2) Any MSP-specific MLR that OPM may set in the best interests of
MSP enrollees or that is necessary to be consistent with a State's
requirements with respect to MLR.
(b) Consequences of not attaining required medical loss ratio. If
an MSPP issuer fails to attain an MLR set forth in paragraph (a) of
this section, OPM may take any appropriate action, including but not
limited to intermediate sanctions, such as suspension of marketing,
decertifying an MSP in one or more States, or terminating an MSPP
issuer's contract pursuant to Sec. 800.404.
Sec. 800.204 Reinsurance, risk corridors, and risk adjustment.
(a) Transitional reinsurance program. An MSPP issuer must comply
with section 1341 of the Affordable Care Act, 45 CFR part 153, and any
applicable Federal or State regulations under section 1341 that set
forth requirements to implement the transitional reinsurance program
for the individual market.
(b) Temporary risk corridors program. An MSPP issuer must comply
with section 1342 of the Affordable Care Act, 45 CFR part 153, and any
applicable Federal regulations under section 1342 that set forth
requirements to implement the risk corridor program.
(c) Risk adjustment program. An MSPP issuer must comply with
section 1343 of the Affordable Care Act, 45 CFR part 153, and any
applicable Federal or State regulations under section 1343 that set
forth requirements to implement the risk adjustment program.
Subpart D--Application and Contracting Procedures
Sec. 800.301 Application process.
(a) Acceptance of applications. Without regard to section 6101(b)-
(d) of title 41, United States Code, or any other statute requiring
competitive bidding, OPM may consider annually applications from health
insurance issuers, including groups of health insurance issuers as
defined in Sec. 800.20, to participate in the MSPP. If OPM determines
that it is not beneficial for the MSPP to consider new applications for
an upcoming year, OPM will issue a notice to that effect.
(b) Form and manner of applications. An applicant must submit to
OPM, in the form and manner and in accordance with the timeline
specified by OPM, the information requested by OPM for determining
whether an applicant meets the requirements of this part.
Sec. 800.302 Review of applications.
(a) Determinations. OPM will determine if an applicant meets the
requirements of this part. If OPM determines that an applicant meets
the
[[Page 15593]]
requirements of this part, OPM may accept the applicant to enter into
contract negotiations with OPM to participate in the MSPP.
(b) Requests for additional information. OPM may request additional
information from an applicant before making a decision about whether to
enter into contract negotiations with that applicant to participate in
the MSPP.
(c) Declination of application. If, after reviewing an application
to participate in the MSPP, OPM declines to enter into contract
negotiations with the applicant, OPM will inform the applicant in
writing of the reasons for that decision.
(d) Discretion. The decision whether to enter into contract
negotiations with a health insurance issuer who has applied to
participate in the MSPP is committed to OPM's discretion.
(e) Impact on future applications. OPM's declination of an
application to participate in the MSPP will not preclude the applicant
from submitting an application for a subsequent year to participate in
the MSPP.
Sec. 800.303 MSPP contracting.
(a) Participation in MSPP. To become an MSPP issuer, the applicant
and the Director or the Director's designee must sign a contract that
meets the requirements of this part.
(b) Standard contract. OPM will establish a standard contract for
the MSPP.
(c) Premiums. OPM and the applicant will negotiate the premiums for
an MSPP for each plan year in accordance with the provisions of subpart
C of this part.
(d) Benefit packages. OPM must approve the applicant's benefit
packages for an MSP.
(e) Additional terms and conditions. OPM may elect to negotiate
with an applicant such additional terms, conditions, and requirements
that:
(1) Are in the interests of MSP enrollees; or
(2) OPM determines to be appropriate.
(f) Certification to offer health insurance coverage.
(1) For each plan year, an MSPP contract will contain a
certification that specifies the Exchanges in which the MSPP issuer is
authorized to offer an MSP, as well as the specific benefit packages
authorized to be offered on each Exchange and the premiums to be
charged for each benefit package on each Exchange.
(2) An MSPP issuer may not offer an MSP on an Exchange unless its
MSPP contract with OPM includes a certification authorizing the MSPP
issuer to offer the MSP on that Exchange in accordance with paragraph
(f)(1) of this section.
Sec. 800.304 Term of the contract.
(a) Term of a contract. The term of the contract will be specified
in the MSPP contract and must be for a period of at least the 12
consecutive months defined as the plan year.
(b) Plan year. The plan year is a consecutive 12-month period
during which an MSP provides coverage for health benefits. A plan year
may be a calendar year or otherwise.
Sec. 800.305 Contract renewal process.
(a) Renewal. To continue participating in the MSPP, an MSPP issuer
must provide to OPM, in the form and manner and in accordance with the
timeline prescribed by OPM, the information requested by OPM for
determining whether the MSPP issuer continues to meet the requirements
of this part.
(b) OPM decision. Subject to paragraph (c) of this section, OPM
will renew the MSPP contract of an MSPP issuer who timely submits the
information described in paragraph (a).
(c) OPM discretion not to renew. OPM may decline to renew the
contract of an MSPP issuer if:
(1) OPM and the MSPP issuer fail to agree on premiums and benefits
for an MSP for the subsequent plan year;
(2) The MSPP issuer has engaged in conduct described in Sec.
800.404(a) of this part; or
(3) OPM determines that the MSPP issuer will be unable to comply
with a material provision of section 1334 of the Affordable Care Act or
this part.
(d) Failure to agree on premiums and benefits. Except as otherwise
provided in this part, if an MSPP issuer has complied with paragraph
(a) of this section and OPM and the MSPP issuer fail to agree on
premiums and benefits for an MSP on one or more Exchanges for the
subsequent plan year by the date required by OPM, either party may
provide notice of nonrenewal pursuant to Sec. 800.306, or OPM may in
its discretion withdraw the certification of that MSP on the Exchange
or Exchanges for that plan year. In addition, if OPM and the MSPP
issuer fail to agree on benefits and premiums for an MSP on one or more
Exchanges by the date set by OPM and in the event of no action (no
notice of nonrenewal or renewal) by either party, the MSPP contract
will be renewed and the existing premiums and benefits for that MSP on
that Exchange or Exchanges will remain in effect for the subsequent
plan year.
Sec. 800.306 Nonrenewal.
(a) Definition of nonrenewal. As used in this subpart and subpart E
of this part, ``nonrenewal'' means a decision by either OPM or an MSPP
issuer not to renew an MSPP contract.
(b) Notice required. Either OPM or an MSPP issuer may decline to
renew an MSPP contract by providing a written notice of nonrenewal to
the other party.
(c) MSPP issuer responsibilities. The MSPP issuer's written notice
of nonrenewal must be made in accordance with its MSPP contract with
OPM. The MSPP issuer also must comply with any requirements regarding
the termination of a plan that are applicable to a QHP offered on an
Exchange on which the MSP was offered, including a requirement to
provide advance written notice of termination to enrollees. If an
Exchange does not have requirements about advance written notice of
termination to enrollees, the MSPP issuer must inform current MSP
enrollees in writing of the nonrenewal of the MSP no later than 90 days
prior to termination of coverage, unless OPM determines that good cause
justifies less than 90 days' notice.
Subpart E--Compliance
Sec. 800.401 Contract performance.
(a) General. An MSPP issuer must perform an MSPP contract with OPM
in accordance with the requirements of section 1334 of the Affordable
Care Act and this part. The MSPP issuer must continue to meet such
requirements while under an MSPP contract with OPM.
(b) Specific requirements for issuers. In addition to the
requirements described in paragraph (a) of this section, the following
requirements apply to each MSPP issuer:
(1) It must have, in the judgment of OPM, the financial resources
to carry out its obligations under the MSPP;
(2) It must keep such reasonable financial and statistical records,
and furnish to OPM such reasonable financial and statistical reports
with respect to the MSP or the MSPP, as may be requested by OPM;
(3) It must permit representatives of OPM (including the OPM Office
of Inspector General), the U.S. Government Accountability Office, and
any other applicable Federal Government auditing entities to audit and
examine its records and accounts that pertain, directly or indirectly,
to the MSP at such reasonable times and places as may be designated by
OPM or the U.S. Government Accountability Office;
(4) It must timely submit to OPM a properly completed and signed
novation
[[Page 15594]]
or change-of-name agreement in accordance with subpart 42.12 of 48 CFR
part 42;
(5) It must perform the MSPP contract in accordance with prudent
business practices, as described in paragraph (c) of this section; and
(6) It must not perform the MSPP contract in accordance with poor
business practices, as described in paragraph (d) of this section.
(c) Prudent business practices. For purposes of paragraph (b)(5) of
this section, prudent business practices include, but are not limited
to, the following:
(1) Timely compliance with OPM instructions and directives;
(2) Legal and ethical business and health care practices;
(3) Compliance with the terms of the MSPP contract, regulations,
and statutes;
(4) Timely and accurate adjudication of claims or rendering of
medical services;
(5) Operating a system for accounting for costs incurred under the
MSPP contract, which includes segregating and pricing MSP medical
utilization and allocating indirect and administrative costs in a
reasonable and equitable manner;
(6) Maintaining accurate accounting reports of costs incurred in
the administration of the MSPP contract;
(7) Applying performance standards for assuring contract quality as
outlined at Sec. 800.402; and
(8) Establishing and maintaining a system of internal controls that
provides reasonable assurance that:
(i) The provision and payments of benefits and other expenses
comply with legal, regulatory, and contractual guidelines;
(ii) MSP funds, property, and other assets are safeguarded against
waste, loss, unauthorized use, or misappropriation; and
(iii) Data are accurately and fairly disclosed in all reports
required by OPM.
(d) Poor business practices. For purposes of paragraph (b)(6) of
this section, poor business practices include, but are not limited to,
the following:
(1) Using fraudulent or unethical business or health care practices
or otherwise displaying a lack of business integrity or honesty;
(2) Repeatedly or knowingly providing false or misleading
information in the rate setting process;
(3) Failing to comply with OPM instructions and directives;
(4) Having an accounting system that is incapable of separately
accounting for costs incurred under the contract and/or that lacks the
internal controls necessary to fulfill the terms of the contract;
(5) Failing to assure that the MSP properly pays or denies claims,
or, if applicable, provides medical services that are inconsistent with
standards of good medical practice; and
(6) Entering into contracts or employment agreements with
providers, provider groups, or health care workers that include
provisions or financial incentives that directly or indirectly create
an inducement to limit or restrict communication about medically
necessary services to any individual covered under the MSPP. Financial
incentives are defined as bonuses, withholds, commissions, profit
sharing or other similar adjustments to basic compensation (e.g.,
service fee, capitation, salary) which have the effect of limiting or
reducing communication about appropriate medically necessary services.
(e) Performance escrow account. OPM may require MSPP issuers to pay
an assessment into an escrow account to ensure contract compliance and
benefit MSP enrollees.
Sec. 800.402 Contract quality assurance.
(a) General. This section prescribes general policies and
procedures to ensure that services acquired under MSPP contracts
conform to the contract's quality requirements.
(b) Internal controls. OPM will periodically evaluate the
contractor's system of internal controls under the quality assurance
program required by the contract and will acknowledge in writing
whether or not the system is consistent with the requirements set forth
in the contract. OPM's reviews do not diminish the contractor's
obligation to implement and maintain an effective and efficient system
to apply the internal controls.
(c) Performance standards. (1) OPM will issue specific performance
standards for MSPP contracts and will inform MSPP issuers of the
applicable performance standards prior to negotiations for the contract
year. OPM may benchmark its standards against standards generally
accepted in the insurance industry. OPM may authorize nationally
recognized standards to be used to fulfill this requirement.
(2) MSPP issuers must comply with the performance standards issued
under this section.
Sec. 800.403 Fraud and abuse.
(a) Program required. An MSPP issuer must conduct a program to
assess its vulnerability to fraud and abuse as well as to address such
vulnerabilities.
(b) Fraud detection system. An MSPP issuer must operate a system
designed to detect and eliminate fraud and abuse by employees and
subcontractors of the MSPP issuer, by providers furnishing goods or
services to MSP enrollees, and by MSP enrollees.
(c) Submission of information. An MSPP issuer must provide to OPM
such information or assistance as may be necessary for the agency to
carry out the duties and responsibilities, including those of the
Office of Inspector General as specified in sections 4 and 6 of the
Inspector General Act of 1978 (5 U.S.C. App.). An MSPP issuer must
provide any requested information in the form, manner, and timeline
prescribed by OPM.
Sec. 800.404 Compliance actions.
(a) Causes for OPM compliance actions. The following constitute
cause for OPM to impose a compliance action described in paragraph (b)
of this section against an MSPP issuer:
(1) Failure by the MSPP issuer to meet the requirements set forth
in Sec. 800.401(a) and (b);
(2) An MSPP issuer's sustained failure to perform the MSPP contract
in accordance with prudent business practices, as described in Sec.
800.401(c);
(3) A pattern of poor conduct or evidence of poor business
practices such as those described in Sec. 800.401(d); or
(4) Such other violations of law or regulation as OPM may
determine.
(b) Compliance actions. (1) OPM may impose a compliance action
against an MSPP issuer at any time during the contract term if it
determines that the MSPP issuer is not in compliance with applicable
law, this part, or the terms of its contract with OPM.
(2) Compliance actions may include, but are not limited to:
(i) Establishment and implementation of a corrective action plan;
(ii) Imposition of intermediate sanctions, such as suspensions of
marketing;
(iii) Performance incentives;
(iv) Reduction of service area or areas;
(v) Withdrawal of the certification of the MSPP issuer to offer the
MSP on one or more Exchanges;
(vi) Nonrenewal of the MSPP contract; and
(vii) Withdrawal of approval or termination of the MSPP contract.
(c) Notice of compliance action. (1) OPM must notify an MSPP issuer
in writing of a compliance action under this section. Such notice must
indicate the specific compliance action undertaken and the reason for
the compliance action.
[[Page 15595]]
(2) For compliance actions listed in paragraphs (b)(2)(v) through
(b)(2)(vii) of this section, such notice must include a statement that
the MSPP issuer is entitled to request a reconsideration of OPM's
determination to impose a compliance action pursuant to Sec. 800.405.
(3) Upon imposition of a compliance action listed in paragraphs
(b)(2)(iv) through (b)(2)(vii) of this section, OPM must notify the
State Insurance Commissioner(s) and Exchange officials in the State or
States in which the compliance action is effective.
(d) Notice to enrollees. If OPM terminates an MSPP issuer's MSPP
contract with OPM, or OPM withdraws the MSPP issuer's certification to
offer the MSP on an Exchange, the MSPP issuer must comply with any
requirements regarding the termination of a plan that are applicable to
a QHP offered on an Exchange on which the MSP was offered, including a
requirement to provide advance written notice of termination to
enrollees. If an Exchange does not have requirements about advance
written notice of termination to enrollees, the MSPP issuer must inform
current MSP enrollees in writing of the nonrenewal of the MSP no later
than 90 days prior to termination of coverage, unless OPM determines
that good cause justifies less than 90 days' notice.
(e) Definition. As used in this subpart, ``termination'' means a
decision by OPM to cancel an MSPP contract prior to the end of its
contract term. The term includes OPM's withdrawal of approval of an
MSPP contract.
Sec. 800.405 Reconsideration of compliance actions.
(a) Right to request reconsideration. An MSPP issuer may request
that OPM reconsider a determination to impose one of the following
compliance actions:
(1) Withdrawal of the certification of the MSPP issuer to offer the
MSP on one or more Exchanges;
(2) Nonrenewal of the MSPP contract; or
(3) Termination of the MSPP contract.
(b) Request for reconsideration and/or hearing. (1) An MSPP issuer
with a right to request reconsideration specified in paragraph (a) of
this section may request a hearing in which OPM will reconsider its
determination to impose a compliance action.
(2) A request under this section must be in writing and contain
contact information, including the name, telephone number, email
address, and mailing address of the person or persons whom OPM may
contact regarding a request for a hearing with respect to the
reconsideration. The request must be in such form, contain such
information, and be submitted in such manner as OPM may prescribe.
(3) The request must be received by OPM within 15 calendar days
after the date of the MSPP issuer's receipt of the notice of compliance
action. The MSPP issuer may request that OPM's reconsideration allow a
representative of the MSPP issuer to appear personally before OPM.
(4) A request under this section must include a detailed statement
of the reasons that the MSPP issuer disagrees with OPM's imposition of
the compliance action, and may include any additional information that
will assist OPM in rendering a final decision under this section.
(5) OPM may obtain additional information relevant to the request
from any source as it may, in its judgment, deem necessary. OPM will
provide the MSPP issuer with a copy of any additional information it
obtains and provide an opportunity for the MSPP issuer to respond
(including by submitting additional information or explanation).
(6) OPM's reconsideration and hearing, if requested, may be
conducted by the Director or a representative designated by the
Director who did not participate in the initial decision that is the
subject of the request for review.
(c) Notice of final decision. OPM will notify the MSPP issuer, in
writing, of OPM's final decision on the MSPP issuer's request for
reconsideration and the specific reasons for that final decision. OPM's
written decision will constitute final agency action that is subject to
review under the Administrative Procedure Act in the appropriate U.S.
district court. Such review is limited to the record that was before
OPM when it made its decision.
Subpart F--Appeals by Enrollees of Denials of Claims for Payment or
Service
Sec. 800.501 General requirements.
(a) Definitions. For purposes of this subpart:
(1) Adverse benefit determination has the meaning given that term
in 45 CFR 147.136(a)(2)(i).
(2) Claim means a request for:
(i) Payment of a health-related bill; or
(ii) Provision of a health-related service or supply.
(b) Applicability. This subpart applies to enrollees and to other
individuals or entities who are acting on behalf of an enrollee and who
have the enrollee's specific written consent to pursue a remedy of an
adverse benefit determination.
Sec. 800.502 MSPP issuer internal claims and appeals.
(a) Processes. MSPP issuers must comply with the internal claims
and appeals processes applicable to group health plans and health
insurance issuers under 45 CFR 147.136(b).
(b) Timeframes and notice of determination. An MSPP issuer must
provide written notice to an enrollee of its determination on a claim
brought under paragraph (a) of this section according to the timeframes
and notification rules under 45 CFR 147.136(b) and (e), including the
timeframes for urgent claims. If the MSPP issuer denies a claim (or a
portion of the claim), the enrollee may appeal the adverse benefit
determination to the MSPP issuer in accordance with 45 CFR 147.136(b).
Sec. 800.503 External review.
(a) External review by OPM. OPM will conduct external review of
adverse benefit determinations using a process similar to OPM review of
disputed claims under 5 CFR 890.105(e), subject to the standards and
timeframes set forth in 45 CFR 147.136(d).
(b) Notice. Notices to MSP enrollees regarding external review
under paragraph (a) of this section must comply with 45 CFR 147.136(e),
and are subject to review and approval by OPM.
(c) Issuer obligation. An MSPP issuer must pay a claim or provide a
health-related service or supply pursuant to OPM's final decision or
the final decision of an independent review organization without delay,
regardless of whether the plan or issuer intends to seek judicial
review of the external review decision and unless or until there is a
judicial decision otherwise.
Sec. 800.504 Judicial review.
(a) OPM's written decision under the external review process
established under Sec. 800.503(a) will constitute final agency action
that is subject to review under the Administrative Procedure Act in the
appropriate U.S. district court. A decision made by an independent
review organization under the process established under Sec.
800.503(a) is not within OPM's discretion and therefore is not final
agency action.
(b) Judicial review under paragraph (a) of this section is limited
to the record that was before OPM when OPM made its decision.
Subpart G--Miscellaneous
Sec. 800.601 Reservation of authority.
OPM reserves the right to implement and supplement these
regulations with written operational guidelines.
[[Page 15596]]
Sec. 800.602 Consumer choice with respect to certain services.
(a) Assured availability of varied coverage. Consistent with Sec.
800.104, OPM will ensure that at least one of the MSPP issuers on each
Exchange in each State offers at least one MSP that does not provide
coverage of services described in section 1303(b)(1)(B)(i) of the
Affordable Care Act.
(b) State opt-out. An MSP may not offer abortion coverage in any
State where such coverage of abortion services is prohibited by State
law.
[FR Doc. 2013-04954 Filed 3-1-13; 11:15 am]
BILLING CODE 6325-64-P